<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" [
<!ENTITY US20030004172A1-20030102-C00001.CDX SYSTEM "US20030004172A1-20030102-C00001.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00001.MOL SYSTEM "US20030004172A1-20030102-C00001.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00001.TIF SYSTEM "US20030004172A1-20030102-C00001.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00002.CDX SYSTEM "US20030004172A1-20030102-C00002.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00002.MOL SYSTEM "US20030004172A1-20030102-C00002.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00002.TIF SYSTEM "US20030004172A1-20030102-C00002.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00003.CDX SYSTEM "US20030004172A1-20030102-C00003.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00003.MOL SYSTEM "US20030004172A1-20030102-C00003.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00003.TIF SYSTEM "US20030004172A1-20030102-C00003.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00004.CDX SYSTEM "US20030004172A1-20030102-C00004.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00004.MOL SYSTEM "US20030004172A1-20030102-C00004.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00004.TIF SYSTEM "US20030004172A1-20030102-C00004.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00005.CDX SYSTEM "US20030004172A1-20030102-C00005.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00005.MOL SYSTEM "US20030004172A1-20030102-C00005.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00005.TIF SYSTEM "US20030004172A1-20030102-C00005.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00006.CDX SYSTEM "US20030004172A1-20030102-C00006.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00006.MOL SYSTEM "US20030004172A1-20030102-C00006.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00006.TIF SYSTEM "US20030004172A1-20030102-C00006.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00007.CDX SYSTEM "US20030004172A1-20030102-C00007.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00007.MOL SYSTEM "US20030004172A1-20030102-C00007.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00007.TIF SYSTEM "US20030004172A1-20030102-C00007.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00008.CDX SYSTEM "US20030004172A1-20030102-C00008.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00008.MOL SYSTEM "US20030004172A1-20030102-C00008.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00008.TIF SYSTEM "US20030004172A1-20030102-C00008.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00009.CDX SYSTEM "US20030004172A1-20030102-C00009.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00009.MOL SYSTEM "US20030004172A1-20030102-C00009.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00009.TIF SYSTEM "US20030004172A1-20030102-C00009.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00010.CDX SYSTEM "US20030004172A1-20030102-C00010.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00010.MOL SYSTEM "US20030004172A1-20030102-C00010.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00010.TIF SYSTEM "US20030004172A1-20030102-C00010.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00011.CDX SYSTEM "US20030004172A1-20030102-C00011.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00011.MOL SYSTEM "US20030004172A1-20030102-C00011.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00011.TIF SYSTEM "US20030004172A1-20030102-C00011.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00012.CDX SYSTEM "US20030004172A1-20030102-C00012.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00012.MOL SYSTEM "US20030004172A1-20030102-C00012.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00012.TIF SYSTEM "US20030004172A1-20030102-C00012.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00013.CDX SYSTEM "US20030004172A1-20030102-C00013.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00013.MOL SYSTEM "US20030004172A1-20030102-C00013.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00013.TIF SYSTEM "US20030004172A1-20030102-C00013.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00014.CDX SYSTEM "US20030004172A1-20030102-C00014.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00014.MOL SYSTEM "US20030004172A1-20030102-C00014.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00014.TIF SYSTEM "US20030004172A1-20030102-C00014.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00015.CDX SYSTEM "US20030004172A1-20030102-C00015.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00015.MOL SYSTEM "US20030004172A1-20030102-C00015.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00015.TIF SYSTEM "US20030004172A1-20030102-C00015.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00016.CDX SYSTEM "US20030004172A1-20030102-C00016.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00016.MOL SYSTEM "US20030004172A1-20030102-C00016.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00016.TIF SYSTEM "US20030004172A1-20030102-C00016.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00017.CDX SYSTEM "US20030004172A1-20030102-C00017.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00017.MOL SYSTEM "US20030004172A1-20030102-C00017.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00017.TIF SYSTEM "US20030004172A1-20030102-C00017.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00018.CDX SYSTEM "US20030004172A1-20030102-C00018.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00018.MOL SYSTEM "US20030004172A1-20030102-C00018.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00018.TIF SYSTEM "US20030004172A1-20030102-C00018.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00019.CDX SYSTEM "US20030004172A1-20030102-C00019.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00019.MOL SYSTEM "US20030004172A1-20030102-C00019.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00019.TIF SYSTEM "US20030004172A1-20030102-C00019.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00020.CDX SYSTEM "US20030004172A1-20030102-C00020.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00020.MOL SYSTEM "US20030004172A1-20030102-C00020.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00020.TIF SYSTEM "US20030004172A1-20030102-C00020.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00021.CDX SYSTEM "US20030004172A1-20030102-C00021.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00021.MOL SYSTEM "US20030004172A1-20030102-C00021.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00021.TIF SYSTEM "US20030004172A1-20030102-C00021.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00022.CDX SYSTEM "US20030004172A1-20030102-C00022.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00022.MOL SYSTEM "US20030004172A1-20030102-C00022.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00022.TIF SYSTEM "US20030004172A1-20030102-C00022.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00023.CDX SYSTEM "US20030004172A1-20030102-C00023.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00023.MOL SYSTEM "US20030004172A1-20030102-C00023.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00023.TIF SYSTEM "US20030004172A1-20030102-C00023.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00024.CDX SYSTEM "US20030004172A1-20030102-C00024.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00024.MOL SYSTEM "US20030004172A1-20030102-C00024.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00024.TIF SYSTEM "US20030004172A1-20030102-C00024.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00025.CDX SYSTEM "US20030004172A1-20030102-C00025.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00025.MOL SYSTEM "US20030004172A1-20030102-C00025.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00025.TIF SYSTEM "US20030004172A1-20030102-C00025.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00026.CDX SYSTEM "US20030004172A1-20030102-C00026.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00026.MOL SYSTEM "US20030004172A1-20030102-C00026.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00026.TIF SYSTEM "US20030004172A1-20030102-C00026.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00027.CDX SYSTEM "US20030004172A1-20030102-C00027.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00027.MOL SYSTEM "US20030004172A1-20030102-C00027.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00027.TIF SYSTEM "US20030004172A1-20030102-C00027.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00028.CDX SYSTEM "US20030004172A1-20030102-C00028.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00028.MOL SYSTEM "US20030004172A1-20030102-C00028.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00028.TIF SYSTEM "US20030004172A1-20030102-C00028.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00029.CDX SYSTEM "US20030004172A1-20030102-C00029.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00029.MOL SYSTEM "US20030004172A1-20030102-C00029.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00029.TIF SYSTEM "US20030004172A1-20030102-C00029.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00030.CDX SYSTEM "US20030004172A1-20030102-C00030.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00030.MOL SYSTEM "US20030004172A1-20030102-C00030.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00030.TIF SYSTEM "US20030004172A1-20030102-C00030.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00031.CDX SYSTEM "US20030004172A1-20030102-C00031.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00031.MOL SYSTEM "US20030004172A1-20030102-C00031.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00031.TIF SYSTEM "US20030004172A1-20030102-C00031.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00032.CDX SYSTEM "US20030004172A1-20030102-C00032.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00032.MOL SYSTEM "US20030004172A1-20030102-C00032.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00032.TIF SYSTEM "US20030004172A1-20030102-C00032.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00033.CDX SYSTEM "US20030004172A1-20030102-C00033.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00033.MOL SYSTEM "US20030004172A1-20030102-C00033.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00033.TIF SYSTEM "US20030004172A1-20030102-C00033.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00034.CDX SYSTEM "US20030004172A1-20030102-C00034.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00034.MOL SYSTEM "US20030004172A1-20030102-C00034.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00034.TIF SYSTEM "US20030004172A1-20030102-C00034.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00035.CDX SYSTEM "US20030004172A1-20030102-C00035.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00035.MOL SYSTEM "US20030004172A1-20030102-C00035.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00035.TIF SYSTEM "US20030004172A1-20030102-C00035.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00036.CDX SYSTEM "US20030004172A1-20030102-C00036.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00036.MOL SYSTEM "US20030004172A1-20030102-C00036.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00036.TIF SYSTEM "US20030004172A1-20030102-C00036.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00037.CDX SYSTEM "US20030004172A1-20030102-C00037.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00037.MOL SYSTEM "US20030004172A1-20030102-C00037.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00037.TIF SYSTEM "US20030004172A1-20030102-C00037.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00038.CDX SYSTEM "US20030004172A1-20030102-C00038.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00038.MOL SYSTEM "US20030004172A1-20030102-C00038.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00038.TIF SYSTEM "US20030004172A1-20030102-C00038.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00039.CDX SYSTEM "US20030004172A1-20030102-C00039.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00039.MOL SYSTEM "US20030004172A1-20030102-C00039.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00039.TIF SYSTEM "US20030004172A1-20030102-C00039.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00040.CDX SYSTEM "US20030004172A1-20030102-C00040.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00040.MOL SYSTEM "US20030004172A1-20030102-C00040.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00040.TIF SYSTEM "US20030004172A1-20030102-C00040.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00041.CDX SYSTEM "US20030004172A1-20030102-C00041.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00041.MOL SYSTEM "US20030004172A1-20030102-C00041.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00041.TIF SYSTEM "US20030004172A1-20030102-C00041.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00042.CDX SYSTEM "US20030004172A1-20030102-C00042.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00042.MOL SYSTEM "US20030004172A1-20030102-C00042.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00042.TIF SYSTEM "US20030004172A1-20030102-C00042.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00043.CDX SYSTEM "US20030004172A1-20030102-C00043.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00043.MOL SYSTEM "US20030004172A1-20030102-C00043.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00043.TIF SYSTEM "US20030004172A1-20030102-C00043.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00044.CDX SYSTEM "US20030004172A1-20030102-C00044.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00044.MOL SYSTEM "US20030004172A1-20030102-C00044.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00044.TIF SYSTEM "US20030004172A1-20030102-C00044.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00045.CDX SYSTEM "US20030004172A1-20030102-C00045.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00045.MOL SYSTEM "US20030004172A1-20030102-C00045.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00045.TIF SYSTEM "US20030004172A1-20030102-C00045.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00046.CDX SYSTEM "US20030004172A1-20030102-C00046.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00046.MOL SYSTEM "US20030004172A1-20030102-C00046.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00046.TIF SYSTEM "US20030004172A1-20030102-C00046.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00047.CDX SYSTEM "US20030004172A1-20030102-C00047.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00047.MOL SYSTEM "US20030004172A1-20030102-C00047.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00047.TIF SYSTEM "US20030004172A1-20030102-C00047.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00048.CDX SYSTEM "US20030004172A1-20030102-C00048.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00048.MOL SYSTEM "US20030004172A1-20030102-C00048.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00048.TIF SYSTEM "US20030004172A1-20030102-C00048.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00049.CDX SYSTEM "US20030004172A1-20030102-C00049.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00049.MOL SYSTEM "US20030004172A1-20030102-C00049.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00049.TIF SYSTEM "US20030004172A1-20030102-C00049.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00050.CDX SYSTEM "US20030004172A1-20030102-C00050.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00050.MOL SYSTEM "US20030004172A1-20030102-C00050.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00050.TIF SYSTEM "US20030004172A1-20030102-C00050.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00051.CDX SYSTEM "US20030004172A1-20030102-C00051.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00051.MOL SYSTEM "US20030004172A1-20030102-C00051.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00051.TIF SYSTEM "US20030004172A1-20030102-C00051.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00052.CDX SYSTEM "US20030004172A1-20030102-C00052.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00052.MOL SYSTEM "US20030004172A1-20030102-C00052.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00052.TIF SYSTEM "US20030004172A1-20030102-C00052.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00053.CDX SYSTEM "US20030004172A1-20030102-C00053.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00053.MOL SYSTEM "US20030004172A1-20030102-C00053.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00053.TIF SYSTEM "US20030004172A1-20030102-C00053.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00054.CDX SYSTEM "US20030004172A1-20030102-C00054.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00054.MOL SYSTEM "US20030004172A1-20030102-C00054.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00054.TIF SYSTEM "US20030004172A1-20030102-C00054.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00055.CDX SYSTEM "US20030004172A1-20030102-C00055.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00055.MOL SYSTEM "US20030004172A1-20030102-C00055.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00055.TIF SYSTEM "US20030004172A1-20030102-C00055.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00056.CDX SYSTEM "US20030004172A1-20030102-C00056.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00056.MOL SYSTEM "US20030004172A1-20030102-C00056.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00056.TIF SYSTEM "US20030004172A1-20030102-C00056.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00057.CDX SYSTEM "US20030004172A1-20030102-C00057.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00057.MOL SYSTEM "US20030004172A1-20030102-C00057.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00057.TIF SYSTEM "US20030004172A1-20030102-C00057.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00058.CDX SYSTEM "US20030004172A1-20030102-C00058.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00058.MOL SYSTEM "US20030004172A1-20030102-C00058.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00058.TIF SYSTEM "US20030004172A1-20030102-C00058.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00059.CDX SYSTEM "US20030004172A1-20030102-C00059.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00059.MOL SYSTEM "US20030004172A1-20030102-C00059.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00059.TIF SYSTEM "US20030004172A1-20030102-C00059.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00060.CDX SYSTEM "US20030004172A1-20030102-C00060.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00060.MOL SYSTEM "US20030004172A1-20030102-C00060.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00060.TIF SYSTEM "US20030004172A1-20030102-C00060.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00061.CDX SYSTEM "US20030004172A1-20030102-C00061.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00061.MOL SYSTEM "US20030004172A1-20030102-C00061.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00061.TIF SYSTEM "US20030004172A1-20030102-C00061.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00062.CDX SYSTEM "US20030004172A1-20030102-C00062.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00062.MOL SYSTEM "US20030004172A1-20030102-C00062.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00062.TIF SYSTEM "US20030004172A1-20030102-C00062.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00063.CDX SYSTEM "US20030004172A1-20030102-C00063.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00063.MOL SYSTEM "US20030004172A1-20030102-C00063.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00063.TIF SYSTEM "US20030004172A1-20030102-C00063.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00064.CDX SYSTEM "US20030004172A1-20030102-C00064.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00064.MOL SYSTEM "US20030004172A1-20030102-C00064.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00064.TIF SYSTEM "US20030004172A1-20030102-C00064.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00065.CDX SYSTEM "US20030004172A1-20030102-C00065.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00065.MOL SYSTEM "US20030004172A1-20030102-C00065.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00065.TIF SYSTEM "US20030004172A1-20030102-C00065.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00066.CDX SYSTEM "US20030004172A1-20030102-C00066.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00066.MOL SYSTEM "US20030004172A1-20030102-C00066.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00066.TIF SYSTEM "US20030004172A1-20030102-C00066.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00067.CDX SYSTEM "US20030004172A1-20030102-C00067.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00067.MOL SYSTEM "US20030004172A1-20030102-C00067.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00067.TIF SYSTEM "US20030004172A1-20030102-C00067.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00068.CDX SYSTEM "US20030004172A1-20030102-C00068.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00068.MOL SYSTEM "US20030004172A1-20030102-C00068.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00068.TIF SYSTEM "US20030004172A1-20030102-C00068.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00069.CDX SYSTEM "US20030004172A1-20030102-C00069.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00069.MOL SYSTEM "US20030004172A1-20030102-C00069.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00069.TIF SYSTEM "US20030004172A1-20030102-C00069.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00070.CDX SYSTEM "US20030004172A1-20030102-C00070.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00070.MOL SYSTEM "US20030004172A1-20030102-C00070.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00070.TIF SYSTEM "US20030004172A1-20030102-C00070.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00071.CDX SYSTEM "US20030004172A1-20030102-C00071.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00071.MOL SYSTEM "US20030004172A1-20030102-C00071.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00071.TIF SYSTEM "US20030004172A1-20030102-C00071.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00072.CDX SYSTEM "US20030004172A1-20030102-C00072.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00072.MOL SYSTEM "US20030004172A1-20030102-C00072.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00072.TIF SYSTEM "US20030004172A1-20030102-C00072.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00073.CDX SYSTEM "US20030004172A1-20030102-C00073.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00073.MOL SYSTEM "US20030004172A1-20030102-C00073.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00073.TIF SYSTEM "US20030004172A1-20030102-C00073.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00074.CDX SYSTEM "US20030004172A1-20030102-C00074.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00074.MOL SYSTEM "US20030004172A1-20030102-C00074.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00074.TIF SYSTEM "US20030004172A1-20030102-C00074.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00075.CDX SYSTEM "US20030004172A1-20030102-C00075.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00075.MOL SYSTEM "US20030004172A1-20030102-C00075.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00075.TIF SYSTEM "US20030004172A1-20030102-C00075.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00076.CDX SYSTEM "US20030004172A1-20030102-C00076.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00076.MOL SYSTEM "US20030004172A1-20030102-C00076.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00076.TIF SYSTEM "US20030004172A1-20030102-C00076.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00077.CDX SYSTEM "US20030004172A1-20030102-C00077.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00077.MOL SYSTEM "US20030004172A1-20030102-C00077.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00077.TIF SYSTEM "US20030004172A1-20030102-C00077.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00078.CDX SYSTEM "US20030004172A1-20030102-C00078.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00078.MOL SYSTEM "US20030004172A1-20030102-C00078.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00078.TIF SYSTEM "US20030004172A1-20030102-C00078.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00079.CDX SYSTEM "US20030004172A1-20030102-C00079.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00079.MOL SYSTEM "US20030004172A1-20030102-C00079.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00079.TIF SYSTEM "US20030004172A1-20030102-C00079.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00080.CDX SYSTEM "US20030004172A1-20030102-C00080.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00080.MOL SYSTEM "US20030004172A1-20030102-C00080.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00080.TIF SYSTEM "US20030004172A1-20030102-C00080.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00081.CDX SYSTEM "US20030004172A1-20030102-C00081.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00081.MOL SYSTEM "US20030004172A1-20030102-C00081.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00081.TIF SYSTEM "US20030004172A1-20030102-C00081.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00082.CDX SYSTEM "US20030004172A1-20030102-C00082.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00082.MOL SYSTEM "US20030004172A1-20030102-C00082.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00082.TIF SYSTEM "US20030004172A1-20030102-C00082.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00083.CDX SYSTEM "US20030004172A1-20030102-C00083.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00083.MOL SYSTEM "US20030004172A1-20030102-C00083.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00083.TIF SYSTEM "US20030004172A1-20030102-C00083.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00084.CDX SYSTEM "US20030004172A1-20030102-C00084.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00084.MOL SYSTEM "US20030004172A1-20030102-C00084.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00084.TIF SYSTEM "US20030004172A1-20030102-C00084.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00085.CDX SYSTEM "US20030004172A1-20030102-C00085.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00085.MOL SYSTEM "US20030004172A1-20030102-C00085.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00085.TIF SYSTEM "US20030004172A1-20030102-C00085.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00086.CDX SYSTEM "US20030004172A1-20030102-C00086.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00086.MOL SYSTEM "US20030004172A1-20030102-C00086.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00086.TIF SYSTEM "US20030004172A1-20030102-C00086.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00087.CDX SYSTEM "US20030004172A1-20030102-C00087.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00087.MOL SYSTEM "US20030004172A1-20030102-C00087.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00087.TIF SYSTEM "US20030004172A1-20030102-C00087.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00088.CDX SYSTEM "US20030004172A1-20030102-C00088.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00088.MOL SYSTEM "US20030004172A1-20030102-C00088.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00088.TIF SYSTEM "US20030004172A1-20030102-C00088.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00089.CDX SYSTEM "US20030004172A1-20030102-C00089.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00089.MOL SYSTEM "US20030004172A1-20030102-C00089.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00089.TIF SYSTEM "US20030004172A1-20030102-C00089.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00090.CDX SYSTEM "US20030004172A1-20030102-C00090.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00090.MOL SYSTEM "US20030004172A1-20030102-C00090.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00090.TIF SYSTEM "US20030004172A1-20030102-C00090.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00091.CDX SYSTEM "US20030004172A1-20030102-C00091.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00091.MOL SYSTEM "US20030004172A1-20030102-C00091.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00091.TIF SYSTEM "US20030004172A1-20030102-C00091.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00092.CDX SYSTEM "US20030004172A1-20030102-C00092.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00092.MOL SYSTEM "US20030004172A1-20030102-C00092.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00092.TIF SYSTEM "US20030004172A1-20030102-C00092.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00093.CDX SYSTEM "US20030004172A1-20030102-C00093.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00093.MOL SYSTEM "US20030004172A1-20030102-C00093.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00093.TIF SYSTEM "US20030004172A1-20030102-C00093.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00094.CDX SYSTEM "US20030004172A1-20030102-C00094.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00094.MOL SYSTEM "US20030004172A1-20030102-C00094.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00094.TIF SYSTEM "US20030004172A1-20030102-C00094.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00095.CDX SYSTEM "US20030004172A1-20030102-C00095.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00095.MOL SYSTEM "US20030004172A1-20030102-C00095.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00095.TIF SYSTEM "US20030004172A1-20030102-C00095.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00096.CDX SYSTEM "US20030004172A1-20030102-C00096.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00096.MOL SYSTEM "US20030004172A1-20030102-C00096.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00096.TIF SYSTEM "US20030004172A1-20030102-C00096.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00097.CDX SYSTEM "US20030004172A1-20030102-C00097.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00097.MOL SYSTEM "US20030004172A1-20030102-C00097.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00097.TIF SYSTEM "US20030004172A1-20030102-C00097.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00098.CDX SYSTEM "US20030004172A1-20030102-C00098.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00098.MOL SYSTEM "US20030004172A1-20030102-C00098.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00098.TIF SYSTEM "US20030004172A1-20030102-C00098.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00099.CDX SYSTEM "US20030004172A1-20030102-C00099.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00099.MOL SYSTEM "US20030004172A1-20030102-C00099.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00099.TIF SYSTEM "US20030004172A1-20030102-C00099.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00100.CDX SYSTEM "US20030004172A1-20030102-C00100.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00100.MOL SYSTEM "US20030004172A1-20030102-C00100.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00100.TIF SYSTEM "US20030004172A1-20030102-C00100.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00101.CDX SYSTEM "US20030004172A1-20030102-C00101.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00101.MOL SYSTEM "US20030004172A1-20030102-C00101.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00101.TIF SYSTEM "US20030004172A1-20030102-C00101.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00102.CDX SYSTEM "US20030004172A1-20030102-C00102.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00102.MOL SYSTEM "US20030004172A1-20030102-C00102.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00102.TIF SYSTEM "US20030004172A1-20030102-C00102.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00103.CDX SYSTEM "US20030004172A1-20030102-C00103.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00103.MOL SYSTEM "US20030004172A1-20030102-C00103.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00103.TIF SYSTEM "US20030004172A1-20030102-C00103.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00104.CDX SYSTEM "US20030004172A1-20030102-C00104.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00104.MOL SYSTEM "US20030004172A1-20030102-C00104.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00104.TIF SYSTEM "US20030004172A1-20030102-C00104.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00105.CDX SYSTEM "US20030004172A1-20030102-C00105.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00105.MOL SYSTEM "US20030004172A1-20030102-C00105.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00105.TIF SYSTEM "US20030004172A1-20030102-C00105.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00106.CDX SYSTEM "US20030004172A1-20030102-C00106.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00106.MOL SYSTEM "US20030004172A1-20030102-C00106.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00106.TIF SYSTEM "US20030004172A1-20030102-C00106.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00107.CDX SYSTEM "US20030004172A1-20030102-C00107.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00107.MOL SYSTEM "US20030004172A1-20030102-C00107.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00107.TIF SYSTEM "US20030004172A1-20030102-C00107.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00108.CDX SYSTEM "US20030004172A1-20030102-C00108.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00108.MOL SYSTEM "US20030004172A1-20030102-C00108.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00108.TIF SYSTEM "US20030004172A1-20030102-C00108.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00109.CDX SYSTEM "US20030004172A1-20030102-C00109.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00109.MOL SYSTEM "US20030004172A1-20030102-C00109.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00109.TIF SYSTEM "US20030004172A1-20030102-C00109.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00110.CDX SYSTEM "US20030004172A1-20030102-C00110.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00110.MOL SYSTEM "US20030004172A1-20030102-C00110.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00110.TIF SYSTEM "US20030004172A1-20030102-C00110.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00111.CDX SYSTEM "US20030004172A1-20030102-C00111.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00111.MOL SYSTEM "US20030004172A1-20030102-C00111.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00111.TIF SYSTEM "US20030004172A1-20030102-C00111.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00112.CDX SYSTEM "US20030004172A1-20030102-C00112.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00112.MOL SYSTEM "US20030004172A1-20030102-C00112.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00112.TIF SYSTEM "US20030004172A1-20030102-C00112.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00113.CDX SYSTEM "US20030004172A1-20030102-C00113.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00113.MOL SYSTEM "US20030004172A1-20030102-C00113.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00113.TIF SYSTEM "US20030004172A1-20030102-C00113.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00114.CDX SYSTEM "US20030004172A1-20030102-C00114.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00114.MOL SYSTEM "US20030004172A1-20030102-C00114.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00114.TIF SYSTEM "US20030004172A1-20030102-C00114.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00115.CDX SYSTEM "US20030004172A1-20030102-C00115.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00115.MOL SYSTEM "US20030004172A1-20030102-C00115.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00115.TIF SYSTEM "US20030004172A1-20030102-C00115.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00116.CDX SYSTEM "US20030004172A1-20030102-C00116.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00116.MOL SYSTEM "US20030004172A1-20030102-C00116.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00116.TIF SYSTEM "US20030004172A1-20030102-C00116.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00117.CDX SYSTEM "US20030004172A1-20030102-C00117.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00117.MOL SYSTEM "US20030004172A1-20030102-C00117.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00117.TIF SYSTEM "US20030004172A1-20030102-C00117.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00118.CDX SYSTEM "US20030004172A1-20030102-C00118.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00118.MOL SYSTEM "US20030004172A1-20030102-C00118.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00118.TIF SYSTEM "US20030004172A1-20030102-C00118.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00119.CDX SYSTEM "US20030004172A1-20030102-C00119.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00119.MOL SYSTEM "US20030004172A1-20030102-C00119.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00119.TIF SYSTEM "US20030004172A1-20030102-C00119.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00120.CDX SYSTEM "US20030004172A1-20030102-C00120.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00120.MOL SYSTEM "US20030004172A1-20030102-C00120.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00120.TIF SYSTEM "US20030004172A1-20030102-C00120.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00121.CDX SYSTEM "US20030004172A1-20030102-C00121.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00121.MOL SYSTEM "US20030004172A1-20030102-C00121.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00121.TIF SYSTEM "US20030004172A1-20030102-C00121.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00122.CDX SYSTEM "US20030004172A1-20030102-C00122.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00122.MOL SYSTEM "US20030004172A1-20030102-C00122.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00122.TIF SYSTEM "US20030004172A1-20030102-C00122.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00123.CDX SYSTEM "US20030004172A1-20030102-C00123.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00123.MOL SYSTEM "US20030004172A1-20030102-C00123.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00123.TIF SYSTEM "US20030004172A1-20030102-C00123.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00124.CDX SYSTEM "US20030004172A1-20030102-C00124.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00124.MOL SYSTEM "US20030004172A1-20030102-C00124.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00124.TIF SYSTEM "US20030004172A1-20030102-C00124.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00125.CDX SYSTEM "US20030004172A1-20030102-C00125.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00125.MOL SYSTEM "US20030004172A1-20030102-C00125.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00125.TIF SYSTEM "US20030004172A1-20030102-C00125.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00126.CDX SYSTEM "US20030004172A1-20030102-C00126.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00126.MOL SYSTEM "US20030004172A1-20030102-C00126.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00126.TIF SYSTEM "US20030004172A1-20030102-C00126.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00127.CDX SYSTEM "US20030004172A1-20030102-C00127.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00127.MOL SYSTEM "US20030004172A1-20030102-C00127.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00127.TIF SYSTEM "US20030004172A1-20030102-C00127.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00128.CDX SYSTEM "US20030004172A1-20030102-C00128.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00128.MOL SYSTEM "US20030004172A1-20030102-C00128.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00128.TIF SYSTEM "US20030004172A1-20030102-C00128.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00129.CDX SYSTEM "US20030004172A1-20030102-C00129.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00129.MOL SYSTEM "US20030004172A1-20030102-C00129.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00129.TIF SYSTEM "US20030004172A1-20030102-C00129.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00130.CDX SYSTEM "US20030004172A1-20030102-C00130.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00130.MOL SYSTEM "US20030004172A1-20030102-C00130.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00130.TIF SYSTEM "US20030004172A1-20030102-C00130.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00131.CDX SYSTEM "US20030004172A1-20030102-C00131.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00131.MOL SYSTEM "US20030004172A1-20030102-C00131.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00131.TIF SYSTEM "US20030004172A1-20030102-C00131.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00132.CDX SYSTEM "US20030004172A1-20030102-C00132.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00132.MOL SYSTEM "US20030004172A1-20030102-C00132.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00132.TIF SYSTEM "US20030004172A1-20030102-C00132.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00133.CDX SYSTEM "US20030004172A1-20030102-C00133.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00133.MOL SYSTEM "US20030004172A1-20030102-C00133.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00133.TIF SYSTEM "US20030004172A1-20030102-C00133.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00134.CDX SYSTEM "US20030004172A1-20030102-C00134.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00134.MOL SYSTEM "US20030004172A1-20030102-C00134.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00134.TIF SYSTEM "US20030004172A1-20030102-C00134.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00135.CDX SYSTEM "US20030004172A1-20030102-C00135.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00135.MOL SYSTEM "US20030004172A1-20030102-C00135.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00135.TIF SYSTEM "US20030004172A1-20030102-C00135.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00136.CDX SYSTEM "US20030004172A1-20030102-C00136.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00136.MOL SYSTEM "US20030004172A1-20030102-C00136.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00136.TIF SYSTEM "US20030004172A1-20030102-C00136.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00137.CDX SYSTEM "US20030004172A1-20030102-C00137.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00137.MOL SYSTEM "US20030004172A1-20030102-C00137.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00137.TIF SYSTEM "US20030004172A1-20030102-C00137.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00138.CDX SYSTEM "US20030004172A1-20030102-C00138.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00138.MOL SYSTEM "US20030004172A1-20030102-C00138.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00138.TIF SYSTEM "US20030004172A1-20030102-C00138.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00139.CDX SYSTEM "US20030004172A1-20030102-C00139.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00139.MOL SYSTEM "US20030004172A1-20030102-C00139.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00139.TIF SYSTEM "US20030004172A1-20030102-C00139.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00140.CDX SYSTEM "US20030004172A1-20030102-C00140.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00140.MOL SYSTEM "US20030004172A1-20030102-C00140.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00140.TIF SYSTEM "US20030004172A1-20030102-C00140.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00141.CDX SYSTEM "US20030004172A1-20030102-C00141.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00141.MOL SYSTEM "US20030004172A1-20030102-C00141.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00141.TIF SYSTEM "US20030004172A1-20030102-C00141.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00142.CDX SYSTEM "US20030004172A1-20030102-C00142.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00142.MOL SYSTEM "US20030004172A1-20030102-C00142.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00142.TIF SYSTEM "US20030004172A1-20030102-C00142.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00143.CDX SYSTEM "US20030004172A1-20030102-C00143.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00143.MOL SYSTEM "US20030004172A1-20030102-C00143.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00143.TIF SYSTEM "US20030004172A1-20030102-C00143.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00144.CDX SYSTEM "US20030004172A1-20030102-C00144.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00144.MOL SYSTEM "US20030004172A1-20030102-C00144.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00144.TIF SYSTEM "US20030004172A1-20030102-C00144.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00145.CDX SYSTEM "US20030004172A1-20030102-C00145.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00145.MOL SYSTEM "US20030004172A1-20030102-C00145.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00145.TIF SYSTEM "US20030004172A1-20030102-C00145.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00146.CDX SYSTEM "US20030004172A1-20030102-C00146.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00146.MOL SYSTEM "US20030004172A1-20030102-C00146.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00146.TIF SYSTEM "US20030004172A1-20030102-C00146.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00147.CDX SYSTEM "US20030004172A1-20030102-C00147.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00147.MOL SYSTEM "US20030004172A1-20030102-C00147.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00147.TIF SYSTEM "US20030004172A1-20030102-C00147.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00148.CDX SYSTEM "US20030004172A1-20030102-C00148.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00148.MOL SYSTEM "US20030004172A1-20030102-C00148.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00148.TIF SYSTEM "US20030004172A1-20030102-C00148.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00149.CDX SYSTEM "US20030004172A1-20030102-C00149.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00149.MOL SYSTEM "US20030004172A1-20030102-C00149.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00149.TIF SYSTEM "US20030004172A1-20030102-C00149.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00150.CDX SYSTEM "US20030004172A1-20030102-C00150.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00150.MOL SYSTEM "US20030004172A1-20030102-C00150.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00150.TIF SYSTEM "US20030004172A1-20030102-C00150.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00151.CDX SYSTEM "US20030004172A1-20030102-C00151.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00151.MOL SYSTEM "US20030004172A1-20030102-C00151.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00151.TIF SYSTEM "US20030004172A1-20030102-C00151.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00152.CDX SYSTEM "US20030004172A1-20030102-C00152.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00152.MOL SYSTEM "US20030004172A1-20030102-C00152.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00152.TIF SYSTEM "US20030004172A1-20030102-C00152.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00153.CDX SYSTEM "US20030004172A1-20030102-C00153.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00153.MOL SYSTEM "US20030004172A1-20030102-C00153.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00153.TIF SYSTEM "US20030004172A1-20030102-C00153.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00154.CDX SYSTEM "US20030004172A1-20030102-C00154.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00154.MOL SYSTEM "US20030004172A1-20030102-C00154.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00154.TIF SYSTEM "US20030004172A1-20030102-C00154.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00155.CDX SYSTEM "US20030004172A1-20030102-C00155.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00155.MOL SYSTEM "US20030004172A1-20030102-C00155.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00155.TIF SYSTEM "US20030004172A1-20030102-C00155.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00156.CDX SYSTEM "US20030004172A1-20030102-C00156.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00156.MOL SYSTEM "US20030004172A1-20030102-C00156.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00156.TIF SYSTEM "US20030004172A1-20030102-C00156.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00157.CDX SYSTEM "US20030004172A1-20030102-C00157.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00157.MOL SYSTEM "US20030004172A1-20030102-C00157.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00157.TIF SYSTEM "US20030004172A1-20030102-C00157.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00158.CDX SYSTEM "US20030004172A1-20030102-C00158.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00158.MOL SYSTEM "US20030004172A1-20030102-C00158.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00158.TIF SYSTEM "US20030004172A1-20030102-C00158.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00159.CDX SYSTEM "US20030004172A1-20030102-C00159.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00159.MOL SYSTEM "US20030004172A1-20030102-C00159.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00159.TIF SYSTEM "US20030004172A1-20030102-C00159.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00160.CDX SYSTEM "US20030004172A1-20030102-C00160.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00160.MOL SYSTEM "US20030004172A1-20030102-C00160.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00160.TIF SYSTEM "US20030004172A1-20030102-C00160.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00161.CDX SYSTEM "US20030004172A1-20030102-C00161.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00161.MOL SYSTEM "US20030004172A1-20030102-C00161.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00161.TIF SYSTEM "US20030004172A1-20030102-C00161.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00162.CDX SYSTEM "US20030004172A1-20030102-C00162.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00162.MOL SYSTEM "US20030004172A1-20030102-C00162.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00162.TIF SYSTEM "US20030004172A1-20030102-C00162.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00163.CDX SYSTEM "US20030004172A1-20030102-C00163.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00163.MOL SYSTEM "US20030004172A1-20030102-C00163.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00163.TIF SYSTEM "US20030004172A1-20030102-C00163.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00164.CDX SYSTEM "US20030004172A1-20030102-C00164.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00164.MOL SYSTEM "US20030004172A1-20030102-C00164.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00164.TIF SYSTEM "US20030004172A1-20030102-C00164.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00165.CDX SYSTEM "US20030004172A1-20030102-C00165.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00165.MOL SYSTEM "US20030004172A1-20030102-C00165.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00165.TIF SYSTEM "US20030004172A1-20030102-C00165.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00166.CDX SYSTEM "US20030004172A1-20030102-C00166.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00166.MOL SYSTEM "US20030004172A1-20030102-C00166.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00166.TIF SYSTEM "US20030004172A1-20030102-C00166.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00167.CDX SYSTEM "US20030004172A1-20030102-C00167.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00167.MOL SYSTEM "US20030004172A1-20030102-C00167.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00167.TIF SYSTEM "US20030004172A1-20030102-C00167.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00168.CDX SYSTEM "US20030004172A1-20030102-C00168.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00168.MOL SYSTEM "US20030004172A1-20030102-C00168.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00168.TIF SYSTEM "US20030004172A1-20030102-C00168.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00169.CDX SYSTEM "US20030004172A1-20030102-C00169.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00169.MOL SYSTEM "US20030004172A1-20030102-C00169.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00169.TIF SYSTEM "US20030004172A1-20030102-C00169.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00170.CDX SYSTEM "US20030004172A1-20030102-C00170.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00170.MOL SYSTEM "US20030004172A1-20030102-C00170.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00170.TIF SYSTEM "US20030004172A1-20030102-C00170.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00171.CDX SYSTEM "US20030004172A1-20030102-C00171.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00171.MOL SYSTEM "US20030004172A1-20030102-C00171.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00171.TIF SYSTEM "US20030004172A1-20030102-C00171.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00172.CDX SYSTEM "US20030004172A1-20030102-C00172.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00172.MOL SYSTEM "US20030004172A1-20030102-C00172.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00172.TIF SYSTEM "US20030004172A1-20030102-C00172.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00173.CDX SYSTEM "US20030004172A1-20030102-C00173.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00173.MOL SYSTEM "US20030004172A1-20030102-C00173.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00173.TIF SYSTEM "US20030004172A1-20030102-C00173.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00174.CDX SYSTEM "US20030004172A1-20030102-C00174.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00174.MOL SYSTEM "US20030004172A1-20030102-C00174.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00174.TIF SYSTEM "US20030004172A1-20030102-C00174.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00175.CDX SYSTEM "US20030004172A1-20030102-C00175.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00175.MOL SYSTEM "US20030004172A1-20030102-C00175.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00175.TIF SYSTEM "US20030004172A1-20030102-C00175.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00176.CDX SYSTEM "US20030004172A1-20030102-C00176.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00176.MOL SYSTEM "US20030004172A1-20030102-C00176.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00176.TIF SYSTEM "US20030004172A1-20030102-C00176.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00177.CDX SYSTEM "US20030004172A1-20030102-C00177.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00177.MOL SYSTEM "US20030004172A1-20030102-C00177.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00177.TIF SYSTEM "US20030004172A1-20030102-C00177.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00178.CDX SYSTEM "US20030004172A1-20030102-C00178.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00178.MOL SYSTEM "US20030004172A1-20030102-C00178.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00178.TIF SYSTEM "US20030004172A1-20030102-C00178.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00179.CDX SYSTEM "US20030004172A1-20030102-C00179.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00179.MOL SYSTEM "US20030004172A1-20030102-C00179.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00179.TIF SYSTEM "US20030004172A1-20030102-C00179.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00180.CDX SYSTEM "US20030004172A1-20030102-C00180.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00180.MOL SYSTEM "US20030004172A1-20030102-C00180.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00180.TIF SYSTEM "US20030004172A1-20030102-C00180.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00181.CDX SYSTEM "US20030004172A1-20030102-C00181.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00181.MOL SYSTEM "US20030004172A1-20030102-C00181.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00181.TIF SYSTEM "US20030004172A1-20030102-C00181.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00182.CDX SYSTEM "US20030004172A1-20030102-C00182.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00182.MOL SYSTEM "US20030004172A1-20030102-C00182.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00182.TIF SYSTEM "US20030004172A1-20030102-C00182.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00183.CDX SYSTEM "US20030004172A1-20030102-C00183.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00183.MOL SYSTEM "US20030004172A1-20030102-C00183.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00183.TIF SYSTEM "US20030004172A1-20030102-C00183.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00184.CDX SYSTEM "US20030004172A1-20030102-C00184.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00184.MOL SYSTEM "US20030004172A1-20030102-C00184.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00184.TIF SYSTEM "US20030004172A1-20030102-C00184.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00185.CDX SYSTEM "US20030004172A1-20030102-C00185.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00185.MOL SYSTEM "US20030004172A1-20030102-C00185.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00185.TIF SYSTEM "US20030004172A1-20030102-C00185.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00186.CDX SYSTEM "US20030004172A1-20030102-C00186.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00186.MOL SYSTEM "US20030004172A1-20030102-C00186.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00186.TIF SYSTEM "US20030004172A1-20030102-C00186.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00187.CDX SYSTEM "US20030004172A1-20030102-C00187.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00187.MOL SYSTEM "US20030004172A1-20030102-C00187.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00187.TIF SYSTEM "US20030004172A1-20030102-C00187.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00188.CDX SYSTEM "US20030004172A1-20030102-C00188.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00188.MOL SYSTEM "US20030004172A1-20030102-C00188.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00188.TIF SYSTEM "US20030004172A1-20030102-C00188.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00189.CDX SYSTEM "US20030004172A1-20030102-C00189.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00189.MOL SYSTEM "US20030004172A1-20030102-C00189.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00189.TIF SYSTEM "US20030004172A1-20030102-C00189.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00190.CDX SYSTEM "US20030004172A1-20030102-C00190.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00190.MOL SYSTEM "US20030004172A1-20030102-C00190.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00190.TIF SYSTEM "US20030004172A1-20030102-C00190.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00191.CDX SYSTEM "US20030004172A1-20030102-C00191.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00191.MOL SYSTEM "US20030004172A1-20030102-C00191.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00191.TIF SYSTEM "US20030004172A1-20030102-C00191.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00192.CDX SYSTEM "US20030004172A1-20030102-C00192.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00192.MOL SYSTEM "US20030004172A1-20030102-C00192.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00192.TIF SYSTEM "US20030004172A1-20030102-C00192.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00193.CDX SYSTEM "US20030004172A1-20030102-C00193.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00193.MOL SYSTEM "US20030004172A1-20030102-C00193.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00193.TIF SYSTEM "US20030004172A1-20030102-C00193.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00194.CDX SYSTEM "US20030004172A1-20030102-C00194.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00194.MOL SYSTEM "US20030004172A1-20030102-C00194.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00194.TIF SYSTEM "US20030004172A1-20030102-C00194.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00195.CDX SYSTEM "US20030004172A1-20030102-C00195.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00195.MOL SYSTEM "US20030004172A1-20030102-C00195.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00195.TIF SYSTEM "US20030004172A1-20030102-C00195.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00196.CDX SYSTEM "US20030004172A1-20030102-C00196.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00196.MOL SYSTEM "US20030004172A1-20030102-C00196.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00196.TIF SYSTEM "US20030004172A1-20030102-C00196.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00197.CDX SYSTEM "US20030004172A1-20030102-C00197.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00197.MOL SYSTEM "US20030004172A1-20030102-C00197.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00197.TIF SYSTEM "US20030004172A1-20030102-C00197.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00198.CDX SYSTEM "US20030004172A1-20030102-C00198.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00198.MOL SYSTEM "US20030004172A1-20030102-C00198.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00198.TIF SYSTEM "US20030004172A1-20030102-C00198.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00199.CDX SYSTEM "US20030004172A1-20030102-C00199.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00199.MOL SYSTEM "US20030004172A1-20030102-C00199.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00199.TIF SYSTEM "US20030004172A1-20030102-C00199.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00200.CDX SYSTEM "US20030004172A1-20030102-C00200.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00200.MOL SYSTEM "US20030004172A1-20030102-C00200.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00200.TIF SYSTEM "US20030004172A1-20030102-C00200.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00201.CDX SYSTEM "US20030004172A1-20030102-C00201.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00201.MOL SYSTEM "US20030004172A1-20030102-C00201.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00201.TIF SYSTEM "US20030004172A1-20030102-C00201.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00202.CDX SYSTEM "US20030004172A1-20030102-C00202.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00202.MOL SYSTEM "US20030004172A1-20030102-C00202.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00202.TIF SYSTEM "US20030004172A1-20030102-C00202.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00203.CDX SYSTEM "US20030004172A1-20030102-C00203.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00203.MOL SYSTEM "US20030004172A1-20030102-C00203.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00203.TIF SYSTEM "US20030004172A1-20030102-C00203.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00204.CDX SYSTEM "US20030004172A1-20030102-C00204.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00204.MOL SYSTEM "US20030004172A1-20030102-C00204.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00204.TIF SYSTEM "US20030004172A1-20030102-C00204.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00205.CDX SYSTEM "US20030004172A1-20030102-C00205.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00205.MOL SYSTEM "US20030004172A1-20030102-C00205.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00205.TIF SYSTEM "US20030004172A1-20030102-C00205.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00206.CDX SYSTEM "US20030004172A1-20030102-C00206.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00206.MOL SYSTEM "US20030004172A1-20030102-C00206.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00206.TIF SYSTEM "US20030004172A1-20030102-C00206.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00207.CDX SYSTEM "US20030004172A1-20030102-C00207.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00207.MOL SYSTEM "US20030004172A1-20030102-C00207.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00207.TIF SYSTEM "US20030004172A1-20030102-C00207.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00208.CDX SYSTEM "US20030004172A1-20030102-C00208.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00208.MOL SYSTEM "US20030004172A1-20030102-C00208.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00208.TIF SYSTEM "US20030004172A1-20030102-C00208.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00209.CDX SYSTEM "US20030004172A1-20030102-C00209.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00209.MOL SYSTEM "US20030004172A1-20030102-C00209.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00209.TIF SYSTEM "US20030004172A1-20030102-C00209.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00210.CDX SYSTEM "US20030004172A1-20030102-C00210.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00210.MOL SYSTEM "US20030004172A1-20030102-C00210.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00210.TIF SYSTEM "US20030004172A1-20030102-C00210.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00211.CDX SYSTEM "US20030004172A1-20030102-C00211.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00211.MOL SYSTEM "US20030004172A1-20030102-C00211.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00211.TIF SYSTEM "US20030004172A1-20030102-C00211.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00212.CDX SYSTEM "US20030004172A1-20030102-C00212.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00212.MOL SYSTEM "US20030004172A1-20030102-C00212.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00212.TIF SYSTEM "US20030004172A1-20030102-C00212.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00213.CDX SYSTEM "US20030004172A1-20030102-C00213.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00213.MOL SYSTEM "US20030004172A1-20030102-C00213.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00213.TIF SYSTEM "US20030004172A1-20030102-C00213.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00214.CDX SYSTEM "US20030004172A1-20030102-C00214.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00214.MOL SYSTEM "US20030004172A1-20030102-C00214.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00214.TIF SYSTEM "US20030004172A1-20030102-C00214.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00215.CDX SYSTEM "US20030004172A1-20030102-C00215.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00215.MOL SYSTEM "US20030004172A1-20030102-C00215.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00215.TIF SYSTEM "US20030004172A1-20030102-C00215.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00216.CDX SYSTEM "US20030004172A1-20030102-C00216.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00216.MOL SYSTEM "US20030004172A1-20030102-C00216.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00216.TIF SYSTEM "US20030004172A1-20030102-C00216.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00217.CDX SYSTEM "US20030004172A1-20030102-C00217.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00217.MOL SYSTEM "US20030004172A1-20030102-C00217.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00217.TIF SYSTEM "US20030004172A1-20030102-C00217.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00218.CDX SYSTEM "US20030004172A1-20030102-C00218.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00218.MOL SYSTEM "US20030004172A1-20030102-C00218.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00218.TIF SYSTEM "US20030004172A1-20030102-C00218.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00219.CDX SYSTEM "US20030004172A1-20030102-C00219.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00219.MOL SYSTEM "US20030004172A1-20030102-C00219.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00219.TIF SYSTEM "US20030004172A1-20030102-C00219.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00220.CDX SYSTEM "US20030004172A1-20030102-C00220.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00220.MOL SYSTEM "US20030004172A1-20030102-C00220.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00220.TIF SYSTEM "US20030004172A1-20030102-C00220.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00221.CDX SYSTEM "US20030004172A1-20030102-C00221.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00221.MOL SYSTEM "US20030004172A1-20030102-C00221.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00221.TIF SYSTEM "US20030004172A1-20030102-C00221.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00222.CDX SYSTEM "US20030004172A1-20030102-C00222.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00222.MOL SYSTEM "US20030004172A1-20030102-C00222.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00222.TIF SYSTEM "US20030004172A1-20030102-C00222.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00223.CDX SYSTEM "US20030004172A1-20030102-C00223.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00223.MOL SYSTEM "US20030004172A1-20030102-C00223.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00223.TIF SYSTEM "US20030004172A1-20030102-C00223.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00224.CDX SYSTEM "US20030004172A1-20030102-C00224.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00224.MOL SYSTEM "US20030004172A1-20030102-C00224.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00224.TIF SYSTEM "US20030004172A1-20030102-C00224.TIF" NDATA TIF>
<!ENTITY US20030004172A1-20030102-C00225.CDX SYSTEM "US20030004172A1-20030102-C00225.CDX" NDATA CDX>
<!ENTITY US20030004172A1-20030102-C00225.MOL SYSTEM "US20030004172A1-20030102-C00225.MOL" NDATA MOL>
<!ENTITY US20030004172A1-20030102-C00225.TIF SYSTEM "US20030004172A1-20030102-C00225.TIF" NDATA TIF>
]>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20030004172</doc-number>
<kind-code>A1</kind-code>
<document-date>20030102</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>10075073</doc-number>
</application-number>
<application-number-series-code>10</application-number-series-code>
<filing-date>20020213</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>A61K031/522</ipc>
</classification-ipc-primary>
<classification-ipc-secondary>
<ipc>A61K031/519</ipc>
</classification-ipc-secondary>
<classification-ipc-secondary>
<ipc>C07D491/02</ipc>
</classification-ipc-secondary>
<classification-ipc-secondary>
<ipc>C07D473/02</ipc>
</classification-ipc-secondary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>514</class>
<subclass>260100</subclass>
</uspc>
</classification-us-primary>
<classification-us-secondary>
<uspc>
<class>514</class>
<subclass>263340</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>514</class>
<subclass>263330</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>514</class>
<subclass>265100</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>544</class>
<subclass>256000</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>544</class>
<subclass>267000</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>544</class>
<subclass>271000</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>544</class>
<subclass>280000</subclass>
</uspc>
</classification-us-secondary>
</classification-us>
<title-of-invention>Fused pyrimidinone matrix metalloproteinase inhibitors</title-of-invention>
</technical-information>
<continuity-data>
<non-provisional-of-provisional>
<document-id>
<doc-number>60268756</doc-number>
<document-date>20010214</document-date>
<country-code>US</country-code>
</document-id>
</non-provisional-of-provisional>
</continuity-data>
<inventors>
<first-named-inventor>
<name>
<given-name>William</given-name>
<middle-name>Glen</middle-name>
<family-name>Harter</family-name>
</name>
<residence>
<residence-us>
<city>Chelsea</city>
<state>MI</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Jie</given-name>
<middle-name>Jack</middle-name>
<family-name>Li</family-name>
</name>
<residence>
<residence-us>
<city>Ann Arbor</city>
<state>MI</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Daniel</given-name>
<middle-name>Fred</middle-name>
<family-name>Ortwine</family-name>
</name>
<residence>
<residence-us>
<city>Saline</city>
<state>MI</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Kevon</given-name>
<middle-name>Ray</middle-name>
<family-name>Shuler</family-name>
</name>
<residence>
<residence-us>
<city>Chelsea</city>
<state>MI</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Wen-Song</given-name>
<family-name>Yue</family-name>
</name>
<residence>
<residence-us>
<city>Ypsilanti</city>
<state>MI</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<correspondence-address>
<name-1>Claude F. Purchase, Jr.</name-1>
<name-2>Warner-Lambert Company</name-2>
<address>
<address-1>2800 Plymouth Road</address-1>
<city>Ann Arbor</city>
<state>MI</state>
<postalcode>48105</postalcode>
<country>
<country-code>US</country-code>
</country>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">Selective MMP-13 inhibitors are fused pyrimidinones of the formula  
<chemistry-cwu id="CHEM-US-00001">
<number>1</number>
<image id="EMI-C00001" he="67.6998" wi="62.6535" file="US20030004172A1-20030102-C00001.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00001" file="US20030004172A1-20030102-C00001.CDX"/>
<chemistry-mol-file id="CHEMMOL-00001" file="US20030004172A1-20030102-C00001.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="A-0002" lvl="7">or a pharmaceutically acceptable salt thereof, wherein: </paragraph>
<paragraph id="A-0003" lvl="2">W, together with the carbon atoms to which it is attached, form a 5-membered ring diradical  
<chemistry-cwu id="CHEM-US-00002">
<number>2</number>
<image id="EMI-C00002" he="346.6071" wi="192.2697" file="US20030004172A1-20030102-C00002.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00002" file="US20030004172A1-20030102-C00002.CDX"/>
<chemistry-mol-file id="CHEMMOL-00002" file="US20030004172A1-20030102-C00002.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="A-0004" lvl="2">X is O, S, SO, SO<highlight><subscript>2</subscript></highlight>, NR<highlight><superscript>5</superscript></highlight>, or CH<highlight><subscript>2</subscript></highlight>;  
<chemistry-cwu id="CHEM-US-00003">
<number>3</number>
<image id="EMI-C00003" he="22.08465" wi="99.13995" file="US20030004172A1-20030102-C00003.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00003" file="US20030004172A1-20030102-C00003.CDX"/>
<chemistry-mol-file id="CHEMMOL-00003" file="US20030004172A1-20030102-C00003.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="A-0005" lvl="2">B is O or NR<highlight><superscript>5</superscript></highlight>; or </paragraph>
<paragraph id="A-0006" lvl="2">A and B are taken together to form &mdash;C&equiv;C&mdash;; </paragraph>
<paragraph id="A-0007" lvl="2">R<highlight><superscript>1</superscript></highlight>, R<highlight><superscript>4</superscript></highlight>, and R<highlight><superscript>5 </superscript></highlight>are hydrogen, alkyl, alkenyl, alkynyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkanoyl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </paragraph>
<paragraph id="A-0008" lvl="2">R<highlight><superscript>2 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>are hydrogen, alkyl, alkenyl, alkynyl CN, NO<highlight><subscript>2</subscript></highlight>, NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </paragraph>
<paragraph id="A-0009" lvl="2">R<highlight><superscript>2 </superscript></highlight>may further be halo; </paragraph>
<paragraph id="A-0010" lvl="2">n is an integer of from 0 to 5; and </paragraph>
<paragraph id="A-0011" lvl="2">R<highlight><superscript>4 </superscript></highlight>and R<highlight><superscript>5 </superscript></highlight>when taken together with a nitrogen to which they are both attached complete a 3- to 8-membered ring containing carbon atoms and optionally containing O, S, or N, and substituted or unsubstituted; </paragraph>
<paragraph id="A-0012" lvl="2">with the proviso that R<highlight><superscript>1 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>are not both selected from hydrogen and C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl. </paragraph>
</subdoc-abstract>
<subdoc-description>
<cross-reference-to-related-applications>
<heading lvl="1">CROSS-REFERENCE TO RELATED APPLICATIONS </heading>
<paragraph id="P-0001" lvl="0"><number>&lsqb;0001&rsqb;</number> This application claims benefit of priority from United States provisional application number 60/268,756, filed Feb. 14, 2001.</paragraph>
</cross-reference-to-related-applications>
<summary-of-invention>
<section>
<heading lvl="1">FIELD OF THE INVENTION </heading>
<paragraph id="P-0002" lvl="0"><number>&lsqb;0002&rsqb;</number> This invention relates to fused bicyclic pyrimidinones that inhibit matrix metalloproteinase enzymes and thus are useful for treating diseases resulting from tissue breakdown, such as heart disease, multiple sclerosis, arthritis, atherosclerosis, and osteoporosis. </paragraph>
</section>
<section>
<heading lvl="1">BACKGROUND OF THE INVENTION </heading>
<paragraph id="P-0003" lvl="0"><number>&lsqb;0003&rsqb;</number> Matrix metalloproteinases (sometimes referred to as MMPs) are naturally-occurring enzymes found in most mammals. Over-expression and activation of MMPs or an imbalance between MMPs and inhibitors of MMPs, have been suggested as factors in the pathogenesis of diseases characterized by the breakdown of extracellular matrix or connective tissues. </paragraph>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> Stromelysin-1 and gelatinase A are members of the matrix metalloproteinases (MMP) family. Other members include fibroblast collagenase (MMP-1), neutrophil collagenase (MMP-8), gelatinase B (92 kDa gelatinase) (MMP-9), stromelysin-2 (MMP-10), stromelysin-3 (MMP-11), matrilysin (MMP-7), collagenase 3 (MMP-13), TNF-alpha converting enzyme (TACE), and other newly discovered membrane-associated matrix metalloproteinases (Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., and Seiki M., <highlight><italic>Nature, </italic></highlight>1994;370:61-65). These enzymes have been implicated with a number of diseases which result from breakdown of connective tissue, including such diseases as rheumatoid arthritis, osteoarthritis, osteoporosis, periodontitis, multiple sclerosis, gingivitis, corneal epidermal and gastric ulceration, atherosclerosis, neointimal proliferation which leads to restenosis and ischemic heart failure, stroke, renal disease, macular degeneration, and tumor metastasis. A method for preventing and treating these and other diseases is now recognized to be by inhibiting metalloproteinase enzymes, thereby curtailing and/or eliminating the breakdown of connective tissues that results in the disease states. </paragraph>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> The catalytic zinc in matrix metalloproteinases is typically the focal point for inhibitor design. The modification of substrates by introducing zinc chelating groups has generated potent inhibitors such as peptide hydroxamates and thiol-containing peptides. Peptide hydroxamates and the natural endogenous inhibitors of MMPs (TIMPs) have been used successfully to treat animal models of cancer and inflammation. MMP inhibitors have also been used to prevent and treat congestive heart failure and other cardiovascular diseases, U.S. Pat. No. 5,948,780. </paragraph>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> A major limitation on the use of currently known MMP inhibitors is their lack of specificity for any particular enzyme. Recent data has established that specific MMP enzymes are associated with some diseases, with no effect on others. The MMPs are generally categorized based on their substrate specificity, and indeed the collagenase subfamily of MMP-1, MMP-8, and MMP-13 selectively cleave native interstitial collagens, and thus are associated only with diseases linked to such interstitial collagen tissue. This is evidenced by the recent discovery that MMP-13 alone is over expressed in breast carcinoma, while MMP-1 alone is over expressed in papillary carcinoma (see Chen et al., <highlight><italic>J. Am. Chem. Soc., </italic></highlight>2000;122:9648-9654). </paragraph>
<paragraph id="P-0007" lvl="0"><number>&lsqb;0007&rsqb;</number> There appears to be few selective inhibitors of MMP-13 reported. A compound named WAY-170523 has been reported by Chen et al., supra., 2000, and a few other compounds are reported in PCT International patent application publication Number WO 01/63244 A1, as allegedly selective inhibitors of MMP-13. Further, U.S. Pat. No. 6,088,243 discloses inhibitors of MMP-13. However, no selective or nonselective inhibitor of MMP-13 has been approved and marketed for the treatment of any disease in any mammal. Accordingly, the need continues to find new low molecular weight compounds that are potent and selective MMP inhibitors, and that have an acceptable therapeutic index of toxicity/potency to make them amenable for use clinically in the prevention and treatment of the associated disease states. An object of this invention is to provide a group of selective MMP-13 inhibitor compounds characterized as being fused bicyclic pyrimidinones. </paragraph>
</section>
<section>
<heading lvl="1">SUMMARY OF THE INVENTION </heading>
<paragraph id="P-0008" lvl="0"><number>&lsqb;0008&rsqb;</number> This invention provides bicyclic pyrimidinones that are inhibitors of matrix metalloproteinase enzymes, and especially MMP-13. The invention is more particularly directed to compounds defined by Formula I  
<chemistry-cwu id="CHEM-US-00004">
<number>4</number>
<image id="EMI-C00004" he="74.41875" wi="198.02475" file="US20030004172A1-20030102-C00004.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00004" file="US20030004172A1-20030102-C00004.CDX"/>
<chemistry-mol-file id="CHEMMOL-00004" file="US20030004172A1-20030102-C00004.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0009" lvl="7"><number>&lsqb;0009&rsqb;</number> or a pharmaceutically acceptable salt thereof; wherein: </paragraph>
<paragraph id="P-0010" lvl="2"><number>&lsqb;0010&rsqb;</number> W, together with the carbon atoms to which it is attached, form a 5-membered ring diradical  
<chemistry-cwu id="CHEM-US-00005">
<number>5</number>
<image id="EMI-C00005" he="346.6071" wi="192.2697" file="US20030004172A1-20030102-C00005.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00005" file="US20030004172A1-20030102-C00005.CDX"/>
<chemistry-mol-file id="CHEMMOL-00005" file="US20030004172A1-20030102-C00005.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0011" lvl="2"><number>&lsqb;0011&rsqb;</number> A is </paragraph>
<paragraph id="P-0012" lvl="2"><number>&lsqb;0012&rsqb;</number> B is O or NR<highlight><superscript>5</superscript></highlight>; or </paragraph>
<paragraph id="P-0013" lvl="2"><number>&lsqb;0013&rsqb;</number> A and B are taken together to form &mdash;C&equiv;C&mdash;; </paragraph>
<paragraph id="P-0014" lvl="2"><number>&lsqb;0014&rsqb;</number> X is O, S, SO, SO<highlight><subscript>2</subscript></highlight>, NR<highlight><superscript>5</superscript></highlight>, or CH<highlight><subscript>2</subscript></highlight>; </paragraph>
<paragraph id="P-0015" lvl="2"><number>&lsqb;0015&rsqb;</number> each Y independently is O or S; </paragraph>
<paragraph id="P-0016" lvl="2"><number>&lsqb;0016&rsqb;</number> R<highlight><superscript>1</superscript></highlight>, R<highlight><superscript>4</superscript></highlight>, and R<highlight><superscript>5 </superscript></highlight>independently are hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heterocyclic, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkanoyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </paragraph>
<paragraph id="P-0017" lvl="2"><number>&lsqb;0017&rsqb;</number> R<highlight><superscript>2 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>independently are hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, CN, NO<highlight><subscript>2</subscript></highlight>, NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; CONR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>, or COR<highlight><superscript>6</superscript></highlight>; </paragraph>
<paragraph id="P-0018" lvl="2"><number>&lsqb;0018&rsqb;</number> R<highlight><superscript>2 </superscript></highlight>may further be halo; </paragraph>
<paragraph id="P-0019" lvl="2"><number>&lsqb;0019&rsqb;</number> n is an integer of from 0 to 5; </paragraph>
<paragraph id="P-0020" lvl="2"><number>&lsqb;0020&rsqb;</number> R<highlight><superscript>4 </superscript></highlight>and R<highlight><superscript>5 </superscript></highlight>when taken together with the nitrogen to which they are attached complete a 3- to 8-membered ring containing carbon atoms and optionally containing O, S, or N, and substituted or unsubstituted; </paragraph>
<paragraph id="P-0021" lvl="2"><number>&lsqb;0021&rsqb;</number> with the proviso that R<highlight><superscript>1 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>are not both selected from: hydrogen and C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl. </paragraph>
<paragraph id="P-0022" lvl="0"><number>&lsqb;0022&rsqb;</number> Another invention embodiment is compounds that are thieno&lsqb;2,3-d&rsqb;pyrimidinones of Formula II  
<chemistry-cwu id="CHEM-US-00006">
<number>6</number>
<image id="EMI-C00006" he="91.4571" wi="198.02475" file="US20030004172A1-20030102-C00006.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00006" file="US20030004172A1-20030102-C00006.CDX"/>
<chemistry-mol-file id="CHEMMOL-00006" file="US20030004172A1-20030102-C00006.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0023" lvl="7"><number>&lsqb;0023&rsqb;</number> or a pharmaceutically acceptable salt thereof, wherein A, B, R<highlight><superscript>1</superscript></highlight>, R<highlight><superscript>2</superscript></highlight>, R<highlight><superscript>3</superscript></highlight>, R<highlight><superscript>4</superscript></highlight>, and Y are as defined above. </paragraph>
<paragraph id="P-0024" lvl="0"><number>&lsqb;0024&rsqb;</number> Another invention embodiment is compounds that of Formula II, or a pharmaceutically acceptable salt thereof, wherein&mdash;A&mdash;B&mdash; is &mdash;C&equiv;C&mdash;,  
<chemistry-cwu id="CHEM-US-00007">
<number>7</number>
<image id="EMI-C00007" he="22.5666" wi="150.0282" file="US20030004172A1-20030102-C00007.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00007" file="US20030004172A1-20030102-C00007.CDX"/>
<chemistry-mol-file id="CHEMMOL-00007" file="US20030004172A1-20030102-C00007.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0025" lvl="7"><number>&lsqb;0025&rsqb;</number> wherein R<highlight><superscript>5 </superscript></highlight>is as defined above for Formula I. </paragraph>
<paragraph id="P-0026" lvl="0"><number>&lsqb;0026&rsqb;</number> Another invention embodiment is compounds that have Formula III  
<chemistry-cwu id="CHEM-US-00008">
<number>8</number>
<image id="EMI-C00008" he="91.4571" wi="198.02475" file="US20030004172A1-20030102-C00008.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00008" file="US20030004172A1-20030102-C00008.CDX"/>
<chemistry-mol-file id="CHEMMOL-00008" file="US20030004172A1-20030102-C00008.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0027" lvl="7"><number>&lsqb;0027&rsqb;</number> or a pharmaceutically acceptable salt thereof, wherein A, B, R<highlight><superscript>1</superscript></highlight>, R<highlight><superscript>2</superscript></highlight>, and R<highlight><superscript>4 </superscript></highlight>are as defined above, and R<highlight><superscript>3 </superscript></highlight>is (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl. </paragraph>
<paragraph id="P-0028" lvl="0"><number>&lsqb;0028&rsqb;</number> Another invention embodiment is compounds that are compounds of Formula III, or a pharmaceutically acceptable salt thereof, wherein R<highlight><superscript>3 </superscript></highlight>is (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl, and&mdash;A&mdash;B&mdash; is &mdash;C&equiv;C&mdash;. </paragraph>
<paragraph id="P-0029" lvl="0"><number>&lsqb;0029&rsqb;</number> Another invention embodiment is compounds that are pyrimidinone MMP-inhibitors of Formula IV  
<chemistry-cwu id="CHEM-US-00009">
<number>9</number>
<image id="EMI-C00009" he="91.4571" wi="198.02475" file="US20030004172A1-20030102-C00009.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00009" file="US20030004172A1-20030102-C00009.CDX"/>
<chemistry-mol-file id="CHEMMOL-00009" file="US20030004172A1-20030102-C00009.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0030" lvl="7"><number>&lsqb;0030&rsqb;</number> or a pharmaceutically acceptable salt thereof, wherein A, B, R<highlight><superscript>1</superscript></highlight>, R<highlight><superscript>2</superscript></highlight>, R<highlight><superscript>3</superscript></highlight>, and R<highlight><superscript>4 </superscript></highlight>are as defined above. </paragraph>
<paragraph id="P-0031" lvl="0"><number>&lsqb;0031&rsqb;</number> Another invention embodiment are pyrimidinone compounds provided by this invention that have Formula V  
<chemistry-cwu id="CHEM-US-00010">
<number>10</number>
<image id="EMI-C00010" he="91.4571" wi="198.02475" file="US20030004172A1-20030102-C00010.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00010" file="US20030004172A1-20030102-C00010.CDX"/>
<chemistry-mol-file id="CHEMMOL-00010" file="US20030004172A1-20030102-C00010.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0032" lvl="7"><number>&lsqb;0032&rsqb;</number> or a pharmaceutically acceptable salt thereof, wherein A, B, R<highlight><superscript>1</superscript></highlight>, R<highlight><superscript>2</superscript></highlight>, R<highlight><superscript>3</superscript></highlight>, R<highlight><superscript>4</superscript></highlight>, and R<highlight><superscript>5 </superscript></highlight>are as defined above. </paragraph>
<paragraph id="P-0033" lvl="0"><number>&lsqb;0033&rsqb;</number> Another invention embodiment is compounds of Formula VI-IX:  
<chemistry-cwu id="CHEM-US-00011">
<number>11</number>
<image id="EMI-C00011" he="468.54045" wi="198.02475" file="US20030004172A1-20030102-C00011.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00011" file="US20030004172A1-20030102-C00011.CDX"/>
<chemistry-mol-file id="CHEMMOL-00011" file="US20030004172A1-20030102-C00011.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0034" lvl="7"><number>&lsqb;0034&rsqb;</number> or a pharmaceutically acceptable salt thereof, wherein A, B, X, R<highlight><superscript>1</superscript></highlight>, R<highlight><superscript>2</superscript></highlight>, R<highlight><superscript>3</superscript></highlight>, and R<highlight><superscript>4 </superscript></highlight>are as defined above. </paragraph>
<paragraph id="P-0035" lvl="0"><number>&lsqb;0035&rsqb;</number> Another embodiment of the invention is a compound of Formula X  
<chemistry-cwu id="CHEM-US-00012">
<number>12</number>
<image id="EMI-C00012" he="91.4571" wi="198.02475" file="US20030004172A1-20030102-C00012.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00012" file="US20030004172A1-20030102-C00012.CDX"/>
<chemistry-mol-file id="CHEMMOL-00012" file="US20030004172A1-20030102-C00012.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0036" lvl="7"><number>&lsqb;0036&rsqb;</number> or a pharmaceutically acceptable salt thereof, wherein R<highlight><superscript>1</superscript></highlight>-R<highlight><superscript>4</superscript></highlight>, A, B, and X are as defined above. </paragraph>
<paragraph id="P-0037" lvl="0"><number>&lsqb;0037&rsqb;</number> Another invention embodiment is a compound, or a pharmaceutically acceptable salt thereof, in any one of the above formulas wherein R<highlight><superscript>4 </superscript></highlight>in the above formulas is hydrogen, methyl, or trifluoromethyl. </paragraph>
<paragraph id="P-0038" lvl="0"><number>&lsqb;0038&rsqb;</number> Another invention embodiment is a compound, or a pharmaceutically acceptable salt thereof, in any one of the above Formulas wherein R<highlight><superscript>4 </superscript></highlight>is methyl or trifluoromethyl. </paragraph>
<paragraph id="P-0039" lvl="0"><number>&lsqb;0039&rsqb;</number> Another invention embodiment is a compound, or a pharmaceutically acceptable salt thereof, in any one of the above formulas wherein R<highlight><superscript>1 </superscript></highlight>in the above formulas is (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heterocyclic, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl, wherein n is as defined above for Formula I. </paragraph>
<paragraph id="P-0040" lvl="0"><number>&lsqb;0040&rsqb;</number> Another invention embodiment is a compound, or a pharmaceutically acceptable salt thereof, in any one of the above formulas wherein R<highlight><superscript>2 </superscript></highlight>in the above Formulas is hydrogen or fluoro. </paragraph>
<paragraph id="P-0041" lvl="0"><number>&lsqb;0041&rsqb;</number> Another invention embodiment is a compound, or a pharmaceutically acceptable salt thereof, in any one of the above formulas wherein n in the above Formulas is 1. </paragraph>
<paragraph id="P-0042" lvl="0"><number>&lsqb;0042&rsqb;</number> Another invention embodiment is a compound, or a pharmaceutically acceptable salt thereof, in any one of the above Formulas  
<chemistry-cwu id="CHEM-US-00013">
<number>13</number>
<image id="EMI-C00013" he="22.31145" wi="113.2866" file="US20030004172A1-20030102-C00013.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00013" file="US20030004172A1-20030102-C00013.CDX"/>
<chemistry-mol-file id="CHEMMOL-00013" file="US20030004172A1-20030102-C00013.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0043" lvl="7"><number>&lsqb;0043&rsqb;</number> where A </paragraph>
<paragraph id="P-0044" lvl="0"><number>&lsqb;0044&rsqb;</number> Another invention embodiment is a compound, or a pharmaceutically acceptable salt thereof, of any one of the above Formulas which comprises a combination of any two or more embodiments selected from:  
<chemistry-cwu id="CHEM-US-00014">
<number>14</number>
<image id="EMI-C00014" he="22.5666" wi="142.0902" file="US20030004172A1-20030102-C00014.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00014" file="US20030004172A1-20030102-C00014.CDX"/>
<chemistry-mol-file id="CHEMMOL-00014" file="US20030004172A1-20030102-C00014.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0045" lvl="2"><number>&lsqb;0045&rsqb;</number> A&mdash;B is &mdash;C&equiv;C&mdash;, </paragraph>
<paragraph id="P-0046" lvl="2"><number>&lsqb;0046&rsqb;</number> &emsp;wherein R<highlight><superscript>5 </superscript></highlight>is as defined above for Formula I; </paragraph>
<paragraph id="P-0047" lvl="2"><number>&lsqb;0047&rsqb;</number> R<highlight><superscript>1 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>independently are (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heterocyclic, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl, wherein n is as defined above for Formula I; </paragraph>
<paragraph id="P-0048" lvl="2"><number>&lsqb;0048&rsqb;</number> R<highlight><superscript>2 </superscript></highlight>is hydrogen or fluoro; </paragraph>
<paragraph id="P-0049" lvl="2"><number>&lsqb;0049&rsqb;</number> R<highlight><superscript>4 </superscript></highlight>is methyl or trifluoromethyl; and </paragraph>
<paragraph id="P-0050" lvl="2"><number>&lsqb;0050&rsqb;</number> n is 1. </paragraph>
<paragraph id="P-0051" lvl="0"><number>&lsqb;0051&rsqb;</number> Another embodiment of the invention is a compound of Formula XI  
<chemistry-cwu id="CHEM-US-00015">
<number>15</number>
<image id="EMI-C00015" he="74.64555" wi="198.02475" file="US20030004172A1-20030102-C00015.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00015" file="US20030004172A1-20030102-C00015.CDX"/>
<chemistry-mol-file id="CHEMMOL-00015" file="US20030004172A1-20030102-C00015.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0052" lvl="7"><number>&lsqb;0052&rsqb;</number> or a pharmaceutically acceptable salt thereof, wherein: </paragraph>
<paragraph id="P-0053" lvl="2"><number>&lsqb;0053&rsqb;</number> W, together with the carbon atoms to which it is attached, form a 5-membered ring diradical  
<chemistry-cwu id="CHEM-US-00016">
<number>16</number>
<image id="EMI-C00016" he="56.89845" wi="54.00675" file="US20030004172A1-20030102-C00016.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00016" file="US20030004172A1-20030102-C00016.CDX"/>
<chemistry-mol-file id="CHEMMOL-00016" file="US20030004172A1-20030102-C00016.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0054" lvl="2"><number>&lsqb;0054&rsqb;</number> each Y independently is O or S; </paragraph>
<paragraph id="P-0055" lvl="2"><number>&lsqb;0055&rsqb;</number> X is S, O, or NR<highlight><superscript>5</superscript></highlight>; </paragraph>
<paragraph id="P-0056" lvl="2"><number>&lsqb;0056&rsqb;</number> R<highlight><superscript>1</superscript></highlight>, R<highlight><superscript>4</superscript></highlight>, and R<highlight><superscript>5 </superscript></highlight>independently are hydrogen, C<highlight><subscript>1</subscript></highlight>&mdash;C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heterocyclic, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkanoyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </paragraph>
<paragraph id="P-0057" lvl="2"><number>&lsqb;0057&rsqb;</number> R<highlight><superscript>2 </superscript></highlight>is hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, CN, NO<highlight><subscript>2</subscript></highlight>, NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </paragraph>
<paragraph id="P-0058" lvl="2"><number>&lsqb;0058&rsqb;</number> R<highlight><superscript>3 </superscript></highlight>is hydrogen, halo, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, CN, NO<highlight><subscript>2</subscript></highlight>, NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>q </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>q </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>q </subscript></highlight>heteroaryl; </paragraph>
<paragraph id="P-0059" lvl="2"><number>&lsqb;0059&rsqb;</number> n is 0, 1, or 2; </paragraph>
<paragraph id="P-0060" lvl="2"><number>&lsqb;0060&rsqb;</number> q is 2, 3, or 4; and </paragraph>
<paragraph id="P-0061" lvl="2"><number>&lsqb;0061&rsqb;</number> R<highlight><superscript>4 </superscript></highlight>and R<highlight><superscript>5 </superscript></highlight>when taken together with the nitrogen to which they are attached complete a 3- to 8-membered ring containing carbon atoms and optionally containing O, S, or N, and substituted or unsubstituted; </paragraph>
<paragraph id="P-0062" lvl="2"><number>&lsqb;0062&rsqb;</number> with the proviso that R<highlight><superscript>1 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>are not both selected from: hydrogen and C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl. </paragraph>
<paragraph id="P-0063" lvl="0"><number>&lsqb;0063&rsqb;</number> Another invention embodiment is the compound of Formula XI, or a pharmaceutically acceptable salt thereof, wherein Y is O and X is S. </paragraph>
<paragraph id="P-0064" lvl="0"><number>&lsqb;0064&rsqb;</number> Another invention embodiment is the compound of Formula XI, or a pharmaceutically acceptable salt thereof, wherein Y is O and X is O. </paragraph>
<paragraph id="P-0065" lvl="0"><number>&lsqb;0065&rsqb;</number> Another invention embodiment is the compound of Formula XI, or a pharmaceutically acceptable salt thereof, wherein Y is O and X is NR<highlight><superscript>5</superscript></highlight>, wherein R<highlight><superscript>5 </superscript></highlight>is hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heterocyclic, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkanoyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl. </paragraph>
<paragraph id="P-0066" lvl="0"><number>&lsqb;0066&rsqb;</number> The compounds of this invention typically will be named according to the following numbering system  
<chemistry-cwu id="CHEM-US-00017">
<number>17</number>
<image id="EMI-C00017" he="67.44465" wi="64.5813" file="US20030004172A1-20030102-C00017.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00017" file="US20030004172A1-20030102-C00017.CDX"/>
<chemistry-mol-file id="CHEMMOL-00017" file="US20030004172A1-20030102-C00017.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0067" lvl="0"><number>&lsqb;0067&rsqb;</number> The compound of the formula  
<chemistry-cwu id="CHEM-US-00018">
<number>18</number>
<image id="EMI-C00018" he="84.73815" wi="92.16585" file="US20030004172A1-20030102-C00018.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00018" file="US20030004172A1-20030102-C00018.CDX"/>
<chemistry-mol-file id="CHEMMOL-00018" file="US20030004172A1-20030102-C00018.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0068" lvl="7"><number>&lsqb;0068&rsqb;</number> will be named 3-ethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid. </paragraph>
<paragraph id="P-0069" lvl="0"><number>&lsqb;0069&rsqb;</number> Another invention embodiment are compounds provided by this invention selected from: </paragraph>
<paragraph id="P-0070" lvl="1"><number>&lsqb;0070&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; and </paragraph>
<paragraph id="P-0071" lvl="1"><number>&lsqb;0071&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester. </paragraph>
<paragraph id="P-0072" lvl="0"><number>&lsqb;0072&rsqb;</number> Another invention embodiment is a compound selected from: </paragraph>
<paragraph id="P-0073" lvl="1"><number>&lsqb;0073&rsqb;</number> 3-(4-Pyridyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0074" lvl="1"><number>&lsqb;0074&rsqb;</number> 3-(4-Pyridyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;-pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0075" lvl="1"><number>&lsqb;0075&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (4-pyridyl)ester; </paragraph>
<paragraph id="P-0076" lvl="1"><number>&lsqb;0076&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (4-pyridyl)ester; </paragraph>
<paragraph id="P-0077" lvl="1"><number>&lsqb;0077&rsqb;</number> 3-(4-Pyridyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (4-pyridyl)ester; </paragraph>
<paragraph id="P-0078" lvl="1"><number>&lsqb;0078&rsqb;</number> 3-(4-Pyridyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;-pyrimidine-6-carboxylic acid (4-pyridyl)ester; </paragraph>
<paragraph id="P-0079" lvl="1"><number>&lsqb;0079&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid piperoyl ester; </paragraph>
<paragraph id="P-0080" lvl="1"><number>&lsqb;0080&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid piperoyl ester; </paragraph>
<paragraph id="P-0081" lvl="1"><number>&lsqb;0081&rsqb;</number> 3-Piperoyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid piperoyl ester; </paragraph>
<paragraph id="P-0082" lvl="1"><number>&lsqb;0082&rsqb;</number> 3-Piperoyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;-pyrimidine-6-carboxylic acid piperoyl ester; </paragraph>
<paragraph id="P-0083" lvl="1"><number>&lsqb;0083&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-furo&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0084" lvl="1"><number>&lsqb;0084&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-1H-pyrrolo&lsqb;2,3-d&rsqb;-pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0085" lvl="1"><number>&lsqb;0085&rsqb;</number> 3-Benzyl-1,7-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-1H-pyrrolo&lsqb;2,3-d&rsqb;-pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0086" lvl="1"><number>&lsqb;0086&rsqb;</number> 3-Benzyl-1,7-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-1H-pyrrolo&lsqb;2,3-d&rsqb;-pyrimidine-6-carboxylic acid benzofuran-6-ylmethyl ester; </paragraph>
<paragraph id="P-0087" lvl="1"><number>&lsqb;0087&rsqb;</number> 3-Benzyl-1-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-1H-pyrrolo&lsqb;2,3-d&rsqb;-pyrimidine-6-carboxylic acid benzofuran-6-ylmethyl ester; </paragraph>
<paragraph id="P-0088" lvl="1"><number>&lsqb;0088&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-furo&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzofuran-6-ylmethyl ester; </paragraph>
<paragraph id="P-0089" lvl="1"><number>&lsqb;0089&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzofuran-6-ylmethyl ester; </paragraph>
<paragraph id="P-0090" lvl="1"><number>&lsqb;0090&rsqb;</number> 3-Benzyl-1,7-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-1H-pyrrolo&lsqb;2,3-d&rsqb;-pyrimidine-6-carboxylic acid benzothiophene-6-ylmethyl ester; </paragraph>
<paragraph id="P-0091" lvl="1"><number>&lsqb;0091&rsqb;</number> 3-Benzyl-1-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-1H-pyrrolo&lsqb;2,3-d&rsqb;-pyrimidine-6-carboxylic acid benzothiophene-6-ylmethyl ester; </paragraph>
<paragraph id="P-0092" lvl="1"><number>&lsqb;0092&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-furo&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzothiophene-6-ylmethyl ester; and </paragraph>
<paragraph id="P-0093" lvl="1"><number>&lsqb;0093&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzothiophene-6-ylmethyl ester. </paragraph>
<paragraph id="P-0094" lvl="0"><number>&lsqb;0094&rsqb;</number> Another invention embodiment is a compound selected from: </paragraph>
<paragraph id="P-0095" lvl="1"><number>&lsqb;0095&rsqb;</number> 3-(3-Methoxy-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0096" lvl="1"><number>&lsqb;0096&rsqb;</number> 3-(4-Chloro-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0097" lvl="1"><number>&lsqb;0097&rsqb;</number> 3-(4-Cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0098" lvl="1"><number>&lsqb;0098&rsqb;</number> 3-(4-Fluoro-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0099" lvl="1"><number>&lsqb;0099&rsqb;</number> 3-(3-Chloro-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0100" lvl="1"><number>&lsqb;0100&rsqb;</number> 1-Methyl-3-(2-methyl-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0101" lvl="1"><number>&lsqb;0101&rsqb;</number> 1-Methyl-3-(4-methyl-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0102" lvl="1"><number>&lsqb;0102&rsqb;</number> 3-(4-Carboxy-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0103" lvl="1"><number>&lsqb;0103&rsqb;</number> 1-Methyl-2,4-dioxo-3-(3-trifluoromethyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0104" lvl="1"><number>&lsqb;0104&rsqb;</number> 3-Biphenyl-4-ylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0105" lvl="1"><number>&lsqb;0105&rsqb;</number> 1-Methyl-2,4-dioxo-3-(2-trifluoromethyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0106" lvl="1"><number>&lsqb;0106&rsqb;</number> 3-(3-Cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0107" lvl="1"><number>&lsqb;0107&rsqb;</number> 3-(2-Cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0108" lvl="1"><number>&lsqb;0108&rsqb;</number> 1-Methyl-2,4-dioxo-3-(4-trifluoromethyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0109" lvl="1"><number>&lsqb;0109&rsqb;</number> 3-&lsqb;2-Hydroxy-3-(naphthalen-1-yloxy)-propyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0110" lvl="1"><number>&lsqb;0110&rsqb;</number> 3-(3-Chloro-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0111" lvl="1"><number>&lsqb;0111&rsqb;</number> 1-Methyl-3-naphthalen-1-ylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0112" lvl="1"><number>&lsqb;0112&rsqb;</number> 3-(6-Chloro-benzo&lsqb;1,3&rsqb;dioxol-5-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0113" lvl="1"><number>&lsqb;0113&rsqb;</number> 1-Methyl-2,4-dioxo-3-(4-oxo-4-thiophen-2-yl-butyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0114" lvl="1"><number>&lsqb;0114&rsqb;</number> 1-Methyl-2,4-dioxo-3-pyridin-4-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0115" lvl="1"><number>&lsqb;0115&rsqb;</number> 1-Methyl-2,4-dioxo-3-(4-m-tolyloxy-butyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0116" lvl="1"><number>&lsqb;0116&rsqb;</number> 3-(3,5-Dimethyl-isoxazol-4-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0117" lvl="1"><number>&lsqb;0117&rsqb;</number> 3-Dioxo-1,3-dihydro-isoindol-2-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0118" lvl="1"><number>&lsqb;0118&rsqb;</number> 3-Dihydro-benzo&lsqb;1,4&rsqb;dioxin-2-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0119" lvl="1"><number>&lsqb;0119&rsqb;</number> 1-Methyl-2,4-dioxo-3-pyridin-2-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0120" lvl="1"><number>&lsqb;0120&rsqb;</number> 3-&lsqb;2-(2,5-Dimethoxy-phenyl)-2-oxo-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0121" lvl="1"><number>&lsqb;0121&rsqb;</number> 3-Benzyloxymethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0122" lvl="1"><number>&lsqb;0122&rsqb;</number> 1-Methyl-2,4-dioxo-3-(4-m-tolyloxy-butyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0123" lvl="1"><number>&lsqb;0123&rsqb;</number> 1-Methyl-2,4-dioxo-3-(2-phenylmethanesulfonyl-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0124" lvl="1"><number>&lsqb;0124&rsqb;</number> 3-(4-Amino-6-phenylamino-&lsqb;1,3,5&rsqb;triazin-2-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0125" lvl="1"><number>&lsqb;0125&rsqb;</number> 3-&lsqb;4-(4-Fluoro-phenyl)-4-oxo-butyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0126" lvl="1"><number>&lsqb;0126&rsqb;</number> 3-&lsqb;4-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-butyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0127" lvl="1"><number>&lsqb;0127&rsqb;</number> 1-Methyl-2,4-dioxo-3-(4-phenoxy-butyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0128" lvl="1"><number>&lsqb;0128&rsqb;</number> 1-Methyl-2,4-dioxo-3-(4-oxo-4-phenyl-butyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0129" lvl="1"><number>&lsqb;0129&rsqb;</number> 1-Methyl-2,4-dioxo-3-(2-phenoxy-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0130" lvl="1"><number>&lsqb;0130&rsqb;</number> 3-&lcub;3-&lsqb;4-(3-Chloro-phenyl)-piperazin-1-yl&rsqb;-propyl&rcub;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0131" lvl="1"><number>&lsqb;0131&rsqb;</number> 3-&lsqb;1-Bromo-2-(1H-indol-3-yl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0132" lvl="1"><number>&lsqb;0132&rsqb;</number> 3-(2-Benzenesulfinyl-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0133" lvl="1"><number>&lsqb;0133&rsqb;</number> 3-&lsqb;3-(3-Fluoro-phenylcarbamoyl)-propyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0134" lvl="1"><number>&lsqb;0134&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lsqb;2-(2-trifluoromethyl-phenylcarbamoyl)-ethyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0135" lvl="1"><number>&lsqb;0135&rsqb;</number> 3-&lsqb;2-(4-Methoxy-phenyl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0136" lvl="1"><number>&lsqb;0136&rsqb;</number> 3-&lsqb;2-(4-Chloro-2-nitro-phenoxy)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0137" lvl="1"><number>&lsqb;0137&rsqb;</number> 1-Methyl-3-(5-nitro-furan-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0138" lvl="1"><number>&lsqb;0138&rsqb;</number> 3-(1-Benzyl-1H-imidazol-2-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0139" lvl="1"><number>&lsqb;0139&rsqb;</number> 3-&lsqb;3-(Benzyl-methyl-amino)-propyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0140" lvl="1"><number>&lsqb;0140&rsqb;</number> 3-(Bis-trifluoromethyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0141" lvl="1"><number>&lsqb;0141&rsqb;</number> 3-&lsqb;3-(2-Bromo-4-methyl-phenoxy)-propyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0142" lvl="1"><number>&lsqb;0142&rsqb;</number> 3-Benzenesulfonylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0143" lvl="1"><number>&lsqb;0143&rsqb;</number> 3-&lsqb;2-(4-Chloro-benzenesulfonyl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0144" lvl="1"><number>&lsqb;0144&rsqb;</number> 3-Benzo&lsqb;1,3&rsqb;dioxol-5-ylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0145" lvl="1"><number>&lsqb;0145&rsqb;</number> 3-(3-Iodo-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0146" lvl="1"><number>&lsqb;0146&rsqb;</number> 1-Methyl-2,4-dioxo-3-(4-trifluoromethoxy-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0147" lvl="1"><number>&lsqb;0147&rsqb;</number> 3-(4-Acetoxy-butyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0148" lvl="1"><number>&lsqb;0148&rsqb;</number> 3-(4-Methanesulfonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0149" lvl="1"><number>&lsqb;0149&rsqb;</number> 1-Methyl-2,4-dioxo-3-(4-&lsqb;1,2,3&rsqb;thiadiazol-4-yl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0150" lvl="1"><number>&lsqb;0150&rsqb;</number> 3-(5-Methoxycarbonyl-furan-2-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0151" lvl="1"><number>&lsqb;0151&rsqb;</number> 3-(2-Carboxy-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0152" lvl="1"><number>&lsqb;0152&rsqb;</number> 1-Methyl-2,4-dioxo-3-(3-pyrrol-1-yl-propyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0153" lvl="1"><number>&lsqb;0153&rsqb;</number> 3-(3-Carboxy-propyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0154" lvl="1"><number>&lsqb;0154&rsqb;</number> 3-(2-Cyano-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0155" lvl="1"><number>&lsqb;0155&rsqb;</number> 3-(3-Ethoxycarbonyl-furan-2-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0156" lvl="1"><number>&lsqb;0156&rsqb;</number> 3-(3-Amino-propyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0157" lvl="1"><number>&lsqb;0157&rsqb;</number> 3-(3-Cyano-propyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0158" lvl="1"><number>&lsqb;0158&rsqb;</number> 3-(2-Hydroxy-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0159" lvl="1"><number>&lsqb;0159&rsqb;</number> 3-(2-Carboxy-hexyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0160" lvl="1"><number>&lsqb;0160&rsqb;</number> 1-Methyl-2,4-dioxo-3-(2,2,2-trifluoro-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0161" lvl="1"><number>&lsqb;0161&rsqb;</number> 1-Methyl-2,4-dioxo-3-(2,2,2-trifluoro-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxyl carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0162" lvl="1"><number>&lsqb;0162&rsqb;</number> Iodomethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0163" lvl="1"><number>&lsqb;0163&rsqb;</number> 3-(2-Fluoro-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0164" lvl="1"><number>&lsqb;0164&rsqb;</number> Methyl-2,4-dioxo-3-(tetrahydro-furan-2-ylmethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0165" lvl="1"><number>&lsqb;0165&rsqb;</number> 3-&lsqb;1-(4-Carboxy-phenyl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0166" lvl="1"><number>&lsqb;0166&rsqb;</number> 3-(Hex-5-enyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0167" lvl="1"><number>&lsqb;0167&rsqb;</number> 3-(2-Ethyl-butyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0168" lvl="1"><number>&lsqb;0168&rsqb;</number> 1-Methyl-2,4-dioxo-3-(2,2,2-trifluoro-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxyl pyrimidine acid benzyl ester; </paragraph>
<paragraph id="P-0169" lvl="1"><number>&lsqb;0169&rsqb;</number> 3-(Diethoxy-phosphorylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0170" lvl="1"><number>&lsqb;0170&rsqb;</number> 3-But-2-ynyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0171" lvl="1"><number>&lsqb;0171&rsqb;</number> Bromo-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid; </paragraph>
<paragraph id="P-0172" lvl="1"><number>&lsqb;0172&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lsqb;2-(tetrahydro-pyran-2-yloxy)-ethyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0173" lvl="1"><number>&lsqb;0173&rsqb;</number> 1-Methyl-2,4-dioxo-3-propyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0174" lvl="1"><number>&lsqb;0174&rsqb;</number> 3-(2-Acetoxy-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid; </paragraph>
<paragraph id="P-0175" lvl="1"><number>&lsqb;0175&rsqb;</number> 3-Butyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0176" lvl="1"><number>&lsqb;0176&rsqb;</number> 3-Isobutyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0177" lvl="1"><number>&lsqb;0177&rsqb;</number> 3-Ethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0178" lvl="1"><number>&lsqb;0178&rsqb;</number> 3-(3-Bromo-propyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0179" lvl="1"><number>&lsqb;0179&rsqb;</number> 3-Cyclohexylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0180" lvl="1"><number>&lsqb;0180&rsqb;</number> 3-(2-Ethylamino-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0181" lvl="1"><number>&lsqb;0181&rsqb;</number> 3-Cyclobutylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0182" lvl="1"><number>&lsqb;0182&rsqb;</number> 3-((R)-3-Hydroxy-2-methyl-propyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0183" lvl="1"><number>&lsqb;0183&rsqb;</number> 3-(4-Hydroxy-butyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0184" lvl="1"><number>&lsqb;0184&rsqb;</number> 3-(2-Ethoxy-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0185" lvl="1"><number>&lsqb;0185&rsqb;</number> 3-Isobutyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0186" lvl="1"><number>&lsqb;0186&rsqb;</number> 3-(2-Chloro-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0187" lvl="1"><number>&lsqb;0187&rsqb;</number> 1-Methyl-3-(3-methyl-but-2-enyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0188" lvl="1"><number>&lsqb;0188&rsqb;</number> 3-Allyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0189" lvl="1"><number>&lsqb;0189&rsqb;</number> 3-(2,2-Dimethoxy-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0190" lvl="1"><number>&lsqb;0190&rsqb;</number> 1-Methyl-3-oxiranylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0191" lvl="1"><number>&lsqb;0191&rsqb;</number> 1-Methyl-2,4-dioxo-3-propyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0192" lvl="1"><number>&lsqb;0192&rsqb;</number> 3-Benzo&lsqb;1,2,5&rsqb;oxadiazol-5-ylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0193" lvl="1"><number>&lsqb;0193&rsqb;</number> 3-(3-Hydroxy-2,2-dimethyl-propyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0194" lvl="1"><number>&lsqb;0194&rsqb;</number> 3-(2-Carboxy-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0195" lvl="1"><number>&lsqb;0195&rsqb;</number> 3-Propyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic benzyl ester; </paragraph>
<paragraph id="P-0196" lvl="1"><number>&lsqb;0196&rsqb;</number> 1-Methyl-2,4-dioxo-3-(4-sulfamoyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0197" lvl="1"><number>&lsqb;0197&rsqb;</number> 1-Methyl-3-(4-methylsulfamoyl-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0198" lvl="1"><number>&lsqb;0198&rsqb;</number> 3-(4-Dimethylsulfamoyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0199" lvl="1"><number>&lsqb;0199&rsqb;</number> 3-(4-Methanesulfonylamino-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0200" lvl="1"><number>&lsqb;0200&rsqb;</number> 3-&lsqb;4-(Methanesulfonyl-methyl-amino)-benzyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0201" lvl="1"><number>&lsqb;0201&rsqb;</number> 3-(4-Acetylamino-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0202" lvl="1"><number>&lsqb;0202&rsqb;</number> 3-&lsqb;4-(Acetyl-methyl-amino)-benzyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0203" lvl="1"><number>&lsqb;0203&rsqb;</number> 3-(4-Dimethylamino-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0204" lvl="1"><number>&lsqb;0204&rsqb;</number> 1-Methyl-3-(4-methylamino-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0205" lvl="1"><number>&lsqb;0205&rsqb;</number> 3-(4-Carbamoyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0206" lvl="1"><number>&lsqb;0206&rsqb;</number> 3-(4-Dimethylcarbamoyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0207" lvl="1"><number>&lsqb;0207&rsqb;</number> 3-(4-Carboxy-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0208" lvl="1"><number>&lsqb;0208&rsqb;</number> 3-(4-Methoxycarbonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0209" lvl="1"><number>&lsqb;0209&rsqb;</number> 3-&lcub;4-&lsqb;Bis-(2-hydroxy-ethyl)-amino&rsqb;-benzyl&rcub;-1-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0210" lvl="1"><number>&lsqb;0210&rsqb;</number> 3-(3,5-Dimethoxy-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0211" lvl="1"><number>&lsqb;0211&rsqb;</number> 3-(4-tert-Butyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0212" lvl="1"><number>&lsqb;0212&rsqb;</number> 1-Methyl-2,4-dioxo-3-(4-trifluoromethoxy-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0213" lvl="1"><number>&lsqb;0213&rsqb;</number> 3-(4-Methanesulfonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0214" lvl="1"><number>&lsqb;0214&rsqb;</number> 2,4-Dioxo-3-&lsqb;1,3,4&rsqb;thiadiazol-2-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0215" lvl="1"><number>&lsqb;0215&rsqb;</number> 3-Isoxazol-3-ylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0216" lvl="1"><number>&lsqb;0216&rsqb;</number> 3-Oxazol-2-ylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0217" lvl="1"><number>&lsqb;0217&rsqb;</number> 2,4-Dioxo-3-thiazol-2-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0218" lvl="1"><number>&lsqb;0218&rsqb;</number> 3-(1H-Imidazol-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0219" lvl="1"><number>&lsqb;0219&rsqb;</number> 3-(1-Methyl-1H-imidazol-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0220" lvl="1"><number>&lsqb;0220&rsqb;</number> 3-(1-Methyl-1H-pyrrol-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0221" lvl="1"><number>&lsqb;0221&rsqb;</number> 2,4-Dioxo-3-(1H-pyrrol-2-ylmethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0222" lvl="1"><number>&lsqb;0222&rsqb;</number> 2,4-Dioxo-3-(1H-pyrrol-2-ylmethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0223" lvl="1"><number>&lsqb;0223&rsqb;</number> 2,4-Dioxo-3-thiophen-2-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0224" lvl="1"><number>&lsqb;0224&rsqb;</number> 2,4-Dioxo-3-&lsqb;1,2,3,4&rsqb;tetrazin-5-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0225" lvl="1"><number>&lsqb;0225&rsqb;</number> 2,4-Dioxo-3-&lsqb;1,2,4,5&rsqb;tetrazin-3-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0226" lvl="1"><number>&lsqb;0226&rsqb;</number> 3-(1-Methyl-piperidin-4-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0227" lvl="1"><number>&lsqb;0227&rsqb;</number> 2,4-Dioxo-3-pyrimidin-2-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0228" lvl="1"><number>&lsqb;0228&rsqb;</number> 2,4-Dioxo-3-(2H-pyran-2-ylmethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0229" lvl="1"><number>&lsqb;0229&rsqb;</number> 3-(1H-Imidazo&lsqb;4,5-b&rsqb;pyridin-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0230" lvl="1"><number>&lsqb;0230&rsqb;</number> 3-(1H-Benzoimidazol-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0231" lvl="1"><number>&lsqb;0231&rsqb;</number> 3-Benzo&lsqb;b&rsqb;thiophen-2-ylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0232" lvl="1"><number>&lsqb;0232&rsqb;</number> 2,4-Dioxo-3-quinolin-2-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0233" lvl="1"><number>&lsqb;0233&rsqb;</number> 3-(2H-Chromen-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0234" lvl="1"><number>&lsqb;0234&rsqb;</number> 3-(1H-Benzoimidazol-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0235" lvl="1"><number>&lsqb;0235&rsqb;</number> 3-(1-Methyl-1H-benzoimidazol-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0236" lvl="1"><number>&lsqb;0236&rsqb;</number> 3-(1H-Indol-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0237" lvl="1"><number>&lsqb;0237&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid furan-3-ylmethyl ester; </paragraph>
<paragraph id="P-0238" lvl="1"><number>&lsqb;0238&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-ethyl-propyl ester; </paragraph>
<paragraph id="P-0239" lvl="1"><number>&lsqb;0239&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1,1-dioxo-tetrahydro-116-thiophen-3-yl ester; </paragraph>
<paragraph id="P-0240" lvl="1"><number>&lsqb;0240&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-hydroxy-benzyl ester; </paragraph>
<paragraph id="P-0241" lvl="1"><number>&lsqb;0241&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-oxy-pyridin-4-ylmethyl ester; </paragraph>
<paragraph id="P-0242" lvl="1"><number>&lsqb;0242&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid but-3-enyl ester; </paragraph>
<paragraph id="P-0243" lvl="1"><number>&lsqb;0243&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-diethylamino-propyl ester; </paragraph>
<paragraph id="P-0244" lvl="1"><number>&lsqb;0244&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-cyano-1-phenyl-methyl ester; </paragraph>
<paragraph id="P-0245" lvl="1"><number>&lsqb;0245&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-amino-benzyl ester; </paragraph>
<paragraph id="P-0246" lvl="1"><number>&lsqb;0246&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzyl ester; </paragraph>
<paragraph id="P-0247" lvl="1"><number>&lsqb;0247&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-oxy-pyridin-3-ylmethyl ester; </paragraph>
<paragraph id="P-0248" lvl="1"><number>&lsqb;0248&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-ethoxy-ethyl ester; </paragraph>
<paragraph id="P-0249" lvl="1"><number>&lsqb;0249&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid thiophen-2-ylmethyl ester; </paragraph>
<paragraph id="P-0250" lvl="1"><number>&lsqb;0250&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,6-dichloro-benzyl ester; </paragraph>
<paragraph id="P-0251" lvl="1"><number>&lsqb;0251&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid dimethylamino-methyl-ethyl ester; </paragraph>
<paragraph id="P-0252" lvl="1"><number>&lsqb;0252&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,2-diphenyl-ethyl ester; </paragraph>
<paragraph id="P-0253" lvl="1"><number>&lsqb;0253&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-pyridin -2-yl-ethyl ester; </paragraph>
<paragraph id="P-0254" lvl="1"><number>&lsqb;0254&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-ethanesulfonyl-ethyl ester; </paragraph>
<paragraph id="P-0255" lvl="1"><number>&lsqb;0255&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid diethylamino-methyl-ethyl ester; </paragraph>
<paragraph id="P-0256" lvl="1"><number>&lsqb;0256&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid dimethylamino-methyl-propyl ester; </paragraph>
<paragraph id="P-0257" lvl="1"><number>&lsqb;0257&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-(2-chloro-phenoxy)-ethyl ester; </paragraph>
<paragraph id="P-0258" lvl="1"><number>&lsqb;0258&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-(2-ethoxy-ethoxy)-ethyl ester; </paragraph>
<paragraph id="P-0259" lvl="1"><number>&lsqb;0259&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-hydroxy-benzyl ester; </paragraph>
<paragraph id="P-0260" lvl="1"><number>&lsqb;0260&rsqb;</number> 1-Methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-morpholin-4-yl-ethyl ester; </paragraph>
<paragraph id="P-0261" lvl="1"><number>&lsqb;0261&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-ethyl ester; </paragraph>
<paragraph id="P-0262" lvl="1"><number>&lsqb;0262&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,3-dihydro-benzo&lsqb;1,4&rsqb;dioxin-2-ylmethyl ester; </paragraph>
<paragraph id="P-0263" lvl="1"><number>&lsqb;0263&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-methyl-piperidin-4-yl ester; </paragraph>
<paragraph id="P-0264" lvl="1"><number>&lsqb;0264&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-(4-hydroxy-phenyl)-ethyl ester; </paragraph>
<paragraph id="P-0265" lvl="1"><number>&lsqb;0265&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-cyano-ethyl ester; </paragraph>
<paragraph id="P-0266" lvl="1"><number>&lsqb;0266&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid hexyl ester; </paragraph>
<paragraph id="P-0267" lvl="1"><number>&lsqb;0267&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-fluoro-benzyl ester; </paragraph>
<paragraph id="P-0268" lvl="1"><number>&lsqb;0268&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-hydroxy-6-methyl-pyridin-2-ylmethyl ester; </paragraph>
<paragraph id="P-0269" lvl="1"><number>&lsqb;0269&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-benzyloxy-ethyl ester; </paragraph>
<paragraph id="P-0270" lvl="1"><number>&lsqb;0270&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-methoxy-benzyl ester; </paragraph>
<paragraph id="P-0271" lvl="1"><number>&lsqb;0271&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzyl ester; </paragraph>
<paragraph id="P-0272" lvl="1"><number>&lsqb;0272&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,2,2-trifluoro-ethyl ester; </paragraph>
<paragraph id="P-0273" lvl="1"><number>&lsqb;0273&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,2,2-trichloro-ethyl ester; </paragraph>
<paragraph id="P-0274" lvl="1"><number>&lsqb;0274&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-3-ylmethyl ester; </paragraph>
<paragraph id="P-0275" lvl="1"><number>&lsqb;0275&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-4-ylmethyl ester; </paragraph>
<paragraph id="P-0276" lvl="1"><number>&lsqb;0276&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-pyridin-3-yl-propyl ester; </paragraph>
<paragraph id="P-0277" lvl="1"><number>&lsqb;0277&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid; </paragraph>
<paragraph id="P-0278" lvl="1"><number>&lsqb;0278&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-phenoxy-ethyl ester; </paragraph>
<paragraph id="P-0279" lvl="1"><number>&lsqb;0279&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1,3-dimethyl-butyl ester; </paragraph>
<paragraph id="P-0280" lvl="1"><number>&lsqb;0280&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-methyl-benzyl ester; </paragraph>
<paragraph id="P-0281" lvl="1"><number>&lsqb;0281&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-phenyl-ethyl ester; </paragraph>
<paragraph id="P-0282" lvl="1"><number>&lsqb;0282&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-benzyl-piperidin-4-yl ester; </paragraph>
<paragraph id="P-0283" lvl="1"><number>&lsqb;0283&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid propyl ester; </paragraph>
<paragraph id="P-0284" lvl="1"><number>&lsqb;0284&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid methyl ester; </paragraph>
<paragraph id="P-0285" lvl="1"><number>&lsqb;0285&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-trifluoromethyl-benzyl ester; </paragraph>
<paragraph id="P-0286" lvl="1"><number>&lsqb;0286&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-p-tolyl-ethyl ester; </paragraph>
<paragraph id="P-0287" lvl="1"><number>&lsqb;0287&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-trifluoromethyl-benzyl ester; </paragraph>
<paragraph id="P-0288" lvl="1"><number>&lsqb;0288&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid tetrahydro-furan-2-ylmethyl ester; </paragraph>
<paragraph id="P-0289" lvl="1"><number>&lsqb;0289&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid octahydro-inden-5-yl ester; </paragraph>
<paragraph id="P-0290" lvl="1"><number>&lsqb;0290&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-amino-benzyl ester; </paragraph>
<paragraph id="P-0291" lvl="1"><number>&lsqb;0291&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-aziridin-1-yl-ethyl ester; </paragraph>
<paragraph id="P-0292" lvl="1"><number>&lsqb;0292&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methyl-but-2-enyl ester; </paragraph>
<paragraph id="P-0293" lvl="1"><number>&lsqb;0293&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0294" lvl="1"><number>&lsqb;0294&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid trifluoro-trifluoromethyl-ethyl ester; </paragraph>
<paragraph id="P-0295" lvl="1"><number>&lsqb;0295&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid phenethyl ester; </paragraph>
<paragraph id="P-0296" lvl="1"><number>&lsqb;0296&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-methoxy-ethyl ester; </paragraph>
<paragraph id="P-0297" lvl="1"><number>&lsqb;0297&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid biphenyl-4-ylmethyl ester; </paragraph>
<paragraph id="P-0298" lvl="1"><number>&lsqb;0298&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-chloro-6-fluoro-benzyl ester; </paragraph>
<paragraph id="P-0299" lvl="1"><number>&lsqb;0299&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid tetrahydro-pyran-4-yl ester; </paragraph>
<paragraph id="P-0300" lvl="1"><number>&lsqb;0300&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-ethyl-oxetan-3-ylmethyl ester; </paragraph>
<paragraph id="P-0301" lvl="1"><number>&lsqb;0301&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid butyl ester; </paragraph>
<paragraph id="P-0302" lvl="1"><number>&lsqb;0302&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-(2-hydroxy-phenyl)-ethyl ester; </paragraph>
<paragraph id="P-0303" lvl="1"><number>&lsqb;0303&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-(4-fluoro-phenyl)-ethyl ester; </paragraph>
<paragraph id="P-0304" lvl="1"><number>&lsqb;0304&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cyclopropylmethyl ester; </paragraph>
<paragraph id="P-0305" lvl="1"><number>&lsqb;0305&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-ethyl-benzyl ester; </paragraph>
<paragraph id="P-0306" lvl="1"><number>&lsqb;0306&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (S)-1-phenyl-ethyl ester; </paragraph>
<paragraph id="P-0307" lvl="1"><number>&lsqb;0307&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,6-difluoro-benzyl ester; </paragraph>
<paragraph id="P-0308" lvl="1"><number>&lsqb;0308&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cyclobutyl methyl ester; </paragraph>
<paragraph id="P-0309" lvl="1"><number>&lsqb;0309&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-pyridin-4-yl-ethyl ester; </paragraph>
<paragraph id="P-0310" lvl="1"><number>&lsqb;0310&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-hydroxy-cyclopentyl ester; </paragraph>
<paragraph id="P-0311" lvl="1"><number>&lsqb;0311&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-pentafluorophenyl-ethyl ester; </paragraph>
<paragraph id="P-0312" lvl="1"><number>&lsqb;0312&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-benzyloxycarbonylamino-ethyl ester; and </paragraph>
<paragraph id="P-0313" lvl="1"><number>&lsqb;0313&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid ethyl ester. </paragraph>
<paragraph id="P-0314" lvl="0"><number>&lsqb;0314&rsqb;</number> Another invention embodiment is any compound of the above formulas wherein  
<chemistry-cwu id="CHEM-US-00019">
<number>19</number>
<image id="EMI-C00019" he="22.5666" wi="48.4785" file="US20030004172A1-20030102-C00019.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00019" file="US20030004172A1-20030102-C00019.CDX"/>
<chemistry-mol-file id="CHEMMOL-00019" file="US20030004172A1-20030102-C00019.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0315" lvl="7"><number>&lsqb;0315&rsqb;</number> and B is NR<highlight><superscript>5</superscript></highlight>, wherein R<highlight><superscript>5 </superscript></highlight>is as defined above. </paragraph>
<paragraph id="P-0316" lvl="0"><number>&lsqb;0316&rsqb;</number> Another invention embodiment is a compound selected from: </paragraph>
<paragraph id="P-0317" lvl="1"><number>&lsqb;0317&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-pyridin-4-yl-ethyl)-amide; </paragraph>
<paragraph id="P-0318" lvl="1"><number>&lsqb;0318&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-morpholin-4-yl-ethyl)-amide; </paragraph>
<paragraph id="P-0319" lvl="1"><number>&lsqb;0319&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methyl-benzylamide; </paragraph>
<paragraph id="P-0320" lvl="1"><number>&lsqb;0320&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid sec-butylamide; </paragraph>
<paragraph id="P-0321" lvl="1"><number>&lsqb;0321&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cyclopentylamide; </paragraph>
<paragraph id="P-0322" lvl="1"><number>&lsqb;0322&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cyclopropylamide; </paragraph>
<paragraph id="P-0323" lvl="1"><number>&lsqb;0323&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cyanomethyl-amide; </paragraph>
<paragraph id="P-0324" lvl="1"><number>&lsqb;0324&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cyclohexylamide; </paragraph>
<paragraph id="P-0325" lvl="1"><number>&lsqb;0325&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methyl-benzylamide; </paragraph>
<paragraph id="P-0326" lvl="1"><number>&lsqb;0326&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (3-ethoxy-propyl)-amide; </paragraph>
<paragraph id="P-0327" lvl="1"><number>&lsqb;0327&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-chloro-benzylamide; </paragraph>
<paragraph id="P-0328" lvl="1"><number>&lsqb;0328&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-methyl-benzylamide; </paragraph>
<paragraph id="P-0329" lvl="1"><number>&lsqb;0329&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2,2-diphenyl-ethyl)-amide; </paragraph>
<paragraph id="P-0330" lvl="1"><number>&lsqb;0330&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (pyridin-3-ylmethyl)-amide; </paragraph>
<paragraph id="P-0331" lvl="1"><number>&lsqb;0331&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cyclopropylmethyl-amide; </paragraph>
<paragraph id="P-0332" lvl="1"><number>&lsqb;0332&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (1-ethyl-pyrrolidin-2-ylmethyl)-amide; </paragraph>
<paragraph id="P-0333" lvl="1"><number>&lsqb;0333&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (pyridin-2-ylmethyl)-amide; </paragraph>
<paragraph id="P-0334" lvl="1"><number>&lsqb;0334&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(3,4-dimethoxy-phenyl)-ethyl&rsqb;-amide; </paragraph>
<paragraph id="P-0335" lvl="1"><number>&lsqb;0335&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (furan-2-ylmethyl)-amide; </paragraph>
<paragraph id="P-0336" lvl="1"><number>&lsqb;0336&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-fluoro-benzylamide; </paragraph>
<paragraph id="P-0337" lvl="1"><number>&lsqb;0337&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-bromo-ethyl)-amide; </paragraph>
<paragraph id="P-0338" lvl="1"><number>&lsqb;0338&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-sulfamoyl-benzylamide; </paragraph>
<paragraph id="P-0339" lvl="1"><number>&lsqb;0339&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0340" lvl="1"><number>&lsqb;0340&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0341" lvl="1"><number>&lsqb;0341&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid phenethyl-amide; </paragraph>
<paragraph id="P-0342" lvl="1"><number>&lsqb;0342&rsqb;</number> (S)-2-&lcub;&lsqb;1-(3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidin-6-yl)-methanoyl&rsqb;-amino&rcub;-propionic acid; </paragraph>
<paragraph id="P-0343" lvl="1"><number>&lsqb;0343&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (1-phenyl-ethyl)-amide; </paragraph>
<paragraph id="P-0344" lvl="1"><number>&lsqb;0344&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-methoxy-benzylamide; </paragraph>
<paragraph id="P-0345" lvl="1"><number>&lsqb;0345&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzylamide; </paragraph>
<paragraph id="P-0346" lvl="1"><number>&lsqb;0346&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-bromo-benzylamide; </paragraph>
<paragraph id="P-0347" lvl="1"><number>&lsqb;0347&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(4-sulfamoyl-phenyl)-ethyl&rsqb;-amide; </paragraph>
<paragraph id="P-0348" lvl="1"><number>&lsqb;0348&rsqb;</number> 2-&lcub;&lsqb;1-(3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidin-6-yl)-methanoyl&rsqb;-amino&rcub;-3-phenyl-propionic acid methyl ester; </paragraph>
<paragraph id="P-0349" lvl="1"><number>&lsqb;0349&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (3-imidazol-1-yl-propyl)-amide; </paragraph>
<paragraph id="P-0350" lvl="1"><number>&lsqb;0350&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(2-methoxy-phenyl)-ethyl&rsqb;-amide; </paragraph>
<paragraph id="P-0351" lvl="1"><number>&lsqb;0351&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-trifluoromethyl-benzylamide; </paragraph>
<paragraph id="P-0352" lvl="1"><number>&lsqb;0352&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-amino-benzylamide; </paragraph>
<paragraph id="P-0353" lvl="1"><number>&lsqb;0353&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(4-fluoro-phenyl)-ethyl&rsqb;-amide; and </paragraph>
<paragraph id="P-0354" lvl="1"><number>&lsqb;0354&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid ((R)-2-hydroxy-1-methyl-ethyl)-amide. </paragraph>
<paragraph id="P-0355" lvl="0"><number>&lsqb;0355&rsqb;</number> Another invention embodiment is a compound selected from: </paragraph>
<paragraph id="P-0356" lvl="1"><number>&lsqb;0356&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzofuran-5-ylmethyl ester; </paragraph>
<paragraph id="P-0357" lvl="1"><number>&lsqb;0357&rsqb;</number> (3-&lcub;&lsqb;1-(3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidin-6-yl)-methanoyl&rsqb;-amino&rcub;-propyl)-carbamic acid tert-butyl ester; </paragraph>
<paragraph id="P-0358" lvl="1"><number>&lsqb;0358&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzofuran-2-ylmethyl ester; </paragraph>
<paragraph id="P-0359" lvl="1"><number>&lsqb;0359&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid thiophen-3-ylmethyl ester; </paragraph>
<paragraph id="P-0360" lvl="1"><number>&lsqb;0360&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3H-&lsqb;1,2,3&rsqb;oxathiazol-5-ylmethyl ester; </paragraph>
<paragraph id="P-0361" lvl="1"><number>&lsqb;0361&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3H-&lsqb;1,2,3&rsqb;oxathiazol-5-ylmethyl ester; </paragraph>
<paragraph id="P-0362" lvl="1"><number>&lsqb;0362&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;1,4,2&rsqb;dioxazol-3-ylmethyl ester; </paragraph>
<paragraph id="P-0363" lvl="1"><number>&lsqb;0363&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;1,4,2&rsqb;dioxazol-3-ylmethyl ester; </paragraph>
<paragraph id="P-0364" lvl="1"><number>&lsqb;0364&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid furazan-3-ylmethyl ester; </paragraph>
<paragraph id="P-0365" lvl="1"><number>&lsqb;0365&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid furazan-3-ylmethyl ester; </paragraph>
<paragraph id="P-0366" lvl="1"><number>&lsqb;0366&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;1,2,4&rsqb;oxadiazol-5-ylmethyl ester; </paragraph>
<paragraph id="P-0367" lvl="1"><number>&lsqb;0367&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;1,2,4&rsqb;oxadiazol-5-ylmethyl ester; </paragraph>
<paragraph id="P-0368" lvl="1"><number>&lsqb;0368&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3H-&lsqb;1,2,3&rsqb;triazol-4-ylmethyl ester; </paragraph>
<paragraph id="P-0369" lvl="1"><number>&lsqb;0369&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3H-&lsqb;1,2,3&rsqb;triazol-4-ylmethyl ester; </paragraph>
<paragraph id="P-0370" lvl="1"><number>&lsqb;0370&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2H-&lsqb;1,2,4&rsqb;triazol-3-ylmethyl ester; </paragraph>
<paragraph id="P-0371" lvl="1"><number>&lsqb;0371&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2H-&lsqb;1,2,4&rsqb;triazol-3-ylmethyl ester; </paragraph>
<paragraph id="P-0372" lvl="1"><number>&lsqb;0372&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid isoxazol-5-ylmethyl ester; </paragraph>
<paragraph id="P-0373" lvl="1"><number>&lsqb;0373&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid isoxazol-5-ylmethyl ester; </paragraph>
<paragraph id="P-0374" lvl="1"><number>&lsqb;0374&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid oxazol-2-ylmethyl ester; </paragraph>
<paragraph id="P-0375" lvl="1"><number>&lsqb;0375&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid oxazol-2-ylmethyl ester; </paragraph>
<paragraph id="P-0376" lvl="1"><number>&lsqb;0376&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid isothiazol-5-ylmethyl ester; </paragraph>
<paragraph id="P-0377" lvl="1"><number>&lsqb;0377&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid isothiazol-5-ylmethyl ester; </paragraph>
<paragraph id="P-0378" lvl="1"><number>&lsqb;0378&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid thiazol-2-ylmethyl ester; </paragraph>
<paragraph id="P-0379" lvl="1"><number>&lsqb;0379&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid thiazol-2-ylmethyl ester; </paragraph>
<paragraph id="P-0380" lvl="1"><number>&lsqb;0380&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1H-imidazol-2-ylmethyl ester; </paragraph>
<paragraph id="P-0381" lvl="1"><number>&lsqb;0381&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2H-imidazol-2-ylmethyl ester; </paragraph>
<paragraph id="P-0382" lvl="1"><number>&lsqb;0382&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1H-pyrazol-3-ylmethyl ester; </paragraph>
<paragraph id="P-0383" lvl="1"><number>&lsqb;0383&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2H-pyrazol-3-ylmethyl ester; </paragraph>
<paragraph id="P-0384" lvl="1"><number>&lsqb;0384&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1H-pyrrol-2-ylmethyl ester; </paragraph>
<paragraph id="P-0385" lvl="1"><number>&lsqb;0385&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2H-pyrrol-2-ylmethyl ester; </paragraph>
<paragraph id="P-0386" lvl="1"><number>&lsqb;0386&rsqb;</number> 3-Furazan-3-ylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0387" lvl="1"><number>&lsqb;0387&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2H-chromen-2-ylmethyl ester; </paragraph>
<paragraph id="P-0388" lvl="1"><number>&lsqb;0388&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2H-thiochromen-2-ylmethyl ester; </paragraph>
<paragraph id="P-0389" lvl="1"><number>&lsqb;0389&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2H-thiochromen-2-ylmethyl ester; </paragraph>
<paragraph id="P-0390" lvl="1"><number>&lsqb;0390&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;1,3,4&rsqb;thiadiazol-2-ylmethyl ester; </paragraph>
<paragraph id="P-0391" lvl="1"><number>&lsqb;0391&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;1,3,4&rsqb;thiadiazol-2-ylmethyl ester; </paragraph>
<paragraph id="P-0392" lvl="1"><number>&lsqb;0392&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1H-benzoimidazol-5-ylmethyl ester; </paragraph>
<paragraph id="P-0393" lvl="1"><number>&lsqb;0393&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1H-benzoimidazol-5-ylmethyl ester; </paragraph>
<paragraph id="P-0394" lvl="1"><number>&lsqb;0394&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1H-benzoimidazol-2-ylmethyl ester; </paragraph>
<paragraph id="P-0395" lvl="1"><number>&lsqb;0395&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1H-benzoimidazol-2-ylmethyl ester; </paragraph>
<paragraph id="P-0396" lvl="1"><number>&lsqb;0396&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1H-indol-2-ylmethyl ester; </paragraph>
<paragraph id="P-0397" lvl="1"><number>&lsqb;0397&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1H-indol-2-ylmethyl ester; </paragraph>
<paragraph id="P-0398" lvl="1"><number>&lsqb;0398&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1H-indol-5-ylmethyl ester; </paragraph>
<paragraph id="P-0399" lvl="1"><number>&lsqb;0399&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1H-indol-5-ylmethyl ester; </paragraph>
<paragraph id="P-0400" lvl="1"><number>&lsqb;0400&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,3-dihydro-benzofuran-5-ylmethyl ester; and </paragraph>
<paragraph id="P-0401" lvl="1"><number>&lsqb;0401&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,3-dihydro-benzofuran-5-ylmethyl ester. </paragraph>
<paragraph id="P-0402" lvl="0"><number>&lsqb;0402&rsqb;</number> Another invention embodiment is a compound selected from: </paragraph>
<paragraph id="P-0403" lvl="1"><number>&lsqb;0403&rsqb;</number> 4-&lcub;6-&lsqb;3-(4-Methoxy-phenyl)-prop-1-ynyl&rsqb;-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid; </paragraph>
<paragraph id="P-0404" lvl="1"><number>&lsqb;0404&rsqb;</number> 3-(4-Methanesulfonyl-benzyl)-6-&lsqb;3-(4-methoxy-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0405" lvl="1"><number>&lsqb;0405&rsqb;</number> 4-&lcub;6-&lsqb;3-(3-Methoxy-phenyl)-prop-1-ynyl&rsqb;-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid; </paragraph>
<paragraph id="P-0406" lvl="1"><number>&lsqb;0406&rsqb;</number> 3-(4-Methanesulfonyl-benzyl)-6-&lsqb;3-(3-methoxy-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0407" lvl="1"><number>&lsqb;0407&rsqb;</number> 4-&lsqb;1-Methyl-2,4-dioxo-6-(3-pyridine-4-yl-prop-1-ynyl)-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rsqb;-benzoic acid; </paragraph>
<paragraph id="P-0408" lvl="1"><number>&lsqb;0408&rsqb;</number> 3-(4-Methanesulfonyl-benzyl)-1-6-(3-pyridin-4-yl-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0409" lvl="1"><number>&lsqb;0409&rsqb;</number> 4-&lsqb;1-Methyl-2,4-dioxo-6-(3-pyridine-3-yl-prop-1-ynyl)-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rsqb;-benzoic acid; </paragraph>
<paragraph id="P-0410" lvl="1"><number>&lsqb;0410&rsqb;</number> 3-(4-Methanesulfonyl-benzyl)-1-6-(3-pyridin-3-yl-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0411" lvl="1"><number>&lsqb;0411&rsqb;</number> 4-&lcub;6-&lsqb;3-(4-Fluoro-phenyl)-prop-1-ynyl&rsqb;-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid 6-&lsqb;3-(4-Fluoro-phenyl)-prop-1-ynyl&rsqb;-3-(4-methanesulfonyl-benzyl)-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0412" lvl="1"><number>&lsqb;0412&rsqb;</number> 4-&lcub;6-&lsqb;3-(3-Fluoro-phenyl)-prop-1-ynyl&rsqb;-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid; </paragraph>
<paragraph id="P-0413" lvl="1"><number>&lsqb;0413&rsqb;</number> 6-&lsqb;3-(3-Fluoro-phenyl)-prop-1-ynyl&rsqb;-3-(4-methanesulfonyl-benzyl)-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0414" lvl="1"><number>&lsqb;0414&rsqb;</number> 4-&lcub;6-&lsqb;3-(4-Chloro-phenyl)-prop-1-ynyl&rsqb;-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid; </paragraph>
<paragraph id="P-0415" lvl="1"><number>&lsqb;0415&rsqb;</number> 6-&lsqb;3-(4-Chloro-phenyl)-prop-1-ynyl&rsqb;-3-(4-methanesulfonyl-benzyl)-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0416" lvl="1"><number>&lsqb;0416&rsqb;</number> 4-&lcub;6-&lsqb;3-(3-Chloro-phenyl)-prop-1-ynyl&rsqb;-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid; </paragraph>
<paragraph id="P-0417" lvl="1"><number>&lsqb;0417&rsqb;</number> 6-&lsqb;3-(3-Chloro-phenyl)-prop-1-ynyl&rsqb;-3-(4-methanesulfonyl-benzyl)-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0418" lvl="1"><number>&lsqb;0418&rsqb;</number> 4-&lcub;6-&lsqb;3-(4-Bromo-phenyl)-prop-1-ynyl&rsqb;-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid; </paragraph>
<paragraph id="P-0419" lvl="1"><number>&lsqb;0419&rsqb;</number> 6-&lsqb;3-(4-Bromo-phenyl)-prop-1-ynyl&rsqb;-3-(4-methanesulfonyl-benzyl)-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0420" lvl="1"><number>&lsqb;0420&rsqb;</number> 4-&lcub;6-&lsqb;3-(3-Bromo-phenyl)-prop-1-ynyl&rsqb;-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid; </paragraph>
<paragraph id="P-0421" lvl="1"><number>&lsqb;0421&rsqb;</number> 6-&lsqb;3-(3-Bromo-phenyl)-prop-1-ynyl&rsqb;-3-(4-methanesulfonyl-benzyl)-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0422" lvl="1"><number>&lsqb;0422&rsqb;</number> 4-&lcub;1-Methyl-6-&lsqb;3-(4-nitro-phenyl)-prop-1-ynyl&rsqb;-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid; </paragraph>
<paragraph id="P-0423" lvl="1"><number>&lsqb;0423&rsqb;</number> 3-(4-Methanesulfonyl-benzyl)-1-methyl-6-&lsqb;3-(4-nitro-phenyl)-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0424" lvl="1"><number>&lsqb;0424&rsqb;</number> 4-&lcub;6-&lsqb;3-(2-Methoxy-pyridin-4-yl)-prop-1-ynyl&rsqb;-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid; </paragraph>
<paragraph id="P-0425" lvl="1"><number>&lsqb;0425&rsqb;</number> 3-(4-Methanesulfonyl-benzyl)-6-&lsqb;3-(2-methoxy-pyridin-4-yl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0426" lvl="1"><number>&lsqb;0426&rsqb;</number> 4-&lcub;1-Methyl-6-&lsqb;3-(4-methylsulfanyl-phenyl)-prop-1-ynyl&rsqb;-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid; </paragraph>
<paragraph id="P-0427" lvl="1"><number>&lsqb;0427&rsqb;</number> 3-(4-Methanesulfonyl-benzyl)-1-methyl-6-&lsqb;3-(4-methylsulfanyl-phenyl)-prop-1-ynyl&rsqb;-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0428" lvl="1"><number>&lsqb;0428&rsqb;</number> 4-&lcub;1-Methyl-6-&lsqb;3-(3-methylsulfanyl-phenyl)-prop-1-ynyl&rsqb;-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid; </paragraph>
<paragraph id="P-0429" lvl="1"><number>&lsqb;0429&rsqb;</number> 3-(4-Methanesulfonyl-benzyl)-1-methyl-6-&lsqb;3-(3-methylsulfanyl-phenyl)-prop-1-ynyl&rsqb;-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0430" lvl="1"><number>&lsqb;0430&rsqb;</number> 4-&lsqb;1-Methyl-2,4-dioxo-6-(3-p-tolyl-prop-1-ynyl)-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;benzoic acid; </paragraph>
<paragraph id="P-0431" lvl="1"><number>&lsqb;0431&rsqb;</number> 3-(4-Methanesulfonyl-benzyl)-1-methyl-6-(3-p-tolyl-prop-1-ynyl)-1 H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0432" lvl="1"><number>&lsqb;0432&rsqb;</number> 4-&lsqb;1-Methyl-2,4-dioxo-6-(3-m-tolyl-prop-1-ynyl)-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;benzoic acid; </paragraph>
<paragraph id="P-0433" lvl="1"><number>&lsqb;0433&rsqb;</number> 3-(4-Methanesulfonyl-benzyl)-1-methyl-6-(3-m-tolyl-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0434" lvl="1"><number>&lsqb;0434&rsqb;</number> 3-Benzyl-6-&lsqb;3-(4-methoxy-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0435" lvl="1"><number>&lsqb;0435&rsqb;</number> 3-Benzyl-6-&lsqb;3-(3-methoxy-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0436" lvl="1"><number>&lsqb;0436&rsqb;</number> 3-Benzyl-1-methyl-6-(3-pyridin-4-yl-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0437" lvl="1"><number>&lsqb;0437&rsqb;</number> 3-Benzyl-1-methyl-6-(3-pyridin-3-yl-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0438" lvl="1"><number>&lsqb;0438&rsqb;</number> 3-Benzyl-6-&lsqb;3-(4-fluoro-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0439" lvl="1"><number>&lsqb;0439&rsqb;</number> 3-Benzyl-6-&lsqb;3-(3-fluoro-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0440" lvl="1"><number>&lsqb;0440&rsqb;</number> 3-Benzyl-6-&lsqb;3-(4-chloro-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0441" lvl="1"><number>&lsqb;0441&rsqb;</number> 3-Benzyl-6-&lsqb;3-(3-chloro-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0442" lvl="1"><number>&lsqb;0442&rsqb;</number> 3-Benzyl-6-&lsqb;3-(4-bromo-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0443" lvl="1"><number>&lsqb;0443&rsqb;</number> 3-Benzyl-6-&lsqb;3-(3-bromo-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0444" lvl="1"><number>&lsqb;0444&rsqb;</number> 3-Benzyl-6-&lsqb;3-(2-methoxy-pyridin-4-yl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0445" lvl="1"><number>&lsqb;0445&rsqb;</number> 3-Benzyl-1-methyl-6-&lsqb;3-(4-methylsulfanyl-phenyl)-prop-1-ynyl&rsqb;-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0446" lvl="1"><number>&lsqb;0446&rsqb;</number> 3-Benzyl-1-methyl-6-&lsqb;3-(3-methylsulfanyl-phenyl)-prop-1-ynyl&rsqb;-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0447" lvl="1"><number>&lsqb;0447&rsqb;</number> 3-Benzyl-1-methyl-6-(3-p-tolyl-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0448" lvl="1"><number>&lsqb;0448&rsqb;</number> 3-Benzyl-1-methyl-6-(3-m-tolyl-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0449" lvl="1"><number>&lsqb;0449&rsqb;</number> 3-(3-Fluoro-benzyl)-6-&lsqb;3-(4-methoxy-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0450" lvl="1"><number>&lsqb;0450&rsqb;</number> 3-(3-Fluoro-benzyl)-6-&lsqb;3-(3-methoxy-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0451" lvl="1"><number>&lsqb;0451&rsqb;</number> 3-(3-Fluoro-benzyl)-1-methyl-6-(3-pyridine-4-yl-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0452" lvl="1"><number>&lsqb;0452&rsqb;</number> 3-(3-Fluoro-benzyl)-1-methyl-6-(3-pyridine-3-yl-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0453" lvl="1"><number>&lsqb;0453&rsqb;</number> 3-(3-Fluoro-benzyl)-6-&lsqb;3-(4-fluoro-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0454" lvl="1"><number>&lsqb;0454&rsqb;</number> 3-(3-Fluoro-benzyl)-6-&lsqb;3-(3-fluoro-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0455" lvl="1"><number>&lsqb;0455&rsqb;</number> 6-&lsqb;3-(4-Chloro-phenyl)-prop-1-ynyl&rsqb;-3-(3-fluoro-benzyl)-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0456" lvl="1"><number>&lsqb;0456&rsqb;</number> 6-&lsqb;3-(3-Chloro-phenyl)-prop-1-ynyl&rsqb;-3-(3-fluoro-benzyl)-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0457" lvl="1"><number>&lsqb;0457&rsqb;</number> 6-&lsqb;3-(4-Bromo-phenyl)-prop-1-ynyl&rsqb;-3-(3-fluoro-benzyl)-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0458" lvl="1"><number>&lsqb;0458&rsqb;</number> 6-&lsqb;3-(3-Bromo-phenyl)-prop-1-ynyl&rsqb;-3-(3-fluoro-benzyl)-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0459" lvl="1"><number>&lsqb;0459&rsqb;</number> 3-(3-Fluoro-benzyl)-6-&lsqb;3-(2-methoxy-pyridin-4-yl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0460" lvl="1"><number>&lsqb;0460&rsqb;</number> 3-(3-Fluoro-benzyl)-1-methyl-6-&lsqb;3-(4-methylsulfanyl-phenyl)-prop-1-ynyl&rsqb;-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0461" lvl="1"><number>&lsqb;0461&rsqb;</number> 3-(3-Fluoro-benzyl)-1-methyl-6-&lsqb;3-(3-methylsulfanyl-phenyl)-prop-1-ynyl&rsqb;-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </paragraph>
<paragraph id="P-0462" lvl="1"><number>&lsqb;0462&rsqb;</number> 3-(3-Fluoro-benzyl)-1-methyl-6-(3-p-tolyl-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; and </paragraph>
<paragraph id="P-0463" lvl="1"><number>&lsqb;0463&rsqb;</number> 3-(3-Fluoro-benzyl)-1-methyl-6-(3-m-tolyl-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione. </paragraph>
<paragraph id="P-0464" lvl="0"><number>&lsqb;0464&rsqb;</number> Another invention embodiment is a compound selected from: </paragraph>
<paragraph id="P-0465" lvl="1"><number>&lsqb;0465&rsqb;</number> 3-(3-Methoxycarbonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0466" lvl="1"><number>&lsqb;0466&rsqb;</number> 3-(3-Methoxycarbonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0467" lvl="1"><number>&lsqb;0467&rsqb;</number> 3-Benzofuran-5-ylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0468" lvl="1"><number>&lsqb;0468&rsqb;</number> 1-Methyl-3-(4-methyl-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0469" lvl="1"><number>&lsqb;0469&rsqb;</number> 3-(4-Acetylamino-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0470" lvl="1"><number>&lsqb;0470&rsqb;</number> 1-Methyl-2,4-dioxo-3-(4-vinyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0471" lvl="1"><number>&lsqb;0471&rsqb;</number> 1-Methyl-2,4-dioxo-3-(4-sulfamoyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0472" lvl="1"><number>&lsqb;0472&rsqb;</number> 3-(4-Bromo-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-4-ylmethyl ester; </paragraph>
<paragraph id="P-0473" lvl="1"><number>&lsqb;0473&rsqb;</number> 1-Methyl-2,4-dioxo-3-phenethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0474" lvl="1"><number>&lsqb;0474&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lsqb;4-(2H-tetrazol-5-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0475" lvl="1"><number>&lsqb;0475&rsqb;</number> 3-(4-Fluoro-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-4-ylmethyl ester; </paragraph>
<paragraph id="P-0476" lvl="1"><number>&lsqb;0476&rsqb;</number> 3-(4-tert-Butyoxycarbonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0477" lvl="1"><number>&lsqb;0477&rsqb;</number> 3-(4-tert-Butyoxycarbonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid; </paragraph>
<paragraph id="P-0478" lvl="1"><number>&lsqb;0478&rsqb;</number> 4-&lsqb;6-(4-Fluoro-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; </paragraph>
<paragraph id="P-0479" lvl="1"><number>&lsqb;0479&rsqb;</number> 4-&lsqb;6-(4-Dimethylamino-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid, compound with trifluoro-acetic acid; </paragraph>
<paragraph id="P-0480" lvl="1"><number>&lsqb;0480&rsqb;</number> 4-&lsqb;6-(2-Ethoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rsqb;-benzoic acid; </paragraph>
<paragraph id="P-0481" lvl="1"><number>&lsqb;0481&rsqb;</number> 1-Methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid; </paragraph>
<paragraph id="P-0482" lvl="1"><number>&lsqb;0482&rsqb;</number> 1-Methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0483" lvl="1"><number>&lsqb;0483&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lsqb;4-(1H-tetrazol-5-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0484" lvl="1"><number>&lsqb;0484&rsqb;</number> 1-Methyl-3-&lsqb;4-(morpholine-4-sulfonyl)-benzyl&rsqb;-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0485" lvl="1"><number>&lsqb;0485&rsqb;</number> 1-Methyl-3-&lsqb;4-(morpholine-4-carbonyl)-benzyl&rsqb;-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0486" lvl="1"><number>&lsqb;0486&rsqb;</number> 3-But-2-ynyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0487" lvl="1"><number>&lsqb;0487&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lsqb;3-(1H-tetrazol-5-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0488" lvl="1"><number>&lsqb;0488&rsqb;</number> 3-(4-Cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0489" lvl="1"><number>&lsqb;0489&rsqb;</number> &lcub;4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-phenyl&rcub;-acetic acid; </paragraph>
<paragraph id="P-0490" lvl="1"><number>&lsqb;0490&rsqb;</number> 3-&lsqb;2-(2,4-Dichloro-benzenesulfonyl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0491" lvl="1"><number>&lsqb;0491&rsqb;</number> 3-(4-Methanesulfonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0492" lvl="1"><number>&lsqb;0492&rsqb;</number> 1-Methyl-2,4-dioxo-3-(4-sulfamoyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0493" lvl="1"><number>&lsqb;0493&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-methoxy-pyridin-4-ylmethyl)-amide; </paragraph>
<paragraph id="P-0494" lvl="1"><number>&lsqb;0494&rsqb;</number> 1-Methyl-3-(4-methylsulfamoyl-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0495" lvl="1"><number>&lsqb;0495&rsqb;</number> 3-(4-Isopropylsulfamoyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0496" lvl="1"><number>&lsqb;0496&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lsqb;4-(pyrrolidine-1-sulfonyl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; and </paragraph>
<paragraph id="P-0497" lvl="1"><number>&lsqb;0497&rsqb;</number> 1-Methyl-3-&lsqb;4-(4-methyl-piperidine-1-sulfonyl)-benzyl&rsqb;-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide. </paragraph>
<paragraph id="P-0498" lvl="0"><number>&lsqb;0498&rsqb;</number> Another invention embodiment is a compound selected from: </paragraph>
<paragraph id="P-0499" lvl="1"><number>&lsqb;0499&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzofuran-2-ylmethyl ester; </paragraph>
<paragraph id="P-0500" lvl="1"><number>&lsqb;0500&rsqb;</number> 3-(4-Bromo-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-4-ylmethyl ester; </paragraph>
<paragraph id="P-0501" lvl="1"><number>&lsqb;0501&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzyl ester; </paragraph>
<paragraph id="P-0502" lvl="1"><number>&lsqb;0502&rsqb;</number> 4-&lcub;1-Methyl-2,4-dioxo-6-&lsqb;(pyridin-4-ylmethyl)-carbamoyl&rsqb;-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rcub;-benzoic acid, compound with trifluoro-acetic acid; </paragraph>
<paragraph id="P-0503" lvl="1"><number>&lsqb;0503&rsqb;</number> 4-&lsqb;6-(4-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; </paragraph>
<paragraph id="P-0504" lvl="1"><number>&lsqb;0504&rsqb;</number> 4-&lsqb;6-(3,4-Dimethoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid tert-butyl ester; </paragraph>
<paragraph id="P-0505" lvl="1"><number>&lsqb;0505&rsqb;</number> 4-&lsqb;6-(3,4-Dimethoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; </paragraph>
<paragraph id="P-0506" lvl="1"><number>&lsqb;0506&rsqb;</number> 4-&lsqb;6-(4-Bromo-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; </paragraph>
<paragraph id="P-0507" lvl="1"><number>&lsqb;0507&rsqb;</number> 4-&lsqb;6-(4-Bromo-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid tert-butyl ester; </paragraph>
<paragraph id="P-0508" lvl="1"><number>&lsqb;0508&rsqb;</number> 4-&lsqb;6-(3,5-Bis-trifluoromethyl-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; </paragraph>
<paragraph id="P-0509" lvl="1"><number>&lsqb;0509&rsqb;</number> 4-&lsqb;6-(4-Chloro-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; </paragraph>
<paragraph id="P-0510" lvl="1"><number>&lsqb;0510&rsqb;</number> 4-&lsqb;1-Methyl-2,4-dioxo-6-(4-sulfamoyl-benzylcarbamoyl)-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; </paragraph>
<paragraph id="P-0511" lvl="1"><number>&lsqb;0511&rsqb;</number> 3-(4-Fluoro-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0512" lvl="1"><number>&lsqb;0512&rsqb;</number> 3-(4-Iodo-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0513" lvl="1"><number>&lsqb;0513&rsqb;</number> 3-(4-Dimethylsulfamoyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0514" lvl="1"><number>&lsqb;0514&rsqb;</number> 3-(3-Methoxy-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0515" lvl="1"><number>&lsqb;0515&rsqb;</number> 3-(4-Cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0516" lvl="1"><number>&lsqb;0516&rsqb;</number> 3-(4-Acetylamino-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0517" lvl="1"><number>&lsqb;0517&rsqb;</number> 5-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-furan-2-carboxylic acid ethyl ester; </paragraph>
<paragraph id="P-0518" lvl="1"><number>&lsqb;0518&rsqb;</number> 3-(4-Cyano-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzyl ester; </paragraph>
<paragraph id="P-0519" lvl="1"><number>&lsqb;0519&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lsqb;4-(5-thioxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0520" lvl="1"><number>&lsqb;0520&rsqb;</number> 4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid 2-dimethylamino-ethyl ester; </paragraph>
<paragraph id="P-0521" lvl="1"><number>&lsqb;0521&rsqb;</number> 3-Cyclohexylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0522" lvl="1"><number>&lsqb;0522&rsqb;</number> 3-Cyclohexylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0523" lvl="1"><number>&lsqb;0523&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid furan-3-ylmethyl ester; </paragraph>
<paragraph id="P-0524" lvl="1"><number>&lsqb;0524&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pentafluorophenylmethyl ester; </paragraph>
<paragraph id="P-0525" lvl="1"><number>&lsqb;0525&rsqb;</number> 3-Benzyl-1-ethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0526" lvl="1"><number>&lsqb;0526&rsqb;</number> 3-Benzyl-1-cyclopropylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0527" lvl="1"><number>&lsqb;0527&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (pyridin-4-ylmethyl)-amide; </paragraph>
<paragraph id="P-0528" lvl="1"><number>&lsqb;0528&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-bromo-benzyl ester; </paragraph>
<paragraph id="P-0529" lvl="1"><number>&lsqb;0529&rsqb;</number> 4-&lsqb;6-(3-Difluoromethoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; </paragraph>
<paragraph id="P-0530" lvl="1"><number>&lsqb;0530&rsqb;</number> 4-&lsqb;6-(3-Difluoromethoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid tert-butyl ester; </paragraph>
<paragraph id="P-0531" lvl="1"><number>&lsqb;0531&rsqb;</number> 4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; </paragraph>
<paragraph id="P-0532" lvl="1"><number>&lsqb;0532&rsqb;</number> 4-&lsqb;6-(4-Methanesulfonyl-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid tert-butyl ester; </paragraph>
<paragraph id="P-0533" lvl="1"><number>&lsqb;0533&rsqb;</number> 4-&lsqb;6-(4-Methanesulfonyl-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; </paragraph>
<paragraph id="P-0534" lvl="1"><number>&lsqb;0534&rsqb;</number> 4-&lsqb;1-Methyl-2,4-dioxo-6-(2-pyridin-4-yl-ethylcarbamoyl)-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; </paragraph>
<paragraph id="P-0535" lvl="1"><number>&lsqb;0535&rsqb;</number> 1-Methyl-2,4-dioxo-3-(4-trifluoromethoxy-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0536" lvl="1"><number>&lsqb;0536&rsqb;</number> 4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid methyl ester; </paragraph>
<paragraph id="P-0537" lvl="1"><number>&lsqb;0537&rsqb;</number> 3-(2,3-Dihydro-benzofuran-6-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0538" lvl="1"><number>&lsqb;0538&rsqb;</number> 1-Methyl-3-(2-methyl-thiazol-5-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0539" lvl="1"><number>&lsqb;0539&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lsqb;4-(1H-tetrazol-5-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-fluoro-benzylamide; </paragraph>
<paragraph id="P-0540" lvl="1"><number>&lsqb;0540&rsqb;</number> 3-Benzyl-2-methoxy-4-oxo-3,4-dihydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0541" lvl="1"><number>&lsqb;0541&rsqb;</number> 4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid 2,2-dimethyl-propionyloxymethyl ester; </paragraph>
<paragraph id="P-0542" lvl="1"><number>&lsqb;0542&rsqb;</number> 4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-cyclohexanecarboxylic acid; </paragraph>
<paragraph id="P-0543" lvl="1"><number>&lsqb;0543&rsqb;</number> 4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-cyclohexanecarboxylic acid methyl ester; </paragraph>
<paragraph id="P-0544" lvl="1"><number>&lsqb;0544&rsqb;</number> 1-&lcub;4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-phenyl&rcub;-cyclopropanecarboxylic acid methyl ester; </paragraph>
<paragraph id="P-0545" lvl="1"><number>&lsqb;0545&rsqb;</number> 1-&lcub;4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-phenyl&rcub;-cyclopropanecarboxylic acid tert-butyl ester; </paragraph>
<paragraph id="P-0546" lvl="1"><number>&lsqb;0546&rsqb;</number> 1-&lcub;4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-phenyl&rcub;-cyclopropanecarboxylic acid; </paragraph>
<paragraph id="P-0547" lvl="1"><number>&lsqb;0547&rsqb;</number> 2-&lcub;4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-phenoxy&rcub;-2-methyl-propionic acid tert-butyl ester; </paragraph>
<paragraph id="P-0548" lvl="1"><number>&lsqb;0548&rsqb;</number> 2-&lcub;4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-phenoxy&rcub;-2-methyl-propionic acid; </paragraph>
<paragraph id="P-0549" lvl="1"><number>&lsqb;0549&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-furo&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0550" lvl="1"><number>&lsqb;0550&rsqb;</number> 3-(3-Methoxy-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0551" lvl="1"><number>&lsqb;0551&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0552" lvl="1"><number>&lsqb;0552&rsqb;</number> 3-Biphenyl-4-ylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0553" lvl="1"><number>&lsqb;0553&rsqb;</number> 3-(4-Methanesulfonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0554" lvl="1"><number>&lsqb;0554&rsqb;</number> 3-(4-Methanesulfonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0555" lvl="1"><number>&lsqb;0555&rsqb;</number> 1-Methyl-3-(4-methyl-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0556" lvl="1"><number>&lsqb;0556&rsqb;</number> 1-Methyl-2,4-dioxo-3-phenethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0557" lvl="1"><number>&lsqb;0557&rsqb;</number> 3-(4-Amino-6-phenylamino-1,3,5-triazin-2-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0558" lvl="1"><number>&lsqb;0558&rsqb;</number> 1-Methyl-2,4-dioxo-3-(4-trifluoromethyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0559" lvl="1"><number>&lsqb;0559&rsqb;</number> 3-(6-Cyano-hexyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0560" lvl="1"><number>&lsqb;0560&rsqb;</number> 3-&lsqb;2-(2,5-Dimethoxy-phenyl)-2-oxo-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0561" lvl="1"><number>&lsqb;0561&rsqb;</number> 3-(3-Iodo-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0562" lvl="1"><number>&lsqb;0562&rsqb;</number> 1-Methyl-2,4-dioxo-3-(3-trifluoromethyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0563" lvl="1"><number>&lsqb;0563&rsqb;</number> 3-(2,4-Bis-trifluoromethyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0564" lvl="1"><number>&lsqb;0564&rsqb;</number> 3-&lsqb;2-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0565" lvl="1"><number>&lsqb;0565&rsqb;</number> 3-&lsqb;2-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0566" lvl="1"><number>&lsqb;0566&rsqb;</number> 3-(2-Carboxy-allyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0567" lvl="1"><number>&lsqb;0567&rsqb;</number> 3-(2-Carboxy-allyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0568" lvl="1"><number>&lsqb;0568&rsqb;</number> 3-(3-Amino-propyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0569" lvl="1"><number>&lsqb;0569&rsqb;</number> 3-(1,3-Dioxo-1,3-dihydro-isoindol-2-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0570" lvl="1"><number>&lsqb;0570&rsqb;</number> 3-(4-Fluoro-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0571" lvl="1"><number>&lsqb;0571&rsqb;</number> 1-Methyl-3-oxiranylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0572" lvl="1"><number>&lsqb;0572&rsqb;</number> 1-Methyl-3-((S)-2-methyl-butyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0573" lvl="1"><number>&lsqb;0573&rsqb;</number> 1-Methyl-2,4-dioxo-3-(4-phenoxy-butyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0574" lvl="1"><number>&lsqb;0574&rsqb;</number> 3-(2-Cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0575" lvl="1"><number>&lsqb;0575&rsqb;</number> 1-Methyl-2,4-dioxo-3-(3-phenoxy-propyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0576" lvl="1"><number>&lsqb;0576&rsqb;</number> 3-Hex-5-enyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0577" lvl="1"><number>&lsqb;0577&rsqb;</number> 1-Methyl-2,4-dioxo-3-pyridin-3-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0578" lvl="1"><number>&lsqb;0578&rsqb;</number> 3-&lsqb;2-Hydroxy-3-(naphthalen-1-yloxy)-propyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0579" lvl="1"><number>&lsqb;0579&rsqb;</number> 1,3-Dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0580" lvl="1"><number>&lsqb;0580&rsqb;</number> 3-Cyclobutylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0581" lvl="1"><number>&lsqb;0581&rsqb;</number> 3-Allyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0582" lvl="1"><number>&lsqb;0582&rsqb;</number> 1-Methyl-2,4-dioxo-3-prop-2-ynyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0583" lvl="1"><number>&lsqb;0583&rsqb;</number> 3-But-2-ynyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0584" lvl="1"><number>&lsqb;0584&rsqb;</number> 1-Methyl-2,4-dioxo-3-(2-phenoxy-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0585" lvl="1"><number>&lsqb;0585&rsqb;</number> 1-Methyl-2,4-dioxo-3-(2-phenoxy-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0586" lvl="1"><number>&lsqb;0586&rsqb;</number> 3-((R)-3-Hydroxy-2-methyl-propyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0587" lvl="1"><number>&lsqb;0587&rsqb;</number> 3-Isobutyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0588" lvl="1"><number>&lsqb;0588&rsqb;</number> 3-(6-Chloro-pyridin-3-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0589" lvl="1"><number>&lsqb;0589&rsqb;</number> 3-(2-Benzenesulfonylmethyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0590" lvl="1"><number>&lsqb;0590&rsqb;</number> 1-Methyl-3-naphthalen-1-ylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0591" lvl="1"><number>&lsqb;0591&rsqb;</number> 1-Methyl-2,4-dioxo-3-(2-trifluoromethyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0592" lvl="1"><number>&lsqb;0592&rsqb;</number> 3-(3-Chloro-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0593" lvl="1"><number>&lsqb;0593&rsqb;</number> 3-(4-Methoxycarbonyl-butyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0594" lvl="1"><number>&lsqb;0594&rsqb;</number> 3-Ethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0595" lvl="1"><number>&lsqb;0595&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-fluoro-benzyl ester; </paragraph>
<paragraph id="P-0596" lvl="1"><number>&lsqb;0596&rsqb;</number> 3-&lsqb;2-(4-Chloro-benzenesulfonyl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0597" lvl="1"><number>&lsqb;0597&rsqb;</number> 3-(2-Acetoxy-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0598" lvl="1"><number>&lsqb;0598&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-phenoxy-ethyl ester; </paragraph>
<paragraph id="P-0599" lvl="1"><number>&lsqb;0599&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0600" lvl="1"><number>&lsqb;0600&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzylamide; </paragraph>
<paragraph id="P-0601" lvl="1"><number>&lsqb;0601&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,6-dichloro-benzyl ester; </paragraph>
<paragraph id="P-0602" lvl="1"><number>&lsqb;0602&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid butyl ester; </paragraph>
<paragraph id="P-0603" lvl="1"><number>&lsqb;0603&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,3-dihydro-1,4-benzodioxin-2-ylmethyl ester; </paragraph>
<paragraph id="P-0604" lvl="1"><number>&lsqb;0604&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-diethylamino-1-methyl-ethyl ester; </paragraph>
<paragraph id="P-0605" lvl="1"><number>&lsqb;0605&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-fluoro-benzyl ester; </paragraph>
<paragraph id="P-0606" lvl="1"><number>&lsqb;0606&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-isopropyl-benzyl ester; </paragraph>
<paragraph id="P-0607" lvl="1"><number>&lsqb;0607&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-p-tolyl-ethyl ester; </paragraph>
<paragraph id="P-0608" lvl="1"><number>&lsqb;0608&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-trifluoromethyl-benzyl ester; </paragraph>
<paragraph id="P-0609" lvl="1"><number>&lsqb;0609&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cyclobutylmethyl ester; </paragraph>
<paragraph id="P-0610" lvl="1"><number>&lsqb;0610&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,6-difluoro-benzyl ester; </paragraph>
<paragraph id="P-0611" lvl="1"><number>&lsqb;0611&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-(2-hydroxy-phenyl)-ethyl ester; </paragraph>
<paragraph id="P-0612" lvl="1"><number>&lsqb;0612&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-(2-hydroxy-phenyl)-ethyl ester; </paragraph>
<paragraph id="P-0613" lvl="1"><number>&lsqb;0613&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-methyl-piperidin-4-yl ester; </paragraph>
<paragraph id="P-0614" lvl="1"><number>&lsqb;0614&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-methyl-piperidin-4-yl ester; </paragraph>
<paragraph id="P-0615" lvl="1"><number>&lsqb;0615&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-3-ylmethyl ester; </paragraph>
<paragraph id="P-0616" lvl="1"><number>&lsqb;0616&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-pyridin-3-yl-propyl ester; </paragraph>
<paragraph id="P-0617" lvl="1"><number>&lsqb;0617&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-dimethylamino-1-methyl-ethyl ester; </paragraph>
<paragraph id="P-0618" lvl="1"><number>&lsqb;0618&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzyl ester; </paragraph>
<paragraph id="P-0619" lvl="1"><number>&lsqb;0619&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid tetrahydro-pyran-4-yl ester; </paragraph>
<paragraph id="P-0620" lvl="1"><number>&lsqb;0620&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,2,2-trifluoro-1-trifluoromethyl-ethyl ester; </paragraph>
<paragraph id="P-0621" lvl="1"><number>&lsqb;0621&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-trifluoromethyl-benzyl ester; </paragraph>
<paragraph id="P-0622" lvl="1"><number>&lsqb;0622&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-benzyloxy-ethyl ester; </paragraph>
<paragraph id="P-0623" lvl="1"><number>&lsqb;0623&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,2,2-trichloro-ethyl ester; </paragraph>
<paragraph id="P-0624" lvl="1"><number>&lsqb;0624&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid phenethyl ester; </paragraph>
<paragraph id="P-0625" lvl="1"><number>&lsqb;0625&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-ethyl-oxetan-3-ylmethyl ester; </paragraph>
<paragraph id="P-0626" lvl="1"><number>&lsqb;0626&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-morpholin-4-yl-ethyl ester; </paragraph>
<paragraph id="P-0627" lvl="1"><number>&lsqb;0627&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-pyrrolidin-1-yl-ethyl ester; </paragraph>
<paragraph id="P-0628" lvl="1"><number>&lsqb;0628&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-pyrrolidin-1-yl-ethyl ester; </paragraph>
<paragraph id="P-0629" lvl="1"><number>&lsqb;0629&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-(2-ethoxy-ethoxy)-ethyl ester; </paragraph>
<paragraph id="P-0630" lvl="1"><number>&lsqb;0630&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid tetrahydro-pyran-2-ylmethyl ester; </paragraph>
<paragraph id="P-0631" lvl="1"><number>&lsqb;0631&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-nitro-benzyl ester; </paragraph>
<paragraph id="P-0632" lvl="1"><number>&lsqb;0632&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pentyl ester; </paragraph>
<paragraph id="P-0633" lvl="1"><number>&lsqb;0633&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-phenyl-propyl ester; </paragraph>
<paragraph id="P-0634" lvl="1"><number>&lsqb;0634&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-phenoxy-benzyl ester; </paragraph>
<paragraph id="P-0635" lvl="1"><number>&lsqb;0635&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3,5-dimethoxy-benzyl ester; </paragraph>
<paragraph id="P-0636" lvl="1"><number>&lsqb;0636&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methyl-butyl ester; </paragraph>
<paragraph id="P-0637" lvl="1"><number>&lsqb;0637&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-chloro-benzyl ester; </paragraph>
<paragraph id="P-0638" lvl="1"><number>&lsqb;0638&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-ethyl-piperidin-3-yl ester; </paragraph>
<paragraph id="P-0639" lvl="1"><number>&lsqb;0639&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-benzyloxy-benzyl ester; </paragraph>
<paragraph id="P-0640" lvl="1"><number>&lsqb;0640&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid isobutyl ester; </paragraph>
<paragraph id="P-0641" lvl="1"><number>&lsqb;0641&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-(4-methoxy-phenyl)-propyl ester; </paragraph>
<paragraph id="P-0642" lvl="1"><number>&lsqb;0642&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-chloro-6-fluoro-benzyl ester; </paragraph>
<paragraph id="P-0643" lvl="1"><number>&lsqb;0643&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (S)-(tetrahydro-furan-3-yl)ester; </paragraph>
<paragraph id="P-0644" lvl="1"><number>&lsqb;0644&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzyl ester; </paragraph>
<paragraph id="P-0645" lvl="1"><number>&lsqb;0645&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzyl ester; </paragraph>
<paragraph id="P-0646" lvl="1"><number>&lsqb;0646&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-pyridin-2-yl-propyl ester; </paragraph>
<paragraph id="P-0647" lvl="1"><number>&lsqb;0647&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-piperidin-2-yl-ethyl ester; </paragraph>
<paragraph id="P-0648" lvl="1"><number>&lsqb;0648&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 5-bromo-2-methoxy-benzyl ester; </paragraph>
<paragraph id="P-0649" lvl="1"><number>&lsqb;0649&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cycloheptylmethyl ester; </paragraph>
<paragraph id="P-0650" lvl="1"><number>&lsqb;0650&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1,2,3,4-tetrahydro-naphthalen-1-yl ester; </paragraph>
<paragraph id="P-0651" lvl="1"><number>&lsqb;0651&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (S)-1-pyrrolidin-2-ylmethyl ester; </paragraph>
<paragraph id="P-0652" lvl="1"><number>&lsqb;0652&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-chloro-benzyl ester; </paragraph>
<paragraph id="P-0653" lvl="1"><number>&lsqb;0653&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1,3-benzodioxol-5-ylmethyl ester; </paragraph>
<paragraph id="P-0654" lvl="1"><number>&lsqb;0654&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methylsulfanyl-benzyl ester; </paragraph>
<paragraph id="P-0655" lvl="1"><number>&lsqb;0655&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methylsulfanyl-benzyl ester; </paragraph>
<paragraph id="P-0656" lvl="1"><number>&lsqb;0656&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3,4-dichloro-benzyl ester; </paragraph>
<paragraph id="P-0657" lvl="1"><number>&lsqb;0657&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3,3-diphenyl-propyl ester; </paragraph>
<paragraph id="P-0658" lvl="1"><number>&lsqb;0658&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-pyridin-2-yl-ethyl ester; </paragraph>
<paragraph id="P-0659" lvl="1"><number>&lsqb;0659&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid furan-3-ylmethyl ester; </paragraph>
<paragraph id="P-0660" lvl="1"><number>&lsqb;0660&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid but-3-enyl ester; </paragraph>
<paragraph id="P-0661" lvl="1"><number>&lsqb;0661&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-cyano-ethyl ester; </paragraph>
<paragraph id="P-0662" lvl="1"><number>&lsqb;0662&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-ethoxy-ethyl ester; </paragraph>
<paragraph id="P-0663" lvl="1"><number>&lsqb;0663&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cyano-phenyl-methyl ester; </paragraph>
<paragraph id="P-0664" lvl="1"><number>&lsqb;0664&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-trifluoromethyl-benzylamide; </paragraph>
<paragraph id="P-0665" lvl="1"><number>&lsqb;0665&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methyl-benzylamide; </paragraph>
<paragraph id="P-0666" lvl="1"><number>&lsqb;0666&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid phenethyl-amide; </paragraph>
<paragraph id="P-0667" lvl="1"><number>&lsqb;0667&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cyclopropylamide; </paragraph>
<paragraph id="P-0668" lvl="1"><number>&lsqb;0668&rsqb;</number> 1-Methyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0669" lvl="1"><number>&lsqb;0669&rsqb;</number> 1-Methyl-2,4-dioxo-3-(4-sulfamoyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0670" lvl="1"><number>&lsqb;0670&rsqb;</number> 1-Methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0671" lvl="1"><number>&lsqb;0671&rsqb;</number> 1-Methyl-2,4-dioxo-3-(3-oxo-3-phenyl-propyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0672" lvl="1"><number>&lsqb;0672&rsqb;</number> 3-&lsqb;4-(N-Hydroxycarbamimidoyl)-benzyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0673" lvl="1"><number>&lsqb;0673&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lsqb;4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0674" lvl="1"><number>&lsqb;0674&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lsqb;4-(5-thioxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0675" lvl="1"><number>&lsqb;0675&rsqb;</number> 4-(5-Isopropyl-2H-pyrazol-3-yl)-pyridine; </paragraph>
<paragraph id="P-0676" lvl="1"><number>&lsqb;0676&rsqb;</number> 3-Cyanomethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0677" lvl="1"><number>&lsqb;0677&rsqb;</number> (E)-4-&lsqb;6-(4-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-yl&rsqb;-but-2-enoic acid methyl ester; </paragraph>
<paragraph id="P-0678" lvl="1"><number>&lsqb;0678&rsqb;</number> (E)-4-&lsqb;6-(4-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-yl&rsqb;-but-2-enoic acid; </paragraph>
<paragraph id="P-0679" lvl="1"><number>&lsqb;0679&rsqb;</number> 3-(2-Benzenesulfonyl-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0680" lvl="1"><number>&lsqb;0680&rsqb;</number> 2-Methoxy-4-&lsqb;6-(4-methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid methyl ester; </paragraph>
<paragraph id="P-0681" lvl="1"><number>&lsqb;0681&rsqb;</number> 3-(2-Methoxymethyl-1,1,3-trioxo-2,3-dihydro-1H-1l<highlight><superscript>6</superscript></highlight>-1,2-benzisothiazol-6-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0682" lvl="1"><number>&lsqb;0682&rsqb;</number> 1-Methyl-3-oct-2-ynyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0683" lvl="1"><number>&lsqb;0683&rsqb;</number> 3-&lsqb;2-(4-Chloro-benzenesulfonylamino)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0684" lvl="1"><number>&lsqb;0684&rsqb;</number> 3-&lsqb;2-(4-Bromo-phenoxy)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0685" lvl="1"><number>&lsqb;0685&rsqb;</number> 3-&lsqb;2-(4-Bromo-phenoxy)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0686" lvl="1"><number>&lsqb;0686&rsqb;</number> 3-&lsqb;2-(4-Fluoro-phenoxy)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0687" lvl="1"><number>&lsqb;0687&rsqb;</number> 3-&lsqb;2-(4-Chloro-benzenesulfonyl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0688" lvl="1"><number>&lsqb;0688&rsqb;</number> 3-&lsqb;2-(4-Fluoro-phenoxy)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0689" lvl="1"><number>&lsqb;0689&rsqb;</number> 1-Methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-methoxy-pyridin-4-ylmethyl)-amide; </paragraph>
<paragraph id="P-0690" lvl="1"><number>&lsqb;0690&rsqb;</number> 3-Cyclohexylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0691" lvl="1"><number>&lsqb;0691&rsqb;</number> 4-&lsqb;6-(4-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-2-methyl-benzoic acid methyl ester; </paragraph>
<paragraph id="P-0692" lvl="1"><number>&lsqb;0692&rsqb;</number> 4-&lsqb;6-(4-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid methyl ester; </paragraph>
<paragraph id="P-0693" lvl="1"><number>&lsqb;0693&rsqb;</number> 2-Methoxy-4-&lsqb;6-(3-methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid methyl ester; </paragraph>
<paragraph id="P-0694" lvl="1"><number>&lsqb;0694&rsqb;</number> 4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-2-methyl-benzoic acid methyl ester; </paragraph>
<paragraph id="P-0695" lvl="1"><number>&lsqb;0695&rsqb;</number> 1-Methyl-2,4-dioxo-3-(3-oxo-3-phenyl-propyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0696" lvl="1"><number>&lsqb;0696&rsqb;</number> 3-&lsqb;2-(4-Chloro-phenoxy)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0697" lvl="1"><number>&lsqb;0697&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lsqb;2-(3-trifluoromethyl-benzenesulfonyl)-ethyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0698" lvl="1"><number>&lsqb;0698&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lsqb;2-(3-trifluoromethyl-benzenesulfonyl)-ethyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0699" lvl="1"><number>&lsqb;0699&rsqb;</number> 3-&lsqb;2-(4-Chloro-benzenesulfonyl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; and </paragraph>
<paragraph id="P-0700" lvl="1"><number>&lsqb;0700&rsqb;</number> 3-(2-Amino-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide. </paragraph>
<paragraph id="P-0701" lvl="0"><number>&lsqb;0701&rsqb;</number> Another invention embodiment is a compound selected from: </paragraph>
<paragraph id="P-0702" lvl="1"><number>&lsqb;0702&rsqb;</number> 1-Methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid; </paragraph>
<paragraph id="P-0703" lvl="1"><number>&lsqb;0703&rsqb;</number> 4-(6-Carbamoyl 1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl)-2-methyl-benzoic acid; </paragraph>
<paragraph id="P-0704" lvl="1"><number>&lsqb;0704&rsqb;</number> 4-(6-Carbamoyl-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl)-2-methyl-benzoic acid methyl ester; </paragraph>
<paragraph id="P-0705" lvl="1"><number>&lsqb;0705&rsqb;</number> 4-&lsqb;6-(3-Hydroxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-2-methyl-benzoic acid; </paragraph>
<paragraph id="P-0706" lvl="1"><number>&lsqb;0706&rsqb;</number> 4-(6-Carbamoyl-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl)-2-hydroxy-benzoic acid; </paragraph>
<paragraph id="P-0707" lvl="1"><number>&lsqb;0707&rsqb;</number> 3-(2-Amino-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; and </paragraph>
<paragraph id="P-0708" lvl="1"><number>&lsqb;0708&rsqb;</number> 4-(2,5-Di-pyridin-4-yl-thiophen-3-yl)-benzaldehyde. </paragraph>
<paragraph id="P-0709" lvl="1"><number>&lsqb;0709&rsqb;</number> Another invention embodiment is a compound selected from: </paragraph>
<paragraph id="P-0710" lvl="1"><number>&lsqb;0710&rsqb;</number> 1-Methyl-2,4-dioxo-3-(1-phenyl-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0711" lvl="1"><number>&lsqb;0711&rsqb;</number> 1-Methyl-2,4-dioxo-3-(3-oxo-3-phenyl-propyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0712" lvl="1"><number>&lsqb;0712&rsqb;</number> 3-((S)-3,7-Dimethyl-oct-6-enyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0713" lvl="1"><number>&lsqb;0713&rsqb;</number> 3-(2-Ethyl-hexyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0714" lvl="1"><number>&lsqb;0714&rsqb;</number> 3-(5-Cyano-pentyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0715" lvl="1"><number>&lsqb;0715&rsqb;</number> 3-(E)-But-2-enyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0716" lvl="1"><number>&lsqb;0716&rsqb;</number> 1-Methyl-3-(2-naphthalen-1-yl-ethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0717" lvl="1"><number>&lsqb;0717&rsqb;</number> 1-Methyl-2,4-dioxo-3-(E)-pent-2-enyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0718" lvl="1"><number>&lsqb;0718&rsqb;</number> 1-Methyl-2,4-dioxo-3-(2-phenylsulfanyl-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0719" lvl="1"><number>&lsqb;0719&rsqb;</number> 3-sec-Butyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0720" lvl="1"><number>&lsqb;0720&rsqb;</number> 1-Methyl-3-(2-methyl-allyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0721" lvl="1"><number>&lsqb;0721&rsqb;</number> 3-(1-Ethyl-propyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0722" lvl="1"><number>&lsqb;0722&rsqb;</number> 1-Methyl-2,4-dioxo-3-pent-2-ynyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0723" lvl="1"><number>&lsqb;0723&rsqb;</number> 3-(2-Benzenesulfonyl-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0724" lvl="1"><number>&lsqb;0724&rsqb;</number> 1-Methyl-3-(3-methyl-but-2-enyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0725" lvl="1"><number>&lsqb;0725&rsqb;</number> 3-&lsqb;2-(4-Fluoro-benzenesulfonyl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0726" lvl="1"><number>&lsqb;0726&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lsqb;2-(toluene-4-sulfonyl)-ethyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0727" lvl="1"><number>&lsqb;0727&rsqb;</number> 3-&lsqb;3-(4-Fluoro-phenyl)-3-oxo-propyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0728" lvl="1"><number>&lsqb;0728&rsqb;</number> 3-&lsqb;3-(4-Chloro-phenyl)-3-oxo-propyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0729" lvl="1"><number>&lsqb;0729&rsqb;</number> 3-(2-Benzoylamino-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0730" lvl="1"><number>&lsqb;0730&rsqb;</number> 3-&lsqb;2-(4-Bromo-phenoxy)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0731" lvl="1"><number>&lsqb;0731&rsqb;</number> 3-Benzofurazan-5-ylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0732" lvl="1"><number>&lsqb;0732&rsqb;</number> 1-Methyl-2,4-dioxo-3-(2-phenoxy-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0733" lvl="1"><number>&lsqb;0733&rsqb;</number> &lcub;5-&lsqb;6-(4-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-isoxazol-3-yl&rcub;-carbamic acid methyl ester; </paragraph>
<paragraph id="P-0734" lvl="1"><number>&lsqb;0734&rsqb;</number> 3-Benzyloxycarbonylamino-5-&lsqb;6-(4-methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-yl&rsqb;-4-oxo-pentanoic acid tert-butyl ester; </paragraph>
<paragraph id="P-0735" lvl="1"><number>&lsqb;0735&rsqb;</number> 3-&lsqb;2-(4-Chloro-phenylsulfanyl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0736" lvl="1"><number>&lsqb;0736&rsqb;</number> 1-Methyl-2,4-dioxo-3-(1-phenyl-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0737" lvl="1"><number>&lsqb;0737&rsqb;</number> 1-Methyl-2,4-dioxo-3-(E)-pent-2-enyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0738" lvl="1"><number>&lsqb;0738&rsqb;</number> 3-(2-Ethyl-hexyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0739" lvl="1"><number>&lsqb;0739&rsqb;</number> 1-Methyl-2,4-dioxo-3-(2-phenylmethanesulfonyl-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0740" lvl="1"><number>&lsqb;0740&rsqb;</number> 3-(5-Cyano-pentyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0741" lvl="1"><number>&lsqb;0741&rsqb;</number> 3-(E)-But-2-enyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0742" lvl="1"><number>&lsqb;0742&rsqb;</number> 1-Methyl-3-(2-naphthalen-1-yl-ethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0743" lvl="1"><number>&lsqb;0743&rsqb;</number> 1-Methyl-2,4-dioxo-3-(E)-pent-2-enyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0744" lvl="1"><number>&lsqb;0744&rsqb;</number> 1-Methyl-2,4-dioxo-3-(2-phenylsulfanyl-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0745" lvl="1"><number>&lsqb;0745&rsqb;</number> 3-sec-Butyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0746" lvl="1"><number>&lsqb;0746&rsqb;</number> 1-Methyl-3-(2-methyl-allyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0747" lvl="1"><number>&lsqb;0747&rsqb;</number> 3-(1-Ethyl-propyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0748" lvl="1"><number>&lsqb;0748&rsqb;</number> 1-Methyl-2,4-dioxo-3-pent-2-ynyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0749" lvl="1"><number>&lsqb;0749&rsqb;</number> 1-Methyl-3-(3-methyl-but-2-enyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0750" lvl="1"><number>&lsqb;0750&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lsqb;2-(toluene-4-sulfonyl)-ethyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0751" lvl="1"><number>&lsqb;0751&rsqb;</number> 3-(2-Benzoylamino-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0752" lvl="1"><number>&lsqb;0752&rsqb;</number> 3-&lsqb;2-(4-Bromo-phenoxy)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0753" lvl="1"><number>&lsqb;0753&rsqb;</number> 3-Benzofurazan-5-ylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0754" lvl="1"><number>&lsqb;0754&rsqb;</number> 1-Methyl-2,4-dioxo-3-(2-phenoxy-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0755" lvl="1"><number>&lsqb;0755&rsqb;</number> &lcub;5-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-isoxazol-3-yl&rcub;-carbamic acid methyl ester; and </paragraph>
<paragraph id="P-0756" lvl="1"><number>&lsqb;0756&rsqb;</number> 3-Benzyloxycarbonylamino-5-&lsqb;6-(3-methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-yl&rsqb;-4-oxo-pentanoic acid tert-butyl ester. </paragraph>
<paragraph id="P-0757" lvl="0"><number>&lsqb;0757&rsqb;</number> Another invention embodiment is a compound selected from: </paragraph>
<paragraph id="P-0758" lvl="1"><number>&lsqb;0758&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid methyl ester; </paragraph>
<paragraph id="P-0759" lvl="1"><number>&lsqb;0759&rsqb;</number> 3-(4-Bromo-benzyl)-5-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0760" lvl="1"><number>&lsqb;0760&rsqb;</number> 3-(4-Fluoro-benzyl)-5-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0761" lvl="1"><number>&lsqb;0761&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-4-ylmethyl ester; </paragraph>
<paragraph id="P-0762" lvl="1"><number>&lsqb;0762&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzo&lsqb;b&rsqb;thiophen-2-ylmethyl ester; </paragraph>
<paragraph id="P-0763" lvl="1"><number>&lsqb;0763&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-methyl-1H-indol-5-ylmethyl ester; </paragraph>
<paragraph id="P-0764" lvl="1"><number>&lsqb;0764&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid thiophen-3-ylmethyl ester; </paragraph>
<paragraph id="P-0765" lvl="1"><number>&lsqb;0765&rsqb;</number> 3-1,3-Benzodioxol-5-ylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0766" lvl="1"><number>&lsqb;0766&rsqb;</number> 1-Methyl-2,4-dioxo-3-pyridin-4-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0767" lvl="1"><number>&lsqb;0767&rsqb;</number> 3-(4-tert-Butyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0768" lvl="1"><number>&lsqb;0768&rsqb;</number> 3-(3,4-Dichloro-benzyl)-5-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0769" lvl="1"><number>&lsqb;0769&rsqb;</number> 1-Methyl-2,4-dioxo-3-(4-trifluoromethoxy-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0770" lvl="1"><number>&lsqb;0770&rsqb;</number> 1-Methyl-3-naphthalen-2-ylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0771" lvl="1"><number>&lsqb;0771&rsqb;</number> 3-(4-Cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0772" lvl="1"><number>&lsqb;0772&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzofuran-5-ylmethyl ester; </paragraph>
<paragraph id="P-0773" lvl="1"><number>&lsqb;0773&rsqb;</number> 3-(3,5-Dimethoxy-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0774" lvl="1"><number>&lsqb;0774&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0775" lvl="1"><number>&lsqb;0775&rsqb;</number> 3-(3,5-Dinitro-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </paragraph>
<paragraph id="P-0776" lvl="1"><number>&lsqb;0776&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid; and </paragraph>
<paragraph id="P-0777" lvl="1"><number>&lsqb;0777&rsqb;</number> 3-(4-Carboxy-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-ethoxy-benzyl ester. </paragraph>
<paragraph id="P-0778" lvl="0"><number>&lsqb;0778&rsqb;</number> Another invention embodiment is a compound selected from: </paragraph>
<paragraph id="P-0779" lvl="1"><number>&lsqb;0779&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(3,4-dimethoxy-phenyl)-ethyl&rsqb;-amide; </paragraph>
<paragraph id="P-0780" lvl="1"><number>&lsqb;0780&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-amino-benzylamide; </paragraph>
<paragraph id="P-0781" lvl="1"><number>&lsqb;0781&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(4-chloro-phenyl)-ethyl&rsqb;-amide; </paragraph>
<paragraph id="P-0782" lvl="1"><number>&lsqb;0782&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (biphenyl-2-ylmethyl)-amide; </paragraph>
<paragraph id="P-0783" lvl="1"><number>&lsqb;0783&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3,4-dimethoxy-benzylamide; </paragraph>
<paragraph id="P-0784" lvl="1"><number>&lsqb;0784&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-pyridin-4-yl-ethyl)-amide; </paragraph>
<paragraph id="P-0785" lvl="1"><number>&lsqb;0785&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-difluoromethoxy-benzylamide; </paragraph>
<paragraph id="P-0786" lvl="1"><number>&lsqb;0786&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(3-ethoxy-phenyl)-ethyl&rsqb;-amide; </paragraph>
<paragraph id="P-0787" lvl="1"><number>&lsqb;0787&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-chloro-4-fluoro-benzylamide; </paragraph>
<paragraph id="P-0788" lvl="1"><number>&lsqb;0788&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,4-dichloro-benzylamide; </paragraph>
<paragraph id="P-0789" lvl="1"><number>&lsqb;0789&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-phenyl-propyl)-amide; </paragraph>
<paragraph id="P-0790" lvl="1"><number>&lsqb;0790&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3,4,5-trimethoxy-benzylamide; </paragraph>
<paragraph id="P-0791" lvl="1"><number>&lsqb;0791&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-chloro-benzylamide; </paragraph>
<paragraph id="P-0792" lvl="1"><number>&lsqb;0792&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3,5-dimethoxy-benzylamide; </paragraph>
<paragraph id="P-0793" lvl="1"><number>&lsqb;0793&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,3-dimethoxy-benzylamide; </paragraph>
<paragraph id="P-0794" lvl="1"><number>&lsqb;0794&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-trifluoromethyl-benzylamide; </paragraph>
<paragraph id="P-0795" lvl="1"><number>&lsqb;0795&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-methoxy-benzylamide; </paragraph>
<paragraph id="P-0796" lvl="1"><number>&lsqb;0796&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-methyl-benzylamide; </paragraph>
<paragraph id="P-0797" lvl="1"><number>&lsqb;0797&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (4-phenyl-butyl)-amide; </paragraph>
<paragraph id="P-0798" lvl="1"><number>&lsqb;0798&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (pyridin-3-ylmethyl)-amide; </paragraph>
<paragraph id="P-0799" lvl="1"><number>&lsqb;0799&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0800" lvl="1"><number>&lsqb;0800&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid ((S)-2,2-dimethyl-4-phenyl-1,3-dioxinan-5-yl)-amide; </paragraph>
<paragraph id="P-0801" lvl="1"><number>&lsqb;0801&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(3-methoxy-phenyl)-ethyl&rsqb;-amide; </paragraph>
<paragraph id="P-0802" lvl="1"><number>&lsqb;0802&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0803" lvl="1"><number>&lsqb;0803&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (thiophen-2-ylmethyl)-amide; </paragraph>
<paragraph id="P-0804" lvl="1"><number>&lsqb;0804&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-chloro-benzylamide; </paragraph>
<paragraph id="P-0805" lvl="1"><number>&lsqb;0805&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (5-methyl-furan-2-ylmethyl)-amide; </paragraph>
<paragraph id="P-0806" lvl="1"><number>&lsqb;0806&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2,2-diphenyl-ethyl)-amide; </paragraph>
<paragraph id="P-0807" lvl="1"><number>&lsqb;0807&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(2-methoxy-phenyl)-ethyl&rsqb;-amide; </paragraph>
<paragraph id="P-0808" lvl="1"><number>&lsqb;0808&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(3-trifluoromethyl-phenyl)-ethyl&rsqb;-amide; </paragraph>
<paragraph id="P-0809" lvl="1"><number>&lsqb;0809&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-bromo-benzylamide; </paragraph>
<paragraph id="P-0810" lvl="1"><number>&lsqb;0810&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(1H-indol-3-yl)-ethyl&rsqb;-amide; </paragraph>
<paragraph id="P-0811" lvl="1"><number>&lsqb;0811&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3,5-dichloro-benzylamide; </paragraph>
<paragraph id="P-0812" lvl="1"><number>&lsqb;0812&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid indan-1-ylamide; </paragraph>
<paragraph id="P-0813" lvl="1"><number>&lsqb;0813&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (furan-2-ylmethyl)-amide; </paragraph>
<paragraph id="P-0814" lvl="1"><number>&lsqb;0814&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(4-methoxy-phenyl)-ethyl&rsqb;-amide; </paragraph>
<paragraph id="P-0815" lvl="1"><number>&lsqb;0815&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,4-dimethoxy-benzylamide; </paragraph>
<paragraph id="P-0816" lvl="1"><number>&lsqb;0816&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-chloro-benzylamide; </paragraph>
<paragraph id="P-0817" lvl="1"><number>&lsqb;0817&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (1-phenyl-ethyl)-amide; </paragraph>
<paragraph id="P-0818" lvl="1"><number>&lsqb;0818&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3,4-dichloro-benzylamide; </paragraph>
<paragraph id="P-0819" lvl="1"><number>&lsqb;0819&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-fluoro-3-trifluoromethyl-benzylamide; </paragraph>
<paragraph id="P-0820" lvl="1"><number>&lsqb;0820&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-pyridin-2-yl-ethyl)-amide; </paragraph>
<paragraph id="P-0821" lvl="1"><number>&lsqb;0821&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(2,4-dimethyl-phenyl)-ethyl&rsqb;-amide; </paragraph>
<paragraph id="P-0822" lvl="1"><number>&lsqb;0822&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(2,4-dichloro-phenyl)-ethyl&rsqb;-amide; </paragraph>
<paragraph id="P-0823" lvl="1"><number>&lsqb;0823&rsqb;</number> 1,3-Dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0824" lvl="1"><number>&lsqb;0824&rsqb;</number> 3-Cyanomethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0825" lvl="1"><number>&lsqb;0825&rsqb;</number> 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0826" lvl="1"><number>&lsqb;0826&rsqb;</number> 3-(4-Cyclopropylsulfamoyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0827" lvl="1"><number>&lsqb;0827&rsqb;</number> 1-Methyl-3-(6-nitro-pyridin-3-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0828" lvl="1"><number>&lsqb;0828&rsqb;</number> 1-Methyl-3-(6-nitro-pyridin-3-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0829" lvl="1"><number>&lsqb;0829&rsqb;</number> 1-Methyl-3-(6-nitro-pyridin-3-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-methoxy-pyridin-4-ylmethyl)-amide; </paragraph>
<paragraph id="P-0830" lvl="1"><number>&lsqb;0830&rsqb;</number> 3-Cyclohexylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-methoxy-pyridin-4-ylmethyl)-amide; </paragraph>
<paragraph id="P-0831" lvl="1"><number>&lsqb;0831&rsqb;</number> 3-&lcub;2-&lsqb;(1H-Benzimidazole-5-carbonyl)-amino&rsqb;-ethyl&rcub;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0832" lvl="1"><number>&lsqb;0832&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lsqb;2-(3-piperidin-1-yl-propionylamino)-ethyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0833" lvl="1"><number>&lsqb;0833&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lcub;2-&lsqb;(6-pyrazol-1-yl-pyridine-3-carbonyl)-amino&rsqb;-ethyl&rcub;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0834" lvl="1"><number>&lsqb;0834&rsqb;</number> 3-&lsqb;2-(4-Diethylamino-benzoylamino)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0835" lvl="1"><number>&lsqb;0835&rsqb;</number> 3-&lcub;2-&lsqb;(6-Chloro-pyridine-3-carbonyl)-amino&rsqb;-ethyl&rcub;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0836" lvl="1"><number>&lsqb;0836&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lcub;2-&lsqb;(1H-pyrrole-2-carbonyl)-amino&rsqb;-ethyl&rcub;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0837" lvl="1"><number>&lsqb;0837&rsqb;</number> 3-&lsqb;2-(2-Dimethylamino-acetylamino)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0838" lvl="1"><number>&lsqb;0838&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lcub;2-&lsqb;(pyrazine-2-carbonyl)-amino&rsqb;-ethyl&rcub;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0839" lvl="1"><number>&lsqb;0839&rsqb;</number> 1-Methyl-3-&lsqb;2-(2-methyl-2-methylamino-propionylamino)-ethyl&rsqb;-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0840" lvl="1"><number>&lsqb;0840&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lcub;2-&lsqb;(pyrrolidine-2-carbonyl)-amino&rsqb;-ethyl&rcub;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0841" lvl="1"><number>&lsqb;0841&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lcub;2-&lsqb;3-(5-phenyl-1H-pyrrol-2-yl)-propionylamino&rsqb;-ethyl&rcub;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0842" lvl="1"><number>&lsqb;0842&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lcub;2-&lsqb;2-(pyridin-4-ylsulfanyl)-acetylamino&rsqb;-ethyl&rcub;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0843" lvl="1"><number>&lsqb;0843&rsqb;</number> 3-(6-Amino-pyridin-3-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </paragraph>
<paragraph id="P-0844" lvl="1"><number>&lsqb;0844&rsqb;</number> 1-Methyl-2,4-dioxo-3-(3-phenyl-prop-2-ynyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0845" lvl="1"><number>&lsqb;0845&rsqb;</number> 3-(6-Amino-pyridin-3-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0846" lvl="1"><number>&lsqb;0846&rsqb;</number> 3-(6-Amino-pyridin-3-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (pyridin-4-ylmethyl)-amide; </paragraph>
<paragraph id="P-0847" lvl="1"><number>&lsqb;0847&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lsqb;2-(pyridin-2-ylamino)-ethyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </paragraph>
<paragraph id="P-0848" lvl="1"><number>&lsqb;0848&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lsqb;2-(pyrimidin-2-ylamino)-ethyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; and </paragraph>
<paragraph id="P-0849" lvl="1"><number>&lsqb;0849&rsqb;</number> 1-Methyl-2,4-dioxo-3-&lsqb;2-(pyrimidin-2-ylamino)-ethyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide. </paragraph>
<paragraph id="P-0850" lvl="0"><number>&lsqb;0850&rsqb;</number> A further embodiment of this invention is use of a compound of Formula I, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment of a disease mediated by an MMP-13 enzyme. </paragraph>
<paragraph id="P-0851" lvl="0"><number>&lsqb;0851&rsqb;</number> Another invention embodiment is use of a compound of Formulas II, III, VI, VII, or XI, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment of a disease mediated by an MMP-13 enzyme. </paragraph>
<paragraph id="P-0852" lvl="0"><number>&lsqb;0852&rsqb;</number> Another invention embodiment is use of a compound of Formula I, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment of cancer. </paragraph>
<paragraph id="P-0853" lvl="0"><number>&lsqb;0853&rsqb;</number> Another invention embodiment is use of a compound of Formula I, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment of rheumatoid arthritis. </paragraph>
<paragraph id="P-0854" lvl="0"><number>&lsqb;0854&rsqb;</number> Another invention embodiment is use of a compound of Formula I, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment of osteoarthritis. </paragraph>
<paragraph id="P-0855" lvl="0"><number>&lsqb;0855&rsqb;</number> A further embodiment of this invention is a pharmaceutical composition, comprising a compound of Formula I, or a pharmaceutically acceptable salt thereof, admixed with a pharmaceutically acceptable carrier, excipient, or diluent. </paragraph>
<paragraph id="P-0856" lvl="0"><number>&lsqb;0856&rsqb;</number> Another invention embodiment is a pharmaceutical composition, comprising a compound of any one of Formulas II, III, VI, VII, and XI, or a pharmaceutically acceptable salt thereof, admixed with a pharmaceutically acceptable carrier, excipient, or diluent. </paragraph>
<paragraph id="P-0857" lvl="0"><number>&lsqb;0857&rsqb;</number> Another embodiment of this invention is a method for inhibiting MMP-13, in an animal, comprising administering to the animal an MMP-13 inhibiting amount of a compound of Formula I, or a pharmaceutically acceptable salt thereof. </paragraph>
<paragraph id="P-0858" lvl="0"><number>&lsqb;0858&rsqb;</number> A further embodiment is a method for treating a disease mediated by MMP-13 enzymes, comprising administering to a patient suffering from such disease a effective amount of a compound of Formula I, or a pharmaceutically acceptable salt thereof. </paragraph>
<paragraph id="P-0859" lvl="0"><number>&lsqb;0859&rsqb;</number> Another invention embodiment is a method for treating a cancer, comprising administering to a patient suffering from such a disease an anticancer effective amount of a compound of Formula I, or a pharmaceutically acceptable salt thereof. </paragraph>
<paragraph id="P-0860" lvl="0"><number>&lsqb;0860&rsqb;</number> Another invention embodiment is a method for treating breast carcinoma, comprising administering to a patient suffering from such a disease an anticancer effective amount of a compound of Formula I, or a pharmaceutically acceptable salt thereof. </paragraph>
<paragraph id="P-0861" lvl="0"><number>&lsqb;0861&rsqb;</number> Another invention embodiment is a method for treating a rheumatoid arthritis, comprising administering to a patient suffering from such a disease an effective amount of a compound of Formula I, or a pharmaceutically acceptable salt thereof. </paragraph>
<paragraph id="P-0862" lvl="0"><number>&lsqb;0862&rsqb;</number> Another invention embodiment is a method for treating a osteoarthritis, comprising administering to a patient suffering from such a disease an effective amount of a compound of Formula I, or a pharmaceutically acceptable salt thereof. </paragraph>
<paragraph id="P-0863" lvl="0"><number>&lsqb;0863&rsqb;</number> Another invention embodiment is a method for treating a heart failure, comprising administering to a patient suffering from such a disease an effective amount of a compound of Formula I, or a pharmaceutically acceptable salt thereof. </paragraph>
<paragraph id="P-0864" lvl="0"><number>&lsqb;0864&rsqb;</number> Another invention embodiment is a method for treating a inflammation, comprising administering to a patient suffering from such a disease an effective amount of a compound of Formula I, or a pharmaceutically acceptable salt thereof. </paragraph>
<paragraph id="P-0865" lvl="0"><number>&lsqb;0865&rsqb;</number> Another invention embodiment is a method of treating a disease mediated by MMP-13 enzymes, comprising administering to a patient suffering from such disease an effective amount of a compound of any one of Formulas II, III, VI, VII, and XI, or a pharmaceutically acceptable salt thereof. </paragraph>
<paragraph id="P-0866" lvl="0"><number>&lsqb;0866&rsqb;</number> Another embodiment of the present invention is a process for preparing a compound of Formula I  
<chemistry-cwu id="CHEM-US-00020">
<number>20</number>
<image id="EMI-C00020" he="74.64555" wi="198.02475" file="US20030004172A1-20030102-C00020.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00020" file="US20030004172A1-20030102-C00020.CDX"/>
<chemistry-mol-file id="CHEMMOL-00020" file="US20030004172A1-20030102-C00020.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0867" lvl="7"><number>&lsqb;0867&rsqb;</number> or a pharmaceutically acceptable salt thereof; wherein: </paragraph>
<paragraph id="P-0868" lvl="2"><number>&lsqb;0868&rsqb;</number> W, together with the carbon atoms to which it is attached, form a 5-membered ring diradical  
<chemistry-cwu id="CHEM-US-00021">
<number>21</number>
<image id="EMI-C00021" he="346.6071" wi="192.2697" file="US20030004172A1-20030102-C00021.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00021" file="US20030004172A1-20030102-C00021.CDX"/>
<chemistry-mol-file id="CHEMMOL-00021" file="US20030004172A1-20030102-C00021.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0869" lvl="2"><number>&lsqb;0869&rsqb;</number> A is </paragraph>
<paragraph id="P-0870" lvl="2"><number>&lsqb;0870&rsqb;</number> B is O or NR<highlight><superscript>5</superscript></highlight>; or </paragraph>
<paragraph id="P-0871" lvl="2"><number>&lsqb;0871&rsqb;</number> A and B are taken together to form &mdash;C&equiv;C&mdash;; </paragraph>
<paragraph id="P-0872" lvl="2"><number>&lsqb;0872&rsqb;</number> X is O, S, SO, SO<highlight><subscript>2</subscript></highlight>, NR<highlight><superscript>5</superscript></highlight>, or CH<highlight><subscript>2</subscript></highlight>; </paragraph>
<paragraph id="P-0873" lvl="2"><number>&lsqb;0873&rsqb;</number> each Y independently is O or S; </paragraph>
<paragraph id="P-0874" lvl="2"><number>&lsqb;0874&rsqb;</number> R<highlight><superscript>1</superscript></highlight>, R<highlight><superscript>4</superscript></highlight>, and R<highlight><superscript>5 </superscript></highlight>independently are hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heterocyclic, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkanoyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </paragraph>
<paragraph id="P-0875" lvl="2"><number>&lsqb;0875&rsqb;</number> R<highlight><superscript>2 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>independently are hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, CN, NO<highlight><subscript>2</subscript></highlight>, NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </paragraph>
<paragraph id="P-0876" lvl="2"><number>&lsqb;0876&rsqb;</number> R<highlight><superscript>2 </superscript></highlight>may further be halo; </paragraph>
<paragraph id="P-0877" lvl="2"><number>&lsqb;0877&rsqb;</number> n is an integer of from 0 to 5; and </paragraph>
<paragraph id="P-0878" lvl="2"><number>&lsqb;0878&rsqb;</number> R<highlight><superscript>4 </superscript></highlight>and R<highlight><superscript>5 </superscript></highlight>when taken together with the nitrogen to which they are attached complete a 3- to 8-membered ring containing carbon atoms and optionally containing O, S, or N, and substituted or unsubstituted; </paragraph>
<paragraph id="P-0879" lvl="2"><number>&lsqb;0879&rsqb;</number> with the proviso that R<highlight><superscript>1 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>are not both selected from: hydrogen and C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, </paragraph>
<paragraph id="P-0880" lvl="2"><number>&lsqb;0880&rsqb;</number> the process comprising the step of: contacting a compound of Formula (A)  
<chemistry-cwu id="CHEM-US-00022">
<number>22</number>
<image id="EMI-C00022" he="74.64555" wi="198.02475" file="US20030004172A1-20030102-C00022.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00022" file="US20030004172A1-20030102-C00022.CDX"/>
<chemistry-mol-file id="CHEMMOL-00022" file="US20030004172A1-20030102-C00022.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0881" lvl="2"><number>&lsqb;0881&rsqb;</number> &emsp;wherein Y, R<highlight><superscript>1</superscript></highlight>, and R<highlight><superscript>4 </superscript></highlight>are as defined above; and </paragraph>
<paragraph id="P-0882" lvl="2"><number>&lsqb;0882&rsqb;</number> W<highlight><superscript>1</superscript></highlight>, together with the carbon atoms to which it is attached, form a 5-membered ring diradical  
<chemistry-cwu id="CHEM-US-00023">
<number>23</number>
<image id="EMI-C00023" he="241.9389" wi="178.34985" file="US20030004172A1-20030102-C00023.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00023" file="US20030004172A1-20030102-C00023.CDX"/>
<chemistry-mol-file id="CHEMMOL-00023" file="US20030004172A1-20030102-C00023.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0883" lvl="2"><number>&lsqb;0883&rsqb;</number> R<highlight><superscript>2 </superscript></highlight>and X are as defined above; and </paragraph>
<paragraph id="P-0884" lvl="2"><number>&lsqb;0884&rsqb;</number> L is a group K or Q, wherein </paragraph>
<paragraph id="P-0885" lvl="2"><number>&lsqb;0885&rsqb;</number> K is halo, B(OH)<highlight><subscript>2</subscript></highlight>, Sn(C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl)<highlight><subscript>3</subscript></highlight>, or OS(O)<highlight><subscript>2</subscript></highlight>CF<highlight><subscript>3</subscript></highlight>, and </paragraph>
<paragraph id="P-0886" lvl="2"><number>&lsqb;0886&rsqb;</number> Q is CO<highlight><subscript>2</subscript></highlight>H, CO<highlight><subscript>2</subscript></highlight>M, C(&boxH;O)-halo, C(&boxH;O)&mdash;OR<highlight><superscript>7</superscript></highlight>, C(&boxH;O)NR<highlight><superscript>8</superscript></highlight>R<highlight><superscript>9</superscript></highlight>, C(&boxH;O)&mdash;C(halo)<highlight><subscript>3</subscript></highlight>, or C&equiv;N, </paragraph>
<paragraph id="P-0887" lvl="2"><number>&lsqb;0887&rsqb;</number> wherein R<highlight><superscript>7 </superscript></highlight>is pentafluorophenyl, C(&boxH;O)R<highlight><superscript>4</superscript></highlight>, wherein R<highlight><superscript>4 </superscript></highlight>is as defined above, or S(O)<highlight><subscript>2</subscript></highlight>R<highlight><superscript>4</superscript></highlight>, wherein R<highlight><superscript>4 </superscript></highlight>is as defined above; </paragraph>
<paragraph id="P-0888" lvl="2"><number>&lsqb;0888&rsqb;</number> R<highlight><superscript>8 </superscript></highlight>and R<highlight><superscript>9 </superscript></highlight>are taken together with the nitrogen atom to which they are attached to form imidazol-1-yl, phthalimid-1-yl, benzotriazol-1-yl, or tetrazol-1-yl; and </paragraph>
<paragraph id="P-0889" lvl="2"><number>&lsqb;0889&rsqb;</number> M is an alkali earth metal cation or alkaline earth metal cation; with a solvent and, when L is the group Q, a compound of Formula (B)</paragraph>
<paragraph lvl="0"><in-line-formula>D&mdash;R<highlight><superscript>3</superscript></highlight>&emsp;&emsp;(B)</in-line-formula></paragraph>
<paragraph id="P-0890" lvl="7"><number>&lsqb;0890&rsqb;</number> wherein R<highlight><superscript>3 </superscript></highlight>is as defined above and D is HO, HN(R<highlight><superscript>5</superscript></highlight>), MO, or MN(R<highlight><superscript>5</superscript></highlight>); </paragraph>
<paragraph id="P-0891" lvl="2"><number>&lsqb;0891&rsqb;</number> wherein R<highlight><superscript>5 </superscript></highlight>and M are as defined above; </paragraph>
<paragraph id="P-0892" lvl="2"><number>&lsqb;0892&rsqb;</number> optionally in the presence of from 1 to 3 agents selected from: </paragraph>
<paragraph id="P-0893" lvl="3"><number>&lsqb;0893&rsqb;</number> a coupling agent, a tertiary organic amine, an acid catalyst, a base catalyst, an acid halide, and an acid anhydride. </paragraph>
<paragraph id="P-0894" lvl="0"><number>&lsqb;0894&rsqb;</number> Another invention embodiment is a process comprising the step of: </paragraph>
<paragraph id="P-0895" lvl="2"><number>&lsqb;0895&rsqb;</number> contacting a compound of Formula (A) </paragraph>
<paragraph id="P-0896" lvl="2"><number>&lsqb;0896&rsqb;</number> as defined above with a solvent and, when </paragraph>
<paragraph id="P-0897" lvl="2"><number>&lsqb;0897&rsqb;</number> L is the group K, a compound of Formula (C)</paragraph>
<paragraph lvl="0"><in-line-formula>G&mdash;C&equiv;C&mdash;R<highlight><superscript>3</superscript></highlight>&emsp;&emsp;(C)</in-line-formula></paragraph>
<paragraph id="P-0898" lvl="2"><number>&lsqb;0898&rsqb;</number> wherein R<highlight><superscript>3 </superscript></highlight>is as defined above and G is hydrogen or halo; </paragraph>
<paragraph id="P-0899" lvl="2"><number>&lsqb;0899&rsqb;</number> optionally in the presence of a coupling catalyst. </paragraph>
<paragraph id="P-0900" lvl="0"><number>&lsqb;0900&rsqb;</number> Another invention embodiment is the invention process wherein Y is O and X is S; or  
<chemistry-cwu id="CHEM-US-00024">
<number>24</number>
<image id="EMI-C00024" he="19.19295" wi="5.0463" file="US20030004172A1-20030102-C00024.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00024" file="US20030004172A1-20030102-C00024.CDX"/>
<chemistry-mol-file id="CHEMMOL-00024" file="US20030004172A1-20030102-C00024.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0901" lvl="0"><number>&lsqb;0901&rsqb;</number> Another invention embodiment is the invention process wherein A is &mdash;C&mdash;, B is O or NR<highlight><superscript>5</superscript></highlight>, Y is O, and X is S. </paragraph>
<paragraph id="P-0902" lvl="0"><number>&lsqb;0902&rsqb;</number> Another invention embodiment is the invention process wherein A and B are taken together to form &mdash;C&equiv;C, Y is O, and X is S. </paragraph>
<paragraph id="P-0903" lvl="0"><number>&lsqb;0903&rsqb;</number> Another invention embodiment is the invention process wherein R<highlight><superscript>1 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>independently are (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl, wherein n is an integer of from 0 to 5. </paragraph>
<paragraph id="P-0904" lvl="0"><number>&lsqb;0904&rsqb;</number> Another invention embodiment is the invention process wherein n is 1. </paragraph>
<paragraph id="P-0905" lvl="0"><number>&lsqb;0905&rsqb;</number> Another invention embodiment is any one of the above invention process embodiments wherein L is CO<highlight><subscript>2</subscript></highlight>H, CO<highlight><subscript>2</subscript></highlight>M, C(&boxH;O)-halo, wherein M is an alkali earth metal cation or an alkaline earth metal cation. </paragraph>
<paragraph id="P-0906" lvl="0"><number>&lsqb;0906&rsqb;</number> Another invention embodiment is any one of the above invention process embodiments wherein L is halo. </paragraph>
<paragraph id="P-0907" lvl="0"><number>&lsqb;0907&rsqb;</number> Another invention embodiment is any one of the above invention process embodiments wherein G is H. </paragraph>
</section>
<section>
<heading lvl="1">DETAILED DESCRIPTION OF THE INVENTION </heading>
<paragraph id="P-0908" lvl="0"><number>&lsqb;0908&rsqb;</number> The compounds provided by this invention are those defined by Formula I. In Formula I, R<highlight><superscript>1</superscript></highlight>-R<highlight><superscript>4 </superscript></highlight>include &ldquo;C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl&rdquo; groups. These are straight and branched carbon chains having from 1 to 6 carbon atoms. Examples of such alkyl groups include methyl, ethyl, isopropyl, tert-butyl, neopentyl, and n-hexyl. The alkyl groups can be substituted if desired, for instance, with groups such as aryl-O&mdash;, wherein aryl is as defined below, heteroaryl-O&mdash;, wherein heteroaryl is as defined below, hydroxy, amino, alkyl, and dialkylamino, halo, trifluoromethyl, carboxy, nitro, and cyano. Typical substituted alkyl groups thus are aminomethyl, 2-nitroethyl, 4-cyanobutyl, 2,3-dichloropentyl, and 3-hydroxy-5-carboxyhexyl. </paragraph>
<paragraph id="P-0909" lvl="0"><number>&lsqb;0909&rsqb;</number> Examples of NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5 </superscript></highlight>groups include amino, methylamino, di-isopropylamino, acetyl amino, propionyl amino, 3-aminopropyl amino, s 3-ethylaminobutyl amino, 3-di-n-propylamino-propyl amino, 4-diethylaminobutyl amino, and 3-carboxypropionyl amino. R<highlight><superscript>4 </superscript></highlight>and R<highlight><superscript>5 </superscript></highlight>can be taken together with the nitrogen to which they are attached to form a ring having 3 to 7 carbon atoms and 1, 2, or 3 heteroatoms selected from the group consisting of nitrogen, substituted nitrogen, oxygen, and sulfur. Examples of such cyclic NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5 </superscript></highlight>groups include pyrrolidinyl, piperazinyl, 4-methylpiperazinyl, 4-benzylpiperazinyl, pyridinyl, piperidinyl, pyrazinyl, morpholinyl, and the like. </paragraph>
<paragraph id="P-0910" lvl="0"><number>&lsqb;0910&rsqb;</number> &ldquo;Halo&rdquo; includes fluoro, chloro, bromo, and iodo. </paragraph>
<paragraph id="P-0911" lvl="0"><number>&lsqb;0911&rsqb;</number> &ldquo;Alkenyl&rdquo; means straight and branched hydrocarbon radicals having from 2 to 6 carbon atoms and one double bond and includes ethenyl, 3-buten-1-yl, 2-ethenylbutyl, 3-hexen-1-yl, and the like. </paragraph>
<paragraph id="P-0912" lvl="0"><number>&lsqb;0912&rsqb;</number> &ldquo;Alkynyl&rdquo; means straight and branched hydrocarbon radicals having from 2 to 6 carbon atoms and one triple bond and includes ethynyl, 3-butyn-1-yl, propynyl, 2-butyn-1-yl, 3-pentyn-1-yl, and the like. </paragraph>
<paragraph id="P-0913" lvl="0"><number>&lsqb;0913&rsqb;</number> &ldquo;Carbocycle&rdquo; or &ldquo;Cycloalkyl&rdquo; mean a monocyclic or polycyclic hydrocarbyl group such as cyclopropyl, cycloheptyl, cyclooctyl, cyclodecyl, cyclobutyl, adamantyl, norpinanyl, decalinyl, norbornyl, cyclohexyl, and cyclopentyl. Such groups can be substituted with groups such as hydroxy, keto, and the like. Also included are rings in which 1 to 3 heteroatoms replace carbons. Such groups are termed &ldquo;heterocycle&rdquo; or &ldquo;heterocyclic&rdquo; or &ldquo;heterocyclyl,&rdquo; which mean a cycloalkyl group also bearing at least one heteroatom selected from O, S, or NR<highlight><subscript>2</subscript></highlight>, examples being oxiranyl, pyrrolidinyl, piperidyl, tetrahydropyran, and morpholine. </paragraph>
<paragraph id="P-0914" lvl="0"><number>&lsqb;0914&rsqb;</number> &ldquo;Alkoxy&rdquo; refers to the alkyl groups mentioned above bound through oxygen, examples of which include methoxy, ethoxy, isopropoxy, tert-butoxy, and the like. In addition, alkoxy refers to polyethers such as &mdash;O&mdash;(CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>2</subscript></highlight>&mdash;O&mdash;OH<highlight><subscript>3</subscript></highlight>, and the like. </paragraph>
<paragraph id="P-0915" lvl="0"><number>&lsqb;0915&rsqb;</number> &ldquo;Alkanoyl&rdquo; groups are alkyl linked through a carbonyl, ie, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>5</subscript></highlight>&mdash;C(O)&mdash;. Such groups include formyl, acetyl, propionyl, butyryl, and isobutyryl. </paragraph>
<paragraph id="P-0916" lvl="0"><number>&lsqb;0916&rsqb;</number> &ldquo;Acyl&rdquo; means an alkyl or aryl (Ar) group bonded through a carbonyl group, i.e., R&mdash;C(O)&mdash;. For example, acyl includes a C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkanoyl, including substituted alkanoyl, wherein the alkyl portion can be substituted by NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5 </superscript></highlight>or a carboxylic or heterocyclic group. Typical acyl groups include acetyl, benzoyl, and the like. </paragraph>
<paragraph id="P-0917" lvl="0"><number>&lsqb;0917&rsqb;</number> The alkyl, alkenyl, alkoxy, and alkynyl groups described above are optionally substituted, preferably by 1 to 3 groups selected from NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>, phenyl, substituted phenyl, thio C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkoxy, hydroxy, carboxy, aryl-O&mdash;, wherein aryl is as defined below, heteroaryl-O&mdash;, wherein heteroaryl is as defined below, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkoxycarbonyl, halo, nitrile, cycloalkyl, and a 5- or 6-membered carbocyclic ring or heterocyclic ring having 1 or 2 heteroatoms selected from nitrogen, substituted nitrogen, oxygen, and sulfur. &ldquo;Substituted nitrogen&rdquo; means nitrogen bearing C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n</subscript></highlight>Ph where n is 1, 2, or 3. Perhalo and polyhalo substitution is also embraced. Oxo (&boxH;O) substitution of a CH<highlight><subscript>2 </subscript></highlight>carbon group to provide a carbonyl (C&boxH;O) is also embraced. </paragraph>
<paragraph id="P-0918" lvl="0"><number>&lsqb;0918&rsqb;</number> Examples of substituted alkyl groups include 2-aminoethyl, pentachloroethyl, trifluoromethyl, 2-diethylaminoethyl, 2-dimethylaminopropyl, ethoxycarbonylmethyl, 3-phenylbutyl, methanylsulfanylmethyl, methoxymethyl, 3-hydroxypentyl, 2-carboxybutyl, 4-chlorobutyl, 3-cyclopropylpropyl, pentafluoroethyl, 3-morpholinopropyl, piperazinylmethyl, and 2-(4-methylpiperazinyl)ethyl. </paragraph>
<paragraph id="P-0919" lvl="0"><number>&lsqb;0919&rsqb;</number> Examples of substituted alkynyl groups include 2-methoxyethynyl, 2-ethylsulfanyethynyl, 4-(1-piperazinyl)-3-(butynyl), 3-phenyl-5-hexynyl, 3-diethylamino-3-butynyl, 4-chloro-3-butynyl, 4-cyclobutyl-4-hexenyl, and the like. </paragraph>
<paragraph id="P-0920" lvl="0"><number>&lsqb;0920&rsqb;</number> Typical substituted alkoxy groups include aminomethoxy, trifluoromethoxy, 2-diethylaminoethoxy, 2-ethoxycarbonylethoxy, 3-hydroxypropoxy, 6-carboxhexyloxy, and the like. </paragraph>
<paragraph id="P-0921" lvl="0"><number>&lsqb;0921&rsqb;</number> Further, examples of substituted alkyl, alkenyl, and alkynyl groups include dimethylaminomethyl, carboxymethyl, 4-dimethylamino-3-buten-1-yl, 5-ethylmethylamino-3-pentyn-1-yl, 4-morpholinobutyl, 4-tetrahydropyrinidylbutyl, 3-imidazolidin-1-ylpropyl, 4-tetrahydrothiazol-3-yl-butyl, phenylmethyl, 3-chlorophenylmethyl, and the like. </paragraph>
<paragraph id="P-0922" lvl="0"><number>&lsqb;0922&rsqb;</number> The terms &ldquo;Ar&rdquo; and &ldquo;aryl&rdquo; refer to unsubstituted and substituted aromatic groups. Heteroaryl groups have from 4 to 10 ring atoms which are carbon atoms, and from 1 to 4 of which are independently selected from the group consisting of O, S, and N. Preferred heteroaryl groups have 1 or 2 heteroatoms in a 5- or 6-membered aromatic ring. Mono and bicyclic aromatic ring systems are included in the definition of aryl and heteroaryl. Typical aryl and heteroaryl groups include phenyl, 3-chlorophenyl, 2,6-dibromophenyl, pyridyl, 3-methylpyridyl, benzothienyl, 2,4,6-tribromophenyl, 4-ethylbenzothienyl, furanyl, 3,4-diethylfuranyl, naphthyl, 4,7-dichloronaphthyl, morpholinyl, indolyl, benzotriazolyl, indazolyl, pyrrole, pyrazole, imidazole, thiazole, and the like. </paragraph>
<paragraph id="P-0923" lvl="0"><number>&lsqb;0923&rsqb;</number> Preferred Ar groups are phenyl and phenyl substituted by 1, 2, or 3 groups independently selected from the group consisting of alkyl, alkoxy, thio, thioalkyl, 1H-tetrazol-5-yl, halo, hydroxy, &mdash;COOR<highlight><superscript>6</superscript></highlight>, trifluoromethyl, nitro, amino of the formula &mdash;NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>, and T(CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>m</subscript></highlight>QR<highlight><superscript>4 </superscript></highlight>or T(CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>m</subscript></highlight>CO<highlight><subscript>2</subscript></highlight>R<highlight><superscript>4 </superscript></highlight>wherein m is 1 to 6, T is O, S, NR<highlight><superscript>4,</superscript></highlight>N(O)R<highlight><superscript>4</superscript></highlight>, NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>Y, or CR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>, Q is O, S, NR<highlight><superscript>5</superscript></highlight>, N(O)R<highlight><superscript>5</superscript></highlight>, or NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>Y wherein R<highlight><superscript>4 </superscript></highlight>and R<highlight><superscript>5 </superscript></highlight>are as described above, and R<highlight><superscript>6 </superscript></highlight>is hydrogen, alkyl, or substituted alkyl, for example, methyl, trichloroethyl, diphenylmethyl, and the like. The alkyl and alkoxy groups can be substituted as defined above. For example, typical groups are carboxyalkyl, alkoxycarbonylalkyl, hydroxyalkyl, hydroxyalkoxy, and alkoxyalkyl. Typical substituted aryl groups include 2,6-dichlorophenyl, 3-methoxyphenyl, 4-trifluoromethylphenyl, 4-styrylphenyl, 3-amino-4-nitrophenyl, 3,5-dihydroxyphenyl, and the like. </paragraph>
<paragraph id="P-0924" lvl="0"><number>&lsqb;0924&rsqb;</number> Most preferred aryl is phenyl, 4- or 3-methoxy-phenyl, 4-fluorophenyl, and 3-fluorophenyl, and each of 3,4-disubstituted phenyls wherein the substituents are methoxy and fluoro. </paragraph>
<paragraph id="P-0925" lvl="0"><number>&lsqb;0925&rsqb;</number> Most preferred heteroaryl is pyridin-4-yl or 2-methoxypyridin-4-yl. </paragraph>
<paragraph id="P-0926" lvl="0"><number>&lsqb;0926&rsqb;</number> The phrase &ldquo;tertiary organic amine&rdquo; means a trisubstituted nitrogen group wherein the 3 substituents are independently selected from C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>12 </subscript></highlight>alkyl, C<highlight><subscript>3</subscript></highlight>-C<highlight><subscript>12 </subscript></highlight>cycloalkyl, benzyl, or wherein two of the substituents are taken together with the nitrogen atom to which they are attached to form a 5- or 6-membered, monocyclic heterocycle containing one nitrogen atom and carbon atoms, and the third substituent is selected from C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>12 </subscript></highlight>alkyl and benzyl, or wherein the three substituents are taken together with the nitrogen atom to which they are attached to form a 7- to 12-membered bicyclic heterocycle containing 1 or 2 nitrogen atoms and carbon atoms, and optionally a C&boxH;N double bond when 2 nitrogen atoms are present. Illustrative examples of tertiary organic amine include triethylamine, diisopropylethylamine, benzyl diethylamino, dicyclohexylmethyl-amine, 1,8-diazabicycle&lsqb;5.4.0&rsqb;undec-7-ene (&ldquo;DBU&rdquo;), 1,4-diazabicyclo&lsqb;2.2.2&rsqb;-octane (&ldquo;TED&rdquo;), and 1,5-diazabicycle&lsqb;4.3.0&rsqb;non-5-ene. </paragraph>
<paragraph id="P-0927" lvl="0"><number>&lsqb;0927&rsqb;</number> The term &ldquo;coupling agent&rdquo; includes any reagent, or any combination of two, three, or four reagents, conventionally used to promote coupling of a carboxylic acid, or a pharmaceutically acceptable salt thereof, with an alcohol or an amine to yield a carboxylic ester or carboxylic amide, respectively. The coupling agents are described in <highlight><italic>Reagents for Organic Synthesis </italic></highlight>by Fieser and Fieser, New York: John Wiley &amp; Sons, Inc., 2000; <highlight><italic>Comprehensive Organic Transformations </italic></highlight>by Richard C. Larock, New York: VCH Publishers, Inc., 1989; the series <highlight><italic>Compendium of Organic Synthetic Methods </italic></highlight>by Wiley-Interscience, 1989; and the text <highlight><italic>Advanced Organic Chemistry, </italic></highlight>5<highlight><superscript>th </superscript></highlight>edition, by Jerry March, New York: Wiley-Interscience, 2001. Illustrative examples of coupling agents include N,N&prime;-carbonyldiimidazole (&ldquo;CDI&rdquo;), N,N&prime;-dicyclohexylcarbodiimide (&ldquo;DCC&rdquo;), triphenylphosphine with diethylazodicarboxylate, bis(2-oxo-3-oxazolidinyl)phosphinic chloride (&ldquo;BOP-Cl&rdquo;), POCl<highlight><subscript>3</subscript></highlight>, Ti(Cl)<highlight><subscript>4</subscript></highlight>, and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (&ldquo;EDAC&rdquo;). </paragraph>
<paragraph id="P-0928" lvl="0"><number>&lsqb;0928&rsqb;</number> The phrase &ldquo;acid catalyst&rdquo; means any protic or Lewis acid that is conventionally used to catalyze coupling of a carboxylic acid, or a pharmaceutically acceptable salt thereof, a nitrile, carboxylic ester, carboxylic amide, carboxylic acid halide, or carboxylic acid anhydride with an alcohol or an amine to yield a carboxylic ester or carboxylic amide, respectively. The acid catalysts are described in Fieser and Fieser, supra., 2000; Larock R C, supra., 1989; Wiley-Interscience, supra., 1989; and March J, supra., 2001. Illustrative examples include anhydrous hydrogen chloride, hydrochloric acid, hydrogen bromide in acetic acid, zinc chloride, titanium tetrachloride, acetic acid, trifluoroacetic acid, phenol, sulfuric acid, methanesulfonic acid, magnesium sulfate, Amberlyst-15 resin, silica gel, and the like. </paragraph>
<paragraph id="P-0929" lvl="0"><number>&lsqb;0929&rsqb;</number> It should be appreciated that a nitrile may be contacted with an alcohol or an amine in the presence of an acid catalyst, and the resulting intermediate imidate or amidine, respectfully, may be contacted with water to yield the carboxylic ester or carboxylic amide, respectively. </paragraph>
<paragraph id="P-0930" lvl="0"><number>&lsqb;0930&rsqb;</number> The phrase &ldquo;base catalyst&rdquo; means any base that is conventionally used to catalyze coupling of a carboxylic acid, or a pharmaceutically acceptable salt thereof, carboxylic ester, carboxylic amide, carboxylic acid halide, or carboxylic acid anhydride with an alcohol or an amine to yield a carboxylic ester or carboxylic amide, respectively. The base catalysts are described in Fieser and Fieser, supra., 2000;. Larock R C, supra., 1989; Wiley-Interscience, supra., 1989; and March J, supra., 2001. Illustrative examples include sodium hydroxide, sodium hydride, potassium tert-butoxide, a tertiary organic amine, titanium tetraisopropoxide, sodium methoxide, sodium acetate, sodium bicarbonate, potassium carbonate, basic alumina, and the like. </paragraph>
<paragraph id="P-0931" lvl="0"><number>&lsqb;0931&rsqb;</number> The phrase &ldquo;acid halide&rdquo; means any carboxylic acid halide or sulfonic acid halide that is conventionally used to catalyze coupling of a carboxylic acid, or a pharmaceutically acceptable salt thereof, with an alcohol or an amine to yield a carboxylic ester or carboxylic amide, respectively. The acid halides are described in Fieser and Fieser, supra., 2000; Larock R C, supra., 1989; Wiley-Interscience, supra., 1989; and March J, supra., 2001. Illustrative examples include acetyl chloride, trifluoromethanesulfonyl chloride, 2,2-dimethylacetyl bromide, para-toluenesulfonyl chloride, pentafluoro-benzoyl chloride, and the like. </paragraph>
<paragraph id="P-0932" lvl="0"><number>&lsqb;0932&rsqb;</number> The phrase &ldquo;acid anhydride&rdquo; means any carboxylic acid anhydride or sulfonic acid anhydride that is conventionally used to catalyze coupling of a carboxylic acid, or a pharmaceutically acceptable salt thereof, with an alcohol or an amine to yield a carboxylic ester or carboxylic amide, respectively. The acid anhydrides are described in Fieser and Fieser, supra., 2000; Larock R C, supra., 1989; Wiley-Interscience, supra., 1989; and March J, supra., 2001. Illustrative examples include acetic anhydride, trifluoroacetic anhydride, trifluoromethanesulfonic acid anhydride, pentafluoro-benzoic anhydride, mixed anhydrides like trifluoroacetyloxycarbonylmethyl, and the like. </paragraph>
<paragraph id="P-0933" lvl="0"><number>&lsqb;0933&rsqb;</number> The term &ldquo;halide&rdquo; includes fluoride, chloride, bromide, and iodide. </paragraph>
<paragraph id="P-0934" lvl="0"><number>&lsqb;0934&rsqb;</number> The phrase &ldquo;coupling catalyst&rdquo; means any metal catalyst, preferably a transition metal catalyst, that is conventionally used to catalyze coupling of an aryl halide, aryl trifluoromethanesulfonate, heteroaryl halide, or heteroaryl trifluoromethanesulfonate, or activated derivatives thereof, including arylboronic acids, heteroarylboronic acids, aryl stannanes, heteroarylstannanes, aryl magnesium halides, heteroaryl magnesium halides, aryl lithiums, or heteroaryl lithiums, with an terminal alkyne to yield an arylalkyne or heteroarylalkyne. The coupling catalysts are described in Fieser and Fieser, supra., 2000; Larock R C, supra., 1989; Wiley-Interscience, supra., 1989; and March J, supra., 2001. Illustrative examples of coupling catalysts include tetrakis(triphenylphosphine)-palladium (0), palladium (II) chloride, palladium (II) acetate, iron (III) chloride, Heck reaction catalysts, Suzuki reaction catalysts, Stille reaction catalysts, and the like. </paragraph>
<paragraph id="P-0935" lvl="0"><number>&lsqb;0935&rsqb;</number> The group  
<chemistry-cwu id="CHEM-US-00025">
<number>25</number>
<image id="EMI-C00025" he="22.7934" wi="194.4243" file="US20030004172A1-20030102-C00025.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00025" file="US20030004172A1-20030102-C00025.CDX"/>
<chemistry-mol-file id="CHEMMOL-00025" file="US20030004172A1-20030102-C00025.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0936" lvl="0"><number>&lsqb;0936&rsqb;</number> The phrase &ldquo;pharmaceutical composition&rdquo; means a composition suitable for administration in medical or veterinary use. </paragraph>
<paragraph id="P-0937" lvl="0"><number>&lsqb;0937&rsqb;</number> The term &ldquo;admixed&rdquo; and the phrase &ldquo;in admixture&rdquo; are synonymous and mean in a state of being in a homogeneous or heterogeneous mixture. Preferred is a homogeneous mixture. </paragraph>
<paragraph id="P-0938" lvl="0"><number>&lsqb;0938&rsqb;</number> The term &ldquo;patient&rdquo; means a mammal. Preferred patients are humans, cats, dogs, cows, horses, pigs, and sheep. </paragraph>
<paragraph id="P-0939" lvl="0"><number>&lsqb;0939&rsqb;</number> The term &ldquo;animal&rdquo; means a mammal, as defined above. Preferred animals include humans, cats, dogs, horses, pigs, sheep, cows, monkeys, rats, mice, guinea pigs, and rabbits. </paragraph>
<paragraph id="P-0940" lvl="0"><number>&lsqb;0940&rsqb;</number> The phrase &ldquo;anticancer effective amount&rdquo; means an amount of invention compound, or a pharmaceutically acceptable salt thereof, sufficient to inhibit, halt, or cause regression of the cancer being treated in a particular patient or patient population. For example in a human or other mammal, an anticancer effective amount can be determined experimentally in a laboratory or clinical setting, or may be the amount required by the guidelines of the United States Food and Drug Administration, or equivalent foreign agency, for the particular cancer and patient being treated. </paragraph>
<paragraph id="P-0941" lvl="0"><number>&lsqb;0941&rsqb;</number> The phrase &ldquo;antiarthritic effective amount&rdquo; means an amount of invention compound, or a pharmaceutically acceptable salt thereof, sufficient to inhibit, halt, or cause regression of the arthritis being treated in a particular patient or patient population. For example in a human or other mammal, an antiarthritic effective amount can be determined experimentally in a laboratory or clinical setting, or may be the amount required by the guidelines of the United States Food and Drug Administration, or equivalent foreign agency, for the particular arthritis and patient being treated. </paragraph>
<paragraph id="P-0942" lvl="0"><number>&lsqb;0942&rsqb;</number> The phrase &ldquo;MMP-13 inhibiting amount&rdquo; means an amount of invention compound, or a pharmaceutically acceptable salt thereof, sufficient to inhibit an enzyme matrix metalloproteinase-13, including a truncated form thereof, including a catalytic domain thereof, in a particular animal or animal population. For example in a human or other mammal, an MMP-13 inhibiting amount can be determined experimentally in a laboratory or clinical setting, or may be the amount required by the guidelines of the United States Food and Drug Administration, or equivalent foreign agency, for the particular MMP-13 enzyme and patient being treated. </paragraph>
<paragraph id="P-0943" lvl="0"><number>&lsqb;0943&rsqb;</number> It should be appreciated that determination of proper dosage forms, dosage amounts, and routes of administration, is within the level of ordinary skill in the pharmaceutical and medical arts, and is described below. </paragraph>
<paragraph id="P-0944" lvl="0"><number>&lsqb;0944&rsqb;</number> The phrases &ldquo;effective amount&rdquo; and &ldquo;therapeutically effective amount&rdquo; are synonymous and mean an amount of a compound of the present invention, a pharmaceutically acceptable salt thereof, or a solvate thereof, sufficient to effect an improvement of the condition being treated when administered to a patient suffering from a disease that is mediated by MMP-13 and optionally from 0 to 12 additional MMP enzymes. </paragraph>
<paragraph id="P-0945" lvl="0"><number>&lsqb;0945&rsqb;</number> The term &ldquo;IC<highlight><subscript>50</subscript></highlight>&rdquo; means the concentration of test compound required to inhibit activity of a biological target, such as a receptor or enzyme, by 50%. </paragraph>
<paragraph id="P-0946" lvl="0"><number>&lsqb;0946&rsqb;</number> It should be appreciated that the matrix metalloproteinases include the following enzymes: </paragraph>
<paragraph id="P-0947" lvl="2"><number>&lsqb;0947&rsqb;</number> MMP-1, also known as interstitial collagenase, collagenase-1, or fibroblast-type collagenase; </paragraph>
<paragraph id="P-0948" lvl="2"><number>&lsqb;0948&rsqb;</number> MMP-2, also known as gelatinase A or 72 kDa Type IV collagenase; </paragraph>
<paragraph id="P-0949" lvl="2"><number>&lsqb;0949&rsqb;</number> MMP-3, also known as stromelysin or stromelysin-1; </paragraph>
<paragraph id="P-0950" lvl="2"><number>&lsqb;0950&rsqb;</number> MMP-7, also known as matrilysin or PUMP-1; </paragraph>
<paragraph id="P-0951" lvl="2"><number>&lsqb;0951&rsqb;</number> MMP-8, also known as collagenase-2, neutrophil collagenase, or polymorphonuclear-type (&ldquo;PMN-type&rdquo;) collagenase; </paragraph>
<paragraph id="P-0952" lvl="2"><number>&lsqb;0952&rsqb;</number> MMP-9, also known as gelatinase B or 92 kDa Type IV collagenase; </paragraph>
<paragraph id="P-0953" lvl="2"><number>&lsqb;0953&rsqb;</number> MMP-10, also known as stromelysin-2; </paragraph>
<paragraph id="P-0954" lvl="2"><number>&lsqb;0954&rsqb;</number> MMP-11, also known as stromelysin-3; </paragraph>
<paragraph id="P-0955" lvl="2"><number>&lsqb;0955&rsqb;</number> MMP-12, also known as metalloelastase; </paragraph>
<paragraph id="P-0956" lvl="2"><number>&lsqb;0956&rsqb;</number> MMP-13, also known as collagenase-3; </paragraph>
<paragraph id="P-0957" lvl="2"><number>&lsqb;0957&rsqb;</number> MMP-14, also known as membrane-type (&ldquo;MT&rdquo;) 1-MMP or MT1-MMP; </paragraph>
<paragraph id="P-0958" lvl="2"><number>&lsqb;0958&rsqb;</number> MMP-15, also known as MT2-MMP; </paragraph>
<paragraph id="P-0959" lvl="2"><number>&lsqb;0959&rsqb;</number> MMP-16, also known as MT3-MMP; </paragraph>
<paragraph id="P-0960" lvl="2"><number>&lsqb;0960&rsqb;</number> MMP-17, also known as MT4-MMP; </paragraph>
<paragraph id="P-0961" lvl="2"><number>&lsqb;0961&rsqb;</number> MMP-18; and </paragraph>
<paragraph id="P-0962" lvl="2"><number>&lsqb;0962&rsqb;</number> MMP-19. </paragraph>
<paragraph id="P-0963" lvl="0"><number>&lsqb;0963&rsqb;</number> Other MMPs include MMP-26, also known as matrilysin-2. </paragraph>
<paragraph id="P-0964" lvl="0"><number>&lsqb;0964&rsqb;</number> One aspect of the present invention is novel compounds that are selective inhibitors of the enzyme MMP-13. A selective inhibitor of MMP-13, as used in the present invention, is a compound that is &gE;5 times more potent in vitro versus MMP-13 than versus at least one other matrix metalloproteinase enzyme such as, for example, MMP-1, MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, or MMP-14, or versus tumor necrosis factor alpha convertase (&ldquo;TACE&rdquo;). A preferred aspect of the present invention is novel compounds that are selective inhibitors of MMP-13 versus MMP-1. Other aspects of the present invention are compounds that are &gE;10, &gE;20, &gE;50, &gE;100, or &gE;1000 times more potent in vitro versus MMP-13 than versus at least one other MMP enzyme or TACE. </paragraph>
<paragraph id="P-0965" lvl="0"><number>&lsqb;0965&rsqb;</number> Still other aspects of the present invention are compounds of Formula I, or a pharmaceutically acceptable salt thereof, that are selective inhibitors of MMP-13 versus 2, 3, 4, 5, 6, or 7 other MMP enzymes, or versus TACE and 1, 2, 3, 4, 5, 6, or 7 other MMP enzymes. </paragraph>
<paragraph id="P-0966" lvl="0"><number>&lsqb;0966&rsqb;</number> Some of the compounds in the present invention may exist as stereoisomers, including enantiomers, diastereomers, and geometric isomers. Geometric isomers include compounds of the present invention that have alkenyl groups, which may exist as entgegen or zusammen conformations, in which case all geometric forms thereof, both entgegen and zusammen, cis and trans, and mixtures thereof, are within the scope of the present invention. Some compounds of the present invention have cycloalkyl groups, which may be substituted at more than one carbon atom, in which case all geometric forms thereof, both cis and trans, and mixtures thereof, are within the scope of the present invention. All of these forms, including (R), (S), epimers, diastereomers, cis, trans, syn, anti, (E), (Z), and mixtures thereof, are contemplated in the invention compounds of Formulas I to XI. </paragraph>
<paragraph id="P-0967" lvl="0"><number>&lsqb;0967&rsqb;</number> The compounds to be used in the present invention can exist in unsolvated forms as well as solvated forms, including hydrated forms. In general, the solvated forms, including hydrated forms, are equivalent to unsolvated forms and are intended to be encompassed within the scope of the present invention. </paragraph>
<paragraph id="P-0968" lvl="0"><number>&lsqb;0968&rsqb;</number> The compounds of Formulas I through XI are capable of further forming both pharmaceutically acceptable salts, including but not limited to acid addition and/or base salts. This invention also provides pharmaceutical compositions comprising a compound of Formula I together with a pharmaceutically acceptable carrier, diluent, or excipient therefor. All of these forms can be used in the method of the present invention. </paragraph>
<paragraph id="P-0969" lvl="0"><number>&lsqb;0969&rsqb;</number> Pharmaceutically acceptable acid addition salts of the compounds of Formula I include salts derived form inorganic acids such as hydrochloric, nitric, phosphoric, sulfuric, hydrobromic, hydroiodic, phosphorus, and the like, as well as the salts derived from organic acids, such as aliphatic mono- and dicarboxylic acids, phenyl-substituted alkanoic acids, hydroxy alkanoic acids, alkanedioic acids, aromatic acids, aliphatic and aromatic sulfonic acids, etc. Such salts thus include sulfate, pyrosulfate, bisulfate, sulfite, bisulfite, nitrate, phosphate, monohydrogenphosphate, dihydrogenphosphate, metaphosphate, pyrophosphate, chloride, bromide, iodide, acetate, propionate, caprylate, isobutyrate, oxalate, malonate, succinate, suberate, sebacate, fumarate, maleate, mandelate, benzoate, chlorobenzoate, methylbenzoate, dinitrobenzoate, phthalate, benzenesulfonate, toluenesulfonate, phenylacetate, citrate, lactate, maleate, tartrate, methanesulfonate, and the like. Also contemplated are the salts of amino acids such as arginate, gluconate, galacturonate, and the like; see, for example, Berge et al., &ldquo;Pharmaceutical Salts,&rdquo; <highlight><italic>J. of Pharmaceutical Science, </italic></highlight>1977;66:1-19. </paragraph>
<paragraph id="P-0970" lvl="0"><number>&lsqb;0970&rsqb;</number> The acid addition salts of the basic compounds are prepared by contacting the free base form with a sufficient amount of the desired acid to produce the salt in the conventional manner. The free base form may be regenerated by contacting the salt form with a base and isolating the free base in the conventional manner. The free base forms differ from their respective salt forms somewhat in certain physical properties such as solubility in polar solvents, but otherwise the salts are equivalent to their respective free base for purposes of the present invention. </paragraph>
<paragraph id="P-0971" lvl="0"><number>&lsqb;0971&rsqb;</number> Pharmaceutically acceptable base addition salts are formed with metals or amines, such as alkali and alkaline earth metal hydroxides, or of organic amines. Examples of metals used as cations are sodium, potassium, magnesium, calcium, and the like. Examples of suitable amines are N,N&prime;-dibenzylethylenediamine, chloroprocaine, choline, diethanolamine, ethylenediamine, N-methylglucamine, and procaine; see, for example, Berge et al., supra., 1977. </paragraph>
<paragraph id="P-0972" lvl="0"><number>&lsqb;0972&rsqb;</number> The base addition salts of acidic compounds are prepared by contacting the free acid form with a sufficient amount of the desired base to produce the salt in the conventional manner. The free acid form may be regenerated by contacting the salt form with an acid and isolating the free acid in a conventional manner. The free acid forms differ from their respective salt forms somewhat in certain physical properties such as solubility in polar solvents, but otherwise the salts are equivalent to their respective free acid for purposes of the present invention. </paragraph>
<paragraph id="P-0973" lvl="0"><number>&lsqb;0973&rsqb;</number> The compounds of the present invention can be formulated and administered in a wide variety of oral and parenteral dosage forms, including transdermal and rectal administration. All that is required is that an MMP inhibitor be administered to a mammal suffering from a disease in an effective amount, which is that amount required to cause an improvement in the disease and/or the symptoms associated with such disease. It will be recognized to those skilled in the art that the following dosage forms may comprise as the active component, either a compound of Formula I or a corresponding pharmaceutically acceptable salt or solvate of a compound of Formula I. </paragraph>
<paragraph id="P-0974" lvl="0"><number>&lsqb;0974&rsqb;</number> A compound of Formula I, or a pharmaceutically acceptable salt thereof, may be prepared by one of ordinary skill in the art of organic chemistry by procedures found in the chemical literature such as, for example, Fieser and Fieser, supra., 2000; Larock R C, supra., 1989; Wiley-Interscience, supra., 1989; March J, supra., 2001; or the <highlight><italic>Handbook of Heterocyclic Chemistry </italic></highlight>by Alan R. Katritzky, London: Pergamon Press Ltd., 1985, to name a few. Alternatively, a skilled artisan may find methods useful for preparing the invention compounds in the chemical literature by searching widely available databases such as, for example, those available from the Chemical Abstracts Service, Columbus, Ohio, or MDL Information Systems GmbH (formerly Beilstein Information Systems GmbH), Frankfurt, Germany. </paragraph>
<paragraph id="P-0975" lvl="0"><number>&lsqb;0975&rsqb;</number> Preparations of the compounds of the present invention may use starting materials, reagents, solvents, and catalysts that may be purchased from commercial sources or they may be readily prepared by adapting procedures in the references or resources cited above. Commercial sources of starting materials, reagents, solvents, and catalysts useful in preparing invention compounds include, for example, The Aldrich Chemical Company, and other subsidiaries of Sigma-Aldrich Corporation, St. Louis, Mo., BACHEM, BACHEM A. G., Switzerland, or Lancaster Synthesis Ltd., United Kingdom. </paragraph>
<paragraph id="P-0976" lvl="0"><number>&lsqb;0976&rsqb;</number> Fieser and Fieser, supra., 2000; Larock R C, supra., 1989; Wiley-Interscience, supra., 1989; March J, supra., 2001; and Katritzky A R, supra., 1985, are hereby incorporated by reference. </paragraph>
<paragraph id="P-0977" lvl="0"><number>&lsqb;0977&rsqb;</number> The invention compounds are prepared by methods well known to those skilled in the art of organic chemistry. The compounds of Formula I are prepared utilizing commercially available starting materials, or reactants that are readily prepared by standard organic synthetic techniques. A typical synthesis of the invention compounds of Formula I is shown in Scheme 1 below. The first step in Scheme 1 comprises reacting a chlorouracil analog with 2-mercapto acetate ester;. The reaction generally is carried out in a solvent such as an alkanol, for example ethanol, and in the presence of a base such as sodium carbonate. The reaction is usually substantially complete after about 2 to 6 hours when carried out at an elevated temperature of about 40&deg; C. to about 80&deg; C. The product, an alkylthio substituted tetrahydro pyrimidine, can be isolated and purified if desired, or can be used directly in the next step. The next step is a cyclization reaction (Vilsmeier reaction). The alkylthio substituted tetrahydro pyrimidine is reacted with POCl<highlight><subscript>3 </subscript></highlight>in a polar solvent such as dimethylformamide or dimethylsulfoxide to effect cyclization to the corresponding tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione. The thienopyrimidinone can be further modified by standard procedures, for example alkylation at the 1-position by reaction with an alkylating agent R<highlight><superscript>4</superscript></highlight>L, where L is a leaving group such as chloro or bromo, and R<highlight><superscript>4 </superscript></highlight>is as defined above. Ester groups can be hydrolyzed by reaction with a base such as sodium hydroxide, and carboxylic groups can be esterified by standard procedures such as reaction with an alcohol R<highlight><superscript>3</superscript></highlight>OH in the presence of an acid such as hydrochloric acid, or in the presence of a coupling reagent such as DCC (dicyclohexylcarbodiimide) and CMC (1-cyclohexyl-3-(2-morpholinoethyl)carbodiimide metho-p-toluenesulfonate. Carboxylic acid groups can be converted to amides by standard methods, for example by first reaction with oxalyl chloride to form an acid chloride, and then reaction of the acid chloride with an amine of the formula HNR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>.  
<chemistry-cwu id="CHEM-US-00026">
<number>26</number>
<image id="EMI-C00026" he="510.55515" wi="297.1647" file="US20030004172A1-20030102-C00026.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00026" file="US20030004172A1-20030102-C00026.CDX"/>
<chemistry-mol-file id="CHEMMOL-00026" file="US20030004172A1-20030102-C00026.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0978" lvl="0"><number>&lsqb;0978&rsqb;</number> Scheme 2 illustrates the synthesis of compounds of Formula 1 starting from a benzyl alkanoylacetate, which reacts with a cyanoacetic acid ester; in the presence of powdered sulfur (when X is S) and a base such as morpholine to give an amino substituted heterocycle. This condensation typically is carried out by combining the reactants in a solvent such as methanol or ethanol, and generally is complete within about 2 to 10 hours when carried out at an elevated temperature of about 40&deg; C. to 60&deg; C. The 5-benzyloxycarbonyl-2-amino-substituted heterocycle (e.g., thiophene when X is S, furan when X is O, and pyrrole when X is NH) is next reacted with an isocyanate (R<highlight><superscript>1</superscript></highlight>NCO) to effect cyclization to form the pyrimidinone ring. This cyclization reaction is carried out by mixing the reactants in a solvent such as dioxane in the presence of a strong base such as sodium hydride. The cyclization is generally complete within about 8 to 24 hours when carried out at a temperature of about 24&deg; C. to 60&deg; C. The product, a compound of Formula I wherein R<highlight><superscript>4 </superscript></highlight>is H, can be alkylated or arylated by reaction with an alkyl or aryl halide (R<highlight><superscript>4</superscript></highlight>L, where L is a leaving group such as chloro or bromo). The invention compound can be further modified by standard methods, for instance by hydrolyzing the ester; forming group R<highlight><superscript>3 </superscript></highlight>to give the corresponding acid (where R<highlight><superscript>3</superscript></highlight>&boxH;H), and then re-esterifying or amidating by reaction with an amine in the presence of a coupling agent such as DCC or CMC.  
<chemistry-cwu id="CHEM-US-00027">
<number>27</number>
<image id="EMI-C00027" he="175.23135" wi="216.2538" file="US20030004172A1-20030102-C00027.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00027" file="US20030004172A1-20030102-C00027.CDX"/>
<chemistry-mol-file id="CHEMMOL-00027" file="US20030004172A1-20030102-C00027.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0979" lvl="0"><number>&lsqb;0979&rsqb;</number> Scheme 3 illustrates reaction of a 4-alkoxycarbonyl-5-amino thiazole (where X is S) with an isocyanate in the presence of a strong base such as sodium hydride to form the 6-member pyrimidinone ring. The unsubstituted ring nitrogen can be alkylated or arylated by standard reactions, for example by reactions with a alkylating agent R<highlight><superscript>4</superscript></highlight>L, where L is a leaving group such as halo.  
<chemistry-cwu id="CHEM-US-00028">
<number>28</number>
<image id="EMI-C00028" he="211.9446" wi="214.35435" file="US20030004172A1-20030102-C00028.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00028" file="US20030004172A1-20030102-C00028.CDX"/>
<chemistry-mol-file id="CHEMMOL-00028" file="US20030004172A1-20030102-C00028.MOL"/>
</chemistry-cwu>
 
<chemistry-cwu id="CHEM-US-00029">
<number>29</number>
<image id="EMI-C00029" he="228.2742" wi="208.11735" file="US20030004172A1-20030102-C00029.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00029" file="US20030004172A1-20030102-C00029.CDX"/>
<chemistry-mol-file id="CHEMMOL-00029" file="US20030004172A1-20030102-C00029.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0980" lvl="7"><number>&lsqb;0980&rsqb;</number> The corresponding sulfoxide and sulfone analogs can be prepared in the same fashion.  
<chemistry-cwu id="CHEM-US-00030">
<number>30</number>
<image id="EMI-C00030" he="248.913" wi="295.94565" file="US20030004172A1-20030102-C00030.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00030" file="US20030004172A1-20030102-C00030.CDX"/>
<chemistry-mol-file id="CHEMMOL-00030" file="US20030004172A1-20030102-C00030.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0981" lvl="7"><number>&lsqb;0981&rsqb;</number> The corresponding ester and amide analogs can be prepared in the same fashion.  
<chemistry-cwu id="CHEM-US-00031">
<number>31</number>
<image id="EMI-C00031" he="234.02925" wi="208.11735" file="US20030004172A1-20030102-C00031.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00031" file="US20030004172A1-20030102-C00031.CDX"/>
<chemistry-mol-file id="CHEMMOL-00031" file="US20030004172A1-20030102-C00031.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0982" lvl="7"><number>&lsqb;0982&rsqb;</number> The corresponding ester and amide analogs can be prepared in the same fashion.  
<chemistry-cwu id="CHEM-US-00032">
<number>32</number>
<image id="EMI-C00032" he="220.59135" wi="213.61725" file="US20030004172A1-20030102-C00032.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00032" file="US20030004172A1-20030102-C00032.CDX"/>
<chemistry-mol-file id="CHEMMOL-00032" file="US20030004172A1-20030102-C00032.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0983" lvl="7"><number>&lsqb;0983&rsqb;</number> The corresponding ester and amide analogs can be prepared in the same fashion.  
<chemistry-cwu id="CHEM-US-00033">
<number>33</number>
<image id="EMI-C00033" he="101.7765" wi="215.54505" file="US20030004172A1-20030102-C00033.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00033" file="US20030004172A1-20030102-C00033.CDX"/>
<chemistry-mol-file id="CHEMMOL-00033" file="US20030004172A1-20030102-C00033.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0984" lvl="7"><number>&lsqb;0984&rsqb;</number> The corresponding ester and amide analogs can be prepared in the same fashion. </paragraph>
<paragraph id="P-0985" lvl="0"><number>&lsqb;0985&rsqb;</number> The alkynes can be prepared in a conventional manner as illustrated in Scheme 9. In Scheme 9, an aryl iodide (or, optionally, an aryl bromide, aryl chloride, or aryl trifluoromethanesulfonate) is coupled to a terminal alkyne in the presence of a palladium catalyst, cuprous (I) iodide, and a base such as a tertiary amine base.  
<chemistry-cwu id="CHEM-US-00034">
<number>34</number>
<image id="EMI-C00034" he="314.20305" wi="215.8002" file="US20030004172A1-20030102-C00034.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00034" file="US20030004172A1-20030102-C00034.CDX"/>
<chemistry-mol-file id="CHEMMOL-00034" file="US20030004172A1-20030102-C00034.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0986" lvl="7"><number>&lsqb;0986&rsqb;</number> wherein R and R&prime; independently are hydrogen or from 1 to 3 substituents as defined above for substituted phenyl. </paragraph>
<paragraph id="P-0987" lvl="0"><number>&lsqb;0987&rsqb;</number> The following detailed examples further illustrate the synthesis of typical invention compounds of Formula I. The examples are representative only, and are not to be construed as limiting the invention in any respect.  
<chemistry-cwu id="CHEM-US-00035">
<number>35</number>
<image id="EMI-C00035" he="67.6998" wi="198.02475" file="US20030004172A1-20030102-C00035.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00035" file="US20030004172A1-20030102-C00035.CDX"/>
<chemistry-mol-file id="CHEMMOL-00035" file="US20030004172A1-20030102-C00035.MOL"/>
</chemistry-cwu>
</paragraph>
</section>
<section>
<heading lvl="1">(1-Benzyl-2,6-dioxo-1,2,3,6-tetrahydro-pyrimidin-4-ylsulfanyl)-acetic acid ethyl ester </heading>
<paragraph id="P-0988" lvl="0"><number>&lsqb;0988&rsqb;</number> To 250 mL of ethanol in a round bottom flask was added 3-benzyl-6-chloro-1H-pyrimidine-2,4-dione (11.55 g, 48.94 mmol), sodium carbonate (5.19 g, 48.94 mmol), and mercapto-acetic acid ethyl ester (6.47 g, 53.83 mmol). The mixture is stirred at reflux for 5 hours. The reaction solution is filtered, and the filtrate is chromatographed on a silica gel column, eluting with 4:1 Hexane/Ethyl Acetate (400 mL) followed by 1000 mL of 4:1 Dichloromethane/Ethyl Acetate. Removing the solvents by vacuum yielded 10.5 g of white powder identified as the titled product (67%). <highlight><superscript>1</superscript></highlight>H NMR (DMSO), &dgr;1.16 (t, J&equals;7.1 Hz, 3H), 4.06 (s, 2H), 4.12 (q, J&equals;7.1 Hz, 2H), 4.88 (s, 2H), 5.54 (s, 1H), 7.22-7.30 (m, 5H), 11.71 (broad s, 1H). MS (APCI&minus;), m/z 321 (M<highlight><superscript>&plus;</superscript></highlight>).  
<chemistry-cwu id="CHEM-US-00036">
<number>36</number>
<image id="EMI-C00036" he="107.53155" wi="198.02475" file="US20030004172A1-20030102-C00036.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00036" file="US20030004172A1-20030102-C00036.CDX"/>
<chemistry-mol-file id="CHEMMOL-00036" file="US20030004172A1-20030102-C00036.MOL"/>
</chemistry-cwu>
</paragraph>
</section>
<section>
<heading lvl="1">3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid ethyl ester </heading>
<paragraph id="P-0989" lvl="0"><number>&lsqb;0989&rsqb;</number> To a solution of (1-benzyl-2,6-dioxo-1,2,3,6-tetrahydro-pyrimidin-4-ylsulfanyl)-acetic acid ethyl ester from Preparation 1 (6.37 g, 19.8 mmol) in anhydrous DMF (60 mL) was added POCl<highlight><subscript>3 </subscript></highlight>(9.11 g, 59.5 mmol) dropwise. The reaction is then stirred at room temperature overnight, and then heated to 70&deg; C. for 30 minutes. The reaction is cooled to room temperature and poured into 600 mL of stirring ice water. The product is filtered and washed with water to yield 6.2 g (95%) very light yellow powder as the titled compound. <highlight><superscript>1</superscript></highlight>H NMR (DMSO), &dgr;1.27 (t, J&equals;7.1 Hz, 3H), 4.26 (q, J&equals;7.1 Hz, 2H), 5.00 (s, 2H), 7.19-7.29 (m, 5H), 7.76 (s, 1H), 12.6 (broad s, 1H). MS (APCI&minus;), m/z 331 (M<highlight><superscript>&plus;</superscript></highlight>).  
<chemistry-cwu id="CHEM-US-00037">
<number>37</number>
<image id="EMI-C00037" he="91.6839" wi="198.02475" file="US20030004172A1-20030102-C00037.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00037" file="US20030004172A1-20030102-C00037.CDX"/>
<chemistry-mol-file id="CHEMMOL-00037" file="US20030004172A1-20030102-C00037.MOL"/>
</chemistry-cwu>
</paragraph>
</section>
<section>
<heading lvl="1">3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid </heading>
<paragraph id="P-0990" lvl="0"><number>&lsqb;0990&rsqb;</number> To a solution of 3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid ethyl ester from Preparation 2 (2.9 g, 8.79 mmol) in a solution of 90% THF: 10% water (v/v) was added lithium hydroxide (3.69 g, 87.9 mmol). The solution is refluxed for 2 hours. The solvent was removed by vacuum, and the residual was diluted with water (100 mL). HCl was added until the solution has a pH of 1. The solution was extracted with ethyl acetate (3&times;100 mL). The combined organic layer was concentrated to yield 2.62 g of white powder as product (96%). <highlight><superscript>1</superscript></highlight>H NMR (DMSO), &dgr;4.99 (s, 2H), 7.19-7.29 (m, 5H), 7.68 (s, 1H). MS (APCI&minus;), m/z 331 (M<highlight><superscript>&plus;</superscript></highlight>).  
<chemistry-cwu id="CHEM-US-00038">
<number>38</number>
<image id="EMI-C00038" he="91.6839" wi="198.02475" file="US20030004172A1-20030102-C00038.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00038" file="US20030004172A1-20030102-C00038.CDX"/>
<chemistry-mol-file id="CHEMMOL-00038" file="US20030004172A1-20030102-C00038.MOL"/>
</chemistry-cwu>
</paragraph>
</section>
<section>
<heading lvl="1">3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid </heading>
<paragraph id="P-0991" lvl="0"><number>&lsqb;0991&rsqb;</number> Step (1): Thiophene-2,5-dicarboxylic acid diethyl ester </paragraph>
<paragraph id="P-0992" lvl="0"><number>&lsqb;0992&rsqb;</number> To a solution of 2,5-thiophene dicarboxylic acid (5.0 g, 29 mmol) in methanol (100 mL) was added sulfuric acid (1.0 mL), and the reaction was refluxed for 72 hours. The mixture was then concentrated under reduced pressure. The crude residue was diluted with ethyl acetate (250 mL), and the mixture was washed with water (3&times;100 mL). The organic phase was dried (MgSO<highlight><subscript>4</subscript></highlight>) and concentrated to yield 6.52 g (98%) of thiophene-2,5-dicarboxylic acid diethyl ester as an orange oil. </paragraph>
<paragraph id="P-0993" lvl="0"><number>&lsqb;0993&rsqb;</number> Step (2): 3-Nitro-thiophene-2,5-dicarboxylic acid diethyl ester </paragraph>
<paragraph id="P-0994" lvl="0"><number>&lsqb;0994&rsqb;</number> To a chloroform solution (40 mL) of the product of Step (1) (6.52 g, 28.6 mmol) and trifluoroacetic anhydride (20 mL) was slowly added copper (II) nitrate hemipentahydrate (7.31 g, 31.5 mmol), and the reaction mixture was heated to 60&deg; C. over 4 hours. The reaction mixture was poured into ice (200 g), and was extracted with chloroform (2&times;150 mL). The chloroform layers were combined, dried (MgSO<highlight><subscript>4</subscript></highlight>), filtered, and concentrated. The resulting orange oil residue was purified by flash chromatography on silica gel (eluting with cyclohexane:ethyl acetate, 4:1) to yield 4.61 g (60%) of 3-nitro-thiophene-2,5-dicarboxylic acid diethyl ester as a yellow solid. </paragraph>
<paragraph id="P-0995" lvl="0"><number>&lsqb;0995&rsqb;</number> Step (3): 3-Amino-thiophene-2,5-dicarboxylic acid diethyl ester </paragraph>
<paragraph id="P-0996" lvl="0"><number>&lsqb;0996&rsqb;</number> A solution of the product of Step (2) (4.61 g, 16.9 mmol) in ethanol (20 mL) was hydrogenated over 10% Pd-C (460 mg, 10 wt %) in a Parr shaker at 200 psi over 48 hours at 60&deg; C. The catalyst was then filtered off, and the filtrate was concentrated under vacuum, and the resulting residue was purified by flash chromatography on silica gel (cyclohexane:ethyl acetate, 4:1) to yield 3.20 g (78%) of 3-amino-thiophene-2,5-dicarboxylic acid diethyl ester as a white solid. </paragraph>
<paragraph id="P-0997" lvl="0"><number>&lsqb;0997&rsqb;</number> Step (4): 3-(3-Benzyl-ureido)-thiophene-2,5-dicarboxylic acid diethyl ester </paragraph>
<paragraph id="P-0998" lvl="0"><number>&lsqb;0998&rsqb;</number> A pyridine solution (10 mL) of the product of Step (3) (2.06 mmol, 500 mg), benzylisocyanate (2.06 mmol, 255 mL), and 4-(dimethylamino)pyridine (0.41 mmol, 50 mg) was heated to 90&deg; C. for 48 hours. The reaction mixture was then concentrated under reduced pressure, and the residue was purified by flash chromatography on silica gel (4:1:5 cyclohexane:ethyl acetate:toluene) to yield 599 mg (77%) of 3-(3-benzyl-ureido)-thiophene-2,5-dicarboxylic acid diethyl ester as a white solid. </paragraph>
<paragraph id="P-0999" lvl="0"><number>&lsqb;0999&rsqb;</number> Step (5): 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid </paragraph>
<paragraph id="P-1000" lvl="0"><number>&lsqb;1000&rsqb;</number> To a solution of the product of Step (4) (1.57 mmol, 590 mg) in ethanol (15 mL) was added sodium ethoxide (3.14 mmol, 214 mg), and resulting solution was refluxed for 4 hours. The reaction mixture was then allowed to reach room temperature, and lithium hydroxide (3.9 mmol, 94 mg) was added. The reaction mixture was stirred for 17 hours and concentrated under reduced pressure to afford a crude product. The crude product was dissolved in 1.0M hydrochloric acid (10 mL). The resulting white precipitate was collected, washed with water (3&times;10 mL), cold acetonitrile (3&times;5 mL), and dried under vacuum to yield 336 mg (71%) of 3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid as a white solid.</paragraph>
</section>
</summary-of-invention>
<detailed-description>
<section>
<heading lvl="1">EXAMPLE 1 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1001" lvl="0"><number>&lsqb;1001&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00039">
<number>39</number>
<image id="EMI-C00039" he="96.5034" wi="177.61275" file="US20030004172A1-20030102-C00039.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00039" file="US20030004172A1-20030102-C00039.CDX"/>
<chemistry-mol-file id="CHEMMOL-00039" file="US20030004172A1-20030102-C00039.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1002" lvl="0"><number>&lsqb;1002&rsqb;</number> A dichloromethane (30 mL) solution of 3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (0.8 g, 2.65 mmol) from Preparation 3, 1-cyclohexyl-3-(2-morpholinoethyl)carbodiimide metho-p-toluenesulfonate (CMC, 1.35 g, 3.18 mmol), and benzyl alcohol (0.32 g, 2.91 mmol) is refluxed for 3 hours. The solution is then diluted with dichloromethane (100 mL) and washed with water (3&times;100 mL). The organic layer is concentrated and purified by chromatography over a silica gel column using 2:1 Hexane:Ethyl Acetate to yield 120 mg of white solid as product (12%). MP: 195-197&deg; C.; <highlight><superscript>1</superscript></highlight>H NMR (CDCl<highlight><subscript>3</subscript></highlight>), &dgr;5.18 (s, 2H), 5.33 (s, 2H), 7.26-7.49 (m, 10H), 8.03 (s, 1H), 10.84 (s, 1H). MS (APCI&minus;), m/z 303 (M<highlight><superscript>&plus;</superscript></highlight>). </paragraph>
<paragraph id="P-1003" lvl="0"><number>&lsqb;1003&rsqb;</number> Calcd for C<highlight><subscript>21</subscript></highlight>H<highlight><subscript>16</subscript></highlight>N<highlight><subscript>2</subscript></highlight>O<highlight><subscript>4</subscript></highlight>S<highlight><subscript>1</subscript></highlight>: C, 64.27; H, 4.11; N, 7.14. Found: C, 64.24; H, 3.80; N, 7.04. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 2 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-4-ylmethyl ester </heading>
<paragraph id="P-1004" lvl="0"><number>&lsqb;1004&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00040">
<number>40</number>
<image id="EMI-C00040" he="96.5034" wi="179.54055" file="US20030004172A1-20030102-C00040.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00040" file="US20030004172A1-20030102-C00040.CDX"/>
<chemistry-mol-file id="CHEMMOL-00040" file="US20030004172A1-20030102-C00040.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1005" lvl="0"><number>&lsqb;1005&rsqb;</number> The procedure of Example 1 was repeated, except that benzyl alcohol is replaced with 4-pyridyl methyl alcohol to provide 3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-4-ylmethyl ester as a white powder. (32%). MP: 248-250&deg; C.; <highlight><superscript>1</superscript></highlight>H NMR (DMSO), &dgr;5.00 (s, 2H), 5.36 (s, 2H), 7.22-7.34 (m, 5H), 7.41 (d, J&equals;5.7 Hz, 2H), 7.91 (s, 1H), 8.57 (d, J&equals;5.7 Hz, 2H), 12.62 (broad s,1H). MS (APCI&minus;), m/z 394 (M<highlight><superscript>&plus;</superscript></highlight>). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 3 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl amide </heading>
<paragraph id="P-1006" lvl="0"><number>&lsqb;1006&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00041">
<number>41</number>
<image id="EMI-C00041" he="100.5858" wi="188.89605" file="US20030004172A1-20030102-C00041.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00041" file="US20030004172A1-20030102-C00041.CDX"/>
<chemistry-mol-file id="CHEMMOL-00041" file="US20030004172A1-20030102-C00041.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1007" lvl="0"><number>&lsqb;1007&rsqb;</number> The procedure of Example 1 was repeated, except that benzyl alcohol is replaced with benzylamine, to provide 3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl amide as a white solid (20%). MP:&gt;255&deg; C.; <highlight><superscript>1</superscript></highlight>H NMR (CDCl<highlight><subscript>3</subscript></highlight>), &dgr;4.53 (s, 2H), 4.90 (s, 1H), 5.17 (s, 2H), 7.16-7.41 (m, 10H), 7.77 (s, 1H). MS (APCI&minus;), m/z 392 (M<highlight><superscript>&plus;</superscript></highlight>). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 4 </heading>
</section>
<section>
<heading lvl="1">3-Benzy-2,4,dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6 carboxylic acid 4-((E)-styryl-benzyl ester </heading>
<paragraph id="P-1008" lvl="0"><number>&lsqb;1008&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00042">
<number>42</number>
<image id="EMI-C00042" he="83.03715" wi="213.1353" file="US20030004172A1-20030102-C00042.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00042" file="US20030004172A1-20030102-C00042.CDX"/>
<chemistry-mol-file id="CHEMMOL-00042" file="US20030004172A1-20030102-C00042.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1009" lvl="0"><number>&lsqb;1009&rsqb;</number> The procedure of Example 1 was repeated, except that benzyl alcohol is replaced with &lsqb;4-((E)-styryl-phenyl&rsqb;-methanol, to give 3-benzy-2,4,dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-((E)-styryl-benzyl ester as a white solid. MP: 247-249&deg; C.; <highlight><superscript>1</superscript></highlight>H NMR (d<highlight><subscript>8</subscript></highlight>-THF), &dgr;10.85 (bd s, 1H), 7.91 (s, 1H), 7.58-7.19 (m, 16H), 5.31 (s, 2H), 5.08 (s, 2H). MS m/z 495.3 (m&plus;1), m/z 493.3 (m&minus;1). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 5 </heading>
</section>
<section>
<heading lvl="1">5-Methyl-2,4-dioxo-3-phenylethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1010" lvl="0"><number>&lsqb;1010&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00043">
<number>43</number>
<image id="EMI-C00043" he="100.5858" wi="188.1873" file="US20030004172A1-20030102-C00043.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00043" file="US20030004172A1-20030102-C00043.CDX"/>
<chemistry-mol-file id="CHEMMOL-00043" file="US20030004172A1-20030102-C00043.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1011" lvl="0"><number>&lsqb;1011&rsqb;</number> To a stirred solution of the 5-amino-3-methyl-thiophene-2,4-dicarboxylic acid 2-benzyl ester 4-ethyl ester in dioxane (0.5 g, 1.57 mmol) was added NaH (0.042 g, 1.72 mmol). The mixture was further stirred until no more hydrogen gas was evolved and then 2-isocyanato-ethyl-benzene (0.23 g, 1.57 mmol) was added slowly. The resulting mixture was refluxed under nitrogen until the reaction was complete by MS and TLC. The dioxane was removed by rotary evaporation. The reaction mixture was then purified by flash column chromatography eluting with 4:1 (Hex:EtOAc), 2:1 (Hex:EtOAc), and 1:1 (Hex:EtOAc) sequentially. The fractions containing the product were collected and concentrated to yield a white solid which was triturated with 4:1 (Hex:EtOAc). 5-Methyl-2,4-dioxo-3-phenylethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester was collected by filtration and dried in a vacuum oven overnight. </paragraph>
<paragraph id="P-1012" lvl="0"><number>&lsqb;1012&rsqb;</number> Calcd for C<highlight><subscript>23</subscript></highlight>H<highlight><subscript>20</subscript></highlight>N<highlight><subscript>2</subscript></highlight>O<highlight><subscript>4</subscript></highlight>: C, 65.70; H, 4.79; N, 6.66. Found: C, 64.90; H, 4.82; N, 6.42. </paragraph>
<paragraph id="P-1013" lvl="0"><number>&lsqb;1013&rsqb;</number> MP: 207-209&deg; C.; <highlight><superscript>1</superscript></highlight>H NMR (d<highlight><subscript>1</subscript></highlight>-CDCl<highlight><subscript>3</subscript></highlight>), &dgr;9.35 (s, 1H), 7.52-7.21 (m, 10H), 5.33 (s, 2H), 4.19 (t, 2H, J&equals;8 Hz), 2.95 (t, 2H, J&equals;8z Hz), 1.55 (s, 3H). MS m/z 467.3 (m&plus;1), m/z 465.2 (m&minus;1). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 6 </heading>
</section>
<section>
<heading lvl="1">3-(4-Acetyl-phenyl)-5-methyl-2,4 dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;-pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1014" lvl="0"><number>&lsqb;1014&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00044">
<number>44</number>
<image id="EMI-C00044" he="100.5858" wi="186.9966" file="US20030004172A1-20030102-C00044.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00044" file="US20030004172A1-20030102-C00044.CDX"/>
<chemistry-mol-file id="CHEMMOL-00044" file="US20030004172A1-20030102-C00044.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1015" lvl="0"><number>&lsqb;1015&rsqb;</number> The procedure of Example 5 was repeated, except that 2-isocyanato-ethyl-benzene is replaced with 4-isocyanatoacetophenone to give 3-(4-acetyl-phenyl)-5-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester as an off white solid. <highlight><superscript>1</superscript></highlight>H NMR (d<highlight><subscript>1</subscript></highlight>-CDCl<highlight><subscript>3</subscript></highlight>), &dgr;8.84 (s, 1H), 8.11 (d, 2H, J&equals;9 Hz) 7.41-7.25 (m, 7H), 5.34 (s, 2H), 2.84 (s, 3H), 2.64 (s, 3H). MS m/z 435.2 (m&plus;1), m/z 434.2 (m&minus;1). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 7 </heading>
</section>
<section>
<heading lvl="1">5-Methyl-2,4-dioxo-3-p-tolyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1016" lvl="0"><number>&lsqb;1016&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00045">
<number>45</number>
<image id="EMI-C00045" he="96.5034" wi="182.65905" file="US20030004172A1-20030102-C00045.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00045" file="US20030004172A1-20030102-C00045.CDX"/>
<chemistry-mol-file id="CHEMMOL-00045" file="US20030004172A1-20030102-C00045.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1017" lvl="0"><number>&lsqb;1017&rsqb;</number> When in the procedure of Example 5,2-isocyanato-ethyl-benzene is replaced with 4-tolyl isocyanate, 5-methyl-2,4-dioxo-3-tolyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;-6-carboxylic acid benzyl ester is obtained as a white solid. MP 267-269&deg; C.; <highlight><superscript>1</superscript></highlight>H NMR (d<highlight><subscript>1</subscript></highlight>-CDCl<highlight><subscript>3</subscript></highlight>), &dgr;8.79 (s, 1H), 7.41-6.99 (m, 9H), 5.33 (s, 2H), 2.84 (s, 3H), 2.40 (s, 3H). MS m/z 407.2 (m&plus;1), m/z 405.3 (m&minus;1). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 8 </heading>
</section>
<section>
<heading lvl="1">5-Methyl-3-(4-nitro-phenyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1018" lvl="0"><number>&lsqb;1018&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00046">
<number>46</number>
<image id="EMI-C00046" he="96.5034" wi="182.43225" file="US20030004172A1-20030102-C00046.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00046" file="US20030004172A1-20030102-C00046.CDX"/>
<chemistry-mol-file id="CHEMMOL-00046" file="US20030004172A1-20030102-C00046.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1019" lvl="0"><number>&lsqb;1019&rsqb;</number> The procedure of Example 5 was repeated, except that 2-isocyanato-ethyl-benzene is replaced with 4-nitrophenyl isocyanate to give 5-methyl-3-(4-nitro-phenyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;-6-carboxylic acid benzyl ester as a yellow solid. 1H NMR (d<highlight><subscript>6</subscript></highlight>-DMSO), &dgr;9.64 (s, 1H), 8.31 (d, 2H, J&equals;9 Hz), 7.62 (d, 2H, J&equals;9 Hz), 7.44-7.35 (m, 5H), 5.30 (s, 2H), 2.70 (s, 3H). MS m/z 436.1 (m&minus;1). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 9 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1020" lvl="0"><number>&lsqb;1020&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00047">
<number>47</number>
<image id="EMI-C00047" he="96.5034" wi="180.9864" file="US20030004172A1-20030102-C00047.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00047" file="US20030004172A1-20030102-C00047.CDX"/>
<chemistry-mol-file id="CHEMMOL-00047" file="US20030004172A1-20030102-C00047.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1021" lvl="0"><number>&lsqb;1021&rsqb;</number> To a solution of 3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;-pyrimidine-6-carboxylic acid benzyl ester (300 mg, 0.765 mmol) in DMF was added NaH (46 mg, 1.5 mmol). After 5 minutes, MeI (0.15 mL, 2.3 mmol) was added, and the reaction mixture was stirred at room temperature for 30 minutes. After removal of all volatiles, the residue was purified using flash chromatography to give the desired product as a white solid (204 mg, 66%). R<highlight><subscript>f</subscript></highlight>&equals;0.51 </paragraph>
<paragraph id="P-1022" lvl="0"><number>&lsqb;1022&rsqb;</number> (2:1 hexane/EtOAc). MP: 143-145&deg; C. </paragraph>
<paragraph id="P-1023" lvl="0"><number>&lsqb;1023&rsqb;</number> Calcd for C<highlight><subscript>22</subscript></highlight>H<highlight><subscript>18</subscript></highlight>N<highlight><subscript>2</subscript></highlight>O<highlight><subscript>4</subscript></highlight>S<highlight><subscript>1</subscript></highlight>: C, 65.01; H, 4.46; N, 6.89. Found: C, 64.61; H4.31; N, 6.74. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 10 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1,3-benzodioxol-5-ylmethyl ester </heading>
<paragraph id="P-1024" lvl="0"><number>&lsqb;1024&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00048">
<number>48</number>
<image id="EMI-C00048" he="86.184" wi="190.1151" file="US20030004172A1-20030102-C00048.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00048" file="US20030004172A1-20030102-C00048.CDX"/>
<chemistry-mol-file id="CHEMMOL-00048" file="US20030004172A1-20030102-C00048.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1025" lvl="0"><number>&lsqb;1025&rsqb;</number> The procedure of Example 1 was repeated, except that benzyl alcohol is replaced with benzo&lsqb;1,3&rsqb;dioxol-5-yl-methanol to give 3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1,3-benzodioxol-5-ylmethyl ester as a white solid. 1H NMR (d<highlight><subscript>8</subscript></highlight>-THF), &dgr;10.86 (s, 1H), 7.89 (s, 1H), 6.80-7.49 (m, 8H), 5.96 (s, 2H), 5.21 (s, 2H), 5.09 (s, 2H). MS (APCI&minus;), m/z 393.2 (M<highlight><superscript>&plus;</superscript></highlight>&plus;1). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 11 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl amide </heading>
<paragraph id="P-1026" lvl="0"><number>&lsqb;1026&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00049">
<number>49</number>
<image id="EMI-C00049" he="100.5858" wi="191.5326" file="US20030004172A1-20030102-C00049.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00049" file="US20030004172A1-20030102-C00049.CDX"/>
<chemistry-mol-file id="CHEMMOL-00049" file="US20030004172A1-20030102-C00049.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1027" lvl="0"><number>&lsqb;1027&rsqb;</number> A dichloromethane (30 mL) solution of 3-benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (367 mg, 1.16 mmol), CMC (392 g, 0.92 mmol), and benzylamine (149 mg, 1.39 mmol) is refluxed for 3 hours. The solution is then diluted with dichloromethane (100 mL) and washed with water (3&times;100 mL). The organic layer is concentrated and purified by chromatography over a silica gel column using 1:1 Hexane:Ethyl Acetate to yield 200 mg of white solid as product. <highlight><superscript>1</superscript></highlight>H NMR (d<highlight><subscript>8</subscript></highlight>-THF), &dgr;9.23 (t, 1H), 8.11 (s, 1H), 7.20-7.38 (m, 10H), 5.04 (s, 2H), 4.43 (s, 2H), 3.46 (s, 3H). MS (APCI&minus;), m/z 406.1 (M<highlight><superscript>&plus;</superscript></highlight>&plus;1). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLES 12-14 </heading>
<paragraph id="P-1028" lvl="0"><number>&lsqb;1028&rsqb;</number> By following the general procedures of Examples 1 through 11, the following invention compounds were prepared: </paragraph>
<paragraph id="P-1029" lvl="1"><number>&lsqb;1029&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-phenylethyl ester; </paragraph>
<paragraph id="P-1030" lvl="1"><number>&lsqb;1030&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid furan-3-ylmethyl ester; and </paragraph>
<paragraph id="P-1031" lvl="1"><number>&lsqb;1031&rsqb;</number> 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid furfuryl-(5-carboxaldelhyde)ester (also known as 3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 5-formyl-furan-2-ylmethyl ester). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 15 </heading>
</section>
<section>
<heading lvl="1">3-(3-Methoxycarbonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1032" lvl="0"><number>&lsqb;1032&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00050">
<number>50</number>
<image id="EMI-C00050" he="110.42325" wi="208.34415" file="US20030004172A1-20030102-C00050.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00050" file="US20030004172A1-20030102-C00050.CDX"/>
<chemistry-mol-file id="CHEMMOL-00050" file="US20030004172A1-20030102-C00050.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1033" lvl="0"><number>&lsqb;1033&rsqb;</number> To a solution of 1-methoyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester (0.2 g, 0.63 mmol) in anhydrous DMF was added cesium carbonate (0.31 g, 0.945 mmol) and 3-bromomethyl-benzoic acid methyl ester (0.145 g, 0.63 mmol). The reaction was stirred at room temperature for overnight. Poured into water (150 mL) and extracted with EtOAc. The organic layer washed with water and brine, dried over MgSO<highlight><subscript>4 </subscript></highlight>and then filtered. The filtrate was concentrated in vacuo. Triturating the residue with 4:1 Hexane/EtOAc yielded a white solid as the desired product (40%). MS (APCI&plus;), m/z 465.1(M&plus;) </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 16 </heading>
</section>
<section>
<heading lvl="1">3-(3-Methoxycarbonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1034" lvl="0"><number>&lsqb;1034&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00051">
<number>51</number>
<image id="EMI-C00051" he="110.42325" wi="197.79795" file="US20030004172A1-20030102-C00051.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00051" file="US20030004172A1-20030102-C00051.CDX"/>
<chemistry-mol-file id="CHEMMOL-00051" file="US20030004172A1-20030102-C00051.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1035" lvl="0"><number>&lsqb;1035&rsqb;</number> The procedure of Example 15 was repeated, except 3-bromomethyl-benzoic acid methyl ester is replaced by 1-chloromethyl-4-methylsulfanyl-benzene, to give 3-(3-methoxycarbonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester as an off white solid (50%). MS (APCI&plus;), m/z 453 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 17 </heading>
</section>
<section>
<heading lvl="1">3-Benzofuran-5-ylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1036" lvl="0"><number>&lsqb;1036&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00052">
<number>52</number>
<image id="EMI-C00052" he="110.42325" wi="194.90625" file="US20030004172A1-20030102-C00052.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00052" file="US20030004172A1-20030102-C00052.CDX"/>
<chemistry-mol-file id="CHEMMOL-00052" file="US20030004172A1-20030102-C00052.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1037" lvl="0"><number>&lsqb;1037&rsqb;</number> The procedure of Example 15 was repeated, except 3-bromomethyl-benzoic acid methyl ester is replaced by 5-bromomethyl-benzofuran. Instead of trituration, the crude product was chromatographed using 8:1 Hexane/EtOAc to 4:1 Hexane/EtOAc to give 3-benzofuran-5-ylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester as a white solid (57%). MS (APCI&plus;), m/z 447 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 18 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-3-(4-methyl-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1038" lvl="0"><number>&lsqb;1038&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00053">
<number>53</number>
<image id="EMI-C00053" he="110.42325" wi="184.1049" file="US20030004172A1-20030102-C00053.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00053" file="US20030004172A1-20030102-C00053.CDX"/>
<chemistry-mol-file id="CHEMMOL-00053" file="US20030004172A1-20030102-C00053.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1039" lvl="0"><number>&lsqb;1039&rsqb;</number> The procedure of Example 15 was repeated, except 3-bromomethyl-benzoic acid methyl ester is replaced by 1-ethyl-4-methyl-benzene, to give 1-methyl-3-(4-methyl-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester as an off white solid (50%). MS (APCI&plus;), m/z 421 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 19 </heading>
</section>
<section>
<heading lvl="1">3-(4-Acetylamino-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1040" lvl="0"><number>&lsqb;1040&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00054">
<number>54</number>
<image id="EMI-C00054" he="110.42325" wi="211.7178" file="US20030004172A1-20030102-C00054.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00054" file="US20030004172A1-20030102-C00054.CDX"/>
<chemistry-mol-file id="CHEMMOL-00054" file="US20030004172A1-20030102-C00054.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1041" lvl="0"><number>&lsqb;1041&rsqb;</number> The procedure of Example 15 was repeated, except 3-bromomethyl-benzoic acid methyl ester is replaced by N-(4-chloromethyl-phenyl)-acetamide, to give 3-(4-Acetylamino-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester as an off white solid (57%). MS (APCI&plus;), m/z 464 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 20 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-(4-vinyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1042" lvl="0"><number>&lsqb;1042&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00055">
<number>55</number>
<image id="EMI-C00055" he="110.1681" wi="197.79795" file="US20030004172A1-20030102-C00055.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00055" file="US20030004172A1-20030102-C00055.CDX"/>
<chemistry-mol-file id="CHEMMOL-00055" file="US20030004172A1-20030102-C00055.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1043" lvl="0"><number>&lsqb;1043&rsqb;</number> The procedure of Example 15 was repeated, except 3-bromomethyl-benzoic acid methyl ester is replaced by 1 ethyl-4-vinyl-benzene. Instead of trituration, the crude product was chromatographed using 8:1 Hexane/EtOAc to 4:1 Hexane/EtOAc to give 1-methyl-2,4-dioxo-3-(4-vinyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester as a white solid (73%). MS (APCI&plus;), m/z 433 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 21 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-(4-sulfamoyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1044" lvl="0"><number>&lsqb;1044&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00056">
<number>56</number>
<image id="EMI-C00056" he="110.1681" wi="199.4706" file="US20030004172A1-20030102-C00056.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00056" file="US20030004172A1-20030102-C00056.CDX"/>
<chemistry-mol-file id="CHEMMOL-00056" file="US20030004172A1-20030102-C00056.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1045" lvl="0"><number>&lsqb;1045&rsqb;</number> The procedure of Example 15 was repeated, except 3-bromomethyl-benzoic acid methyl ester is replaced by 4-bromomethyl-benzenesulfonamide. Instead of trituration, the crude product was chromatographed using 2:1 EtOAc/EtOAc to 100% EtOAc to give 1-methyl-2,4-dioxo-3-(4-sulfamoyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester as a white solid (60%). MS (APCI&plus;), m/z 486 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 22 </heading>
</section>
<section>
<heading lvl="1">3-(4-Bromo-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-4-ylmethyl ester </heading>
<paragraph id="P-1046" lvl="0"><number>&lsqb;1046&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00057">
<number>57</number>
<image id="EMI-C00057" he="166.32945" wi="144.2448" file="US20030004172A1-20030102-C00057.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00057" file="US20030004172A1-20030102-C00057.CDX"/>
<chemistry-mol-file id="CHEMMOL-00057" file="US20030004172A1-20030102-C00057.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1047" lvl="0"><number>&lsqb;1047&rsqb;</number> The procedure of Example 15 was repeated, except 3-bromomethyl-benzoic acid methyl ester is replaced by 4-ethylbenzoic acid methyl ester, to give 3-(4-bromo-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-4-ylmethyl ester as an off white solid (82%). MS (APCI&plus;), m/z 465 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 23 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-phenethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1048" lvl="0"><number>&lsqb;1048&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00058">
<number>58</number>
<image id="EMI-C00058" he="140.64435" wi="170.18505" file="US20030004172A1-20030102-C00058.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00058" file="US20030004172A1-20030102-C00058.CDX"/>
<chemistry-mol-file id="CHEMMOL-00058" file="US20030004172A1-20030102-C00058.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1049" lvl="0"><number>&lsqb;1049&rsqb;</number> The procedure of Example 15 was repeated, except 3-bromomethyl-benzoic acid methyl ester is replaced by (2-bromo-ethyl)-benzene, to give 1-methyl-2,4-dioxo-3-phenethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester as an off white solid (50%). MS (APCI&plus;), m/z 421 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 24 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-&lsqb;4-(2H-tetrazol-5-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1050" lvl="0"><number>&lsqb;1050&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00059">
<number>59</number>
<image id="EMI-C00059" he="110.1681" wi="210.27195" file="US20030004172A1-20030102-C00059.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00059" file="US20030004172A1-20030102-C00059.CDX"/>
<chemistry-mol-file id="CHEMMOL-00059" file="US20030004172A1-20030102-C00059.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1051" lvl="0"><number>&lsqb;1051&rsqb;</number> To a solution of 3-(4-cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (0.615 g, 1.42 mmol) in 10 mL of dioxane was added tributyltin azide (0.71 g, 2.14 mmol). The reaction solution was refluxed overnight. After removing the solvent in vacuo, the residue was dissolved in ether and HCl gas was bubbled in for 1 hour. The precipitant was filtered, dissolved in chloroform and chromatographed using EtOAc and THF. The fractions were collected and concentrated. The residue was triturated with 4:1 Hexane/EtOAc, to yield the 1-methyl-2,4-dioxo-3-&lsqb;4-(2H-tetrazol-5-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester as a white solid (20%). MS (APCI), m/z 473 (M&minus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 25 </heading>
</section>
<section>
<heading lvl="1">3-(4-Fluoro-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-4-ylmethyl ester </heading>
<paragraph id="P-1052" lvl="0"><number>&lsqb;1052&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00060">
<number>60</number>
<image id="EMI-C00060" he="110.1681" wi="186.9966" file="US20030004172A1-20030102-C00060.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00060" file="US20030004172A1-20030102-C00060.CDX"/>
<chemistry-mol-file id="CHEMMOL-00060" file="US20030004172A1-20030102-C00060.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1053" lvl="0"><number>&lsqb;1053&rsqb;</number> The procedure of Example 2 was repeated, except the 3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid was replaced by 3-(4-fluoro-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid made using 4-flurobenzyl in place of benzyl during the synthesis outlined in preparation 1-3, to give 3-(4-fluoro-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-4-ylmethyl ester as a pink solid. MS (APCI&plus;), m/z 412 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 26 </heading>
</section>
<section>
<heading lvl="1">3-(4-tert-butyoxycarbonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1054" lvl="0"><number>&lsqb;1054&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00061">
<number>61</number>
<image id="EMI-C00061" he="110.1681" wi="211.7178" file="US20030004172A1-20030102-C00061.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00061" file="US20030004172A1-20030102-C00061.CDX"/>
<chemistry-mol-file id="CHEMMOL-00061" file="US20030004172A1-20030102-C00061.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1055" lvl="0"><number>&lsqb;1055&rsqb;</number> The procedure of Example 15 was repeated, except 3-bromomethyl-benzoic acid methyl ester is replaced by 4-bromomethyl-benzoic acid tert-butyl ester, to 3-(4-tert-butyoxycarbonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester as a white solid (70%). MS (APCI&plus;), m/z 493 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 27 </heading>
</section>
<section>
<heading lvl="1">3-(4-tert-butyoxycarbonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid </heading>
<paragraph id="P-1056" lvl="0"><number>&lsqb;1056&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00062">
<number>62</number>
<image id="EMI-C00062" he="96.7302" wi="155.04615" file="US20030004172A1-20030102-C00062.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00062" file="US20030004172A1-20030102-C00062.CDX"/>
<chemistry-mol-file id="CHEMMOL-00062" file="US20030004172A1-20030102-C00062.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1057" lvl="0"><number>&lsqb;1057&rsqb;</number> To a solution of 3-(4-tert-butyoxycarbonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester (0.5 g, 0.98 mmol) in 40 mL of 10:1 THF/water, was added 0.24 g of LiOH. Reaction was stirred at room temperature for 5 hours. THF was removed in reduced pressure, and 50 mL of water was added along with 150 mL of EtOAc. The solution is then acidified by HCl and shaken. The organic layer was washed by water and brine, and concentrated to yield 3-(4-tert-butyoxycarbonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid as an off white solid (66%). MS (APCI&plus;), m/z 417 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 28 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(4-Fluoro-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid </heading>
<paragraph id="P-1058" lvl="0"><number>&lsqb;1058&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00063">
<number>63</number>
<image id="EMI-C00063" he="108.2403" wi="212.65335" file="US20030004172A1-20030102-C00063.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00063" file="US20030004172A1-20030102-C00063.CDX"/>
<chemistry-mol-file id="CHEMMOL-00063" file="US20030004172A1-20030102-C00063.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1059" lvl="0"><number>&lsqb;1059&rsqb;</number> To a solution of 3-(4-tert-butyoxycarbonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (0.2 g, 0.48 mmol) and Mukiyama reagent (0.147 g, 0.57 mmol) in 6 mL of CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2 </subscript></highlight>was added Et<highlight><subscript>3</subscript></highlight>N (0.116 g, 1.14 mmol) and 4-fluorobenzyl amine (0.065 g, 0.52 mmol). The reaction solution was stirred at room temperature for overnight. The reaction solution was then chromatographed using 4:1 Hexane/EtOAc. The isolated product was then concentrated and dissolved in 5 mL of TFA. After stirring at room temperature for 30 minutes, the solution was concentrated and triturated using 4:1 Hexane/EtOAc to yield 4-&lsqb;6-(4-fluoro-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid as a white solid (77%). MS (APCI&plus;), m/z 468 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 29 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(4-Dimethylamino-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; compound with trifluoro-acetic acid </heading>
<paragraph id="P-1060" lvl="0"><number>&lsqb;1060&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00064">
<number>64</number>
<image id="EMI-C00064" he="147.39165" wi="213.61725" file="US20030004172A1-20030102-C00064.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00064" file="US20030004172A1-20030102-C00064.CDX"/>
<chemistry-mol-file id="CHEMMOL-00064" file="US20030004172A1-20030102-C00064.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1061" lvl="0"><number>&lsqb;1061&rsqb;</number> The procedure of Example 28 was repeated, 4-fluorobenzyl amine is replaced by (4-ethyl-phenyl)-dimethyl-amine, to give 4-&lsqb;6-(4-dimethylamino-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; compound with trifluoro-acetic acid as an off white solid (15%). MS (APCI&plus;), m/z 549 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 30 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(2-Ethoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rsqb;-benzoic acid </heading>
<paragraph id="P-1062" lvl="0"><number>&lsqb;1062&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00065">
<number>65</number>
<image id="EMI-C00065" he="108.2403" wi="195.87015" file="US20030004172A1-20030102-C00065.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00065" file="US20030004172A1-20030102-C00065.CDX"/>
<chemistry-mol-file id="CHEMMOL-00065" file="US20030004172A1-20030102-C00065.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1063" lvl="0"><number>&lsqb;1063&rsqb;</number> The procedure of Example 28 was repeated, 4-fluorobenzyl amine is replaced by 1-ethoxy-2-ethyl-benzene, to give 4-&lsqb;6-(2-ethoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rsqb;-benzoic acid as an off white solid (20%). MS (APCI&plus;), m/z 494 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 31 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid </heading>
<paragraph id="P-1064" lvl="0"><number>&lsqb;1064&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00066">
<number>66</number>
<image id="EMI-C00066" he="98.40285" wi="76.0914" file="US20030004172A1-20030102-C00066.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00066" file="US20030004172A1-20030102-C00066.CDX"/>
<chemistry-mol-file id="CHEMMOL-00066" file="US20030004172A1-20030102-C00066.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1065" lvl="0"><number>&lsqb;1065&rsqb;</number> 1-Methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester (4.45 g, 14.1 mmol) was put in 100 mL of HBr in Acetic acid. The solution was stirred at room temperature for overnight. The precipitant was filtered and washed with excess water to yield 1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid as a white solid (2.89 g). MS (APCI&plus;), m/z 227 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 32 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1066" lvl="0"><number>&lsqb;1066&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00067">
<number>67</number>
<image id="EMI-C00067" he="110.42325" wi="146.1726" file="US20030004172A1-20030102-C00067.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00067" file="US20030004172A1-20030102-C00067.CDX"/>
<chemistry-mol-file id="CHEMMOL-00067" file="US20030004172A1-20030102-C00067.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1067" lvl="0"><number>&lsqb;1067&rsqb;</number> To a suspension of 1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (1.25 g, 5.53 mmol) in 50 mL of 2:1 CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>/THF was added HOBT (0.821 g, 6.08 mmol), 4-methyl morpholine (2.79 g, 27.6 mmol), 4-methoxy benzyl amine (0.91 g, 6.63 mmol) and EDAC (1.27 g, 6.631 mmol) in that order. The reaction is stirred at room temperature for overnight, and then was acidified by 5% HCl. The reaction was diluted with 100 mL of CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2 </subscript></highlight>and was shaken. The precipitant was filtered and washed with 100 mL of 5% HCl and 100 mL of 5% NaHCO<highlight><subscript>3 </subscript></highlight>to yield 1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide as a white solid (79%). MS (APCI&plus;), m/z 346 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 33 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-&lsqb;4-(1H-tetrazol-5-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1068" lvl="0"><number>&lsqb;1068&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00068">
<number>68</number>
<image id="EMI-C00068" he="102.7404" wi="210.49875" file="US20030004172A1-20030102-C00068.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00068" file="US20030004172A1-20030102-C00068.CDX"/>
<chemistry-mol-file id="CHEMMOL-00068" file="US20030004172A1-20030102-C00068.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1069" lvl="0"><number>&lsqb;1069&rsqb;</number> To a solution of 1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (0.58 g, 2.07 mmol) in DMF was added cesium carbonate (0.68 g, 2.08 mmol) and 5-(4-bromomethyl-phenyl)-2-phenyl-2H-tetrazole (1.0 g, 2.08 mmol). The solution was stirred overnight at room temperature. 170 mL of water was then added, causing precipitation. The precipitant was filtered and then stirred in excess TFA at room temperature for overnight, concentrated and washed with Hexane and ether to give 3-(3-methoxycarbonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester as an off white solid (61%). MS (APCI&plus;), m/z 504 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 34 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-3-&lsqb;4-(morpholine-4-sulfonyl)-benzyl&rsqb;-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1070" lvl="0"><number>&lsqb;1070&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00069">
<number>69</number>
<image id="EMI-C00069" he="95.7663" wi="212.65335" file="US20030004172A1-20030102-C00069.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00069" file="US20030004172A1-20030102-C00069.CDX"/>
<chemistry-mol-file id="CHEMMOL-00069" file="US20030004172A1-20030102-C00069.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1071" lvl="0"><number>&lsqb;1071&rsqb;</number> To a solution of 1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide (0.3 g, 0.87 mmol) in 50 mL of DMF was added cesium carbonate (0.283 g, 0.87 mmol) and 4-(4-bromomethyl-benzenesulfonyl)-morpholine (0.287 g, 0.87 mmol). The reaction was then stirred at room temperature overnight. The solution was then poured into 500 mL of water and extracted with EtOAc. The organic layer was washed with water and brine, dried over MgSO<highlight><subscript>4 </subscript></highlight>and concentrated. The residue was triturated with 4:1 Hexane/EtOAc to yield 1-methyl-3-&lsqb;4-(morpholine-4-sulfonyl)-benzyl&rsqb;-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide as a white solid (66%). MS (APCI&plus;), m/z 585 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 35 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-3-&lsqb;4-(morpholine-4-carbonyl)-benzyl&rsqb;-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1072" lvl="0"><number>&lsqb;1072&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00070">
<number>70</number>
<image id="EMI-C00070" he="108.2403" wi="211.7178" file="US20030004172A1-20030102-C00070.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00070" file="US20030004172A1-20030102-C00070.CDX"/>
<chemistry-mol-file id="CHEMMOL-00070" file="US20030004172A1-20030102-C00070.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1073" lvl="0"><number>&lsqb;1073&rsqb;</number> The procedure of Example 34 was repeated, except 4-(4-bromomethyl-benzenesulfonyl)-morpholine is replaced by 1-(4-bromomethyl-phenyl)-1-morpholin-4-yl-methanone, to give 1-methyl-3-&lsqb;4-(morpholine-4-carbonyl)-benzyl&rsqb;-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide as an off white solid (25%). MS (APCI&plus;), m/z 459 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 36 </heading>
</section>
<section>
<heading lvl="1">3-But-2-ynyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1074" lvl="0"><number>&lsqb;1074&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00071">
<number>71</number>
<image id="EMI-C00071" he="108.49545" wi="175.45815" file="US20030004172A1-20030102-C00071.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00071" file="US20030004172A1-20030102-C00071.CDX"/>
<chemistry-mol-file id="CHEMMOL-00071" file="US20030004172A1-20030102-C00071.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1075" lvl="0"><number>&lsqb;1075&rsqb;</number> The procedure of Example 34 was repeated, except 4-(4-bromomethyl-benzenesulfonyl)-morpholine is replaced by 1-bromo-but-2-yne, to give 3-but-2-ynyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide as an off white solid (97%). MS (APCI&plus;), m/z 398 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 37 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-&lsqb;3-(1H-tetrazol-5-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1076" lvl="0"><number>&lsqb;1076&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00072">
<number>72</number>
<image id="EMI-C00072" he="110.42325" wi="172.8216" file="US20030004172A1-20030102-C00072.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00072" file="US20030004172A1-20030102-C00072.CDX"/>
<chemistry-mol-file id="CHEMMOL-00072" file="US20030004172A1-20030102-C00072.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1077" lvl="0"><number>&lsqb;1077&rsqb;</number> The procedure of Example 33 was repeated, except 5-(4-bromomethyl-phenyl)-2-phenyl-2H-tetrazole is replaced by except 5-(3-bromomethyl-phenyl)-2-phenyl-2H-tetrazole, to give 1-methyl-2,4-dioxo-3-&lsqb;3-(1H-tetrazol-5-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide as an off white solid (70%). MS (APCI&plus;), m/z 504 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 38 </heading>
</section>
<section>
<heading lvl="1">3-(4-Cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1078" lvl="0"><number>&lsqb;1078&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00073">
<number>73</number>
<image id="EMI-C00073" he="110.42325" wi="201.3984" file="US20030004172A1-20030102-C00073.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00073" file="US20030004172A1-20030102-C00073.CDX"/>
<chemistry-mol-file id="CHEMMOL-00073" file="US20030004172A1-20030102-C00073.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1079" lvl="0"><number>&lsqb;1079&rsqb;</number> The procedure of Example 34 was repeated, except 4-(4-bromomethyl-benzenesulfonyl)-morpholine is replaced by 4-bromomethyl benzonitrile, to give 3-(4-cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide as an off white solid (70%). MS (APCI&plus;), m/z 431 (M&minus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 39 </heading>
</section>
<section>
<heading lvl="1">&lcub;4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-phenyl&rcub;-acetic acid </heading>
<paragraph id="P-1080" lvl="0"><number>&lsqb;1080&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00074">
<number>74</number>
<image id="EMI-C00074" he="182.43225" wi="159.86565" file="US20030004172A1-20030102-C00074.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00074" file="US20030004172A1-20030102-C00074.CDX"/>
<chemistry-mol-file id="CHEMMOL-00074" file="US20030004172A1-20030102-C00074.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1081" lvl="0"><number>&lsqb;1081&rsqb;</number> The procedure of Example 33 was repeated, except 5-(4-bromomethyl-phenyl)-2-phenyl-2H-tetrazole is replaced by (4-bromomethyl-phenyl)-acetic acid tert-butyl ester, to give &lcub;4-&lsqb;6-(3-methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-phenyl&rcub;-acetic acid as a white solid (70%). MS (APCI&plus;), m/z 494 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 40 </heading>
</section>
<section>
<heading lvl="1">3-&lsqb;2-(2,4-Dichloro-benzenesulfonyl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1082" lvl="0"><number>&lsqb;1082&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00075">
<number>75</number>
<image id="EMI-C00075" he="123.12405" wi="212.9085" file="US20030004172A1-20030102-C00075.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00075" file="US20030004172A1-20030102-C00075.CDX"/>
<chemistry-mol-file id="CHEMMOL-00075" file="US20030004172A1-20030102-C00075.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1083" lvl="0"><number>&lsqb;1083&rsqb;</number> The procedure of Example 34 was repeated, except 4-(4-bromomethyl-benzenesulfonyl)-morpholine is replaced by 2,4-dichloro-1-(2-chloro-ethanesulfonyl)-benzene, to 3-&lsqb;2-(2,4-dichloro-benzenesulfonyl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide as a white solid. MS (APCI&plus;), m/z 582 (M&plus;) </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 41 </heading>
</section>
<section>
<heading lvl="1">3-(4-Methanesulfonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1084" lvl="0"><number>&lsqb;1084&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00076">
<number>76</number>
<image id="EMI-C00076" he="110.42325" wi="199.4706" file="US20030004172A1-20030102-C00076.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00076" file="US20030004172A1-20030102-C00076.CDX"/>
<chemistry-mol-file id="CHEMMOL-00076" file="US20030004172A1-20030102-C00076.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1085" lvl="0"><number>&lsqb;1085&rsqb;</number> The procedure of Example 34 was repeated, except 4-(4-bromomethyl-benzenesulfonyl)-morpholine is replaced by 1-chloromethyl-4-methanesulfonyl-benzene, to give 3-(4-methanesulfonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide as a white solid. MS (APCI&plus;), m/z 514 (M&plus;) </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 42 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-(4-sulfamoyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1086" lvl="0"><number>&lsqb;1086&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00077">
<number>77</number>
<image id="EMI-C00077" he="110.42325" wi="201.14325" file="US20030004172A1-20030102-C00077.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00077" file="US20030004172A1-20030102-C00077.CDX"/>
<chemistry-mol-file id="CHEMMOL-00077" file="US20030004172A1-20030102-C00077.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1087" lvl="0"><number>&lsqb;1087&rsqb;</number> The procedure of Example 34 was repeated, except 4-(4-bromomethyl-benzenesulfonyl)-morpholine is replaced by 4-bromomethyl-benzenesulfonamide, to give 1-methyl-2,4-dioxo-3-(4-sulfamoyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide as a white solid. MS (APCI&plus;), m/z 515 (M&plus;) </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 43 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-methoxy-pyridin-4-ylmethyl)-amide </heading>
<paragraph id="P-1088" lvl="0"><number>&lsqb;1088&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00078">
<number>78</number>
<image id="EMI-C00078" he="110.42325" wi="172.11285" file="US20030004172A1-20030102-C00078.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00078" file="US20030004172A1-20030102-C00078.CDX"/>
<chemistry-mol-file id="CHEMMOL-00078" file="US20030004172A1-20030102-C00078.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1089" lvl="0"><number>&lsqb;1089&rsqb;</number> The procedure of Example 34 was repeated, except 4-(4-bromomethyl-benzenesulfonyl)-morpholine is replaced by benzyl bromide, and the amide starting material was a 2-methoxy-pyridine-4-yl methyl amide, to give 3-benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-methoxy-pyridin-4-ylmethyl)-amide as a white solid (30%). <highlight><superscript>1</superscript></highlight>H NMR (DMSO), &dgr;3.47 (s, 3H), 3.81 (s, 3H), 4.41 (d, J&equals;7.0 Hz, 2H), 5.03 (s, 2H), 6.66 (s, 1H), 6.88 (d, J&equals;4.9 Hz, 1H), 7.21-7.36 (m, 5H), 8.08 (d, J&equals;7.0 Hz, 2H), 8.14 (s, 1H), 9.27 (t, J&equals;7.0 Hz, 1H). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 44 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-3-(4-methylsulfamoyl-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1090" lvl="0"><number>&lsqb;1090&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00079">
<number>79</number>
<image id="EMI-C00079" he="103.44915" wi="212.9085" file="US20030004172A1-20030102-C00079.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00079" file="US20030004172A1-20030102-C00079.CDX"/>
<chemistry-mol-file id="CHEMMOL-00079" file="US20030004172A1-20030102-C00079.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1091" lvl="0"><number>&lsqb;1091&rsqb;</number> The procedure of Example 34 was repeated, except 4-(4-bromomethyl-benzenesulfonyl)-morpholine is replaced by 4-bromomethyl-N-methyl-benzenesulfonamide, to give 1-methyl-3-(4-methylsulfamoyl-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide as a white solid. <highlight><superscript>1</superscript></highlight>H NMR (DMSO), &dgr;2.37 (d, J&equals;5.0 Hz, 3H), 3.47 (s, 3H), 3.72 (s, 3H), 4.41 (d, J&equals;5.9 Hz, 2H), 5.12 (s, 2H), 6.80-6.87 (m, 3H), 7.24 (t, J&equals;8.0 Hz, 1H), 7.40-7.51 (m, 3H), 7.69 (d, J&equals;8.0 Hz, 2H), 8.13 (s, 1H), 9.21 (t,J&equals;5.7 Hz, 1H). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 45 </heading>
</section>
<section>
<heading lvl="1">3-(4-Isopropylsulfamoyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1092" lvl="0"><number>&lsqb;1092&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00080">
<number>80</number>
<image id="EMI-C00080" he="97.43895" wi="212.19975" file="US20030004172A1-20030102-C00080.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00080" file="US20030004172A1-20030102-C00080.CDX"/>
<chemistry-mol-file id="CHEMMOL-00080" file="US20030004172A1-20030102-C00080.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1093" lvl="0"><number>&lsqb;1093&rsqb;</number> The procedure of Example 34 was repeated, except 4-(4-bromomethyl-benzenesulfonyl)-morpholine is replaced by 4-bromomethyl-N-isopropyl-benzenesulfonamide, to give 3-(4-isopropylsulfamoyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide as a white solid. <highlight><superscript>1</superscript></highlight>H NMR (DMSO), &dgr;0.92 (d, J&equals;6.6 Hz, 6H), 3.48 (s, 3H), 3.72 (s, 3H), 4.41 (d, J&equals;5.8 Hz, 2H), 5.12 (s, 2H), 6.80-6.87 (m, 3H), 7.24 (t, J&equals;8.1 Hz, 1H), 7.46-7.55 (m, 3H), 7.71 (d, J&equals;8.0 Hz, 2H), 8.13 (s, 1H), 9.21 (t, J&equals;5.7 Hz, 1H). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 46 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-&lsqb;4-(pyrrolidine-1-sulfonyl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1094" lvl="0"><number>&lsqb;1094&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00081">
<number>81</number>
<image id="EMI-C00081" he="98.17605" wi="212.42655" file="US20030004172A1-20030102-C00081.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00081" file="US20030004172A1-20030102-C00081.CDX"/>
<chemistry-mol-file id="CHEMMOL-00081" file="US20030004172A1-20030102-C00081.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1095" lvl="0"><number>&lsqb;1095&rsqb;</number> The procedure of Example 34 was repeated, except 4-(4-bromomethyl-benzenesulfonyl)-morpholine is replaced by 1-(4-bromomethyl-benezensulfonyl)-pyrrolidine, to give 1-methyl-2,4-dioxo-3-&lsqb;4-(pyrrolidine-1-sulfonyl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide as a white solid. <highlight><superscript>1</superscript></highlight>H NMR (DMSO), &dgr;1.64 (m, 4H), 3.11 (m, 4H), 3.49 (s, 3H), 3.73 (s, 3H), 4.42 (d, J&equals;5.8 Hz, 2H), 5.14 (s, 2H), 6.83-6.88 (m, 3H), 7.24 (m, 1H), 7.53 (d, J&equals;8.1, 2H), 7.73 (d, J&equals;8.0 Hz, 2H), 8.13 (s, 1H), 9.21 (t, J&equals;5.7 Hz, 1H). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 47 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-3-&lsqb;4-(4-methyl-piperidine-1-sulfonyl)-benzyl&rsqb;-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1096" lvl="0"><number>&lsqb;1096&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00082">
<number>82</number>
<image id="EMI-C00082" he="92.421" wi="212.65335" file="US20030004172A1-20030102-C00082.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00082" file="US20030004172A1-20030102-C00082.CDX"/>
<chemistry-mol-file id="CHEMMOL-00082" file="US20030004172A1-20030102-C00082.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1097" lvl="0"><number>&lsqb;1097&rsqb;</number> The procedure of Example 34 was repeated, except 4-(4-bromomethyl-benzenesulfonyl)-morpholine is replaced by 1-(4-bromomethyl-benzenesulfonyl)-4-methyl-piperidine, to give 1-methyl-3-&lsqb;4-(4-methyl-piperidine-1-sulfonyl)-benzyl&rsqb;-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide as a white solid. <highlight><superscript>1</superscript></highlight>H NMR (DMSO), &dgr;0.83 (d, J&equals;5.4 Hz, 3H), 1.15 (m, 2H), 1.28 (s, 1H), 1.62 (d, J&equals;12.7 Hz, 2H), 2.16 (t, J&equals;12.3 Hz, 2H), 3.49 (s, 3H), 3.58 (d, J&equals;10.5 Hz, 2H), 3.73 (s, 3H), 4.43 (d, J&equals;5.1 Hz, 2H), 5.15 (s, 2H), 6.81-6.87 (m, 3H), 7.24 (m, 1H), 7.53 (d, J&equals;7.1, 2H), 7.66 (d, J&equals;6.8 Hz, 2H), 8.14 (s, 1H), 9.23 (t, J&equals;5.7 Hz, 1H). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 48 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzofuran-2-ylmethyl ester </heading>
<paragraph id="P-1098" lvl="0"><number>&lsqb;1098&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00083">
<number>83</number>
<image id="EMI-C00083" he="142.57215" wi="162.98415" file="US20030004172A1-20030102-C00083.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00083" file="US20030004172A1-20030102-C00083.CDX"/>
<chemistry-mol-file id="CHEMMOL-00083" file="US20030004172A1-20030102-C00083.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1099" lvl="0"><number>&lsqb;1099&rsqb;</number> To a solution of 3-benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (0.2 g, 0.63 mmol) and Mukiyama reagent (0.194 g, 0.76 mmol) in 6 mL of CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2 </subscript></highlight>was added Et<highlight><subscript>3</subscript></highlight>N (0.154 g, 1.52 mmol) and benzofuran-2-yl-methanol (0.103 g, 0.696 mmol). The reaction solution was stirred at room temperature for overnight. The reaction solution was then chromatographed using 4:1 Hexane/EtOAc, to yield 3-benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzofuran-2-ylmethyl ester as a white solid (135 mg, 48%). MS (APCI&plus;), m/z 447 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 49 </heading>
</section>
<section>
<heading lvl="1">3-(4-Bromo-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-4-ylmethyl ester </heading>
<paragraph id="P-1100" lvl="0"><number>&lsqb;1100&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00084">
<number>84</number>
<image id="EMI-C00084" he="110.1681" wi="191.05065" file="US20030004172A1-20030102-C00084.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00084" file="US20030004172A1-20030102-C00084.CDX"/>
<chemistry-mol-file id="CHEMMOL-00084" file="US20030004172A1-20030102-C00084.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1101" lvl="0"><number>&lsqb;1101&rsqb;</number> The procedure of Example 2 was repeated, except the 3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid was replaced by 3-(4-bromo-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid made using 4-bromo in place of benzyl during the synthesis outlined in preparation 1-3, to give 3-(4-bromo-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-4-ylmethyl ester as an off white solid. MS (APCI&plus;), m/z 472 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 50 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzyl ester </heading>
<paragraph id="P-1102" lvl="0"><number>&lsqb;1102&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00085">
<number>85</number>
<image id="EMI-C00085" he="140.41755" wi="166.5846" file="US20030004172A1-20030102-C00085.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00085" file="US20030004172A1-20030102-C00085.CDX"/>
<chemistry-mol-file id="CHEMMOL-00085" file="US20030004172A1-20030102-C00085.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1103" lvl="0"><number>&lsqb;1103&rsqb;</number> The procedure of Example 1 was repeated, except that benzyl alcohol is replaced by 4-methoxy benzyl alcohol to provide 3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzyl ester as a white powder (30 mg, 10%). MS (APCI&plus;), m/z 423 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 51 </heading>
</section>
<section>
<heading lvl="1">4-&lcub;1-Methyl-2,4-dioxo-6-&lsqb;(pyridin-4-ylmethyl)-carbamoyl&rsqb;-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rcub;-benzoic acid; compound with trifluoro-acetic acid </heading>
<paragraph id="P-1104" lvl="0"><number>&lsqb;1104&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00086">
<number>86</number>
<image id="EMI-C00086" he="163.94805" wi="201.6252" file="US20030004172A1-20030102-C00086.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00086" file="US20030004172A1-20030102-C00086.CDX"/>
<chemistry-mol-file id="CHEMMOL-00086" file="US20030004172A1-20030102-C00086.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1105" lvl="0"><number>&lsqb;1105&rsqb;</number> The procedure of Example 28 was repeated, except that 4-fluorobenzyl amine is replaced by (4-methylamino) pyridine, to give 4-&lcub;1-methyl-2,4-dioxo-6-&lsqb;(pyridin-4-ylmethyl)-carbamoyl&rsqb;-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rcub;-benzoic acid; compound with trifluoro-acetic acid as an off white solid (82%). MS (APCI&plus;), m/z 451 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 52 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(4-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid </heading>
<paragraph id="P-1106" lvl="0"><number>&lsqb;1106&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00087">
<number>87</number>
<image id="EMI-C00087" he="105.60375" wi="213.61725" file="US20030004172A1-20030102-C00087.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00087" file="US20030004172A1-20030102-C00087.CDX"/>
<chemistry-mol-file id="CHEMMOL-00087" file="US20030004172A1-20030102-C00087.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1107" lvl="0"><number>&lsqb;1107&rsqb;</number> The procedure of Example 28 was repeated, except that 4-fluorobenzyl amine is replaced by 4-methoxy benzyl amine, to give 4-&lsqb;6-(4-methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid as an off white solid (38%). MS (APCI&plus;), m/z 480 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 53 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(3,4-Dimethoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid tert-butyl ester </heading>
<paragraph id="P-1108" lvl="0"><number>&lsqb;1108&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00088">
<number>88</number>
<image id="EMI-C00088" he="89.3025" wi="212.65335" file="US20030004172A1-20030102-C00088.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00088" file="US20030004172A1-20030102-C00088.CDX"/>
<chemistry-mol-file id="CHEMMOL-00088" file="US20030004172A1-20030102-C00088.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1109" lvl="0"><number>&lsqb;1109&rsqb;</number> To a solution of 3-(4-tert-butyoxycarbonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (0.15 g, 0.36 mmol) and Mukiyama reagent (0.11 g, 0.43 mmol) in 6 mL of CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2 </subscript></highlight>was added Et<highlight><subscript>3</subscript></highlight>N (0.87 g, 87 mmol) and 3,4-dimethoxy benzyl amine (0.067 g, 0.39 mmol). The reaction solution was stirred at room temperature for overnight. The reaction solution was then chromatographed using 4:1 Hexane/EtOAc, to yield 4-&lsqb;6-(3,4-dimethoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid tert-butyl ester as a white solid (78%). MS (APCI&plus;), m/z 567 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 54 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(3,4-Dimethoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid </heading>
<paragraph id="P-1110" lvl="0"><number>&lsqb;1110&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00089">
<number>89</number>
<image id="EMI-C00089" he="96.7302" wi="211.46265" file="US20030004172A1-20030102-C00089.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00089" file="US20030004172A1-20030102-C00089.CDX"/>
<chemistry-mol-file id="CHEMMOL-00089" file="US20030004172A1-20030102-C00089.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1111" lvl="0"><number>&lsqb;1111&rsqb;</number> 4-&lsqb;6-(3,4-Dimethoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid tert-butyl ester (0.1 g, 0.176 mmol) was dissolved in 5 mL of TFA. The solution was stirred at room temperature for 30 minutes then concentrated. The residue was triturated with 4:1 Hexane/EtOAc to yield 4-&lsqb;6-(3,4-dimethoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid as a white solid (65 mg, 73%). MS (APCI&plus;), m/z 510 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 55 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(4-Bromo-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid </heading>
<paragraph id="P-1112" lvl="0"><number>&lsqb;1112&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00090">
<number>90</number>
<image id="EMI-C00090" he="106.34085" wi="212.65335" file="US20030004172A1-20030102-C00090.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00090" file="US20030004172A1-20030102-C00090.CDX"/>
<chemistry-mol-file id="CHEMMOL-00090" file="US20030004172A1-20030102-C00090.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1113" lvl="0"><number>&lsqb;1113&rsqb;</number> The procedure of Example 28 was repeated, except that 4-fluorobenzyl amine is replaced by 4-bromobenzyl amine, to give 4-&lsqb;6-(4-bromo-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid as an off white solid (55%). MS (APCI&plus;), m/z 530 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 56 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(4-Bromo-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid tert-butyl ester </heading>
<paragraph id="P-1114" lvl="0"><number>&lsqb;1114&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00091">
<number>91</number>
<image id="EMI-C00091" he="100.33065" wi="212.19975" file="US20030004172A1-20030102-C00091.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00091" file="US20030004172A1-20030102-C00091.CDX"/>
<chemistry-mol-file id="CHEMMOL-00091" file="US20030004172A1-20030102-C00091.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1115" lvl="0"><number>&lsqb;1115&rsqb;</number> The procedure of Example 53 was repeated, except that 3,4-dimethoxy benzyl amine is replaced by 4-bromobenzyl amine, to give 4-&lsqb;6-(4-bromo-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid tert-butyl ester as an off white solid (71%). MS (APCI&minus;), m/z 584 (M&minus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 57 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(3,5-Bis-trifluoromethyl-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid </heading>
<paragraph id="P-1116" lvl="0"><number>&lsqb;1116&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00092">
<number>92</number>
<image id="EMI-C00092" he="137.29905" wi="212.9085" file="US20030004172A1-20030102-C00092.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00092" file="US20030004172A1-20030102-C00092.CDX"/>
<chemistry-mol-file id="CHEMMOL-00092" file="US20030004172A1-20030102-C00092.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1117" lvl="0"><number>&lsqb;1117&rsqb;</number> The procedure of Example 28 was repeated, except that 4-fluorobenzyl amine is replaced by 3,5-bis-trifluoromethyl benzyl amine, to give 4-&lsqb;6-(3,5-bis-trifluoromethyl-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid as an off white solid (65%). MS (APCI&plus;), m/z 586 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 58 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(4-Chloro-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid </heading>
<paragraph id="P-1118" lvl="0"><number>&lsqb;1118&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00093">
<number>93</number>
<image id="EMI-C00093" he="107.30475" wi="212.9085" file="US20030004172A1-20030102-C00093.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00093" file="US20030004172A1-20030102-C00093.CDX"/>
<chemistry-mol-file id="CHEMMOL-00093" file="US20030004172A1-20030102-C00093.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1119" lvl="0"><number>&lsqb;1119&rsqb;</number> The procedure of Example 28 was repeated, 4-fluorobenzyl amine is replaced by 4-chlorobenzyl amine, to give 4-&lsqb;6-(4-chloro-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoicacid as an off white solid (39%). MS (APCI&plus;), m/z 484 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 59 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;1-Methyl-2,4-dioxo-6-(4-sulfamoyl-benzylcarbamoyl)-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid </heading>
<paragraph id="P-1120" lvl="0"><number>&lsqb;1120&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00094">
<number>94</number>
<image id="EMI-C00094" he="103.7043" wi="211.9446" file="US20030004172A1-20030102-C00094.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00094" file="US20030004172A1-20030102-C00094.CDX"/>
<chemistry-mol-file id="CHEMMOL-00094" file="US20030004172A1-20030102-C00094.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1121" lvl="0"><number>&lsqb;1121&rsqb;</number> The procedure of Example 28 was repeated, except that 4-fluorobenzyl amine is replaced by 4-aminoethyl-benzenesulfonamide, to give 4-&lsqb;1-methyl-2,4-dioxo-6-(4-sulfamoyl-benzylcarbamoyl)-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid as an off white solid (41%). MS (APCI&plus;), m/z 529 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 60 </heading>
</section>
<section>
<heading lvl="1">3-(4-Fluoro-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1122" lvl="0"><number>&lsqb;1122&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00095">
<number>95</number>
<image id="EMI-C00095" he="111.84075" wi="211.9446" file="US20030004172A1-20030102-C00095.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00095" file="US20030004172A1-20030102-C00095.CDX"/>
<chemistry-mol-file id="CHEMMOL-00095" file="US20030004172A1-20030102-C00095.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1123" lvl="0"><number>&lsqb;1123&rsqb;</number> The procedure of Example 34 was repeated, except that 4-(4-bromomethyl-benzenesulfonyl)-morpholine is replaced by 1-bromomethyl-4-fluoro-benzene, and 1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide is replaced by 1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide, to give 3-(4-fluoro-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide as an off white solid (65%). MS (APCI&plus;), m/z 454 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 61 </heading>
</section>
<section>
<heading lvl="1">3-(4-Iodo-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1124" lvl="0"><number>&lsqb;1124&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00096">
<number>96</number>
<image id="EMI-C00096" he="111.84075" wi="202.5891" file="US20030004172A1-20030102-C00096.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00096" file="US20030004172A1-20030102-C00096.CDX"/>
<chemistry-mol-file id="CHEMMOL-00096" file="US20030004172A1-20030102-C00096.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1125" lvl="0"><number>&lsqb;1125&rsqb;</number> The procedure of Example 34 was repeated, except that 4-(4-bromomethyl-benzenesulfonyl)-morpholine is replaced by 1-bromomethyl-4-iodo-benzene, to give 3-(4-iodo-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide as an off white solid (27%). MS (APCI&plus;), m/z 562 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 62 </heading>
</section>
<section>
<heading lvl="1">3-(4-Dimethylsulfamoyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1126" lvl="0"><number>&lsqb;1126&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00097">
<number>97</number>
<image id="EMI-C00097" he="99.8487" wi="212.42655" file="US20030004172A1-20030102-C00097.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00097" file="US20030004172A1-20030102-C00097.CDX"/>
<chemistry-mol-file id="CHEMMOL-00097" file="US20030004172A1-20030102-C00097.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1127" lvl="0"><number>&lsqb;1127&rsqb;</number> The procedure of Example 34 was repeated, except that 4-(4-bromomethyl-benzenesulfonyl)-morpholine is replaced by 4-bromomethyl-N,N-dimethyl-benzenesulfonamide, and 1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide is replaced by 1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide, to give 3-(4-dimethylsulfamoyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide as an off white solid (67%). MS (APCI&plus;), m/z 543 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 63 </heading>
</section>
<section>
<heading lvl="1">3-(3-Methoxy-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1128" lvl="0"><number>&lsqb;1128&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00098">
<number>98</number>
<image id="EMI-C00098" he="110.42325" wi="209.79" file="US20030004172A1-20030102-C00098.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00098" file="US20030004172A1-20030102-C00098.CDX"/>
<chemistry-mol-file id="CHEMMOL-00098" file="US20030004172A1-20030102-C00098.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1129" lvl="0"><number>&lsqb;1129&rsqb;</number> The procedure of Example 34 was repeated, except that 4-(4-bromomethyl-benzenesulfonyl)-morpholine is replaced by 3-methoxy benzyl bromide, and 1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide is replaced by 1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide, to give 3-(3-methoxy-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide as an off white solid (83%). MS (APCI&plus;), m/z 5466 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 64 </heading>
</section>
<section>
<heading lvl="1">3-(4-Cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1130" lvl="0"><number>&lsqb;1130&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00099">
<number>99</number>
<image id="EMI-C00099" he="105.1218" wi="212.65335" file="US20030004172A1-20030102-C00099.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00099" file="US20030004172A1-20030102-C00099.CDX"/>
<chemistry-mol-file id="CHEMMOL-00099" file="US20030004172A1-20030102-C00099.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1131" lvl="0"><number>&lsqb;1131&rsqb;</number> The procedure of Example 34 was repeated, except that 4-(4-bromomethyl-benzenesulfonyl)-morpholine is replaced by 4-cyanobenzyl bromide, and 1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide is replaced by 1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide, to give 3-(4-cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide as an off white solid (97%). MS (APCI&plus;), m/z 461 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 65 </heading>
</section>
<section>
<heading lvl="1">3-(4-Acetylamino-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1132" lvl="0"><number>&lsqb;1132&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00100">
<number>100</number>
<image id="EMI-C00100" he="103.44915" wi="212.65335" file="US20030004172A1-20030102-C00100.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00100" file="US20030004172A1-20030102-C00100.CDX"/>
<chemistry-mol-file id="CHEMMOL-00100" file="US20030004172A1-20030102-C00100.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1133" lvl="0"><number>&lsqb;1133&rsqb;</number> The procedure of Example 34 was repeated, except that 4-(4-bromomethyl-benzenesulfonyl)-morpholine is replaced by N-(4-chloromethyl-phenyl)-acetamide, to give 3-(4-acetylamino-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide as an off white solid (42%). MS (APCI&plus;), m/z 493 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 65a </heading>
</section>
<section>
<heading lvl="1">5-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-furan-2-carboxylic acid ethyl ester </heading>
<paragraph id="P-1134" lvl="0"><number>&lsqb;1134&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00101">
<number>101</number>
<image id="EMI-C00101" he="117.85095" wi="208.5993" file="US20030004172A1-20030102-C00101.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00101" file="US20030004172A1-20030102-C00101.CDX"/>
<chemistry-mol-file id="CHEMMOL-00101" file="US20030004172A1-20030102-C00101.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1135" lvl="0"><number>&lsqb;1135&rsqb;</number> The procedure of Example 34 was repeated, except that 4-(4-bromomethyl-benzenesulfonyl)-morpholine is replaced by 5-chloromethyl-furan-2-carboxylic acid ethyl ester, to give 5-&lsqb;6-(3-methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-furan-2-carboxylic acid ethyl ester as an off which solid (41%). MS (APCI&plus;), m/z 498 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 66 </heading>
</section>
<section>
<heading lvl="1">3-(4-Cyano-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzyl ester </heading>
<paragraph id="P-1136" lvl="0"><number>&lsqb;1136&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00102">
<number>102</number>
<image id="EMI-C00102" he="174.49425" wi="158.193" file="US20030004172A1-20030102-C00102.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00102" file="US20030004172A1-20030102-C00102.CDX"/>
<chemistry-mol-file id="CHEMMOL-00102" file="US20030004172A1-20030102-C00102.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1137" lvl="0"><number>&lsqb;1137&rsqb;</number> The procedure of preparation 2 was repeated, except that 3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid ethyl ester is replaced by &lsqb;1-(4-cyano-benyl)-2,6-dioxo-1,2,3,6-tetrahydro-pyrimidine-4-sulfanyl-acetic acid 3-methoxy-benzyl ester, to yield 3-(4-cyano-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzyl ester as an off white solid (91%). <highlight><superscript>1</superscript></highlight>H NMR (DMSO), &dgr;3.74 (s, 3H), 5.07 (s, 2H), 5.28 (s, 2H), 6.91 (d, J&equals;8.2 Hz, 1H), 6.99 (d, J&equals;3.0 Hz, 2H), 7.30 (t, J&equals;8.0 Hz, 1H), 7.47 (d, J&equals;7.7 Hz, 2H), 7.75 (d, J&equals;8.0 Hz, 2H), 7.83 (s, 1H), 12.68 (s, 1H). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 67 </heading>
</section>
<section>
<heading lvl="1">2,4-Dioxo-3-&lsqb;4-(2H-tetrazol-4-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzyl ester </heading>
<paragraph id="P-1138" lvl="0"><number>&lsqb;1138&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00103">
<number>103</number>
<image id="EMI-C00103" he="182.9142" wi="158.90175" file="US20030004172A1-20030102-C00103.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00103" file="US20030004172A1-20030102-C00103.CDX"/>
<chemistry-mol-file id="CHEMMOL-00103" file="US20030004172A1-20030102-C00103.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1139" lvl="0"><number>&lsqb;1139&rsqb;</number> The procedure of Example 24 was repeated, except that 3-(4-cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzyl ester is replaced by 3-(4-cyano-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester, to give 2,4-dioxo-3-&lsqb;4-(2H-tetrazol-5-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzyl ester as an off white solid (7%). MS (APCI&plus;), m/z 491 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 68 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid 2-dimethylamino-ethyl ester </heading>
<paragraph id="P-1140" lvl="0"><number>&lsqb;1140&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00104">
<number>104</number>
<image id="EMI-C00104" he="102.0033" wi="212.65335" file="US20030004172A1-20030102-C00104.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00104" file="US20030004172A1-20030102-C00104.CDX"/>
<chemistry-mol-file id="CHEMMOL-00104" file="US20030004172A1-20030102-C00104.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1141" lvl="0"><number>&lsqb;1141&rsqb;</number> To a solution of 4-&lsqb;6-(3-methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid (100 mg, 0.289 mmol) in 50 mL of 2:1 CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>/THF, was added HOBT (43 mg, 0.32 mmol), 4-methyl morpholine (146 g, 1.44 mmol), 2-dimethylamino-ethanol (28 mg, 0.318 mmol) and EDAC (66.5 mg, 0.347 mmol) in that order. The reaction is stirred at room temperature for overnight, and directly chromatographed with 10:1 CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>/MeOH. The crude product was then triturated with 4:1 Hexane/EtOAc to yield 4-&lsqb;6-(3-methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid 2-dimethylamino-ethyl ester as a white powder (89%). MS (APCI&plus;), m/z 551 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 69 </heading>
</section>
<section>
<heading lvl="1">3-Cylcohexylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid-3methoxy-benzylamide </heading>
<paragraph id="P-1142" lvl="0"><number>&lsqb;1142&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00105">
<number>105</number>
<image id="EMI-C00105" he="110.42325" wi="186.0327" file="US20030004172A1-20030102-C00105.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00105" file="US20030004172A1-20030102-C00105.CDX"/>
<chemistry-mol-file id="CHEMMOL-00105" file="US20030004172A1-20030102-C00105.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1143" lvl="0"><number>&lsqb;1143&rsqb;</number> The procedure of Example 34 was repeated, except that 4-(4-bromomethyl-benzenesulfonyl)-morpholine is replaced by bromomethyl-cyclohexane, to give 3-cylcohexylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide as a white solid (62%). MS (APCI&plus;), m/z 442 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 70 </heading>
</section>
<section>
<heading lvl="1">3-cylcohexylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid-4methoxy-benzylamide </heading>
<paragraph id="P-1144" lvl="0"><number>&lsqb;1144&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00106">
<number>106</number>
<image id="EMI-C00106" he="140.41755" wi="166.5846" file="US20030004172A1-20030102-C00106.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00106" file="US20030004172A1-20030102-C00106.CDX"/>
<chemistry-mol-file id="CHEMMOL-00106" file="US20030004172A1-20030102-C00106.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1145" lvl="0"><number>&lsqb;1145&rsqb;</number> The procedure of Example 69 was repeated, except that 1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide is replaced by 1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide, to give 3-cylcohexylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide as a white solid (80%). MS (APCI&plus;), m/z 442 (M&plus;). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 71 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid furan-3-ylmethyl ester </heading>
<paragraph id="P-1146" lvl="0"><number>&lsqb;1146&rsqb;</number> The title compound was prepared according to the procedure of Example 1; MS (M&plus;1) 383.2. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 72 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pentafluorophenylmethyl ester </heading>
<paragraph id="P-1147" lvl="0"><number>&lsqb;1147&rsqb;</number> The title compound was prepared according to the procedure of Example 28; MS (M&plus;1) 497.4. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 73 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-ethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1148" lvl="0"><number>&lsqb;1148&rsqb;</number> The title compound was prepared according to the procedure of Example 9; mp 147-148&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 74 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-cyclopropylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1149" lvl="0"><number>&lsqb;1149&rsqb;</number> The title compound was prepared according to the procedure of Example 9; MS (M&plus;1) 447.1. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 75 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (pyridin-4-ylmethyl)-amide </heading>
<paragraph id="P-1150" lvl="0"><number>&lsqb;1150&rsqb;</number> The title compound was prepared according to the procedure of Example 28; MS (M&plus;1) 407.1. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 76 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-bromo-benzyl ester </heading>
<paragraph id="P-1151" lvl="0"><number>&lsqb;1151&rsqb;</number> The title compound was prepared according to the procedure of Example 1; MS (M&plus;1) 485.2. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 77 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(3-Difluoromethoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid </heading>
<paragraph id="P-1152" lvl="0"><number>&lsqb;1152&rsqb;</number> The title compound was prepared according to the procedure of Example 28; MS (M&plus;1) 516.1. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 78 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(3-Difluoromethoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid tert-butyl ester </heading>
<paragraph id="P-1153" lvl="0"><number>&lsqb;1153&rsqb;</number> The title compound was prepared according to the procedure of Example 15; MS (M&minus;C<highlight><subscript>4</subscript></highlight>H<highlight><subscript>9</subscript></highlight>) 516.1. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 79 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid </heading>
<paragraph id="P-1154" lvl="0"><number>&lsqb;1154&rsqb;</number> The title compound was prepared according to the procedure of Example 28; MS (M&plus;1) 480.1. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 80 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(4-Methanesulfonyl-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid tert-butyl ester </heading>
<paragraph id="P-1155" lvl="0"><number>&lsqb;1155&rsqb;</number> The title compound was prepared according to the procedure of Example 15; <highlight><superscript>1</superscript></highlight>H-NMR (CDCl<highlight><subscript>3</subscript></highlight>, d): 7.90 (m, 3H), 7.75 (d, 2H), 7.40 (m, 4H), 5.19 (s, 2H), 4.63 (d, 2H), 3.59 (s, 3H), 3.02 (s, 3H), 1.58 (s, 9H). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 81 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(4-Methanesulfonyl-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid </heading>
<paragraph id="P-1156" lvl="0"><number>&lsqb;1156&rsqb;</number> The title compound was prepared according to the procedure of Example 28; MS (M&plus;1) 528.1. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 82 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;1-Methyl-2,4-dioxo-6-(2-pyridin-4-yl-ethylcarbamoyl)-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid </heading>
<paragraph id="P-1157" lvl="0"><number>&lsqb;1157&rsqb;</number> The title compound was prepared according to the procedure of Example 28; MS (M&plus;1) 465.1. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 83 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-(4-trifluoromethoxy-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1158" lvl="0"><number>&lsqb;1158&rsqb;</number> The title compound was prepared according to the procedure of Example 15; MS (M&plus;1) 520.1. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 84 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid methyl ester </heading>
<paragraph id="P-1159" lvl="0"><number>&lsqb;1159&rsqb;</number> The title compound was prepared according to the procedure of Example 15; MS (M&plus;1) 494.2. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 85 </heading>
</section>
<section>
<heading lvl="1">3-(2,3-Dihydro-benzofuran-6-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1160" lvl="0"><number>&lsqb;1160&rsqb;</number> The title compound was prepared according to the procedure of Example 28; MS (M&plus;1) 478.2. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 86 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-3-(2-methyl-thiazol-5-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1161" lvl="0"><number>&lsqb;1161&rsqb;</number> The title compound was prepared according to the procedure of Example 15; MS (M&plus;1) 457.2. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 87 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-&lsqb;4-(1H-tetrazol-5-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-fluoro-benzylamide </heading>
<paragraph id="P-1162" lvl="0"><number>&lsqb;1162&rsqb;</number> The title compound was prepared according to the procedure of Example 24; MS (M&plus;1) 492.2. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 88 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-2-methoxy-4-oxo-3,4-dihydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1163" lvl="0"><number>&lsqb;1163&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00107">
<number>107</number>
<image id="EMI-C00107" he="270.5157" wi="215.8002" file="US20030004172A1-20030102-C00107.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00107" file="US20030004172A1-20030102-C00107.CDX"/>
<chemistry-mol-file id="CHEMMOL-00107" file="US20030004172A1-20030102-C00107.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1164" lvl="0"><number>&lsqb;1164&rsqb;</number> To a solution of 3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester (550 mg, 1.27 mmol) was added Me<highlight><subscript>3</subscript></highlight>O<highlight><superscript>&plus;</superscript></highlight>BF<highlight><subscript>3</subscript></highlight><highlight><superscript>&minus; </superscript></highlight>(376 mg, 2.54 mmol). The resulting yellow suspension was stirred at room temperature for 3 days, and MeOH was added to quench the reaction. After removal of volatile solvents in vacuo, the residue was purified using flash chromatography to give the desired product as a brownish oil. M&plus;1 407.2. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 89 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid 2,2-dimethyl-propionyloxymethyl ester </heading>
<paragraph id="P-1165" lvl="0"><number>&lsqb;1165&rsqb;</number> The title compound was prepared according to the procedure of Example 68; MS (M&minus;CH<highlight><subscript>3</subscript></highlight>) 479.2. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 90 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-cyclohexanecarboxylic acid </heading>
<paragraph id="P-1166" lvl="0"><number>&lsqb;1166&rsqb;</number> The title compound was prepared according to the procedure of Example 28; MS (M&plus;1) 486.2. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 91 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-cyclohexanecarboxylic acid methyl ester </heading>
<paragraph id="P-1167" lvl="0"><number>&lsqb;1167&rsqb;</number> The title compound was prepared according to the procedure of Example 15; MS (M&plus;1) 500.1. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 92 </heading>
</section>
<section>
<heading lvl="1">1-&lcub;4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-phenyl&rcub;-cyclopropanecarboxylic acid methyl ester </heading>
<paragraph id="P-1168" lvl="0"><number>&lsqb;1168&rsqb;</number> The title compound was prepared according to the procedure of Example 15; MS (M&plus;1) 534.2. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 93 </heading>
</section>
<section>
<heading lvl="1">1-&lcub;4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-phenyl&rcub;-cyclopropanecarboxylic acid tert-butyl ester </heading>
<paragraph id="P-1169" lvl="0"><number>&lsqb;1169&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00108">
<number>108</number>
<image id="EMI-C00108" he="123.606" wi="216.027" file="US20030004172A1-20030102-C00108.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00108" file="US20030004172A1-20030102-C00108.CDX"/>
<chemistry-mol-file id="CHEMMOL-00108" file="US20030004172A1-20030102-C00108.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1170" lvl="0"><number>&lsqb;1170&rsqb;</number> To a 0&deg; C. solution of the starting carboxylic acid (2.63 g, 14.9 mmol) in cyclohexane (100 mL) was added BF<highlight><subscript>3 </subscript></highlight>etherate (0.18 mL, catalytic). White precipitate was observed. After the reaction was stirred for 1.5 hours, the reaction was then filtered, and the filtrate was purified using a flash chromatography to give the desired ester as a colorless oil. 3.13 g, 90% yield.  
<chemistry-cwu id="CHEM-US-00109">
<number>109</number>
<image id="EMI-C00109" he="118.58805" wi="216.027" file="US20030004172A1-20030102-C00109.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00109" file="US20030004172A1-20030102-C00109.CDX"/>
<chemistry-mol-file id="CHEMMOL-00109" file="US20030004172A1-20030102-C00109.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1171" lvl="0"><number>&lsqb;1171&rsqb;</number> The t-butyl ester (3.13 g, 13.5 mmol), NBS (2.88 g, 16.2 mmol), and a catalytic amount of AIBN (0.2 g) were dissolved in CCl<highlight><subscript>4 </subscript></highlight>(100 mL). The solution was refluxed for 2 hours and cooled to room temperature. After filtration of the white precipitate, the filtrate was filtered, and the filtrate was purified using a flash chromatography to give the desired ester as an oil. 4.01 g, 96% yield. MS, 267.0, 269.0; <highlight><superscript>1</superscript></highlight>H NMR (CDCl<highlight><subscript>3</subscript></highlight>): &dgr;7.35 (m, 4H), 4.49 (s, 2H), 3.62 (s, 3H), 1.60 (m, 2H), 1.18 (m, 2H), 1.00-1.60 (m, 4H). </paragraph>
<paragraph id="P-1172" lvl="7"><number>&lsqb;1172&rsqb;</number> Step (3) </paragraph>
<paragraph id="P-1173" lvl="0"><number>&lsqb;1173&rsqb;</number> The title compound was prepared according to the procedure of Example 28; <highlight><superscript>1</superscript></highlight>H-NMR (CDCl<highlight><subscript>3</subscript></highlight>): &dgr;7.67 (s, 1H), 7.40 (d, 1H), 7.22 (2H), 6.85 (d, 3H), 6.40 (t, 1H), 5.18 (s, 2H), 4.59 (d, 2H), 3.80 (s, 3H), 3.58 (s, 3H), 1.40 (s, 9H). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 94 </heading>
</section>
<section>
<heading lvl="1">1-&lcub;4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-phenyl&rcub;-cyclopropanecarboxylic acid </heading>
<paragraph id="P-1174" lvl="0"><number>&lsqb;1174&rsqb;</number> The title compound was prepared according to the procedure of Example 28; MS (M&plus;1) 520. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 95 </heading>
</section>
<section>
<heading lvl="1">2-&lcub;4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-phenoxy&rcub;-2-methyl-propionic acid tert-butyl ester </heading>
<paragraph id="P-1175" lvl="0"><number>&lsqb;1175&rsqb;</number> The title compound was prepared according to the procedure of Example 15; <highlight><superscript>1</superscript></highlight>H-NMR (CDCl<highlight><subscript>3</subscript></highlight>, d) 7.66 (s, 1H), 7.37 (d, 2H), 7.80 (m, 4H), 6.40 (t, 1H), 5.08 (s, 2H), 4.57 (d, 2H), 3.80 (s, 3H), 1.52 (s, 6H), 1.43 (s, 9H). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 96 </heading>
</section>
<section>
<heading lvl="1">2-&lcub;4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-phenoxy&rcub;-2-methyl-propionic acid </heading>
<paragraph id="P-1176" lvl="0"><number>&lsqb;1176&rsqb;</number> The title compound was prepared according to the procedure of Example 28; MS (M&plus;1) 538.2. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 97 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-furo&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1177" lvl="0"><number>&lsqb;1177&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00110">
<number>110</number>
<image id="EMI-C00110" he="250.8408" wi="215.8002" file="US20030004172A1-20030102-C00110.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00110" file="US20030004172A1-20030102-C00110.CDX"/>
<chemistry-mol-file id="CHEMMOL-00110" file="US20030004172A1-20030102-C00110.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1178" lvl="0"><number>&lsqb;1178&rsqb;</number> To a solution of the starting furano-pyrimidine-dione (265 mmg, 1.03 mmol) in THF at &minus;78&deg; C. was added LiN(TMS)<highlight><subscript>2 </subscript></highlight>(1.3 mmol). After 5 minutes, benzyl chloroformate (0.17 mL, 264 mg, 1.55 mmol) was added dropwise, and the reaction was warmed up to room temperature and quenched by aq. NH<highlight><subscript>4</subscript></highlight>Cl. Then extracted with EtOAc. The organic layer was washed with water and brine, dried over MgSO<highlight><subscript>4</subscript></highlight>. After removal of volatile solvents in vacuo, the residue was purified using flash chromatography to give the desired product as a brownish oil. M&plus;1 257.1 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 98 </heading>
</section>
<section>
<heading lvl="1">3-(3-Methoxy-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1179" lvl="0"><number>&lsqb;1179&rsqb;</number> To a 0.1 M solution of 1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester in dimethylformamide was added 60% NaH in mineral oil (1.5 mol equivalents). After stirring for 20 minutes, 1 mL (0.1 mmol) of the reaction mixture was transferred to a 8 mL screw cap vial. To this was added a solution of 1-chloromethyl-3-methoxy-benzene (0.047 g, 0.3 mmol) in dimethylformamide (1 mL). The vial was capped, and the reaction mixture was shaken for 24 hours at room temperature. The reaction mixture was filtered, and the solvent was removed under vacuum. Purification was carried out via reverse-phase HPLC (3% n-propanol in acetonitrile and 3% n-propanol in water as the eluent; C-18 column). 0.023 g (50% yield). MS-APCI: (M&plus;1)&equals;437.486. </paragraph>
<paragraph id="P-1180" lvl="0"><number>&lsqb;1180&rsqb;</number> The procedure of Example 98 was used to prepare the compounds of Examples 99 to 145. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 99 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2.3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1181" lvl="0"><number>&lsqb;1181&rsqb;</number> MS-APCI (M&plus;1) 407.4602 (The compound of Example 99 is the same as the compound of Example 147.) </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 100 </heading>
</section>
<section>
<heading lvl="1">3-Biphenyl-4-ylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1182" lvl="0"><number>&lsqb;1182&rsqb;</number> MS-APCI (M&plus;1) 483.5578 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 101 </heading>
</section>
<section>
<heading lvl="1">3-(4-Methanesulfonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1183" lvl="0"><number>&lsqb;1183&rsqb;</number> MS-APCI (M&plus;1) 485.551 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 102 </heading>
</section>
<section>
<heading lvl="1">3-(4-Methanesulfonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1184" lvl="0"><number>&lsqb;1184&rsqb;</number> MS-APCI (M&plus;1) 485.551 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 103 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-3-(4-methyl-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1185" lvl="0"><number>&lsqb;1185&rsqb;</number> MS-APCI (M&plus;1) 421.487 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 104 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-phenethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1186" lvl="0"><number>&lsqb;1186&rsqb;</number> MS-APCI (M&plus;1) 421.487 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 105 </heading>
</section>
<section>
<heading lvl="1">3(4-Amino-6-phenylamino-1,3,5-triazin-2-ylmethyl)-1-methyl-2,4-dioxo-1,2,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1187" lvl="0"><number>&lsqb;1187&rsqb;</number> MS-APCI (M&plus;1) 516.552 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 106 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-(4-trifluoromethyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1188" lvl="0"><number>&lsqb;1188&rsqb;</number> MS-APCI (M&plus;1) 475.457 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 107 </heading>
</section>
<section>
<heading lvl="1">3-(6-Cyano-hexyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1189" lvl="0"><number>&lsqb;1189&rsqb;</number> MS-APCI (M&plus;1) 426.507 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 108 </heading>
</section>
<section>
<heading lvl="1">3-&lsqb;2-(2,5-Dimethoxy-phenyl)-2-oxo-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1190" lvl="0"><number>&lsqb;1190&rsqb;</number> MS-APCI (M&plus;1) 495.522 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 109 </heading>
</section>
<section>
<heading lvl="1">3-(3-Iodo-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1191" lvl="0"><number>&lsqb;1191&rsqb;</number> MS-APCI (M&plus;1) 533.352 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 110 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-(3-trifluoromethyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1192" lvl="7"><number>&lsqb;1192&rsqb;</number> MS-APCI (M&plus;1) 475.457 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 111 </heading>
</section>
<section>
<heading lvl="1">3-(2,4-Bis-trifluoromethyl-benzyl)-1-methyl-2,4-dioxo-1.2.3.4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1193" lvl="0"><number>&lsqb;1193&rsqb;</number> MS-APCI (M&plus;1) 543.454 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 112 </heading>
</section>
<section>
<heading lvl="1">3-&lsqb;2-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1194" lvl="0"><number>&lsqb;1194&rsqb;</number> MS-APCI (M&plus;1) 490.506 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 113 </heading>
</section>
<section>
<heading lvl="1">3-&lsqb;2-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1195" lvl="0"><number>&lsqb;1195&rsqb;</number> MS-APCI (M&plus;1) 490.506 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 114 </heading>
</section>
<section>
<heading lvl="1">3-(2-Carboxy-allyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&rsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1196" lvl="0"><number>&lsqb;1196&rsqb;</number> MS-APCI (M&plus;1) 401.4094 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 115 </heading>
</section>
<section>
<heading lvl="1">3-(2-Carboxy-allyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1197" lvl="0"><number>&lsqb;1197&rsqb;</number> MS-APCI (M&plus;1) 401.4094 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 116 </heading>
</section>
<section>
<heading lvl="1">3-(3-Amino-propyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1198" lvl="0"><number>&lsqb;1198&rsqb;</number> MS-APCI (M&plus;1) 374.431 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 117 </heading>
</section>
<section>
<heading lvl="1">3-(1,3-Dioxo-1,3-dihydro-isoindol-2-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1199" lvl="0"><number>&lsqb;1199&rsqb;</number> MS-APCI (M&plus;1) 476.479 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 118 </heading>
</section>
<section>
<heading lvl="1">3-(4-Fluoro-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1200" lvl="0"><number>&lsqb;1200&rsqb;</number> MS-APCI (M&plus;1) 425.45 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 119 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-3-oxiranylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1201" lvl="0"><number>&lsqb;1201&rsqb;</number> MS-APCI (M&plus;1) 373.399 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 120 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-3-(2-methyl-butyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1202" lvl="0"><number>&lsqb;1202&rsqb;</number> MS-APCI (M&plus;1) 387.47 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 121 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-(4-phenoxy-butyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1203" lvl="0"><number>&lsqb;1203&rsqb;</number> MS-APCI (M&plus;1) 465.54 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 122 </heading>
</section>
<section>
<heading lvl="1">3-(2-Cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1204" lvl="0"><number>&lsqb;1204&rsqb;</number> MS-APCI (M&plus;1) 432.47 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 123 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-(3-phenoxy-propyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1205" lvl="0"><number>&lsqb;1205&rsqb;</number> MS-APCI (M&plus;1) 451.513 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 124 </heading>
</section>
<section>
<heading lvl="1">3-Hex-5-enyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1206" lvl="0"><number>&lsqb;1206&rsqb;</number> MS-APCI (M&plus;1) 399.481 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 125 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-pyridin-3-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1207" lvl="0"><number>&lsqb;1207&rsqb;</number> MS-APCI (M&plus;1) 408.448 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 126 </heading>
</section>
<section>
<heading lvl="1">3-&lsqb;2-Hydroxy-3-(naphthalen-1-yloxy)-propyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1208" lvl="0"><number>&lsqb;1208&rsqb;</number> MS-APCI (M&plus;1) 517.572 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 127 </heading>
</section>
<section>
<heading lvl="1">1,3-Dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1209" lvl="0"><number>&lsqb;1209&rsqb;</number> MS-APCI (M&plus;1) 331.363 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 28 </heading>
</section>
<section>
<heading lvl="1">3-Cyclobutylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1210" lvl="0"><number>&lsqb;1210&rsqb;</number> MS-APCI (M&plus;1) 385.454 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 129 </heading>
</section>
<section>
<heading lvl="1">3-Allyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1211" lvl="0"><number>&lsqb;1211&rsqb;</number> MS-APCI (M&plus;1) 357.4 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 130 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-prop-2-ynyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1212" lvl="0"><number>&lsqb;1212&rsqb;</number> MS-APCI (M&plus;1) 355.385 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 131 </heading>
</section>
<section>
<heading lvl="1">3-But-2-ynyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1213" lvl="0"><number>&lsqb;1213&rsqb;</number> MS-APCI (M&plus;1) 369.411 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 132 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-(2-phenoxy-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1214" lvl="0"><number>&lsqb;1214&rsqb;</number> MS-APCI (M&plus;1) 437.486 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 133 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-(2-phenoxy-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1215" lvl="0"><number>&lsqb;1215&rsqb;</number> MS-APCI (M&plus;1) 437.486 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 134 </heading>
</section>
<section>
<heading lvl="1">3-(3-Hydroxy-2-methyl-propyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1216" lvl="0"><number>&lsqb;1216&rsqb;</number> MS-APCI (M&plus;1) 390.442 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 135 </heading>
</section>
<section>
<heading lvl="1">3-Isobutyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1217" lvl="0"><number>&lsqb;1217&rsqb;</number> MS-APCI (M&plus;1) 373.443 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 136 </heading>
</section>
<section>
<heading lvl="1">3-(6-Chloro-pyridin-3-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1218" lvl="0"><number>&lsqb;1218&rsqb;</number> MS-APCI (M&plus;1) 442.8934 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 137 </heading>
</section>
<section>
<heading lvl="1">3-(2-Benzenesulfonylmethyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1219" lvl="0"><number>&lsqb;1219&rsqb;</number> MS-APCI (M&plus;1) 561.649 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 138 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-3-naphthalen-1-ylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1220" lvl="0"><number>&lsqb;1220&rsqb;</number> MS-APCI (M&plus;1) 457.52 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 139 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-(2-trifluoromethyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1221" lvl="0"><number>&lsqb;1221&rsqb;</number> MS-APCI (M&plus;1) 475.457 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 140 </heading>
</section>
<section>
<heading lvl="1">3-(3-Chloro-benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1222" lvl="0"><number>&lsqb;1222&rsqb;</number> MS-APCI (M&plus;1) 441.905 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 141 </heading>
</section>
<section>
<heading lvl="1">3-(4-Methoxycarboxyl-butyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1223" lvl="0"><number>&lsqb;1223&rsqb;</number> MS-APCI (M&plus;1) 431.479 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 142 </heading>
</section>
<section>
<heading lvl="1">3-Ethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1224" lvl="0"><number>&lsqb;1224&rsqb;</number> MS-APCI (M&plus;1) 345.389 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 143 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-(3-phenyl-propyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1225" lvl="0"><number>&lsqb;1225&rsqb;</number> MS-APCI (M&plus;1) 435.514 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 144 </heading>
</section>
<section>
<heading lvl="1">3-&lsqb;2-(4-Chloro-benzenesulfonyl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1226" lvl="0"><number>&lsqb;1226&rsqb;</number> MS-APCI (M&plus;1) 519.996 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 145 </heading>
</section>
<section>
<heading lvl="1">3-(2-Acetoxy-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1227" lvl="0"><number>&lsqb;1227&rsqb;</number> MS-APCI (M&plus;1) 403.425 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 146 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-phenoxyethyl ester </heading>
<paragraph id="P-1228" lvl="0"><number>&lsqb;1228&rsqb;</number> In a 8 mL screw cap vial was added a mixture of 3-benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid, (0.032 g, 0.1 mmol), triethylamine (0.024 g, 0.24 mmol), and 2-chloro-1-methylpyridinium iodine (0.031 g, 0.12 mmol) in dichloromethane (2 mL), followed by 2-phenoxy ethanol (0.015 g, 0.11 mmol) in dichloromethane (1 mL). The vial was capped, and the reaction mixture was shaken for 24 hours at room temperature. The solvent was removed under vacuum. Purification was carried out via reverse-phase HPLC (3% n-propanol in acetonitrile and 3% n-propanol in water as the eluent; C-18 column). 0.023 g (50% yield). MS-APCI (M&plus;1)&equals;437.486. </paragraph>
<paragraph id="P-1229" lvl="0"><number>&lsqb;1229&rsqb;</number> The procedure of Example 146 was used to prepare the compounds of Examples 147 to 215. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 147 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1230" lvl="0"><number>&lsqb;1230&rsqb;</number> MS-APCI (M&plus;1) 407.4602 (The compound of Example 147 is the same as the compound of Example 99). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 148 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl amide </heading>
<paragraph id="P-1231" lvl="0"><number>&lsqb;1231&rsqb;</number> MS-APCI (M&plus;1) 406.4761 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 149 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,6-dichloro-benzyl ester </heading>
<paragraph id="P-1232" lvl="0"><number>&lsqb;1232&rsqb;</number> MS-APCI (M&plus;1) 476.35 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 150 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid butyl ester </heading>
<paragraph id="P-1233" lvl="0"><number>&lsqb;1233&rsqb;</number> MS-APCI (M&plus;1) 373.443 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 151 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,3-dihydro-1,4-benzodioxin-2-ylmethyl ester </heading>
<paragraph id="P-1234" lvl="0"><number>&lsqb;1234&rsqb;</number> MS-APCI (M&plus;1) 465.496 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 152 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-diethylamino-1-methyl-ethyl ester </heading>
<paragraph id="P-1235" lvl="0"><number>&lsqb;1235&rsqb;</number> MS-APCI (M&plus;1) 430.538 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 153 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-fluoro-benzyl ester </heading>
<paragraph id="P-1236" lvl="0"><number>&lsqb;1236&rsqb;</number> MS-APCI (M&plus;1) 425.45 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 154 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-isopropyl-benzyl ester </heading>
<paragraph id="P-1237" lvl="0"><number>&lsqb;1237&rsqb;</number> MS-APCI (M&plus;1) 449.541 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 155 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-p-tolyl-ethyl ester </heading>
<paragraph id="P-1238" lvl="0"><number>&lsqb;1238&rsqb;</number> MS-APCI (M&plus;1) 435.514 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 156 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-trifluoromethyl-benzyl ester </heading>
<paragraph id="P-1239" lvl="0"><number>&lsqb;1239&rsqb;</number> MS-APCI (M&plus;1) 475.457 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 157 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cyclobutylmethyl ester </heading>
<paragraph id="P-1240" lvl="0"><number>&lsqb;1240&rsqb;</number> MS-APCI (M&plus;1) 385.454 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 158 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,6-difluoro-benzyl ester </heading>
<paragraph id="P-1241" lvl="0"><number>&lsqb;1241&rsqb;</number> MS-APCI (M&plus;1) 443.44 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 159 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-(2-hydroxy-phenyl)-ethyl ester </heading>
<paragraph id="P-1242" lvl="0"><number>&lsqb;1242&rsqb;</number> MS-APCI (M&plus;1) 437.486 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 160 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-(2-hydroxy-phenyl)-ethyl ester </heading>
<paragraph id="P-1243" lvl="0"><number>&lsqb;1243&rsqb;</number> MS-APCI (M&plus;1) 437.486 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 161 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-methyl-piperidin-4-yl ester </heading>
<paragraph id="P-1244" lvl="0"><number>&lsqb;1244&rsqb;</number> MS-APCI (M&plus;1) 414.496 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 162 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-methyl-piperidin-4-yl ester </heading>
<paragraph id="P-1245" lvl="0"><number>&lsqb;1245&rsqb;</number> MS-APCI (M&plus;1) 414.496 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 163 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-3-ylmethyl ester </heading>
<paragraph id="P-1246" lvl="0"><number>&lsqb;1246&rsqb;</number> MS-APCI (M&plus;1) 408.448 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 164 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-pyridin-3-yl-propyl ester </heading>
<paragraph id="P-1247" lvl="0"><number>&lsqb;1247&rsqb;</number> MS-APCI (M&plus;1) 436.502 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 165 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-dimethylamino-1-methyl-ethyl ester </heading>
<paragraph id="P-1248" lvl="0"><number>&lsqb;1248&rsqb;</number> MS-APCI (M&plus;1) 402.485 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 166 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzyl ester </heading>
<paragraph id="P-1249" lvl="0"><number>&lsqb;1249&rsqb;</number> MS-APCI (M&plus;1) 437.486 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 167 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid tetrahydro-pyran-4-yl ester </heading>
<paragraph id="P-1250" lvl="0"><number>&lsqb;1250&rsqb;</number> MS-APCI (M&plus;1) 401.453 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 168 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,2,2-trifluoro-1-trifluoromethyl-ethyl ester </heading>
<paragraph id="P-1251" lvl="0"><number>&lsqb;1251&rsqb;</number> MS-APCI (M&plus;1) 487.357 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 169 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-trifluoromethyl-benzyl ester </heading>
<paragraph id="P-1252" lvl="0"><number>&lsqb;1252&rsqb;</number> MS-APCI (M&plus;1) 475.457 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 170 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-benzyloxy-ethyl ester </heading>
<paragraph id="P-1253" lvl="0"><number>&lsqb;1253&rsqb;</number> MS-APCI (M&plus;1) 451.513 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 171 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,2,2-trichloro-ethyl ester </heading>
<paragraph id="P-1254" lvl="0"><number>&lsqb;1254&rsqb;</number> MS-APCI (M&plus;1) 448.725 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 172 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid phenethyl ester </heading>
<paragraph id="P-1255" lvl="0"><number>&lsqb;1255&rsqb;</number> MS-APCI (M&plus;1) 421.487 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 173 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-ethyl-oxetan-3-ylmethyl ester </heading>
<paragraph id="P-1256" lvl="0"><number>&lsqb;1256&rsqb;</number> MS-APCI (M&plus;1) 415.48 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 174 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-morpholin-4-yl-ethyl ester </heading>
<paragraph id="P-1257" lvl="0"><number>&lsqb;1257&rsqb;</number> MS-APCI (M&plus;1) 430.495 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 175 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-pyrrolidin-1-yl-ethyl ester </heading>
<paragraph id="P-1258" lvl="0"><number>&lsqb;1258&rsqb;</number> MS-APCI (M&plus;1) 414.496 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 176 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidin-6-carboxylic acid 2-pyrrolidin-1-yl-ethyl ester </heading>
<paragraph id="P-1259" lvl="0"><number>&lsqb;1259&rsqb;</number> MS-APCI (M&plus;1) 414.96 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 177 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-(2-ethoxy-ethoxy)-ethyl ester </heading>
<paragraph id="P-1260" lvl="0"><number>&lsqb;1260&rsqb;</number> MS-APCI (M&plus;1) 433.495 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 178 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid tetrahydro-pyran-2-ylmethyl ester </heading>
<paragraph id="P-1261" lvl="0"><number>&lsqb;1261&rsqb;</number> MS-APCI (M&plus;1) 415.48 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 179 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-nitro-benzyl ester </heading>
<paragraph id="P-1262" lvl="0"><number>&lsqb;1262&rsqb;</number> MS-APCI (M&plus;1) 452.457 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 180 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pentyl ester </heading>
<paragraph id="P-1263" lvl="0"><number>&lsqb;1263&rsqb;</number> MS-APCI (M&plus;1) 387.47 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 181 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-phenyl-propyl ester </heading>
<paragraph id="P-1264" lvl="0"><number>&lsqb;1264&rsqb;</number> MS-APCI (M&plus;1) 435.514 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 182 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-phenoxy-benzyl ester </heading>
<paragraph id="P-1265" lvl="0"><number>&lsqb;1265&rsqb;</number> MS-APCI (M&plus;1) 499.557 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 183 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3,5-dimethoxy-benzyl ester </heading>
<paragraph id="P-1266" lvl="0"><number>&lsqb;1266&rsqb;</number> MS-APCI (M&plus;1) 467.512 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 184 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,2-d&rsqb;pyrimidine-6-caboxylic acid 3-methyl-butyl ester </heading>
<paragraph id="P-1267" lvl="0"><number>&lsqb;1267&rsqb;</number> MS-APCI (M&plus;1) 387.47 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 185 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-chloro-benzyl ester </heading>
<paragraph id="P-1268" lvl="0"><number>&lsqb;1268&rsqb;</number> MS-APCI (M&plus;1) 441.905 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 186 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1.2.3.4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-ethyl-piperidin-3-yl ester </heading>
<paragraph id="P-1269" lvl="0"><number>&lsqb;1269&rsqb;</number> MS-APCI (M&plus;1) 428.522 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 187 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-benzyloxy-benzyl ester </heading>
<paragraph id="P-1270" lvl="0"><number>&lsqb;1270&rsqb;</number> MS-APCI (M&plus;1) 513.584 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 188 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid isobutyl ester </heading>
<paragraph id="P-1271" lvl="0"><number>&lsqb;1271&rsqb;</number> MS-APCI (M&plus;1) 373.443 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 189 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-(4-methoxy-phenyl)-propyl ester </heading>
<paragraph id="P-1272" lvl="0"><number>&lsqb;1272&rsqb;</number> MS-APCI (M&plus;1) 465.54 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 190 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-chloro-6-fluoro-benzyl ester </heading>
<paragraph id="P-1273" lvl="0"><number>&lsqb;1273&rsqb;</number> MS-APCI (M&plus;1) 459.895 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 191 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid tetrahydro-furan-3-yl ester </heading>
<paragraph id="P-1274" lvl="0"><number>&lsqb;1274&rsqb;</number> MS-APCI (M&plus;1) 387.426 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 192 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzyl ester </heading>
<paragraph id="P-1275" lvl="0"><number>&lsqb;1275&rsqb;</number> MS-APCI (M&plus;1) 437.486 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 193 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzyl ester </heading>
<paragraph id="P-1276" lvl="0"><number>&lsqb;1276&rsqb;</number> MS-APCI (M&plus;1) 437.486 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 194 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-pyridin-2-yl-propyl ester </heading>
<paragraph id="P-1277" lvl="0"><number>&lsqb;1277&rsqb;</number> MS-APCI (M&plus;1) 436.502 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 195 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-piperidin-2-yl-ethyl ester </heading>
<paragraph id="P-1278" lvl="7"><number>&lsqb;1278&rsqb;</number> MS-APCI (M&plus;1) 428.522 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 196 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 5-bromo-2-methoxy-benzyl ester </heading>
<paragraph id="P-1279" lvl="0"><number>&lsqb;1279&rsqb;</number> MS-APCI (M&plus;1) 516.382 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 197 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cycloheptylmethyl ester </heading>
<paragraph id="P-1280" lvl="0"><number>&lsqb;1280&rsqb;</number> MS-APCI (M&plus;1) 427.534 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 198 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1,2,3,4-tetrahydro-naphthalen-1-yl ester </heading>
<paragraph id="P-1281" lvl="0"><number>&lsqb;1281&rsqb;</number> MS-APCI (M&plus;1) 447.525 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 199 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyrrolidin-2-ylmethyl ester </heading>
<paragraph id="P-1282" lvl="0"><number>&lsqb;1282&rsqb;</number> MS-APCI (M&plus;1) 400.469 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 200 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-chloro-benzyl ester </heading>
<paragraph id="P-1283" lvl="0"><number>&lsqb;1283&rsqb;</number> MS-APCI (M&plus;1) 441.905 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 201 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1,3-benzodioxol-5-ylmethyl ester </heading>
<paragraph id="P-1284" lvl="0"><number>&lsqb;1284&rsqb;</number> MS-APCI (M&plus;1) 451.469 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 202 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methylsulfanyl-benzyl ester </heading>
<paragraph id="P-1285" lvl="0"><number>&lsqb;1285&rsqb;</number> MS-APCI (M&plus;1) 453.553 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 203 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methylsulfanyl-benzyl ester </heading>
<paragraph id="P-1286" lvl="0"><number>&lsqb;1286&rsqb;</number> MS-APCI (M&plus;1) 453.553 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 204 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3,4-dichloro-benzyl ester </heading>
<paragraph id="P-1287" lvl="0"><number>&lsqb;1287&rsqb;</number> MS-APCI (M&plus;1) 476.35 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 205 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3,3-diphenyl-propyl ester </heading>
<paragraph id="P-1288" lvl="0"><number>&lsqb;1288&rsqb;</number> MS-APCI (M&plus;1) 511.611 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 206 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-pyridin-2-yl-ethyl ester </heading>
<paragraph id="P-1289" lvl="0"><number>&lsqb;1289&rsqb;</number> MS-APCI (M&plus;1) 422.475 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 207 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid furan-3-ylmethyl ester </heading>
<paragraph id="P-1290" lvl="0"><number>&lsqb;1290&rsqb;</number> MS-APCI (M&plus;1) 397.421 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 208 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid but-3-enyl ester </heading>
<paragraph id="P-1291" lvl="0"><number>&lsqb;1291&rsqb;</number> MS-APCI (M&plus;1) 371.427 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 209 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-cyano-ethyl ester </heading>
<paragraph id="P-1292" lvl="0"><number>&lsqb;1292&rsqb;</number> MS-APCI (M&plus;1) 370.399 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 210 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-ethoxy-ethyl ester </heading>
<paragraph id="P-1293" lvl="0"><number>&lsqb;1293&rsqb;</number> MS-APCI (M&plus;1) 389.442 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 211 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cyano-phenyl-methyl ester </heading>
<paragraph id="P-1294" lvl="0"><number>&lsqb;1294&rsqb;</number> MS-APCI (M&plus;1) 432.47 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 212 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-trifluoromethyl-benzylamide </heading>
<paragraph id="P-1295" lvl="0"><number>&lsqb;1295&rsqb;</number> MS-APCI (M&plus;1) 474.473 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 213 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methyl-benzylamide </heading>
<paragraph id="P-1296" lvl="0"><number>&lsqb;1296&rsqb;</number> MS-APCI (M&plus;1) 420.503 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 214 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid phenethyl-amide </heading>
<paragraph id="P-1297" lvl="0"><number>&lsqb;1297&rsqb;</number> MS-APCI (M&plus;1) 420.503 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 215 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cyclopropylamide </heading>
<paragraph id="P-1298" lvl="0"><number>&lsqb;1298&rsqb;</number> MS-APCI (M&plus;1) 356.416 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 216 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1299" lvl="0"><number>&lsqb;1299&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00111">
<number>111</number>
<image id="EMI-C00111" he="191.5326" wi="216.027" file="US20030004172A1-20030102-C00111.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00111" file="US20030004172A1-20030102-C00111.CDX"/>
<chemistry-mol-file id="CHEMMOL-00111" file="US20030004172A1-20030102-C00111.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1300" lvl="0"><number>&lsqb;1300&rsqb;</number> 1-Methyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (1.0589 g, 4.681 mmol) was suspended in 50 mL methylene chloride and 50 mL THF. To this solution, 4-methyl morpholine (2,5895 g, 26.59 mmol), 1-hydroxybenzotriazole monohydrate (&ldquo;HOBT-H<highlight><subscript>2</subscript></highlight>O&rdquo;) (0.7685 g, 5,688 mmol), and 4-methoxybenzylamine (0.7848 g, 5.721 mmol) were added. Then 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (&ldquo;EDAC-HCl&rdquo;) (1.0795 g, 5.631 mmol) was added, and the reaction was stirred at room temperature overnight. The solvent was removed under vacuum, and &tilde;20 mL 5% HCl was added, stirred for approximately 30 minutes, and the product was suction filtered. The filter cake was washed with 5% HCl, then 5% NaHCO<highlight><subscript>3</subscript></highlight>, water, and dried at 40&deg; C. under vacuum, to yield 1.4877 g white solid; mp 252-254&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 217 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-(4-sulfamoyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1301" lvl="0"><number>&lsqb;1301&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00112">
<number>112</number>
<image id="EMI-C00112" he="231.87465" wi="216.027" file="US20030004172A1-20030102-C00112.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00112" file="US20030004172A1-20030102-C00112.CDX"/>
<chemistry-mol-file id="CHEMMOL-00112" file="US20030004172A1-20030102-C00112.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1302" lvl="0"><number>&lsqb;1302&rsqb;</number> 1-Methyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide (0.1484 g, 0.4297 mmol) was dissolved in 8 mL DMF, then cesium carbonate (0.2020 g, 0.62 mmol) was added and stirred at room temperature for 10 minutes. The 4-bromomethyl benzenesulfonamide (0.1084 g, 0.4334 mmol) was added and stirred at room temperature overnight. The solution was added dropwise to 70 mL of water, and the precipitate was suction filtered and dried under vacuum to give a white solid (0.1038 g). NMR (DMSO, ppm) 9.19 (1H, t, J&equals;5.9 Hz), 8.12 (1H, s), 7.75 (2H, d, J&equals;8.3 Hz), 7.47 (2H, d, J&equals;8.5 Hz), 7.32 (2H, br), 7.23 (2H, d, J&equals;8.5 Hz), 6.90 (2H, d, J&equals;8.5 Hz), 5.12 (2H, s), 4.38 (2H, d, J&equals;5.6 Hz), 3.73 (3H, s), 3.48 (3H, s). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 218 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1303" lvl="0"><number>&lsqb;1303&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00113">
<number>113</number>
<image id="EMI-C00113" he="118.58805" wi="141.60825" file="US20030004172A1-20030102-C00113.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00113" file="US20030004172A1-20030102-C00113.CDX"/>
<chemistry-mol-file id="CHEMMOL-00113" file="US20030004172A1-20030102-C00113.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1304" lvl="0"><number>&lsqb;1304&rsqb;</number> Made by the procedure of Example 216 using 3-methoxybenzyl amine; mp 279-281&deg; C., </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 219 </heading>
</section>
<section>
<heading lvl="1">1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-methoxy-pyridin-4-ylmethyl)-amide </heading>
<paragraph id="P-1305" lvl="0"><number>&lsqb;1305&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00114">
<number>114</number>
<image id="EMI-C00114" he="110.42325" wi="146.1726" file="US20030004172A1-20030102-C00114.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00114" file="US20030004172A1-20030102-C00114.CDX"/>
<chemistry-mol-file id="CHEMMOL-00114" file="US20030004172A1-20030102-C00114.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1306" lvl="0"><number>&lsqb;1306&rsqb;</number> Made by the procedure of Example 216 with 1-methyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid and 4-(aminomethyl)-2-methoxy-pyridine. NMR (DMSO) 11.58 (1H, br), 9.25 (1H, t, J&equals;6.1 Hz), 8.15-8.05 (2H, m), 6.9 (1H, m), 6.70 (1H, s), 4.42 (2H, d, J&equals;5.9 Hz), 3.83 (3H, s), 3.41 (3H, s). MS (APCI&plus;)&equals;347. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 220 </heading>
</section>
<section>
<heading lvl="1">3-&lsqb;4-(N-Hydroxycarbamimidoyl)-benzyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1307" lvl="0"><number>&lsqb;1307&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00115">
<number>115</number>
<image id="EMI-C00115" he="98.658" wi="214.0992" file="US20030004172A1-20030102-C00115.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00115" file="US20030004172A1-20030102-C00115.CDX"/>
<chemistry-mol-file id="CHEMMOL-00115" file="US20030004172A1-20030102-C00115.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1308" lvl="0"><number>&lsqb;1308&rsqb;</number> 3-(4-Cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide (3.03 g, 6.59 mmol) was suspended in 50 absolute ethanol, and hydroxylamine hydrochloride (2.17 g, 31.16 mmol) and solid potassium hydroxide (1.92 g, 34.15 mmol) were added. The solution was refluxed for 4 hours, cooled to room temperature, and the solid was filtered off, washed with cold water, and dried under vacuum to give a white solid (2.69 g). mp 226-228&deg; C. (dec.), MS (APCI&plus;)&equals;494. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 221 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-&lsqb;4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1309" lvl="0"><number>&lsqb;1309&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00116">
<number>116</number>
<image id="EMI-C00116" he="101.52135" wi="212.42655" file="US20030004172A1-20030102-C00116.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00116" file="US20030004172A1-20030102-C00116.CDX"/>
<chemistry-mol-file id="CHEMMOL-00116" file="US20030004172A1-20030102-C00116.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1310" lvl="0"><number>&lsqb;1310&rsqb;</number> 3-&lsqb;4-(N-Hydroxycarbamimidoyl)-benzyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide (0.2897 g, 0.5870 mmol) was dissolved in 5 mL DMF and cooled in an ice bath, and pyridine (dissolved in 0.5 mL DMF) was added to this solution. Then ethyl chloroformate (0.0742 g, 0.6837 mmol) dissolved in 0.5 mL DMF was added, and the reaction stirred at 0&deg; C. for 45 minutes. The reaction mixture was poured into 50 mL of water, the solid filtered off, washed with hexane, and suction dried to give a white powder, 1-methyl-2,4-dioxo-3-&lsqb;4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide (0.24 g). CHNS calculated: C, 57.80%; H, 4.07%; N, 13.58%; S, 6.17%. Found: C, 57.47%; H, 4.19%; N, 13.19%; S, 6.13%. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 222 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-&lsqb;4-(5-thioxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1311" lvl="0"><number>&lsqb;1311&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00117">
<number>117</number>
<image id="EMI-C00117" he="101.52135" wi="212.42655" file="US20030004172A1-20030102-C00117.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00117" file="US20030004172A1-20030102-C00117.CDX"/>
<chemistry-mol-file id="CHEMMOL-00117" file="US20030004172A1-20030102-C00117.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1312" lvl="0"><number>&lsqb;1312&rsqb;</number> 3-&lsqb;4-(N-Hydroxycarbamimidoyl)-benzyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide (0.2137 g, 0.4330 mmol) was suspended in 5 mL DMF, then thiocarbonyl diimidazole (0.1225 g, 0.6187 mmol) and 1,8-diazabicyclo&lsqb;5.4.0&rsqb;undec-7-ene (&ldquo;DBU&rdquo;) (0.3427 g, 2.25 mmol) were added. After stirring at room temperature for 4 hours, the solution was poured into 60 mL water and acidified to pH 5 with 5% citric acid solution. The solid was filtered, resuspended in 5% citric acid solution, and sonicated. The solid was filtered and vacuum dried to give 1-methyl-2,4-dioxo-3-&lsqb;4-(5-thioxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide (0.2511 g) as a tan powder. NMR (DMSO): 9.18 (1H, t, J&equals;5.9 Hz), 8.12, (1H, s), 7.81 (2H, d, J&equals;8.3 Hz), 7.48 (2H, d, J&equals;8.3 Hz), 7.23 (2H, d, J&equals;9.12 Hz), 6.90 (2H, d, J&equals;8.8 Hz), 5.13 (2H, s), 4.38 (2H, d, J&equals;5.9 Hz), 3.73 (3H, s), 3.49 (3H, s). MS (APCI&plus;)&equals;536. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 223 </heading>
</section>
<section>
<heading lvl="1">3-Cyanomethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1313" lvl="0"><number>&lsqb;1313&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00118">
<number>118</number>
<image id="EMI-C00118" he="73.45485" wi="193.94235" file="US20030004172A1-20030102-C00118.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00118" file="US20030004172A1-20030102-C00118.CDX"/>
<chemistry-mol-file id="CHEMMOL-00118" file="US20030004172A1-20030102-C00118.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1314" lvl="0"><number>&lsqb;1314&rsqb;</number> Made by the procedure of Example 217 with chloroacetonitrile; mp 180-183&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 224 </heading>
</section>
<section>
<heading lvl="1">3-Cyanomethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1315" lvl="0"><number>&lsqb;1315&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00119">
<number>119</number>
<image id="EMI-C00119" he="83.5191" wi="180.73125" file="US20030004172A1-20030102-C00119.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00119" file="US20030004172A1-20030102-C00119.CDX"/>
<chemistry-mol-file id="CHEMMOL-00119" file="US20030004172A1-20030102-C00119.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1316" lvl="0"><number>&lsqb;1316&rsqb;</number> Made by the procedure of Example 217 with chloroacetonitrile; mp 159-163&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 225 </heading>
</section>
<section>
<heading lvl="1">(E)-4-&lsqb;6-(4-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-yl&rsqb;-but-2-enoic acid methyl ester </heading>
<paragraph id="P-1317" lvl="0"><number>&lsqb;1317&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00120">
<number>120</number>
<image id="EMI-C00120" he="106.56765" wi="214.0992" file="US20030004172A1-20030102-C00120.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00120" file="US20030004172A1-20030102-C00120.CDX"/>
<chemistry-mol-file id="CHEMMOL-00120" file="US20030004172A1-20030102-C00120.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1318" lvl="0"><number>&lsqb;1318&rsqb;</number> Made by the procedure of Example 217 with methyl 4-bromocrotonate; mp 169-171&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 226 </heading>
</section>
<section>
<heading lvl="1">(E)-4-&lsqb;6-(4-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-yl&rsqb;-but-2-enoic acid </heading>
<paragraph id="P-1319" lvl="0"><number>&lsqb;1319&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00121">
<number>121</number>
<image id="EMI-C00121" he="106.56765" wi="207.38025" file="US20030004172A1-20030102-C00121.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00121" file="US20030004172A1-20030102-C00121.CDX"/>
<chemistry-mol-file id="CHEMMOL-00121" file="US20030004172A1-20030102-C00121.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1320" lvl="0"><number>&lsqb;1320&rsqb;</number> (E)-4-&lsqb;6-(4-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3yl&rsqb;-but-2-enoic acid (0.053 g, 0.1195 mmol) was dissolved in 5 mL methanol and 5 mL water with potassium carbonate (0.0264 g, 0.191 mmol) and heated to reflux for 4 hours. The reaction was cooled to room temperature, and the solution concentrated to approximately 5 mL. The solution was acidified with 5% HCl, and the white precipitate was filtered and dried under vacuum. NMR (DMSO, ppm): 9.17 (1H, t, J&equals;6.1 Hz), 8.11 (1H, s), 7.23 (2H, d, J&equals;8.5 Hz), 6.91 (2H, d), 6.8 (1H, m), 5.76 (1H, m), 4.62 (2H, m), 4.37 (2H, d, J&equals;5.9 Hz), 3.72 (3H, s), 3.48 (3H, s). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 227 </heading>
</section>
<section>
<heading lvl="1">3-(2-Benzenesulfonyl-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1321" lvl="0"><number>&lsqb;1321&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00122">
<number>122</number>
<image id="EMI-C00122" he="106.56765" wi="213.61725" file="US20030004172A1-20030102-C00122.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00122" file="US20030004172A1-20030102-C00122.CDX"/>
<chemistry-mol-file id="CHEMMOL-00122" file="US20030004172A1-20030102-C00122.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1322" lvl="0"><number>&lsqb;1322&rsqb;</number> Made by the procedure of Example 217 with (2-chloro-ethanesulfonyl)-benzene; mp 118-121&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 228 </heading>
</section>
<section>
<heading lvl="1">2-Methoxy-4-&lsqb;6-(4-methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid methyl ester </heading>
<paragraph id="P-1323" lvl="0"><number>&lsqb;1323&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00123">
<number>123</number>
<image id="EMI-C00123" he="96.7302" wi="212.65335" file="US20030004172A1-20030102-C00123.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00123" file="US20030004172A1-20030102-C00123.CDX"/>
<chemistry-mol-file id="CHEMMOL-00123" file="US20030004172A1-20030102-C00123.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1324" lvl="0"><number>&lsqb;1324&rsqb;</number> Made by the procedure of Example 217 with methyl 4-bromomethyl-2-methoxybenzoate; mp 201-203&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 229 </heading>
</section>
<section>
<heading lvl="1">3-(2-Methoxymethyl-1,1,3-trioxo-2,3-dihydro-1H-1l<highlight><superscript>6</superscript></highlight>l -1,2-benzisothiazol-6-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1325" lvl="0"><number>&lsqb;1325&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00124">
<number>124</number>
<image id="EMI-C00124" he="91.20195" wi="212.65335" file="US20030004172A1-20030102-C00124.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00124" file="US20030004172A1-20030102-C00124.CDX"/>
<chemistry-mol-file id="CHEMMOL-00124" file="US20030004172A1-20030102-C00124.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1326" lvl="0"><number>&lsqb;1326&rsqb;</number> Made by the procedure of Example 217 with 6-bromomethyl-(2-methoxymethyl-1,1,3-trioxo-2,3-dihydro-1H-1l<highlight><superscript>6</superscript></highlight>-1,2-benzisothiazole. NMR (DMSO) 9.22 (1H, m), 8.3-7.9 (4H, m), 7.24 (2H, d, J&equals;8.88 Hz), 6.9 (2H, d, J&equals;8.5 Hz), 5.27 (2H, s), 5.15 (2H, s), 4.37 (2H, m), 3.73 (3H, s), 3.51 (3H, s), 3.35 (3H, s). MS (APCI&minus;)&equals;583. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 230 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-3-oct-2-ynyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1327" lvl="0"><number>&lsqb;1327&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00125">
<number>125</number>
<image id="EMI-C00125" he="106.56765" wi="197.316" file="US20030004172A1-20030102-C00125.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00125" file="US20030004172A1-20030102-C00125.CDX"/>
<chemistry-mol-file id="CHEMMOL-00125" file="US20030004172A1-20030102-C00125.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1328" lvl="0"><number>&lsqb;1328&rsqb;</number> Made by the procedure of Example 217 with 1-bromo-2-octyne. NMR (DMSO): 9.18 (1H, t, J&equals;6.1 Hz), 8.11 (1H, s), 7.24, (2H, d, J&equals;8.5), 6.90 (2H, d, J&equals;8.5), 4.58 (2H, s), 4.38 (2H, d, J&equals;5.9 Hz), 3.73 (3H, s), 3.49 (3H, s), 2.13 (2H, m), 1.45-1.2 (6H, m), 0.83 (3H, m). MS (APCI&plus;)&equals;454. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 231 </heading>
</section>
<section>
<heading lvl="1">3-&lsqb;2-(4-Chloro-benzenesulfonylamino)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1329" lvl="0"><number>&lsqb;1329&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00126">
<number>126</number>
<image id="EMI-C00126" he="78.0192" wi="212.65335" file="US20030004172A1-20030102-C00126.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00126" file="US20030004172A1-20030102-C00126.CDX"/>
<chemistry-mol-file id="CHEMMOL-00126" file="US20030004172A1-20030102-C00126.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1330" lvl="0"><number>&lsqb;1330&rsqb;</number> Made by the procedure of Example 217 with 1-chloro-2-(4-chloro-benzenesulfonylamino)-ethane. NMR (DMSO): 9.16 (1H, t, J&equals;5.9 Hz), 8.04 (1H, s), 7.71 (2H, d), 7.60 (2H, d), 7.24 (2H, d), 6.90 (2H, d), 4.37 (2H, d), 3.91 (2H, t), 3.73 (3H, s), 3.44 (s), 3.06 (2H, t). MS (APCI&plus;)&equals;563. </paragraph>
<paragraph id="P-1331" lvl="0"><number>&lsqb;1331&rsqb;</number> EXAMPLE 231a  
<chemistry-cwu id="CHEM-US-00127">
<number>127</number>
<image id="EMI-C00127" he="133.9254" wi="215.54505" file="US20030004172A1-20030102-C00127.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00127" file="US20030004172A1-20030102-C00127.CDX"/>
<chemistry-mol-file id="CHEMMOL-00127" file="US20030004172A1-20030102-C00127.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1332" lvl="0"><number>&lsqb;1332&rsqb;</number> 1-Methyl-2,4-dioxo-3-(4-sulfamoyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide (0.1031 g, 0.2002 mmol) was dissolved in 2 mL N,N-dimethylformamide (&ldquo;DMF&rdquo;), cooled in an ice bath, and sodium hydride (60% in oil, 0.019 g, 0.8041 mmol) was added, and stirred at 0&deg; for 1 hour. Then n-butyl isocyanate (0.0273 g, 0.2752 mmol) was added and stirred for 2 hours. The reaction mixture was added dropwise to 25 mL of water, and the pH was adjusted to 4 with 5% citric acid solution. The mixture was extracted twice with ethyl acetate, and once with chloroform. The combined organic extracts were washed with water, then brine, and dried over magnesium sulfate. The solution was filtered, and the solvent removed to give a solid that was triturated with ethyl acetate. The solid was collected by filtration and suction dried to give a white solid (0.0691 g) NMR (DMSO): 10.35 (1H, s), 9.24 (1H, t), 8.15 (1H, s), 7.81 (2H, d), 7.50 (2H, d), 7.24 (1H, m), 6.9-6.8 (3H, m), 6.43 (1H, m), 5.14 (2H, s), 4.43 (2H, d), 3.73 (3H, s), 3.49 (3H, s), 2.9 (2H, m), 1.4-1.1 (4H, m), 0.8 (3H, m). CHNS (calculated): C, 54.80%; H, 5.09%; N, 11.41%; S, 10.45%. Found: C, 54.29%; H5.06%; N, 11.40%; S, 10.69%; water 0.64%. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 232 </heading>
</section>
<section>
<heading lvl="1">3-&lsqb;2-(4-Bromo-phenoxy)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1333" lvl="0"><number>&lsqb;1333&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00128">
<number>128</number>
<image id="EMI-C00128" he="97.43895" wi="211.9446" file="US20030004172A1-20030102-C00128.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00128" file="US20030004172A1-20030102-C00128.CDX"/>
<chemistry-mol-file id="CHEMMOL-00128" file="US20030004172A1-20030102-C00128.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1334" lvl="0"><number>&lsqb;1334&rsqb;</number> Made by the procedure of Example 217 with 1-methyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide and 1-bromo-2-(2-chloro-ethoxy)benzene; mp 184-185&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 233 </heading>
</section>
<section>
<heading lvl="1">3-&lsqb;2-(4-Bromo-phenoxy)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1335" lvl="0"><number>&lsqb;1335&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00129">
<number>129</number>
<image id="EMI-C00129" he="120.2607" wi="211.7178" file="US20030004172A1-20030102-C00129.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00129" file="US20030004172A1-20030102-C00129.CDX"/>
<chemistry-mol-file id="CHEMMOL-00129" file="US20030004172A1-20030102-C00129.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1336" lvl="0"><number>&lsqb;1336&rsqb;</number> Made by the procedure of Example 217 from 1-methyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide and 1-bromo-4-(2-chloro-ethoxy)benzene; mp 165-167&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 234 </heading>
</section>
<section>
<heading lvl="1">3-&lsqb;2-(4-Fluoro-phenoxy)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1337" lvl="0"><number>&lsqb;1337&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00130">
<number>130</number>
<image id="EMI-C00130" he="98.8848" wi="211.9446" file="US20030004172A1-20030102-C00130.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00130" file="US20030004172A1-20030102-C00130.CDX"/>
<chemistry-mol-file id="CHEMMOL-00130" file="US20030004172A1-20030102-C00130.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1338" lvl="0"><number>&lsqb;1338&rsqb;</number> Made by the procedure of Example 217 from 1-methyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide and 1-fluoro-4-(2-chloro-ethoxy)benzene; mp 170-171&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 235 </heading>
</section>
<section>
<heading lvl="1">3-(2-aminoethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1339" lvl="0"><number>&lsqb;1339&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00131">
<number>131</number>
<image id="EMI-C00131" he="110.1681" wi="189.63315" file="US20030004172A1-20030102-C00131.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00131" file="US20030004172A1-20030102-C00131.CDX"/>
<chemistry-mol-file id="CHEMMOL-00131" file="US20030004172A1-20030102-C00131.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1340" lvl="0"><number>&lsqb;1340&rsqb;</number> 3-Cyanomethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide (1.95 g) was dissolved in 95 mL tetrahydrofuran (&ldquo;THF&rdquo;) with 5 mL triethylamine, and 0.45 Raney Ni catalyst added. The reaction was placed under a hydrogen atmosphere (50 psi) and shaken for 39 hours. The catalyst was filtered off, and the solvent removed to give a white solid. NMR (DMSO): 9.15 (1H, t, J&equals;5.6), 8.09 (1H, s), 7.23 (2H, d, J&equals;8.5 Hz), 6.90 (2H, d, J&equals;8.5 Hz), 4.37 (2H, d, J&equals;5.9 Hz), 3.88 (2H, t, J&equals;6.4 Hz), 3.73 (3H, s), 4.47 (3H, s), 2.7 (2H, t, J&equals;6.8 Hz). MS (APCI&plus;)&equals;389. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 236 </heading>
</section>
<section>
<heading lvl="1">3-&lsqb;2-(4-fluoro-phenoxy)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1341" lvl="0"><number>&lsqb;1341&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00132">
<number>132</number>
<image id="EMI-C00132" he="122.89725" wi="213.39045" file="US20030004172A1-20030102-C00132.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00132" file="US20030004172A1-20030102-C00132.CDX"/>
<chemistry-mol-file id="CHEMMOL-00132" file="US20030004172A1-20030102-C00132.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1342" lvl="0"><number>&lsqb;1342&rsqb;</number> Made by the procedure of Example 217 from 1-methyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide and 1-fluoro-4-(2-chloro-ethoxy)benzene. NMR (DMSO): 9.21 (1H, t, J&equals;5.9 Hz), 8.13 (1H, s), 7.3-6.8 (8H, m), 4.5-4.1 (6H, m), 3.74 (3H, s), 3.49 (3H, s). MS (APCI&plus;)&equals;484. CHNS calculated: C, 59.62%; H, 4.59%; N, 8.69%; S, 6.63%. F, 3.93%. Found: C, 59.71%; H, 4.61%; N, 8.62%; S, 6.69%; F, 4.03%. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 237 </heading>
</section>
<section>
<heading lvl="1">3-&lsqb;2-(4-chloro-phenoxy)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1343" lvl="0"><number>&lsqb;1343&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00133">
<number>133</number>
<image id="EMI-C00133" he="121.2246" wi="213.1353" file="US20030004172A1-20030102-C00133.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00133" file="US20030004172A1-20030102-C00133.CDX"/>
<chemistry-mol-file id="CHEMMOL-00133" file="US20030004172A1-20030102-C00133.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1344" lvl="0"><number>&lsqb;1344&rsqb;</number> Made by the procedure of Example 217 from 1-methyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide and 4-(2-bromo-ethoxy)-1-chlorobenzene; mp 109-112&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 238 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(4-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-2-methyl-benzoic acid methyl ester </heading>
<paragraph id="P-1345" lvl="0"><number>&lsqb;1345&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00134">
<number>134</number>
<image id="EMI-C00134" he="64.09935" wi="212.9085" file="US20030004172A1-20030102-C00134.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00134" file="US20030004172A1-20030102-C00134.CDX"/>
<chemistry-mol-file id="CHEMMOL-00134" file="US20030004172A1-20030102-C00134.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1346" lvl="0"><number>&lsqb;1346&rsqb;</number> Made by the procedure of Example 217 with 4-bromomethyl-2-methylbenzoic acid methyl ester; mp 179-181&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 239 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(4-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid methyl ester </heading>
<paragraph id="P-1347" lvl="0"><number>&lsqb;1347&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00135">
<number>135</number>
<image id="EMI-C00135" he="64.09935" wi="210.9807" file="US20030004172A1-20030102-C00135.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00135" file="US20030004172A1-20030102-C00135.CDX"/>
<chemistry-mol-file id="CHEMMOL-00135" file="US20030004172A1-20030102-C00135.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1348" lvl="0"><number>&lsqb;1348&rsqb;</number> Made by the procedure of Example 217 with 4-bromomethyl benzoic acid methyl ester; mp 235-237&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 240 </heading>
</section>
<section>
<heading lvl="1">2-Methoxy-4-&lsqb;6-(3-methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid methyl ester </heading>
<paragraph id="P-1349" lvl="0"><number>&lsqb;1349&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00136">
<number>136</number>
<image id="EMI-C00136" he="79.91865" wi="212.19975" file="US20030004172A1-20030102-C00136.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00136" file="US20030004172A1-20030102-C00136.CDX"/>
<chemistry-mol-file id="CHEMMOL-00136" file="US20030004172A1-20030102-C00136.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1350" lvl="0"><number>&lsqb;1350&rsqb;</number> Made by the procedure of Example 217 with 4-bromomethyl-2-methoxy-benzoic acid methyl ester; mp 200-203&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 241 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-2-methyl-benzoic acid methyl ester </heading>
<paragraph id="P-1351" lvl="0"><number>&lsqb;1351&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00137">
<number>137</number>
<image id="EMI-C00137" he="79.91865" wi="212.19975" file="US20030004172A1-20030102-C00137.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00137" file="US20030004172A1-20030102-C00137.CDX"/>
<chemistry-mol-file id="CHEMMOL-00137" file="US20030004172A1-20030102-C00137.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1352" lvl="0"><number>&lsqb;1352&rsqb;</number> Made by the procedure of Example 217 with 4-bromomethyl-2-methyl-benzoic acid methyl ester; mp 175-177&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 242 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-(3-oxo-3-phenyl-propyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1353" lvl="0"><number>&lsqb;1353&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00138">
<number>138</number>
<image id="EMI-C00138" he="56.4165" wi="211.7178" file="US20030004172A1-20030102-C00138.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00138" file="US20030004172A1-20030102-C00138.CDX"/>
<chemistry-mol-file id="CHEMMOL-00138" file="US20030004172A1-20030102-C00138.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1354" lvl="0"><number>&lsqb;1354&rsqb;</number> Made by the procedure of Example 217 with 3-chloro-1-phenyl-propan-1-one; mp. 208-211&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 243 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-(3-oxo-3-phenyl-propyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1355" lvl="0"><number>&lsqb;1355&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00139">
<number>139</number>
<image id="EMI-C00139" he="84.00105" wi="204.5169" file="US20030004172A1-20030102-C00139.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00139" file="US20030004172A1-20030102-C00139.CDX"/>
<chemistry-mol-file id="CHEMMOL-00139" file="US20030004172A1-20030102-C00139.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1356" lvl="0"><number>&lsqb;1356&rsqb;</number> Made by the procedure of Example 217 with 3-chloro-1-phenyl-propan-1-one; mp 188-191&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 244 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-&lsqb;2-(3-trifluoromethyl-benzenesulfonyl)-ethyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1357" lvl="0"><number>&lsqb;1357&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00140">
<number>140</number>
<image id="EMI-C00140" he="72.9729" wi="212.9085" file="US20030004172A1-20030102-C00140.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00140" file="US20030004172A1-20030102-C00140.CDX"/>
<chemistry-mol-file id="CHEMMOL-00140" file="US20030004172A1-20030102-C00140.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1358" lvl="0"><number>&lsqb;1358&rsqb;</number> Made by the procedure of Example 217 with (2-chloro-ethanesulfanyl)-3-trifluoromethyl benzene; mp 203-205&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 245 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-&lsqb;2-(3-trifluoromethyl-benzenesulfonyl)-ethyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1359" lvl="0"><number>&lsqb;1359&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00141">
<number>141</number>
<image id="EMI-C00141" he="53.298" wi="208.5993" file="US20030004172A1-20030102-C00141.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00141" file="US20030004172A1-20030102-C00141.CDX"/>
<chemistry-mol-file id="CHEMMOL-00141" file="US20030004172A1-20030102-C00141.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1360" lvl="0"><number>&lsqb;1360&rsqb;</number> Made by the procedure of Example 217 with (2-chloro-ethanesulfanyl)-3-trifluoromethyl benzene; mp 222-225&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 246 </heading>
</section>
<section>
<heading lvl="1">3-&lsqb;2-(4-Chloro-benzenesulfonyl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1361" lvl="0"><number>&lsqb;1361&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00142">
<number>142</number>
<image id="EMI-C00142" he="87.85665" wi="215.8002" file="US20030004172A1-20030102-C00142.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00142" file="US20030004172A1-20030102-C00142.CDX"/>
<chemistry-mol-file id="CHEMMOL-00142" file="US20030004172A1-20030102-C00142.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1362" lvl="0"><number>&lsqb;1362&rsqb;</number> Made by the procedure of Example 217 with 4-(2-chloro-ethanesulfanyl)-chlorobenzene; mp 186-190&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 247 </heading>
</section>
<section>
<heading lvl="1">3-&lsqb;2-(4-Chloro-benzenesulfonyl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1363" lvl="0"><number>&lsqb;1363&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00143">
<number>143</number>
<image id="EMI-C00143" he="78.72795" wi="215.54505" file="US20030004172A1-20030102-C00143.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00143" file="US20030004172A1-20030102-C00143.CDX"/>
<chemistry-mol-file id="CHEMMOL-00143" file="US20030004172A1-20030102-C00143.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1364" lvl="0"><number>&lsqb;1364&rsqb;</number> Made by the procedure of Example 217 with 4-(2-chloro-ethanesulfanyl)-chlorobenzene; mp 222-225&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 248 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid </heading>
<paragraph id="P-1365" lvl="0"><number>&lsqb;1365&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00144">
<number>144</number>
<image id="EMI-C00144" he="98.40285" wi="81.1377" file="US20030004172A1-20030102-C00144.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00144" file="US20030004172A1-20030102-C00144.CDX"/>
<chemistry-mol-file id="CHEMMOL-00144" file="US20030004172A1-20030102-C00144.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1366" lvl="0"><number>&lsqb;1366&rsqb;</number> 1-Methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester (1.70 g, 5.387 mmol) was stirred with anhydrous HBr/acetic acid for 3 days at room temperature. An equal volume of water was added, and the solid was filtered off and dried under vacuum to give 1.06 g white solid. MS (APCI&minus;) 225. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 249 </heading>
<paragraph id="P-1367" lvl="0"><number>&lsqb;1367&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00145">
<number>145</number>
<image id="EMI-C00145" he="106.34085" wi="153.62865" file="US20030004172A1-20030102-C00145.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00145" file="US20030004172A1-20030102-C00145.CDX"/>
<chemistry-mol-file id="CHEMMOL-00145" file="US20030004172A1-20030102-C00145.MOL"/>
</chemistry-cwu>
</paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 249a </heading>
<paragraph id="P-1368" lvl="0"><number>&lsqb;1368&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00146">
<number>146</number>
<image id="EMI-C00146" he="92.421" wi="159.12855" file="US20030004172A1-20030102-C00146.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00146" file="US20030004172A1-20030102-C00146.CDX"/>
<chemistry-mol-file id="CHEMMOL-00146" file="US20030004172A1-20030102-C00146.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1369" lvl="0"><number>&lsqb;1369&rsqb;</number> 4-&lsqb;6-(4-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-2-methyl-benzoic acid methyl ester (0.1543 g, 0.304 mmol) was stirred with 5 mL anhydrous HBr/acetic acid for 2 days at room temperature. The solution was added dropwise to 50 mL water, and the solid filtered off. The solid was purified by column chromatography to give Example 249 &lsqb;MS (APCI&plus;) 374&rsqb; and Example 249a &lsqb;MS (APCI&plus;) 388&rsqb;. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 250 </heading>
</section>
<section>
<heading lvl="1">4-&lsqb;6-(3-hydroxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-2-methyl-benzoic acid </heading>
<paragraph id="P-1370" lvl="0"><number>&lsqb;1370&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00147">
<number>147</number>
<image id="EMI-C00147" he="125.05185" wi="193.2336" file="US20030004172A1-20030102-C00147.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00147" file="US20030004172A1-20030102-C00147.CDX"/>
<chemistry-mol-file id="CHEMMOL-00147" file="US20030004172A1-20030102-C00147.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1371" lvl="0"><number>&lsqb;1371&rsqb;</number> 4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-2-methyl-benzoic acid methyl ester (0.2489 g, 0.4903 mmol) was stirred with 5 mL anhydrous HBr/acetic acid for 3 days at room temperature. The solution was added dropwise to 50 mL of 5% hydrochloric acid and stirred 1 hour. The solid was filtered off and suction dried. The process was repeated, and the resulting solid was purified by column chromatography to give 4-&lsqb;6-(3-hydroxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-2-methyl-benzoic acid. MS (APCI&plus;) 480. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 251 </heading>
<paragraph id="P-1372" lvl="0"><number>&lsqb;1372&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00148">
<number>148</number>
<image id="EMI-C00148" he="108.49545" wi="155.78325" file="US20030004172A1-20030102-C00148.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00148" file="US20030004172A1-20030102-C00148.CDX"/>
<chemistry-mol-file id="CHEMMOL-00148" file="US20030004172A1-20030102-C00148.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1373" lvl="0"><number>&lsqb;1373&rsqb;</number> This was made analogously to Example 249. MS (APCI&minus;) 374. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 252 </heading>
</section>
<section>
<heading lvl="1">3-(2-Aminoethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1374" lvl="0"><number>&lsqb;1374&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00149">
<number>149</number>
<image id="EMI-C00149" he="83.5191" wi="188.1873" file="US20030004172A1-20030102-C00149.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00149" file="US20030004172A1-20030102-C00149.CDX"/>
<chemistry-mol-file id="CHEMMOL-00149" file="US20030004172A1-20030102-C00149.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1375" lvl="0"><number>&lsqb;1375&rsqb;</number> 3-Cyanomethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide (4.3 g, 11.19 mmol) was reduced with Raney Nickel in THF under hydrogen. The catalyst was filtered off, and the solvent removed under vacuum to give the product as a white solid. MS (APCI&plus;) 389. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 252a </heading>
<paragraph id="P-1376" lvl="0"><number>&lsqb;1376&rsqb;</number> In a 8 mL screw cap vial was added a solution of the compound of Example 216 (0.034 g, 0.1 mmol) in dimethylformamide (1 mL), a solution of 3-chloro-1-(Z)-phenyl-propan-1-one(0.039 g, 0.23 mmol) in dimethylformamide (575 mL) and anhydrous cesium carbonate(0.075 g, 0.023 mmol). The vial was capped, and the reaction mixture was shaken for 24 hours at room temperature. The reaction mixture was filtered, and the solvent was removed under vacuum. Purification was carried out via reverse-phase HPLC (3% n-propanol in acetonitrile and 3% n-propanol in water as the eluent; C-18 column). 0.012 g 30% yield). MS-APCI (M&plus;1) 478.1. </paragraph>
<paragraph id="P-1377" lvl="0"><number>&lsqb;1377&rsqb;</number> In a manner similar to the procedure of Example 252a, the following invention compounds were prepared:  
<table-cwu id="TABLE-US-00001">
<number>1</number>
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="1" colwidth="35PT" align="center"/>
<colspec colname="2" colwidth="294PT" align="center"/>
<colspec colname="3" colwidth="63PT" align="center"/>
<thead>
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="3" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Example</entry>
<entry></entry>
<entry></entry>
</row>
<row>
<entry>No.</entry>
<entry>Structure</entry>
<entry>APCI MS (M &plus; 1)</entry>
</row>
<row><entry namest="1" nameend="3" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry></entry>
<entry></entry>
</row>
<row>
<entry>253</entry>
<entry>
<chemistry-cwu id="CHEM-US-00150">
<number>150</number>
<image id="EMI-C00150" he="114.0237" wi="203.29785" file="US20030004172A1-20030102-C00150.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00150" file="US20030004172A1-20030102-C00150.CDX"/>
<chemistry-mol-file id="CHEMMOL-00150" file="US20030004172A1-20030102-C00150.MOL"/>
</chemistry-cwu>
</entry>
<entry>450.5287</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>254</entry>
<entry>
<chemistry-cwu id="CHEM-US-00151">
<number>151</number>
<image id="EMI-C00151" he="71.0451" wi="263.5416" file="US20030004172A1-20030102-C00151.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00151" file="US20030004172A1-20030102-C00151.CDX"/>
<chemistry-mol-file id="CHEMMOL-00151" file="US20030004172A1-20030102-C00151.MOL"/>
</chemistry-cwu>
</entry>
<entry>478.5387</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>255</entry>
<entry>
<chemistry-cwu id="CHEM-US-00152">
<number>152</number>
<image id="EMI-C00152" he="186.0327" wi="226.1196" file="US20030004172A1-20030102-C00152.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00152" file="US20030004172A1-20030102-C00152.CDX"/>
<chemistry-mol-file id="CHEMMOL-00152" file="US20030004172A1-20030102-C00152.MOL"/>
</chemistry-cwu>
</entry>
<entry>484.6297</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>256</entry>
<entry>
<chemistry-cwu id="CHEM-US-00153">
<number>153</number>
<image id="EMI-C00153" he="112.0959" wi="240.03945" file="US20030004172A1-20030102-C00153.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00153" file="US20030004172A1-20030102-C00153.CDX"/>
<chemistry-mol-file id="CHEMMOL-00153" file="US20030004172A1-20030102-C00153.MOL"/>
</chemistry-cwu>
</entry>
<entry>458.5919</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>257</entry>
<entry>
<chemistry-cwu id="CHEM-US-00154">
<number>154</number>
<image id="EMI-C00154" he="112.3227" wi="246.7584" file="US20030004172A1-20030102-C00154.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00154" file="US20030004172A1-20030102-C00154.CDX"/>
<chemistry-mol-file id="CHEMMOL-00154" file="US20030004172A1-20030102-C00154.MOL"/>
</chemistry-cwu>
</entry>
<entry>441.5216</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>258</entry>
<entry>
<chemistry-cwu id="CHEM-US-00155">
<number>155</number>
<image id="EMI-C00155" he="112.3227" wi="212.42655" file="US20030004172A1-20030102-C00155.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00155" file="US20030004172A1-20030102-C00155.CDX"/>
<chemistry-mol-file id="CHEMMOL-00155" file="US20030004172A1-20030102-C00155.MOL"/>
</chemistry-cwu>
</entry>
<entry>400.4689</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>259</entry>
<entry>
<chemistry-cwu id="CHEM-US-00156">
<number>156</number>
<image id="EMI-C00156" he="118.58805" wi="230.91075" file="US20030004172A1-20030102-C00156.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00156" file="US20030004172A1-20030102-C00156.CDX"/>
<chemistry-mol-file id="CHEMMOL-00156" file="US20030004172A1-20030102-C00156.MOL"/>
</chemistry-cwu>
</entry>
<entry>500.5885</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>260</entry>
<entry>
<chemistry-cwu id="CHEM-US-00157">
<number>157</number>
<image id="EMI-C00157" he="146.1726" wi="198.5067" file="US20030004172A1-20030102-C00157.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00157" file="US20030004172A1-20030102-C00157.CDX"/>
<chemistry-mol-file id="CHEMMOL-00157" file="US20030004172A1-20030102-C00157.MOL"/>
</chemistry-cwu>
</entry>
<entry>414.4957</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>261</entry>
<entry>
<chemistry-cwu id="CHEM-US-00158">
<number>158</number>
<image id="EMI-C00158" he="112.3227" wi="230.91075" file="US20030004172A1-20030102-C00158.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00158" file="US20030004172A1-20030102-C00158.CDX"/>
<chemistry-mol-file id="CHEMMOL-00158" file="US20030004172A1-20030102-C00158.MOL"/>
</chemistry-cwu>
</entry>
<entry>482.5947</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>262</entry>
<entry>
<chemistry-cwu id="CHEM-US-00159">
<number>159</number>
<image id="EMI-C00159" he="114.0237" wi="198.5067" file="US20030004172A1-20030102-C00159.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00159" file="US20030004172A1-20030102-C00159.CDX"/>
<chemistry-mol-file id="CHEMMOL-00159" file="US20030004172A1-20030102-C00159.MOL"/>
</chemistry-cwu>
</entry>
<entry>402.4847</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>263</entry>
<entry>
<chemistry-cwu id="CHEM-US-00160">
<number>160</number>
<image id="EMI-C00160" he="112.3227" wi="198.5067" file="US20030004172A1-20030102-C00160.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00160" file="US20030004172A1-20030102-C00160.CDX"/>
<chemistry-mol-file id="CHEMMOL-00160" file="US20030004172A1-20030102-C00160.MOL"/>
</chemistry-cwu>
</entry>
<entry>400.4689</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>264</entry>
<entry>
<chemistry-cwu id="CHEM-US-00161">
<number>161</number>
<image id="EMI-C00161" he="121.93335" wi="184.58685" file="US20030004172A1-20030102-C00161.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00161" file="US20030004172A1-20030102-C00161.CDX"/>
<chemistry-mol-file id="CHEMMOL-00161" file="US20030004172A1-20030102-C00161.MOL"/>
</chemistry-cwu>
</entry>
<entry>416.5115</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>265</entry>
<entry>
<chemistry-cwu id="CHEM-US-00162">
<number>162</number>
<image id="EMI-C00162" he="112.3227" wi="212.42655" file="US20030004172A1-20030102-C00162.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00162" file="US20030004172A1-20030102-C00162.CDX"/>
<chemistry-mol-file id="CHEMMOL-00162" file="US20030004172A1-20030102-C00162.MOL"/>
</chemistry-cwu>
</entry>
<entry>412.4799</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>266</entry>
<entry>
<chemistry-cwu id="CHEM-US-00163">
<number>163</number>
<image id="EMI-C00163" he="108.49545" wi="233.3205" file="US20030004172A1-20030102-C00163.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00163" file="US20030004172A1-20030102-C00163.CDX"/>
<chemistry-mol-file id="CHEMMOL-00163" file="US20030004172A1-20030102-C00163.MOL"/>
</chemistry-cwu>
</entry>
<entry>514.5927</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>267</entry>
<entry>
<chemistry-cwu id="CHEM-US-00164">
<number>164</number>
<image id="EMI-C00164" he="138.0078" wi="198.5067" file="US20030004172A1-20030102-C00164.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00164" file="US20030004172A1-20030102-C00164.CDX"/>
<chemistry-mol-file id="CHEMMOL-00164" file="US20030004172A1-20030102-C00164.MOL"/>
</chemistry-cwu>
</entry>
<entry>414.4957</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>268</entry>
<entry>
<chemistry-cwu id="CHEM-US-00165">
<number>165</number>
<image id="EMI-C00165" he="112.3227" wi="246.0213" file="US20030004172A1-20030102-C00165.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00165" file="US20030004172A1-20030102-C00165.CDX"/>
<chemistry-mol-file id="CHEMMOL-00165" file="US20030004172A1-20030102-C00165.MOL"/>
</chemistry-cwu>
</entry>
<entry>532.5828</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>269</entry>
<entry>
<chemistry-cwu id="CHEM-US-00166">
<number>166</number>
<image id="EMI-C00166" he="112.3227" wi="246.27645" file="US20030004172A1-20030102-C00166.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00166" file="US20030004172A1-20030102-C00166.CDX"/>
<chemistry-mol-file id="CHEMMOL-00166" file="US20030004172A1-20030102-C00166.MOL"/>
</chemistry-cwu>
</entry>
<entry>528.6195</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>270</entry>
<entry>
<chemistry-cwu id="CHEM-US-00167">
<number>167</number>
<image id="EMI-C00167" he="112.3227" wi="246.0213" file="US20030004172A1-20030102-C00167.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00167" file="US20030004172A1-20030102-C00167.CDX"/>
<chemistry-mol-file id="CHEMMOL-00167" file="US20030004172A1-20030102-C00167.MOL"/>
</chemistry-cwu>
</entry>
<entry>496.5288</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>271</entry>
<entry>
<chemistry-cwu id="CHEM-US-00168">
<number>168</number>
<image id="EMI-C00168" he="112.3227" wi="248.43105" file="US20030004172A1-20030102-C00168.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00168" file="US20030004172A1-20030102-C00168.CDX"/>
<chemistry-mol-file id="CHEMMOL-00168" file="US20030004172A1-20030102-C00168.MOL"/>
</chemistry-cwu>
</entry>
<entry>512.9838</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>272</entry>
<entry>
<chemistry-cwu id="CHEM-US-00169">
<number>169</number>
<image id="EMI-C00169" he="166.32945" wi="216.9909" file="US20030004172A1-20030102-C00169.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00169" file="US20030004172A1-20030102-C00169.CDX"/>
<chemistry-mol-file id="CHEMMOL-00169" file="US20030004172A1-20030102-C00169.MOL"/>
</chemistry-cwu>
</entry>
<entry>493.5536</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>273</entry>
<entry>
<chemistry-cwu id="CHEM-US-00170">
<number>170</number>
<image id="EMI-C00170" he="108.2403" wi="252.0315" file="US20030004172A1-20030102-C00170.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00170" file="US20030004172A1-20030102-C00170.CDX"/>
<chemistry-mol-file id="CHEMMOL-00170" file="US20030004172A1-20030102-C00170.MOL"/>
</chemistry-cwu>
</entry>
<entry>545.4238</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>274</entry>
<entry>
<chemistry-cwu id="CHEM-US-00171">
<number>171</number>
<image id="EMI-C00171" he="112.3227" wi="229.72005" file="US20030004172A1-20030102-C00171.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00171" file="US20030004172A1-20030102-C00171.CDX"/>
<chemistry-mol-file id="CHEMMOL-00171" file="US20030004172A1-20030102-C00171.MOL"/>
</chemistry-cwu>
</entry>
<entry>478.4991</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>275</entry>
<entry>
<chemistry-cwu id="CHEM-US-00172">
<number>172</number>
<image id="EMI-C00172" he="112.3227" wi="230.91075" file="US20030004172A1-20030102-C00172.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00172" file="US20030004172A1-20030102-C00172.CDX"/>
<chemistry-mol-file id="CHEMMOL-00172" file="US20030004172A1-20030102-C00172.MOL"/>
</chemistry-cwu>
</entry>
<entry>466.5277</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>276</entry>
<entry>
<chemistry-cwu id="CHEM-US-00173">
<number>173</number>
<image id="EMI-C00173" he="112.0959" wi="257.3046" file="US20030004172A1-20030102-C00173.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00173" file="US20030004172A1-20030102-C00173.CDX"/>
<chemistry-mol-file id="CHEMMOL-00173" file="US20030004172A1-20030102-C00173.MOL"/>
</chemistry-cwu>
</entry>
<entry>500.5019</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>277</entry>
<entry>
<chemistry-cwu id="CHEM-US-00174">
<number>174</number>
<image id="EMI-C00174" he="158.193" wi="286.36335" file="US20030004172A1-20030102-C00174.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00174" file="US20030004172A1-20030102-C00174.CDX"/>
<chemistry-mol-file id="CHEMMOL-00174" file="US20030004172A1-20030102-C00174.MOL"/>
</chemistry-cwu>
</entry>
<entry>665.7324</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>278</entry>
<entry>
<chemistry-cwu id="CHEM-US-00175">
<number>175</number>
<image id="EMI-C00175" he="110.42325" wi="240.26625" file="US20030004172A1-20030102-C00175.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00175" file="US20030004172A1-20030102-C00175.CDX"/>
<chemistry-mol-file id="CHEMMOL-00175" file="US20030004172A1-20030102-C00175.MOL"/>
</chemistry-cwu>
</entry>
<entry>517.0398</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>279</entry>
<entry>
<chemistry-cwu id="CHEM-US-00176">
<number>176</number>
<image id="EMI-C00176" he="112.0959" wi="195.13305" file="US20030004172A1-20030102-C00176.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00176" file="US20030004172A1-20030102-C00176.CDX"/>
<chemistry-mol-file id="CHEMMOL-00176" file="US20030004172A1-20030102-C00176.MOL"/>
</chemistry-cwu>
</entry>
<entry>450.5287</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>280</entry>
<entry>
<chemistry-cwu id="CHEM-US-00177">
<number>177</number>
<image id="EMI-C00177" he="184.1049" wi="218.1816" file="US20030004172A1-20030102-C00177.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00177" file="US20030004172A1-20030102-C00177.CDX"/>
<chemistry-mol-file id="CHEMMOL-00177" file="US20030004172A1-20030102-C00177.MOL"/>
</chemistry-cwu>
</entry>
<entry>484.6297</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>281</entry>
<entry>
<chemistry-cwu id="CHEM-US-00178">
<number>178</number>
<image id="EMI-C00178" he="110.42325" wi="232.10145" file="US20030004172A1-20030102-C00178.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00178" file="US20030004172A1-20030102-C00178.CDX"/>
<chemistry-mol-file id="CHEMMOL-00178" file="US20030004172A1-20030102-C00178.MOL"/>
</chemistry-cwu>
</entry>
<entry>458.5919</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>282</entry>
<entry>
<chemistry-cwu id="CHEM-US-00179">
<number>179</number>
<image id="EMI-C00179" he="169.9299" wi="201.3984" file="US20030004172A1-20030102-C00179.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00179" file="US20030004172A1-20030102-C00179.CDX"/>
<chemistry-mol-file id="CHEMMOL-00179" file="US20030004172A1-20030102-C00179.MOL"/>
</chemistry-cwu>
</entry>
<entry>528.6195</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>283</entry>
<entry>
<chemistry-cwu id="CHEM-US-00180">
<number>180</number>
<image id="EMI-C00180" he="110.42325" wi="238.5936" file="US20030004172A1-20030102-C00180.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00180" file="US20030004172A1-20030102-C00180.CDX"/>
<chemistry-mol-file id="CHEMMOL-00180" file="US20030004172A1-20030102-C00180.MOL"/>
</chemistry-cwu>
</entry>
<entry>441.5216</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>284</entry>
<entry>
<chemistry-cwu id="CHEM-US-00181">
<number>181</number>
<image id="EMI-C00181" he="110.42325" wi="204.26175" file="US20030004172A1-20030102-C00181.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00181" file="US20030004172A1-20030102-C00181.CDX"/>
<chemistry-mol-file id="CHEMMOL-00181" file="US20030004172A1-20030102-C00181.MOL"/>
</chemistry-cwu>
</entry>
<entry>400.4689</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>285</entry>
<entry>
<chemistry-cwu id="CHEM-US-00182">
<number>182</number>
<image id="EMI-C00182" he="116.66025" wi="223.0011" file="US20030004172A1-20030102-C00182.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00182" file="US20030004172A1-20030102-C00182.CDX"/>
<chemistry-mol-file id="CHEMMOL-00182" file="US20030004172A1-20030102-C00182.MOL"/>
</chemistry-cwu>
</entry>
<entry>500.5885</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>286</entry>
<entry>
<chemistry-cwu id="CHEM-US-00183">
<number>183</number>
<image id="EMI-C00183" he="144.018" wi="190.59705" file="US20030004172A1-20030102-C00183.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00183" file="US20030004172A1-20030102-C00183.CDX"/>
<chemistry-mol-file id="CHEMMOL-00183" file="US20030004172A1-20030102-C00183.MOL"/>
</chemistry-cwu>
</entry>
<entry>414.4957</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>287</entry>
<entry>
<chemistry-cwu id="CHEM-US-00184">
<number>184</number>
<image id="EMI-C00184" he="110.42325" wi="223.0011" file="US20030004172A1-20030102-C00184.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00184" file="US20030004172A1-20030102-C00184.CDX"/>
<chemistry-mol-file id="CHEMMOL-00184" file="US20030004172A1-20030102-C00184.MOL"/>
</chemistry-cwu>
</entry>
<entry>482.5947</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>288</entry>
<entry>
<chemistry-cwu id="CHEM-US-00185">
<number>185</number>
<image id="EMI-C00185" he="112.0959" wi="190.59705" file="US20030004172A1-20030102-C00185.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00185" file="US20030004172A1-20030102-C00185.CDX"/>
<chemistry-mol-file id="CHEMMOL-00185" file="US20030004172A1-20030102-C00185.MOL"/>
</chemistry-cwu>
</entry>
<entry>402.4847</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>289</entry>
<entry>
<chemistry-cwu id="CHEM-US-00186">
<number>186</number>
<image id="EMI-C00186" he="110.42325" wi="190.59705" file="US20030004172A1-20030102-C00186.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00186" file="US20030004172A1-20030102-C00186.CDX"/>
<chemistry-mol-file id="CHEMMOL-00186" file="US20030004172A1-20030102-C00186.MOL"/>
</chemistry-cwu>
</entry>
<entry>400.4689</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>290</entry>
<entry>
<chemistry-cwu id="CHEM-US-00187">
<number>187</number>
<image id="EMI-C00187" he="120.00555" wi="176.64885" file="US20030004172A1-20030102-C00187.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00187" file="US20030004172A1-20030102-C00187.CDX"/>
<chemistry-mol-file id="CHEMMOL-00187" file="US20030004172A1-20030102-C00187.MOL"/>
</chemistry-cwu>
</entry>
<entry>416.5115</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>291</entry>
<entry>
<chemistry-cwu id="CHEM-US-00188">
<number>188</number>
<image id="EMI-C00188" he="110.42325" wi="204.26175" file="US20030004172A1-20030102-C00188.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00188" file="US20030004172A1-20030102-C00188.CDX"/>
<chemistry-mol-file id="CHEMMOL-00188" file="US20030004172A1-20030102-C00188.MOL"/>
</chemistry-cwu>
</entry>
<entry>412.4799</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>292</entry>
<entry>
<chemistry-cwu id="CHEM-US-00189">
<number>189</number>
<image id="EMI-C00189" he="136.10835" wi="190.59705" file="US20030004172A1-20030102-C00189.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00189" file="US20030004172A1-20030102-C00189.CDX"/>
<chemistry-mol-file id="CHEMMOL-00189" file="US20030004172A1-20030102-C00189.MOL"/>
</chemistry-cwu>
</entry>
<entry>414.4957</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>293</entry>
<entry>
<chemistry-cwu id="CHEM-US-00190">
<number>190</number>
<image id="EMI-C00190" he="110.42325" wi="238.33845" file="US20030004172A1-20030102-C00190.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00190" file="US20030004172A1-20030102-C00190.CDX"/>
<chemistry-mol-file id="CHEMMOL-00190" file="US20030004172A1-20030102-C00190.MOL"/>
</chemistry-cwu>
</entry>
<entry>528.6195</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>294</entry>
<entry>
<chemistry-cwu id="CHEM-US-00191">
<number>191</number>
<image id="EMI-C00191" he="164.6568" wi="209.0529" file="US20030004172A1-20030102-C00191.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00191" file="US20030004172A1-20030102-C00191.CDX"/>
<chemistry-mol-file id="CHEMMOL-00191" file="US20030004172A1-20030102-C00191.MOL"/>
</chemistry-cwu>
</entry>
<entry>493.5536</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>295</entry>
<entry>
<chemistry-cwu id="CHEM-US-00192">
<number>192</number>
<image id="EMI-C00192" he="122.1885" wi="227.05515" file="US20030004172A1-20030102-C00192.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00192" file="US20030004172A1-20030102-C00192.CDX"/>
<chemistry-mol-file id="CHEMMOL-00192" file="US20030004172A1-20030102-C00192.MOL"/>
</chemistry-cwu>
</entry>
<entry>545.4238</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>296</entry>
<entry>
<chemistry-cwu id="CHEM-US-00193">
<number>193</number>
<image id="EMI-C00193" he="110.42325" wi="221.55525" file="US20030004172A1-20030102-C00193.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00193" file="US20030004172A1-20030102-C00193.CDX"/>
<chemistry-mol-file id="CHEMMOL-00193" file="US20030004172A1-20030102-C00193.MOL"/>
</chemistry-cwu>
</entry>
<entry>478.4991</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>297</entry>
<entry>
<chemistry-cwu id="CHEM-US-00194">
<number>194</number>
<image id="EMI-C00194" he="110.42325" wi="223.0011" file="US20030004172A1-20030102-C00194.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00194" file="US20030004172A1-20030102-C00194.CDX"/>
<chemistry-mol-file id="CHEMMOL-00194" file="US20030004172A1-20030102-C00194.MOL"/>
</chemistry-cwu>
</entry>
<entry>466.5277</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>298</entry>
<entry>
<chemistry-cwu id="CHEM-US-00195">
<number>195</number>
<image id="EMI-C00195" he="110.42325" wi="249.1398" file="US20030004172A1-20030102-C00195.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00195" file="US20030004172A1-20030102-C00195.CDX"/>
<chemistry-mol-file id="CHEMMOL-00195" file="US20030004172A1-20030102-C00195.MOL"/>
</chemistry-cwu>
</entry>
<entry>500.5019</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>299</entry>
<entry>
<chemistry-cwu id="CHEM-US-00196">
<number>196</number>
<image id="EMI-C00196" he="156.2652" wi="278.42535" file="US20030004172A1-20030102-C00196.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00196" file="US20030004172A1-20030102-C00196.CDX"/>
<chemistry-mol-file id="CHEMMOL-00196" file="US20030004172A1-20030102-C00196.MOL"/>
</chemistry-cwu>
</entry>
<entry>665.7324</entry>
</row>
<row><entry namest="1" nameend="3" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-1378" lvl="0"><number>&lsqb;1378&rsqb;</number> Also prepared by the methods exemplified above are the compounds of 300 to 386. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 300 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid methyl ester made by the procedure of Example 97 </heading>
<paragraph id="P-1379" lvl="0"><number>&lsqb;1379&rsqb;</number> MS-APCI (M&plus;1) 331.2. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 301 </heading>
</section>
<section>
<heading lvl="1">3-(4-Bromo-benzyl)-5-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1380" lvl="0"><number>&lsqb;1380&rsqb;</number> To a solution of 5-amino-3-methyl-thiophene-2,4-dicarboxylic acid 2-benzyl ester 4-ethyl ester (0.5 g, 1.57 mmol) in dioxane (50 mL), was added sodium hydride (42 mg, 1.72 mmol). 1-bromo-4-isocyanatomethyl-benzene (0.332 g, 1.57 mmol) was added 5 minutes later. The reaction mixture was stirred at room temperature for 1 hour. The reaction mixture was chromatographed using 2:1 hexane:ethyl acetate to yield 82 mg of title compound as a white solid (11%); MS-APCI (M&plus;) 487. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 302 </heading>
</section>
<section>
<heading lvl="1">3-(4-Fluoro-benzyl)-5-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1381" lvl="0"><number>&lsqb;1381&rsqb;</number> The procedure of Example 74 was repeated, except 1-bromo-4-isocyanatomethyl-benzene was replaced by 1-fluoro-4-isocyanatomethyl-benzene to give 3-(4-fluoro-benzyl)-5-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester as a white solid (13%); MS-APCI (M&plus;) 425. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 303 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-4-ylmethyl ester </heading>
</section>
<section>
<heading lvl="1">EXAMPLE 304 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzo&lsqb;b&rsqb;thiophen-2-ylmethyl ester </heading>
<paragraph id="P-1382" lvl="0"><number>&lsqb;1382&rsqb;</number> The procedure of Example 48 was repeated, except and benzofuran-2-yl-methanol was replaced by benzothiophene-2-yl-methanol to give 3-benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzo&lsqb;b&rsqb;thiophene-2-ylmethyl ester as a white solid (54%); <highlight><superscript>1</superscript></highlight>H NMR (CDCl<highlight><subscript>3</subscript></highlight>), &dgr;3.50 (S, 3H), 5.19 (s, 2H), 5.58 (s, 2H), 7.21-7.38 (m, 6H), 7.49 (d, J&equals;8.7 Hz, 2H), 7.74-7.82 (m, 2H), 8.11 (s, 1H). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 305 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-methyl-1H-indol-5-ylmethyl ester </heading>
<paragraph id="P-1383" lvl="0"><number>&lsqb;1383&rsqb;</number> The procedure of Example 48 was repeated, except and benzofuran-2-yl-methanol was replaced by (1-methyl-1H-indol-5-yl)-methanol to give 3-benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-methyl-1H-indo-5-ylmethyl ester as a white solid (59%); <highlight><superscript>1</superscript></highlight>H NMR (CDCl<highlight><subscript>3</subscript></highlight>), &dgr;3.51 (s, 3H), 3.80 (s, 3H), 5.17 (s, 2H), 5.43 (s, 2H), 6.50 (d, J&equals;3.2 Hz, 1H), 7.08 (d, J&equals;3.1 Hz, 1H), 7.22-7.34 (m, 5 H), 7.49 (m, 2H), 7.70 (s, 1H), 8.06 (s, 1H). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 306 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid thiophen-3-ylmethyl ester </heading>
<paragraph id="P-1384" lvl="0"><number>&lsqb;1384&rsqb;</number> The procedure of Example 1 was repeated, except that benzyl alcohol was replaced by thiophene-2-ylmethanol to provide 3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid thiophen-3-ylmethyl ester as a white powder (19%); MS-APCI (M&plus;) 400. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 307 </heading>
</section>
<section>
<heading lvl="1">3-1,3-Benzodioxol-5-ylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1385" lvl="0"><number>&lsqb;1385&rsqb;</number> The procedure of Example 15 was repeated, except 3-bromomethyl-benzoic acid methyl ester was replaced by 5-bromoethyl-benzo&lsqb;1,3&rsqb;dioxole. The crude product was chromatographed using 2:1 hexane/ethyl acetate to 100% ethyl acetate to give 3-1,3-benzodioxol-5-ylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester as a white solid (40%); MS-APCI (M&plus;) 451. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 308 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-pyridin-4-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1386" lvl="0"><number>&lsqb;1386&rsqb;</number> The procedure of Example 15 was repeated, except 3-bromomethyl-benzoic acid methyl ester was replaced by 4-bromomethyl pyridine. The crude product was chromatographed using 2:1 hexane:ethyl acetate to 100% ethyl acetate to give 1-methyl-2,4-dioxo-3-pyridin-4-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester as a white solid (49%); MS-APCI (M&plus;) 408. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 309 </heading>
</section>
<section>
<heading lvl="1">3-(4-tert-Butyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1387" lvl="0"><number>&lsqb;1387&rsqb;</number> The procedure of Example 15 was repeated, except 3-bromomethyl-benzoic acid methyl ester was replaced by 1-bromomethyl-4-tert-butyl-benzene. The crude product was chromatographed using 2:1 hexane/ethyl acetate to 100% ethyl acetate to give 3-(4-tert-butyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester as a white solid (63%); MS-APCI (M&plus;) 463. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 310 </heading>
</section>
<section>
<heading lvl="1">3-(3,4-Dichloro-benzyl)-5-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1388" lvl="0"><number>&lsqb;1388&rsqb;</number> The procedure of Example 74 was repeated, except 1-bromo-4-isocyanatomethyl-benzene was replaced by 1,2-dichloro-4-isocyanatomethyl-benzene to give 3-(3,4-dichloro-benzyl)-5-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester as a white solid (19%); MS-APCI (M&plus;) 475. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 311 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-(4-trifluoromethoxy-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1389" lvl="0"><number>&lsqb;1389&rsqb;</number> The procedure of Example 15 was repeated, except 3-bromomethyl-benzoic acid methyl ester was replaced by 1-bromomethyl-4-trifluoromethoxy-benzene. The crude product was chromatographed using 2:1 hexane/ethyl acetate to 100% ethyl acetate to give 1-methyl-2,4-dioxo-3-(4-trifluoromethoxy-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester as a white solid (50%); MS-APCI (M&plus;) 491. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 312 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-3-naphthalen-2-ylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1390" lvl="0"><number>&lsqb;1390&rsqb;</number> The procedure of Example 15 was repeated, except 3-bromomethyl-benzoic acid methyl ester was replaced by 2-bromomethyl naphthalene. The crude product was chromatographed using 2:1 hexane/ethyl acetate to 100% ethyl acetate to give 1-methyl-3-naphthalen-1-ylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester as a white solid (72%); MS-APCI (M&plus;) 457. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 313 </heading>
</section>
<section>
<heading lvl="1">3-(4-Cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1391" lvl="0"><number>&lsqb;1391&rsqb;</number> The procedure of Example 15 was repeated, except 3-bromomethyl-benzoic acid methyl ester was replaced by 4-bromomethyl-benzonitrile. The crude product was chromatographed using 2:1 hexane/ethyl acetate to 100% ethyl acetate to give 3-(4-cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester as a white solid (80%); MS-APCI (M&plus;) 432. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 314 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzofuran-5-ylmethyl ester </heading>
<paragraph id="P-1392" lvl="0"><number>&lsqb;1392&rsqb;</number> The procedure of Example 1 was repeated, except that benzyl alcohol was replaced by benzofuran-5-yl-methanol to provide 3-benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzofuran-5-ylmethyl ester as a white powder (24%); MS-APCI (M&plus;) 447. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 315 </heading>
</section>
<section>
<heading lvl="1">3-(3,5-Dimethoxy-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1393" lvl="0"><number>&lsqb;1393&rsqb;</number> The procedure of Example 15 was repeated, except 3-bromomethyl-benzoic acid methyl ester was replaced by 1-chloromethyl-3,5-dimethoxy-benzene. The crude product was chromatographed using 2:1 hexane/ethyl acetate to 100% ethyl acetate to give 3-(3,5-dimethoxy-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester as a white solid (52%); MS-APCI (M&plus;) 467. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 316 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
</section>
<section>
<heading lvl="1">EXAMPLE 317 </heading>
</section>
<section>
<heading lvl="1">3-(3,5-Dinitro-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1394" lvl="0"><number>&lsqb;1394&rsqb;</number> The procedure of Example 15 was repeated, except 3-bromomethyl-benzoic acid methyl ester was replaced by 1-chloromethyl-3,5-dinitro-benzene. The crude product was chromatographed using 2:1 hexane/ethyl acetate to 100% ethyl acetate to give 3-(3,5-dinitro-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester as a white solid (10%); MS-APCI (M&plus;) 501. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 318 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid </heading>
<paragraph id="P-1395" lvl="0"><number>&lsqb;1395&rsqb;</number> To a solution of 3-benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid ethyl ester (5.0 g, 14.5 mmol) in 90% THF/10% water, was added 5.0 g of LiOH. The solution was stirred at room temperature for 5 hours, then poured into 400 mL of 1:1 ethyl acetate/water, and acidified with hydrochloric acid until the pH is acidic. The organic layer was dried over magnesium sulfate and concentrated. The residue was triturated with 4:1 hexane/ethyl acetate to yield 2.8 g (62%) of the title compound as a white solid; MS-APCI (M&plus;) 317. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 319 </heading>
</section>
<section>
<heading lvl="1">3-(4-Carboxy-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-ethoxy-benzyl ester </heading>
<paragraph id="P-1396" lvl="0"><number>&lsqb;1396&rsqb;</number> The procedure of Examples 53 and 54 were repeated, 3,4-dimethoxy benzyl amine was replaced by 2-ethoxy benzylamine, to give 4-&lsqb;6-(2-ethoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid as a white solid (20%); MS-APCI (M&plus;) 494. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 320 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(3,4-dimethoxy-phenyl)-ethyl&rsqb;-amide </heading>
<paragraph id="P-1397" lvl="0"><number>&lsqb;1397&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00197">
<number>197</number>
<image id="EMI-C00197" he="156.2652" wi="216.027" file="US20030004172A1-20030102-C00197.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00197" file="US20030004172A1-20030102-C00197.CDX"/>
<chemistry-mol-file id="CHEMMOL-00197" file="US20030004172A1-20030102-C00197.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1398" lvl="0"><number>&lsqb;1398&rsqb;</number> In a 8-mL screw cap vial was added a mixture of the compound of Example 318, namely 3-benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid, (0.032 g, 0.1 mmol), triethylamine (0.024g, 0.24 mmol), and 2-chloro-1-methylpyridinium iodide (0.031 g, 0.12 mmol) in dichloromethane (2 mL) followed by 3,4-methoxyethyl amine,(0.020 g, 0. 11 mmol) in dichloromethane (1 mL). The vial was capped, and the reaction mixture was shaken for 24 hours at room temperature. The solvent was removed under vacuum. Purification was carried out via reverse-phase HPLC (3% n-propanol in acetonitrile and 3% n-propanol in water as the eluent; C-18 column). 0.023 g (50% yield). MS-APCI (M&plus;1): 480.5. </paragraph>
<paragraph id="P-1399" lvl="0"><number>&lsqb;1399&rsqb;</number> In a manner similar to the procedure of Example 320, the compounds of Examples 321 to 363 were prepared. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 321 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-amino-benzylamide </heading>
<paragraph id="P-1400" lvl="0"><number>&lsqb;1400&rsqb;</number> MS APCI (M&plus;1): 421.491. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 322 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(4-chloro-phenyl)-ethyl&rsqb;-amide </heading>
<paragraph id="P-1401" lvl="0"><number>&lsqb;1401&rsqb;</number> MS APCI (M&plus;1): 454.948. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 323 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (biphenyl-2-ylmethyl)-amide </heading>
<paragraph id="P-1402" lvl="0"><number>&lsqb;1402&rsqb;</number> MS APCI (M&plus;1): 482.5737. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 324 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3,4-dimethoxy-benzylamide </heading>
<paragraph id="P-1403" lvl="0"><number>&lsqb;1403&rsqb;</number> MS APCI (M&plus;1): 466.5277. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 325 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-pyridin-4-yl-ethyl)-amide </heading>
<paragraph id="P-1404" lvl="0"><number>&lsqb;1404&rsqb;</number> MS APCI (M&plus;1): 421.491. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 326 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-difluoromethoxy-benzylamide </heading>
<paragraph id="P-1405" lvl="0"><number>&lsqb;1405&rsqb;</number> MS APCI (M&plus;1): 472.4821. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 327 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(3-ethoxy-phenyl)-ethyl&rsqb;-amide </heading>
<paragraph id="P-1406" lvl="0"><number>&lsqb;1406&rsqb;</number> MS APCI (M&plus;1): 464.5555. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 328 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-chloro-4-fluoro-benzylamide </heading>
<paragraph id="P-1407" lvl="0"><number>&lsqb;1407&rsqb;</number> MS APCI (M&plus;1): 458.9113. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 329 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,4-dichloro-benzylamide </heading>
<paragraph id="P-1408" lvl="0"><number>&lsqb;1408&rsqb;</number> MS APCI (M&plus;1): 475.3663. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 330 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-phenyl-propyl)-amide </heading>
<paragraph id="P-1409" lvl="0"><number>&lsqb;1409&rsqb;</number> MS APCI (M&plus;1): 434.5297. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 331 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3,4,5-trimethoxy-benzylamide </heading>
<paragraph id="P-1410" lvl="0"><number>&lsqb;1410&rsqb;</number> MS APCI (M&plus;1): 496.5535. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 332 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-chloro-benzylamide </heading>
<paragraph id="P-1411" lvl="0"><number>&lsqb;1411&rsqb;</number> MS APCI (M&plus;1): 440.9212. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 333 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3,5-dimethoxy-benzylamide </heading>
<paragraph id="P-1412" lvl="0"><number>&lsqb;1412&rsqb;</number> MS APCI (M&plus;1): 466.5277 </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 334 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,3-dimethoxy-benzylamide </heading>
<paragraph id="P-1413" lvl="0"><number>&lsqb;1413&rsqb;</number> MS APCI (M&plus;1): 466.5277. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 335 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-trifluoromethyl-benzylamide </heading>
<paragraph id="P-1414" lvl="0"><number>&lsqb;1414&rsqb;</number> MS APCI (M&plus;1): MS APCI (M&plus;1): 474.4732. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 336 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-methoxy-benzylamide </heading>
<paragraph id="P-1415" lvl="0"><number>&lsqb;1415&rsqb;</number> MS APCI (M&plus;1): 436.5019. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 337 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-methyl-benzylamide </heading>
<paragraph id="P-1416" lvl="0"><number>&lsqb;1416&rsqb;</number> MS APCI (M&plus;1): 420.5029. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 338 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (4-phenyl-butyl)-amide </heading>
<paragraph id="P-1417" lvl="0"><number>&lsqb;1417&rsqb;</number> MS APCI (M&plus;1): 448.5565. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 339 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (pyridin-3-ylmethyl)-amide </heading>
<paragraph id="P-1418" lvl="0"><number>&lsqb;1418&rsqb;</number> MS APCI (M&plus;1): 407.4642. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 340 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1419" lvl="0"><number>&lsqb;1419&rsqb;</number> MS APCI (M&plus;1): 436.5019. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 341 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid ((S)-2,2-dimethyl-4-phenyl-1,3-dioxinan-5-yl)-amide </heading>
<paragraph id="P-1420" lvl="0"><number>&lsqb;1420&rsqb;</number> MS APCI (M&plus;1): 405.5923. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 342 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(3-methoxy-phenyl)-ethyl&rsqb;-amide </heading>
<paragraph id="P-1421" lvl="0"><number>&lsqb;1421&rsqb;</number> MS APCI (M&plus;1): 450.5287. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 343 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1422" lvl="0"><number>&lsqb;1422&rsqb;</number> MS APCI (M&plus;1): 436.5019. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 344 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (thiophen-2-ylmethyl)-amide </heading>
<paragraph id="P-1423" lvl="0"><number>&lsqb;1423&rsqb;</number> MS APCI (M&plus;1): 412.5043. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 345 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-chloro-benzylamide </heading>
<paragraph id="P-1424" lvl="0"><number>&lsqb;1424&rsqb;</number> MS APCI (M&plus;1): 440.9212. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 346 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (5-methyl-furan-2-ylmethyl)-amide </heading>
<paragraph id="P-1425" lvl="0"><number>&lsqb;1425&rsqb;</number> MS APCI (M&plus;1): 410.4641. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 347 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2,2-diphenyl-ethyl)-amide </heading>
<paragraph id="P-1426" lvl="0"><number>&lsqb;1426&rsqb;</number> MS APCI (M&plus;1): 496.6005. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 348 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(2-methoxy-phenyl)-ethyl&rsqb;-amide </heading>
<paragraph id="P-1427" lvl="0"><number>&lsqb;1427&rsqb;</number> MS APCI (M&plus;1): 450.5287. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 349 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(3-trifluoromethyl-phenyl)-ethyl&rsqb;-amide </heading>
<paragraph id="P-1428" lvl="0"><number>&lsqb;1428&rsqb;</number> MS APCI (M&plus;1): 488.5. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 350 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-bromo-benzylamide </heading>
<paragraph id="P-1429" lvl="0"><number>&lsqb;1429&rsqb;</number> MS APCI (M&plus;1): 485.3722. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 351 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(1H-indol-3-yl)-ethyl&rsqb;-amide </heading>
<paragraph id="P-1430" lvl="0"><number>&lsqb;1430&rsqb;</number> MS APCI (M&plus;1): 459.5398. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 352 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3 ,5-dichloro-benzylamide </heading>
<paragraph id="P-1431" lvl="0"><number>&lsqb;1431&rsqb;</number> MS APCI (M&plus;1): 475.3663. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 353 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid indan-1-ylamide </heading>
<paragraph id="P-1432" lvl="0"><number>&lsqb;1432&rsqb;</number> MS APCI (M&plus;1): 432.5139. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 354 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (furan-2-ylmethyl)-amide </heading>
<paragraph id="P-1433" lvl="0"><number>&lsqb;1433&rsqb;</number> MS APCI (M&plus;1): 396.4373. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 355 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(4-methoxy-phenyl)-ethyl&rsqb;-amide </heading>
<paragraph id="P-1434" lvl="0"><number>&lsqb;1434&rsqb;</number> MS APCI (M&plus;1): 450.5287. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 356 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,4-dimethoxy-benzylamide </heading>
<paragraph id="P-1435" lvl="0"><number>&lsqb;1435&rsqb;</number> MS APCI (M&plus;1): 466.5277. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 357 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-chloro-benzylamide </heading>
<paragraph id="P-1436" lvl="0"><number>&lsqb;1436&rsqb;</number> MS APCI (M&plus;1): 440.9212. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 358 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (1-phenyl-ethyl)-amide </heading>
<paragraph id="P-1437" lvl="0"><number>&lsqb;1437&rsqb;</number> MS APCI (M&plus;1): 420.5029. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 359 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3,4-dichloro-benzylamide </heading>
<paragraph id="P-1438" lvl="0"><number>&lsqb;1438&rsqb;</number> MS APCI (M&plus;1): 475.3663. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 360 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-fluoro-3-trifluoromethyl-benzylamide </heading>
<paragraph id="P-1439" lvl="0"><number>&lsqb;1439&rsqb;</number> MS APCI (M&plus;1): 492.4633. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 361 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-pyridin-2-yl-ethyl)-amide </heading>
<paragraph id="P-1440" lvl="0"><number>&lsqb;1440&rsqb;</number> MS APCI (M&plus;1): 421.491. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 362 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(2,4-dimethyl-phenyl)-ethyl&rsqb;-amide </heading>
<paragraph id="P-1441" lvl="0"><number>&lsqb;1441&rsqb;</number> MS APCI (M&plus;1): 448.5565. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 363 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(2,4-dichloro-phenyl)-ethyl&rsqb;-amide </heading>
<paragraph id="P-1442" lvl="0"><number>&lsqb;1442&rsqb;</number> MS APCI (M&plus;1): 489.3931. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 364 </heading>
</section>
<section>
<heading lvl="1">1,3-Dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1443" lvl="0"><number>&lsqb;1443&rsqb;</number> The procedure of Example 34 was repeated, except 4-(4-bromomethyl-benzenesulfonyl)-morpholine was replaced by 4-bromomethyl-benzenesulfonic acid methyl ester to give 1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide as a white solid (15%); MS APCI (M&plus;) 360. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 365 </heading>
</section>
<section>
<heading lvl="1">3-Cyanomethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
</section>
<section>
<heading lvl="1">EXAMPLE 366 </heading>
</section>
<section>
<heading lvl="1">3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1444" lvl="0"><number>&lsqb;1444&rsqb;</number> The procedure of Example 34 was repeated, except 4-(4-bromomethyl-benzenesulfonyl)-morpholine was replaced by benzyl bromide to give 3-benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide as a white solid (86%); MS APCI (M&plus;) 494. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 367 </heading>
</section>
<section>
<heading lvl="1">3-(4-Cyclopropylsulfamoyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1445" lvl="0"><number>&lsqb;1445&rsqb;</number> The procedure of Example 34 was repeated, except 4-(4-bromomethyl-benzenesulfonyl)-morpholine was replaced by 1-bromomethyl-4-cyclopropylmethanesulfonyl-benzene, to 3-(4-cyclopropylsulfamoyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide as a white solid (95%); <highlight><superscript>1</superscript></highlight>H NMR (DMSO), &dgr;0.37 (d, J&equals;2.9 Hz, 2H), 0.46 (d, J&equals;4.9 Hz, 2H), 2.04 (m, 1H), 3.49 (s, 3H), 3.73 (s, 3H), 4.42 (d, J&equals;5.9 Hz, 2H), 5.14 (s, 2H), 7.02-6.89 (m, 3H), 7.25 (t, J&equals;8.1 Hz, 1H), 7.52 (d, J&equals;8.1 Hz, 2H), 7.74 (d, J&equals;8.4 Hz, 2H), 7.91 (s, 1H), 8.1 (s, 1H), 9.23 (t, J&equals;5.6 Hz, 1H). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 368 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-3-(6-nitro-pyridin-3-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1446" lvl="0"><number>&lsqb;1446&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00198">
<number>198</number>
<image id="EMI-C00198" he="80.88255" wi="214.35435" file="US20030004172A1-20030102-C00198.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00198" file="US20030004172A1-20030102-C00198.CDX"/>
<chemistry-mol-file id="CHEMMOL-00198" file="US20030004172A1-20030102-C00198.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1447" lvl="0"><number>&lsqb;1447&rsqb;</number> Made by the procedure of Example 217 from 1-methyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide and 5-(bromomethyl)-2-nitropyridine; mp 213-215&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 369 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-3-(6-nitro-pyridin-3-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1448" lvl="0"><number>&lsqb;1448&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00199">
<number>199</number>
<image id="EMI-C00199" he="60.01695" wi="215.0631" file="US20030004172A1-20030102-C00199.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00199" file="US20030004172A1-20030102-C00199.CDX"/>
<chemistry-mol-file id="CHEMMOL-00199" file="US20030004172A1-20030102-C00199.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1449" lvl="0"><number>&lsqb;1449&rsqb;</number> Made by the procedure of Example 217 from 1-methyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide and 5-(bromomethyl)-2-nitropyridine; mp 238-241&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 370 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-3-(6-nitro-pyridin-3-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-methoxy-pyridin-4-ylmethyl)-amide </heading>
<paragraph id="P-1450" lvl="0"><number>&lsqb;1450&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00200">
<number>200</number>
<image id="EMI-C00200" he="79.91865" wi="214.0992" file="US20030004172A1-20030102-C00200.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00200" file="US20030004172A1-20030102-C00200.CDX"/>
<chemistry-mol-file id="CHEMMOL-00200" file="US20030004172A1-20030102-C00200.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1451" lvl="0"><number>&lsqb;1451&rsqb;</number> Made by the procedure of Example 217 from 1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-methoxy-pyridin-4-ylmethyl)-amide and 5-(bromomethyl)-2-nitropyridine; mp 200-207&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 371 </heading>
</section>
<section>
<heading lvl="1">3-Cyclohexylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-methoxy-pyridin-4-ylmethyl)-amide </heading>
<paragraph id="P-1452" lvl="0"><number>&lsqb;1452&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00201">
<number>201</number>
<image id="EMI-C00201" he="83.5191" wi="194.1975" file="US20030004172A1-20030102-C00201.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00201" file="US20030004172A1-20030102-C00201.CDX"/>
<chemistry-mol-file id="CHEMMOL-00201" file="US20030004172A1-20030102-C00201.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1453" lvl="0"><number>&lsqb;1453&rsqb;</number> Made by the procedure of Example 217 from 1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-methoxy-pyridin-4-ylmethyl)-amide and bromomethyl-cyclohexane; mp 167-210&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 372 </heading>
</section>
<section>
<heading lvl="1">3-&lcub;2-&lsqb;(1H-Benzimidazole-5-carbonyl)-amino&rsqb;-ethyl&rcub;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1454" lvl="0"><number>&lsqb;1454&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00202">
<number>202</number>
<image id="EMI-C00202" he="180.9864" wi="174.49425" file="US20030004172A1-20030102-C00202.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00202" file="US20030004172A1-20030102-C00202.CDX"/>
<chemistry-mol-file id="CHEMMOL-00202" file="US20030004172A1-20030102-C00202.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1455" lvl="0"><number>&lsqb;1455&rsqb;</number> In an 8-mL screw cap vial was added a mixture of the compound of Example 252, namely 3-(2-amino-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzyl amide, (0.038 g, 0.1 mmol), diisopropylethylamine (0.038 g, 0.30 mmol), O-(benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (0.114 g, 0.30), and 1-hydroxy-7-azabenzotriazole (0.053 g, 0.30 mmol) in dimethylformamide (2 mL) followed by 1 H-benzoimidazole-5-carboxylic acid,(0.045 g, 0.3 mmol) in dimethylformamide (1 mL). The vial was capped and the reaction mixture was shaken for 24 hours at room temperature. The solvent was removed under vacuum. Purification was carried out via reverse-phase HPLC (3% n-propanol in acetonitrile and 3% n-propanol in water as the eluent; C-18 column). 0.023 g (50% yield). MS APCI (M&plus;1): 533.5. </paragraph>
<paragraph id="P-1456" lvl="0"><number>&lsqb;1456&rsqb;</number> In a manner similar to the procedure of Example 372, the compounds of Examples 373 to 383 were prepared. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 373 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-&lsqb;2-(3-piperidin-1-yl-propionylamino)-ethyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1457" lvl="0"><number>&lsqb;1457&rsqb;</number> MS APCI (M&plus;1): 528.6427. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 374 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-&lcub;2-&lsqb;(6-pyrazol-1-yl-pyridine-3-carbonyl)-amino&rsqb;-ethyl&rcub;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1458" lvl="0"><number>&lsqb;1458&rsqb;</number> MS APCI (M&plus;1): 560.6045. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 375 </heading>
</section>
<section>
<heading lvl="1">3-&lsqb;2-(4-Diethylamino-benzoylamino)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1459" lvl="0"><number>&lsqb;1459&rsqb;</number> MS APCI (M&plus;1):564.6757. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 376 </heading>
</section>
<section>
<heading lvl="1">3-&lcub;2-&lsqb;(6-Chloro-pyridine-3-carbonyl)-amino&rsqb;-ethyl&rcub;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1460" lvl="0"><number>&lsqb;1460&rsqb;</number> MS APCI (M&plus;1): 528.9868. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 377 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-&lcub;2-&lsqb;(1H-pyrrole-2-carbonyl)-amino&rsqb;-ethyl&rcub;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1461" lvl="0"><number>&lsqb;1461&rsqb;</number> MS APCI (M&plus;1): 482.5307. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 378 </heading>
</section>
<section>
<heading lvl="1">3-&lsqb;2-(2-Dimethylamino-acetylamino)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1462" lvl="0"><number>&lsqb;1462&rsqb;</number> MS APCI (M&plus;1): 474.5513. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 379 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-&lcub;2-&lsqb;(pyrazine-2-carbonyl)-amino&rsqb;-ethyl&rcub;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1463" lvl="0"><number>&lsqb;1463&rsqb;</number> MS APCI (M&plus;1): 495.5298. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 380 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-3-&lsqb;2-(2-methyl-2-methylamino-propionylamino)-ethyl&rsqb;-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1464" lvl="0"><number>&lsqb;1464&rsqb;</number> MS APCI (M&plus;1): 488.5781. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 381 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-&lcub;2-&lsqb;(pyrrolidine-2-carbonyl)-amino&rsqb;-ethyl&rcub;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1465" lvl="0"><number>&lsqb;1465&rsqb;</number> MS APCI (M&plus;1): 486.5623. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 382 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-&lcub;2-&lsqb;3-(5-phenyl-1H-pyrrol-2-yl)-propionylamino&rsqb;-ethyl&rcub;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1466" lvl="0"><number>&lsqb;1466&rsqb;</number> MS APCI (M&plus;1): 586.6819. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 383 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-&lcub;2-&lsqb;2-(pyridin-4-ylsulfanyl)-acetylamino&rsqb;-ethyl&rcub;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1467" lvl="0"><number>&lsqb;1467&rsqb;</number> MS APCI (M&plus;1): 540.6345. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 384 </heading>
</section>
<section>
<heading lvl="1">3-(6-Amino-pyridin-3-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </heading>
<paragraph id="P-1468" lvl="0"><number>&lsqb;1468&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00203">
<number>203</number>
<image id="EMI-C00203" he="122.89725" wi="194.6511" file="US20030004172A1-20030102-C00203.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00203" file="US20030004172A1-20030102-C00203.CDX"/>
<chemistry-mol-file id="CHEMMOL-00203" file="US20030004172A1-20030102-C00203.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1469" lvl="0"><number>&lsqb;1469&rsqb;</number> Made by catalytic hydrogenation of the compound of Example 368 with Raney nickel; mp 131-134&deg; C. (dec.). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 385 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-3-(3-phenyl-prop-2-ynyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1470" lvl="0"><number>&lsqb;1470&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00204">
<number>204</number>
<image id="EMI-C00204" he="106.56765" wi="214.58115" file="US20030004172A1-20030102-C00204.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00204" file="US20030004172A1-20030102-C00204.CDX"/>
<chemistry-mol-file id="CHEMMOL-00204" file="US20030004172A1-20030102-C00204.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1471" lvl="0"><number>&lsqb;1471&rsqb;</number> Made by the procedure of Example 217 from 1-methyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide and (3-bromo-prop-1-ynyl)-benzene; mp 168-171&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 386 </heading>
</section>
<section>
<heading lvl="1">3-(6-Amino-pyridin-3-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide </heading>
<paragraph id="P-1472" lvl="0"><number>&lsqb;1472&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00205">
<number>205</number>
<image id="EMI-C00205" he="106.56765" wi="209.79" file="US20030004172A1-20030102-C00205.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00205" file="US20030004172A1-20030102-C00205.CDX"/>
<chemistry-mol-file id="CHEMMOL-00205" file="US20030004172A1-20030102-C00205.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-1473" lvl="0"><number>&lsqb;1473&rsqb;</number> Made by catalytic hydrogenation of the compound of Example 369 with Raney nickel; mp 240-241&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 387 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </heading>
<paragraph id="P-1474" lvl="7"><number>&lsqb;1474&rsqb;</number> Step (1): 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </paragraph>
<paragraph id="P-1475" lvl="0"><number>&lsqb;1475&rsqb;</number> To a solution of 3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid (obtained by the method of Preparation 4) (0.26 mmol, 80 mg) in anhydrous DMF (4 mL) were added benzyl alcohol (0.29 mmol, 30 &mgr;L), diisopropylethylamine (0.58 mmol, 101 &mgr;L), and O (7-azabenzotriazol-1-yl)-N,N,N&prime;,N&prime;-tetramethyluronium hexafluorophosphate (&ldquo;HATU&rdquo;) (0.29 mmol, 111 mg). The reaction mixture was stirred at room temperature for 17 hours, and then concentrated under reduced pressure to yield an orange oil. The orange oil was dissolved with 20 mL of dichloromethane. The organic phase was washed with water (2&times;10 mL), dried (MgSO<highlight><subscript>4</subscript></highlight>), filtered, and concentrated. The resulting orange oil was purified by flash chromatography on silica gel (98:2 dichloromethane/methanol) to yield 53.9 mg (52%) of 3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester as a white solid. </paragraph>
<paragraph id="P-1476" lvl="7"><number>&lsqb;1476&rsqb;</number> Step (2): 1-Methyl-3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester </paragraph>
<paragraph id="P-1477" lvl="0"><number>&lsqb;1477&rsqb;</number> To a solution of the product of Step (1) (89.2 &mgr;mol, 35 mg) in anhydrous DMF (3 mL) were added iodomethane (267.8 &mgr;mol, 17 &mgr;L) and potassium carbonate (133.8 &mgr;mol, 18.5 mg). The heterogeneous reaction mixture was then stirred at room temperature for 17 hours, filtered, and concentrated under reduced pressure to afford an orange oil. The orange oil was dissolved with diethyl ether (5 mL). The resulting white precipitate was collected, washed with diethyl ether (2&times;3 mL), and dried under vacuum to yield 28.8 mg (80%) of 1-methyl-3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester as a white solid. </paragraph>
<paragraph id="P-1478" lvl="0"><number>&lsqb;1478&rsqb;</number> N.M.R: DMSO <highlight><superscript>1</superscript></highlight>H &dgr; (ppm): 3.55 (s, 3H), 5.10 (s, 2H), 5.40 (s, 2H), 7.20-7.50 (m, 10 H), 8.25 (s, 1H); Purity (HPLC, Ultraviolet light detector at 214 nm): 98.0%. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 388 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3.2-d&rsqb;pyrimidine-6-carboxylic acid benzyl amide </heading>
<paragraph id="P-1479" lvl="7"><number>&lsqb;1479&rsqb;</number> Step (1): 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid benzyl amide </paragraph>
<paragraph id="P-1480" lvl="0"><number>&lsqb;1480&rsqb;</number> To a solution of 3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid (obtained by the method of Preparation 4) (0.12 mmol, 35 mg) in anhydrous DMF (3 mL) were added benzylamine (0.115 mmol, 13 &mgr;L), diisopropylethylamine (0.253 mmol, 44 &mgr;L), and HATU (0.127 mmol, 49 mg). The reaction mixture was stirred at room temperature for 17 hours, and then concentrated under reduced pressure to yield a white solid. The white solid was dissolved with 4 mL of acetonitrile. The resulting precipitate was collected, washed with cold acetonitrile (2&times;2 mL), and dried under vacuum to yield 40.1 mg (88%) of 3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid benzyl amide as a white solid. </paragraph>
<paragraph id="P-1481" lvl="7"><number>&lsqb;1481&rsqb;</number> Step (2): 1-Methyl-3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid benzyl amide </paragraph>
<paragraph id="P-1482" lvl="0"><number>&lsqb;1482&rsqb;</number> To a solution of the product of Step (1) (76.7 &mgr;mol, 30 mg) in anhydrous DMF (3 mL) were added iodomethane (230.1 &mgr;mol, 15 &mgr;L) and potassium carbonate (115.1 &mgr;mol, 16 mg). The heterogeneous reaction mixture was then stirred at room temperature for 17 hours, filtered, and concentrated under reduced pressure to yield an orange oil. The orange oil was dissolved with diisopropyl ether (5 mL). The resulting white precipitate was collected, washed with diisopropyl ether (3&times;5 mL), and dried under vacuum to yield 28.2 mg (90%) of 1-methyl-3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid benzyl amide as a beige solid. </paragraph>
<paragraph id="P-1483" lvl="0"><number>&lsqb;1483&rsqb;</number> N.M.R: DMSO <highlight><superscript>1</superscript></highlight>H &dgr; (ppm): 3.50 (s, 3H), 4.50 (d, 2H), 5.08 (s, 2H), 7.20-7.40 (m, 10H), 8.00 (s, 1H), 9.40 (t, 1H); Purity (HPLC 214 nm): 95.4%. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 389 </heading>
</section>
<section>
<heading lvl="1">1-Methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid benzyl amide </heading>
<paragraph id="P-1484" lvl="7"><number>&lsqb;1484&rsqb;</number> Step (1): 3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid methyl ester </paragraph>
<paragraph id="P-1485" lvl="0"><number>&lsqb;1485&rsqb;</number> To a solution of 3-benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid (obtained by the method of Preparation 4) (0.33 mmol, 100 mg) in anhydrous DMF (4 mL) were added iodomethane (0.99 mmol, 63 &mgr;L) and potassium carbonate (0.99 mmol, 138 mg). The heterogeneous reaction mixture was then stirred at room temperature for 17 hours, filtered, and concentrated under reduced pressure to yield an orange solid. The orange oil was dissolved with pentane (5 mL). The resulting precipitate was collected, washed with pentane (2&times;5 mL), and dried under vacuum to yield 93.2 mg (84%) of 3-benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid methyl ester as a yellow solid. </paragraph>
<paragraph id="P-1486" lvl="7"><number>&lsqb;1486&rsqb;</number> Step (2): 1-Methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid methyl ester </paragraph>
<paragraph id="P-1487" lvl="0"><number>&lsqb;1487&rsqb;</number> To a solution of the product of Step (1) (0.328 mmol, 108.3 mg) in benzene (12 mL) was added aluminum chloride (1.97 mmol, 262 mg), and the reaction mixture was allowed to warm to 45&deg; C. for 7 hours. The reaction mixture was then diluted with ethyl acetate (20 mL), and the organic phase was washed with water (3&times;10 mL), dried (MgSO<highlight><subscript>4</subscript></highlight>), and concentrated under reduced pressure to provide a brown solid. The brown solid was dissolved with diethyl ether. The resulting precipitate was collected, washed with diethyl ether (3&times;5 mL), and dried under vacuum to yield 42.3 mg (53%) of 1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid methyl ester as a mauve-colored solid. </paragraph>
<paragraph id="P-1488" lvl="7"><number>&lsqb;1488&rsqb;</number> Step (3): 1-Methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid </paragraph>
<paragraph id="P-1489" lvl="0"><number>&lsqb;1489&rsqb;</number> To a solution of the product of Step (2) (0.175 mmol, 42 mg) in methanol (2 mL) was added a solution of lithium hydroxide (0.437 mmol, 11 mg) in water (1 mL), and the resulting reaction mixture was stirred at room temperature for 17 hours. After concentration under reduced pressure, the crude product was dissolved in 1.0 M hydrochloric acid (10 mL) and extracted with ethyl acetate (2&times;15 mL). The combined organic phases were washed with water (2&times;15 mL), dried (MgSO<highlight><subscript>4</subscript></highlight>), filtered, and concentrated under reduced pressure to yield 34.8 mg (88%) of 1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid as a white solid. </paragraph>
<paragraph id="P-1490" lvl="7"><number>&lsqb;1490&rsqb;</number> Step (4): 1-Methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid benzyl amide </paragraph>
<paragraph id="P-1491" lvl="0"><number>&lsqb;1491&rsqb;</number> To a solution of the product of Step (3) (0.152 mmol, 34.5 mg) in anhydrous DMF (3 mL) were added benzylamine (0.17 mmol, 19 &mgr;L), diisopropylethylamine (0.34 mmol, 59 &mgr;L), and HATU (0.17 mmol, 64 mg). The reaction mixture was then stirred at room temperature for 17 hours and evaporated under reduced pressure to yield an orange oil. The orange oil was dissolved with 5 mL of ethanol. The resulting precipitate was collected, washed with cold ethanol (2&times;3 mL), pentane (2&times;3 mL), and dried under vacuum to yield 33.8 mg (70%) of 1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;3,2-d&rsqb;pyrimidine-6-carboxylic acid benzyl amide as a white solid. </paragraph>
<paragraph id="P-1492" lvl="0"><number>&lsqb;1492&rsqb;</number> N.M.R: DMSO <highlight><superscript>1</superscript></highlight>H &dgr; (ppm): 3.42 (s, 3H), 4.50 (d, 2H), 7.25-7.40 (m, 5H), 7.95 (s, 1H), 9.35 (t, 1H); Purity (HPLC 214 nm): 96.5%. </paragraph>
<paragraph id="P-1493" lvl="0"><number>&lsqb;1493&rsqb;</number> The invention compounds of Formula I have been evaluated in standard assays for their ability to inhibit the catalytic activity of various MMP enzymes. The assays used to evaluate the biological activity of the invention compounds are well known and routinely used by those skilled in the study of MMP inhibitors and their use to treat clinical conditions. </paragraph>
<paragraph id="P-1494" lvl="0"><number>&lsqb;1494&rsqb;</number> The assays measure the amount by which a test compound reduces the hydrolysis of a thiopeptolide substrate caused by a matrix metalloproteinase enzyme. Such assays are described in detail by Ye et al., in <highlight><italic>Biochemistry, </italic></highlight>1992;31(45):11231-11235, which is incorporated herein by reference. </paragraph>
<paragraph id="P-1495" lvl="0"><number>&lsqb;1495&rsqb;</number> Thiopeptolide substrates show virtually no decomposition or hydrolysis at or below neutral pH in the absence of a matrix metalloproteinase enzyme. A typical thiopeptolide substrate commonly utilized for assays is Ac-Pro-Leu-Gly-thioester; -Leu-Leu-Gly-OEt. A 100 &mgr;L assay mixture will contain 50 mM of N-2-hydroxyethylpiperazine-N&prime;-2-ethanesulfonic acid buffer (&ldquo;HEPES,&rdquo; pH 7.0) 10 mM CaCl<highlight><subscript>2</subscript></highlight>, 100 &mgr;M thiopeptolide substrate, and 1 mM 5,5&prime;-dithio-bis-(2-nitro-benzoic acid) (DTNB). The thiopeptolide substrate concentration may be varied from, for example, 10 to 800 &mgr;M to obtain Km and Kcat values. The change in absorbance at 405 nm is monitored on a Thermo Max microplate reader (Molecular Devices, Menlo Park, Calif.) at room temperature (22&deg; C.). The calculation of the amount of hydrolysis of the thiopeptolide substrate is based on E<highlight><subscript>412</subscript></highlight>&equals;13600 M<highlight><superscript>&minus;1 </superscript></highlight>cm<highlight><superscript>&minus;1 </superscript></highlight>for the DTNB-derived product 3-carboxy-4-nitrothiophenoxide. Assays are carried out with and without matrix metalloproteinase inhibitor compounds, and the amount of hydrolysis is compared for a determination of inhibitory activity of the test compounds. </paragraph>
<paragraph id="P-1496" lvl="0"><number>&lsqb;1496&rsqb;</number> Several representative compounds have been evaluated for their ability to inhibit various matrix metalloproteinase enzymes. The invention compounds are uniquely active in inhibiting MMP-13. Table I below presents inhibitory activity for compounds from various classes. In the table, MMP-13CD refers to the catalytic domain of collagenase-3. Test compounds were evaluated at various concentrations in order to determine their respective IC<highlight><subscript>50 </subscript></highlight>values, the micromolar concentration of compound required to cause a 50% inhibition of the hydrolytic activity of the respective enzyme.  
<table-cwu id="TABLE-US-00002">
<number>2</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="28PT" align="left"/>
<colspec colname="1" colwidth="84PT" align="center"/>
<colspec colname="2" colwidth="105PT" align="center"/>
<thead>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center">TABLE I</entry>
</row>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>MMP-13CD</entry>
</row>
<row>
<entry></entry>
<entry>Compound of Example No.</entry>
<entry>IC<highlight><subscript>50</subscript></highlight>, (&mgr;M)</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="28PT" align="left"/>
<colspec colname="1" colwidth="84PT" align="center"/>
<colspec colname="2" colwidth="105PT" align="char" char="."/>
<tbody valign="top">
<row>
<entry></entry>
<entry>&emsp;1</entry>
<entry>0.74</entry>
</row>
<row>
<entry></entry>
<entry>&emsp;2</entry>
<entry>0.31</entry>
</row>
<row>
<entry></entry>
<entry>&emsp;3</entry>
<entry>30.0</entry>
</row>
<row>
<entry></entry>
<entry>&emsp;4</entry>
<entry>16.0</entry>
</row>
<row>
<entry></entry>
<entry>&emsp;5</entry>
<entry>51.0</entry>
</row>
<row>
<entry></entry>
<entry>&emsp;6</entry>
<entry>&gt;100.0</entry>
</row>
<row>
<entry></entry>
<entry>&emsp;7</entry>
<entry>10.0</entry>
</row>
<row>
<entry></entry>
<entry>&emsp;8</entry>
<entry>15.0</entry>
</row>
<row>
<entry></entry>
<entry>&emsp;9</entry>
<entry>0.007</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;10</entry>
<entry>0.068</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;11</entry>
<entry>0.47</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;12</entry>
<entry>&gt;100.0</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;13</entry>
<entry>18.0</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;14</entry>
<entry>7.5</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;48</entry>
<entry>1.45</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;49</entry>
<entry>0.26</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;50</entry>
<entry>0.0875</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;51</entry>
<entry>0.0205</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;52</entry>
<entry>0.00395</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;53</entry>
<entry>30</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;54</entry>
<entry>4.5</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;55</entry>
<entry>0.011</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;56</entry>
<entry>30</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;57</entry>
<entry>5.6</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;58</entry>
<entry>0.0115</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;59</entry>
<entry>2</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;60</entry>
<entry>0.16</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;61</entry>
<entry>0.045</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;62</entry>
<entry>0.0535</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;63</entry>
<entry>0.11</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;64</entry>
<entry>0.062</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;65</entry>
<entry>0.0535</entry>
</row>
<row>
<entry></entry>
<entry><highlight><superscript>&thinsp;&thinsp;</superscript></highlight>65a</entry>
<entry>1.05</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;66</entry>
<entry>0.0275</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;67</entry>
<entry>0.00168</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;68</entry>
<entry>0.0635</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;69</entry>
<entry>0.057</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;70</entry>
<entry>0.1185</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;71</entry>
<entry>12.96</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;72</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;73</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;74</entry>
<entry>71.5</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;75</entry>
<entry>0.345</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;76</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;77</entry>
<entry>0.00655</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;78</entry>
<entry>0.900</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;79</entry>
<entry>0.00205</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;80</entry>
<entry>25</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;81</entry>
<entry>3.899</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;82</entry>
<entry>3.700</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;83</entry>
<entry>0.140</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;84</entry>
<entry>0.02050</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;85</entry>
<entry>0.04750</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;86</entry>
<entry>1.3999</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;87</entry>
<entry>0.0185</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;88</entry>
<entry>3.149</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;89</entry>
<entry>0.1135</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;90</entry>
<entry>0.00543</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;91</entry>
<entry>0.0496</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;92</entry>
<entry>0.0109</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;93</entry>
<entry>0.111</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;94</entry>
<entry>0.005349</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;95</entry>
<entry>0.10349</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;96</entry>
<entry>0.018499</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;97</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;98</entry>
<entry>0.063</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;99</entry>
<entry>0.16</entry>
</row>
<row>
<entry></entry>
<entry>100</entry>
<entry>0.61</entry>
</row>
<row>
<entry></entry>
<entry>101</entry>
<entry>0.034</entry>
</row>
<row>
<entry></entry>
<entry>102</entry>
<entry>0.034</entry>
</row>
<row>
<entry></entry>
<entry>103</entry>
<entry>0.03</entry>
</row>
<row>
<entry></entry>
<entry>104</entry>
<entry>1.1</entry>
</row>
<row>
<entry></entry>
<entry>105</entry>
<entry>0.52</entry>
</row>
<row>
<entry></entry>
<entry>106</entry>
<entry>0.59</entry>
</row>
<row>
<entry></entry>
<entry>107</entry>
<entry>2.4</entry>
</row>
<row>
<entry></entry>
<entry>108</entry>
<entry>1.7</entry>
</row>
<row>
<entry></entry>
<entry>109</entry>
<entry>0.94</entry>
</row>
<row>
<entry></entry>
<entry>110</entry>
<entry>0.42</entry>
</row>
<row>
<entry></entry>
<entry>111</entry>
<entry>3.2</entry>
</row>
<row>
<entry></entry>
<entry>112</entry>
<entry>2.9</entry>
</row>
<row>
<entry></entry>
<entry>113</entry>
<entry>2.9</entry>
</row>
<row>
<entry></entry>
<entry>114</entry>
<entry>0.33</entry>
</row>
<row>
<entry></entry>
<entry>115</entry>
<entry>0.33</entry>
</row>
<row>
<entry></entry>
<entry>116</entry>
<entry>13</entry>
</row>
<row>
<entry></entry>
<entry>117</entry>
<entry>0.036</entry>
</row>
<row>
<entry></entry>
<entry>118</entry>
<entry>0.015</entry>
</row>
<row>
<entry></entry>
<entry>119</entry>
<entry>0.51</entry>
</row>
<row>
<entry></entry>
<entry>120</entry>
<entry>0.13</entry>
</row>
<row>
<entry></entry>
<entry>121</entry>
<entry>0.25</entry>
</row>
<row>
<entry></entry>
<entry>122</entry>
<entry>4.5</entry>
</row>
<row>
<entry></entry>
<entry>123</entry>
<entry>7.8</entry>
</row>
<row>
<entry></entry>
<entry>124</entry>
<entry>0.11</entry>
</row>
<row>
<entry></entry>
<entry>125</entry>
<entry>0.09</entry>
</row>
<row>
<entry></entry>
<entry>126</entry>
<entry>13</entry>
</row>
<row>
<entry></entry>
<entry>127</entry>
<entry>3.9</entry>
</row>
<row>
<entry></entry>
<entry>128</entry>
<entry>0.19</entry>
</row>
<row>
<entry></entry>
<entry>129</entry>
<entry>0.16</entry>
</row>
<row>
<entry></entry>
<entry>130</entry>
<entry>0.097</entry>
</row>
<row>
<entry></entry>
<entry>131</entry>
<entry>0.019</entry>
</row>
<row>
<entry></entry>
<entry>132</entry>
<entry>0.074</entry>
</row>
<row>
<entry></entry>
<entry>133</entry>
<entry>0.074</entry>
</row>
<row>
<entry></entry>
<entry>134</entry>
<entry>1.5</entry>
</row>
<row>
<entry></entry>
<entry>135</entry>
<entry>0.086</entry>
</row>
<row>
<entry></entry>
<entry>136</entry>
<entry>0.051</entry>
</row>
<row>
<entry></entry>
<entry>137</entry>
<entry>8.3</entry>
</row>
<row>
<entry></entry>
<entry>138</entry>
<entry>0.66</entry>
</row>
<row>
<entry></entry>
<entry>139</entry>
<entry>0.25</entry>
</row>
<row>
<entry></entry>
<entry>140</entry>
<entry>0.017</entry>
</row>
<row>
<entry></entry>
<entry>141</entry>
<entry>0.15</entry>
</row>
<row>
<entry></entry>
<entry>142</entry>
<entry>0.39</entry>
</row>
<row>
<entry></entry>
<entry>143</entry>
<entry>0.28</entry>
</row>
<row>
<entry></entry>
<entry>144</entry>
<entry>0.003</entry>
</row>
<row>
<entry></entry>
<entry>145</entry>
<entry>1.3</entry>
</row>
<row>
<entry></entry>
<entry>146</entry>
<entry>47</entry>
</row>
<row>
<entry></entry>
<entry>147</entry>
<entry>0.16</entry>
</row>
<row>
<entry></entry>
<entry>148</entry>
<entry>0.54</entry>
</row>
<row>
<entry></entry>
<entry>149</entry>
<entry>15</entry>
</row>
<row>
<entry></entry>
<entry>150</entry>
<entry>13</entry>
</row>
<row>
<entry></entry>
<entry>151</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>152</entry>
<entry>9.9</entry>
</row>
<row>
<entry></entry>
<entry>153</entry>
<entry>0.004</entry>
</row>
<row>
<entry></entry>
<entry>154</entry>
<entry>32</entry>
</row>
<row>
<entry></entry>
<entry>155</entry>
<entry>62</entry>
</row>
<row>
<entry></entry>
<entry>156</entry>
<entry>0.18</entry>
</row>
<row>
<entry></entry>
<entry>157</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>158</entry>
<entry>16</entry>
</row>
<row>
<entry></entry>
<entry>159</entry>
<entry>30</entry>
</row>
<row>
<entry></entry>
<entry>160</entry>
<entry>30</entry>
</row>
<row>
<entry></entry>
<entry>161</entry>
<entry>11</entry>
</row>
<row>
<entry></entry>
<entry>162</entry>
<entry>11</entry>
</row>
<row>
<entry></entry>
<entry>163</entry>
<entry>0.016</entry>
</row>
<row>
<entry></entry>
<entry>164</entry>
<entry>69</entry>
</row>
<row>
<entry></entry>
<entry>165</entry>
<entry>20</entry>
</row>
<row>
<entry></entry>
<entry>166</entry>
<entry>0.92</entry>
</row>
<row>
<entry></entry>
<entry>167</entry>
<entry>26</entry>
</row>
<row>
<entry></entry>
<entry>168</entry>
<entry>25</entry>
</row>
<row>
<entry></entry>
<entry>169</entry>
<entry>30</entry>
</row>
<row>
<entry></entry>
<entry>170</entry>
<entry>0.72</entry>
</row>
<row>
<entry></entry>
<entry>171</entry>
<entry>14</entry>
</row>
<row>
<entry></entry>
<entry>172</entry>
<entry>32</entry>
</row>
<row>
<entry></entry>
<entry>173</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>174</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>175</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>176</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>177</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>178</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>179</entry>
<entry>0.25</entry>
</row>
<row>
<entry></entry>
<entry>180</entry>
<entry>30</entry>
</row>
<row>
<entry></entry>
<entry>181</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>182</entry>
<entry>8.6</entry>
</row>
<row>
<entry></entry>
<entry>183</entry>
<entry>30</entry>
</row>
<row>
<entry></entry>
<entry>184</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>185</entry>
<entry>0.014</entry>
</row>
<row>
<entry></entry>
<entry>186</entry>
<entry>4.5</entry>
</row>
<row>
<entry></entry>
<entry>187</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>188</entry>
<entry>19</entry>
</row>
<row>
<entry></entry>
<entry>189</entry>
<entry>4.9</entry>
</row>
<row>
<entry></entry>
<entry>190</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>191</entry>
<entry>2.3</entry>
</row>
<row>
<entry></entry>
<entry>192</entry>
<entry>0.0034</entry>
</row>
<row>
<entry></entry>
<entry>193</entry>
<entry>0.0034</entry>
</row>
<row>
<entry></entry>
<entry>194</entry>
<entry>88</entry>
</row>
<row>
<entry></entry>
<entry>195</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>196</entry>
<entry>30</entry>
</row>
<row>
<entry></entry>
<entry>197</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>198</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>199</entry>
<entry>17</entry>
</row>
<row>
<entry></entry>
<entry>200</entry>
<entry>0.067</entry>
</row>
<row>
<entry></entry>
<entry>201</entry>
<entry>0.3</entry>
</row>
<row>
<entry></entry>
<entry>202</entry>
<entry>0.36</entry>
</row>
<row>
<entry></entry>
<entry>203</entry>
<entry>0.36</entry>
</row>
<row>
<entry></entry>
<entry>204</entry>
<entry>0.072</entry>
</row>
<row>
<entry></entry>
<entry>205</entry>
<entry>19</entry>
</row>
<row>
<entry></entry>
<entry>206</entry>
<entry>15</entry>
</row>
<row>
<entry></entry>
<entry>207</entry>
<entry>0.2</entry>
</row>
<row>
<entry></entry>
<entry>208</entry>
<entry>0.1</entry>
</row>
<row>
<entry></entry>
<entry>209</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>210</entry>
<entry>1.2</entry>
</row>
<row>
<entry></entry>
<entry>211</entry>
<entry>2.1</entry>
</row>
<row>
<entry></entry>
<entry>212</entry>
<entry>0.67</entry>
</row>
<row>
<entry></entry>
<entry>213</entry>
<entry>1.7</entry>
</row>
<row>
<entry></entry>
<entry>214</entry>
<entry>20</entry>
</row>
<row>
<entry></entry>
<entry>215</entry>
<entry>24</entry>
</row>
<row>
<entry></entry>
<entry>216</entry>
<entry>18</entry>
</row>
<row>
<entry></entry>
<entry>217</entry>
<entry>0.0785</entry>
</row>
<row>
<entry></entry>
<entry>218</entry>
<entry>18</entry>
</row>
<row>
<entry></entry>
<entry>219</entry>
<entry>17</entry>
</row>
<row>
<entry></entry>
<entry>220</entry>
<entry>0.061</entry>
</row>
<row>
<entry></entry>
<entry>221</entry>
<entry>0.0046</entry>
</row>
<row>
<entry></entry>
<entry>222</entry>
<entry>0.0042</entry>
</row>
<row>
<entry></entry>
<entry>223</entry>
<entry>N/A<highlight><superscript>a</superscript></highlight></entry>
</row>
<row>
<entry></entry>
<entry>224</entry>
<entry>0.783</entry>
</row>
<row>
<entry></entry>
<entry>225</entry>
<entry>0.225</entry>
</row>
<row>
<entry></entry>
<entry>226</entry>
<entry>4.9</entry>
</row>
<row>
<entry></entry>
<entry>227</entry>
<entry>3.8</entry>
</row>
<row>
<entry></entry>
<entry>228</entry>
<entry>0.435</entry>
</row>
<row>
<entry></entry>
<entry>229</entry>
<entry>0.68</entry>
</row>
<row>
<entry></entry>
<entry>230</entry>
<entry>0.077</entry>
</row>
<row>
<entry></entry>
<entry>231</entry>
<entry>2.9</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;231a</entry>
<entry>0.00895</entry>
</row>
<row>
<entry></entry>
<entry>232</entry>
<entry>0.175</entry>
</row>
<row>
<entry></entry>
<entry>233</entry>
<entry>0.069</entry>
</row>
<row>
<entry></entry>
<entry>234</entry>
<entry>0.15</entry>
</row>
<row>
<entry></entry>
<entry>235</entry>
<entry>18</entry>
</row>
<row>
<entry></entry>
<entry>236</entry>
<entry>0.0495</entry>
</row>
<row>
<entry></entry>
<entry>237</entry>
<entry>0.0925</entry>
</row>
<row>
<entry></entry>
<entry>238</entry>
<entry>0.0555</entry>
</row>
<row>
<entry></entry>
<entry>239</entry>
<entry>0.0585</entry>
</row>
<row>
<entry></entry>
<entry>240</entry>
<entry>0.18</entry>
</row>
<row>
<entry></entry>
<entry>241</entry>
<entry>0.0195</entry>
</row>
<row>
<entry></entry>
<entry>242</entry>
<entry>3</entry>
</row>
<row>
<entry></entry>
<entry>243</entry>
<entry>1.4</entry>
</row>
<row>
<entry></entry>
<entry>244</entry>
<entry>1.25</entry>
</row>
<row>
<entry></entry>
<entry>245</entry>
<entry>30</entry>
</row>
<row>
<entry></entry>
<entry>246</entry>
<entry>5.65</entry>
</row>
<row>
<entry></entry>
<entry>247</entry>
<entry>7.2</entry>
</row>
<row>
<entry></entry>
<entry>248</entry>
<entry>N/A</entry>
</row>
<row>
<entry></entry>
<entry>249</entry>
<entry>7.8</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;249a</entry>
<entry>0.64</entry>
</row>
<row>
<entry></entry>
<entry>250</entry>
<entry>0.00765</entry>
</row>
<row>
<entry></entry>
<entry>251</entry>
<entry>0.655</entry>
</row>
<row>
<entry></entry>
<entry>252</entry>
<entry>24</entry>
</row>
<row>
<entry></entry>
<entry>&ensp;252a</entry>
<entry>N/A</entry>
</row>
<row>
<entry></entry>
<entry>253</entry>
<entry>0.81</entry>
</row>
<row>
<entry></entry>
<entry>254</entry>
<entry>1.5</entry>
</row>
<row>
<entry></entry>
<entry>255</entry>
<entry>14</entry>
</row>
<row>
<entry></entry>
<entry>256</entry>
<entry>27.5</entry>
</row>
<row>
<entry></entry>
<entry>257</entry>
<entry>1.5</entry>
</row>
<row>
<entry></entry>
<entry>258</entry>
<entry>0.27</entry>
</row>
<row>
<entry></entry>
<entry>259</entry>
<entry>30</entry>
</row>
<row>
<entry></entry>
<entry>260</entry>
<entry>0.063</entry>
</row>
<row>
<entry></entry>
<entry>261</entry>
<entry>0.58</entry>
</row>
<row>
<entry></entry>
<entry>262</entry>
<entry>3.4</entry>
</row>
<row>
<entry></entry>
<entry>263</entry>
<entry>2.15</entry>
</row>
<row>
<entry></entry>
<entry>264</entry>
<entry>7.4</entry>
</row>
<row>
<entry></entry>
<entry>265</entry>
<entry>0.038</entry>
</row>
<row>
<entry></entry>
<entry>266</entry>
<entry>4</entry>
</row>
<row>
<entry></entry>
<entry>267</entry>
<entry>1.1</entry>
</row>
<row>
<entry></entry>
<entry>268</entry>
<entry>3.6</entry>
</row>
<row>
<entry></entry>
<entry>269</entry>
<entry>26</entry>
</row>
<row>
<entry></entry>
<entry>270</entry>
<entry>1.8</entry>
</row>
<row>
<entry></entry>
<entry>271</entry>
<entry>5.9</entry>
</row>
<row>
<entry></entry>
<entry>272</entry>
<entry>30</entry>
</row>
<row>
<entry></entry>
<entry>273</entry>
<entry>0.059</entry>
</row>
<row>
<entry></entry>
<entry>274</entry>
<entry>0.018</entry>
</row>
<row>
<entry></entry>
<entry>275</entry>
<entry>0.036</entry>
</row>
<row>
<entry></entry>
<entry>276</entry>
<entry>0.23</entry>
</row>
<row>
<entry></entry>
<entry>277</entry>
<entry>20</entry>
</row>
<row>
<entry></entry>
<entry>278</entry>
<entry>7.6</entry>
</row>
<row>
<entry></entry>
<entry>279</entry>
<entry>3.5</entry>
</row>
<row>
<entry></entry>
<entry>280</entry>
<entry>17</entry>
</row>
<row>
<entry></entry>
<entry>281</entry>
<entry>8.9</entry>
</row>
<row>
<entry></entry>
<entry>282</entry>
<entry>10</entry>
</row>
<row>
<entry></entry>
<entry>283</entry>
<entry>1.7</entry>
</row>
<row>
<entry></entry>
<entry>284</entry>
<entry>1.5</entry>
</row>
<row>
<entry></entry>
<entry>285</entry>
<entry>30</entry>
</row>
<row>
<entry></entry>
<entry>286</entry>
<entry>0.27</entry>
</row>
<row>
<entry></entry>
<entry>287</entry>
<entry>1.9</entry>
</row>
<row>
<entry></entry>
<entry>288</entry>
<entry>4.2</entry>
</row>
<row>
<entry></entry>
<entry>289</entry>
<entry>2.7</entry>
</row>
<row>
<entry></entry>
<entry>290</entry>
<entry>15</entry>
</row>
<row>
<entry></entry>
<entry>291</entry>
<entry>0.12</entry>
</row>
<row>
<entry></entry>
<entry>292</entry>
<entry>10</entry>
</row>
<row>
<entry></entry>
<entry>293</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>294</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>295</entry>
<entry>0.23</entry>
</row>
<row>
<entry></entry>
<entry>296</entry>
<entry>0.0505</entry>
</row>
<row>
<entry></entry>
<entry>297</entry>
<entry>0.057</entry>
</row>
<row>
<entry></entry>
<entry>298</entry>
<entry>0.49</entry>
</row>
<row>
<entry></entry>
<entry>299</entry>
<entry>30</entry>
</row>
<row>
<entry></entry>
<entry>300</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>301</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>302</entry>
<entry>30</entry>
</row>
<row>
<entry></entry>
<entry>303</entry>
<entry>0.0036</entry>
</row>
<row>
<entry></entry>
<entry>304</entry>
<entry>3.1</entry>
</row>
<row>
<entry></entry>
<entry>305</entry>
<entry>46.6666</entry>
</row>
<row>
<entry></entry>
<entry>306</entry>
<entry>30</entry>
</row>
<row>
<entry></entry>
<entry>307</entry>
<entry>0.0052</entry>
</row>
<row>
<entry></entry>
<entry>308</entry>
<entry>0.00715</entry>
</row>
<row>
<entry></entry>
<entry>309</entry>
<entry>0.056</entry>
</row>
<row>
<entry></entry>
<entry>310</entry>
<entry>30</entry>
</row>
<row>
<entry></entry>
<entry>311</entry>
<entry>0.0845</entry>
</row>
<row>
<entry></entry>
<entry>312</entry>
<entry>0.0275</entry>
</row>
<row>
<entry></entry>
<entry>313</entry>
<entry>0.00645</entry>
</row>
<row>
<entry></entry>
<entry>314</entry>
<entry>0.0185</entry>
</row>
<row>
<entry></entry>
<entry>315</entry>
<entry>0.0205</entry>
</row>
<row>
<entry></entry>
<entry>316</entry>
<entry>NA</entry>
</row>
<row>
<entry></entry>
<entry>317</entry>
<entry>NA</entry>
</row>
<row>
<entry></entry>
<entry>318</entry>
<entry>NA</entry>
</row>
<row>
<entry></entry>
<entry>319</entry>
<entry>8</entry>
</row>
<row>
<entry></entry>
<entry>320</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>321</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>322</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>323</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>324</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>325</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>326</entry>
<entry>&minus;9999</entry>
</row>
<row>
<entry></entry>
<entry>327</entry>
<entry>2.8</entry>
</row>
<row>
<entry></entry>
<entry>328</entry>
<entry>2.7</entry>
</row>
<row>
<entry></entry>
<entry>329</entry>
<entry>30</entry>
</row>
<row>
<entry></entry>
<entry>330</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>331</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>332</entry>
<entry>1</entry>
</row>
<row>
<entry></entry>
<entry>333</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>334</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>335</entry>
<entry>0.25</entry>
</row>
<row>
<entry></entry>
<entry>336</entry>
<entry>30</entry>
</row>
<row>
<entry></entry>
<entry>337</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>338</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>339</entry>
<entry>0.38</entry>
</row>
<row>
<entry></entry>
<entry>340</entry>
<entry>0.12</entry>
</row>
<row>
<entry></entry>
<entry>341</entry>
<entry>14</entry>
</row>
<row>
<entry></entry>
<entry>342</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>343</entry>
<entry>0.044</entry>
</row>
<row>
<entry></entry>
<entry>344</entry>
<entry>3.6</entry>
</row>
<row>
<entry></entry>
<entry>345</entry>
<entry>30</entry>
</row>
<row>
<entry></entry>
<entry>346</entry>
<entry>9.9</entry>
</row>
<row>
<entry></entry>
<entry>347</entry>
<entry>16</entry>
</row>
<row>
<entry></entry>
<entry>348</entry>
<entry>30</entry>
</row>
<row>
<entry></entry>
<entry>349</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>350</entry>
<entry>0.93</entry>
</row>
<row>
<entry></entry>
<entry>351</entry>
<entry>2</entry>
</row>
<row>
<entry></entry>
<entry>352</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>353</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>354</entry>
<entry>30</entry>
</row>
<row>
<entry></entry>
<entry>355</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>356</entry>
<entry>10</entry>
</row>
<row>
<entry></entry>
<entry>357</entry>
<entry>0.32</entry>
</row>
<row>
<entry></entry>
<entry>358</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>359</entry>
<entry>1</entry>
</row>
<row>
<entry></entry>
<entry>360</entry>
<entry>0.27</entry>
</row>
<row>
<entry></entry>
<entry>361</entry>
<entry>7.7</entry>
</row>
<row>
<entry></entry>
<entry>362</entry>
<entry>&gt;100</entry>
</row>
<row>
<entry></entry>
<entry>363</entry>
<entry>30</entry>
</row>
<row>
<entry></entry>
<entry>364</entry>
<entry>NA</entry>
</row>
<row>
<entry></entry>
<entry>365</entry>
<entry>1.55</entry>
</row>
<row>
<entry></entry>
<entry>366</entry>
<entry>NA</entry>
</row>
<row>
<entry></entry>
<entry>367</entry>
<entry>0.00825</entry>
</row>
<row>
<entry></entry>
<entry>368</entry>
<entry>0.735</entry>
</row>
<row>
<entry></entry>
<entry>369</entry>
<entry>1.04</entry>
</row>
<row>
<entry></entry>
<entry>370</entry>
<entry>1.17</entry>
</row>
<row>
<entry></entry>
<entry>371</entry>
<entry>0.22</entry>
</row>
<row>
<entry></entry>
<entry>372</entry>
<entry>NA</entry>
</row>
<row>
<entry></entry>
<entry>373</entry>
<entry>NA</entry>
</row>
<row>
<entry></entry>
<entry>374</entry>
<entry>NA</entry>
</row>
<row>
<entry></entry>
<entry>375</entry>
<entry>NA</entry>
</row>
<row>
<entry></entry>
<entry>376</entry>
<entry>NA</entry>
</row>
<row>
<entry></entry>
<entry>377</entry>
<entry>NA</entry>
</row>
<row>
<entry></entry>
<entry>378</entry>
<entry>NA</entry>
</row>
<row>
<entry></entry>
<entry>379</entry>
<entry>NA</entry>
</row>
<row>
<entry></entry>
<entry>380</entry>
<entry>NA</entry>
</row>
<row>
<entry></entry>
<entry>381</entry>
<entry>NA</entry>
</row>
<row>
<entry></entry>
<entry>382</entry>
<entry>NA</entry>
</row>
<row>
<entry></entry>
<entry>383</entry>
<entry>NA</entry>
</row>
<row>
<entry></entry>
<entry>384</entry>
<entry>0.66</entry>
</row>
<row>
<entry></entry>
<entry>385</entry>
<entry>0.007</entry>
</row>
<row>
<entry></entry>
<entry>386</entry>
<entry>NA</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00001"><highlight><superscript>a</superscript></highlight>NA means data not available </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-1497" lvl="0"><number>&lsqb;1497&rsqb;</number> Selectivity of the invention compounds for inhibiting MMP-13 over certain other MMP enzymes is illustrated by a few randomly selected examples in Table II below. </paragraph>
<paragraph id="P-1498" lvl="0"><number>&lsqb;1498&rsqb;</number> In Table II, MMP-1FL refers to full-length interstitial collagenase; MMP-2FL refers to full length Gelatinase A; MMP-3CD refers to the catalytic domain of stromelysin-1; MMP-7FL refers to full-length matrilysin; MMP-9FL refers to full-length Gelatinase B; MMP-13CD refers to the catalytic domain of collagenase-3; and MMP-14CD refers to the catalytic domain of MMP-14. Test compounds were evaluated at various concentrations in order to determine their respective IC<highlight><subscript>50 </subscript></highlight>values, the micromolar concentration of compound required to cause a 50% inhibition of the hydrolytic activity of the respective enzyme. </paragraph>
<paragraph id="P-1499" lvl="0"><number>&lsqb;1499&rsqb;</number> It should be appreciated that the assay buffer used with MMP-3CD is 50 mM N-morpholinoethanesulfonate (&ldquo;MES&rdquo;) at pH 6.0 rather than the HEPES buffer at pH 7.0 described above.  
<table-cwu id="TABLE-US-00003">
<number>3</number>
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="280PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE II</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>IC<highlight><subscript>50 </subscript></highlight>With Certain MMP Enzymes</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="9">
<colspec colname="1" colwidth="28PT" align="center"/>
<colspec colname="2" colwidth="35PT" align="center"/>
<colspec colname="3" colwidth="28PT" align="center"/>
<colspec colname="4" colwidth="35PT" align="center"/>
<colspec colname="5" colwidth="28PT" align="center"/>
<colspec colname="6" colwidth="35PT" align="center"/>
<colspec colname="7" colwidth="28PT" align="center"/>
<colspec colname="8" colwidth="35PT" align="center"/>
<colspec colname="9" colwidth="28PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>MMP-</entry>
<entry>MMP-</entry>
<entry>MMP-</entry>
<entry>MMP-</entry>
<entry>MMP-</entry>
<entry>MMP-</entry>
<entry>MMP-</entry>
<entry>MMP-</entry>
</row>
<row>
<entry>Ex. No.</entry>
<entry>1FL</entry>
<entry>2FL</entry>
<entry>3CD</entry>
<entry>7FL</entry>
<entry>9FL</entry>
<entry>12CD</entry>
<entry>13CD</entry>
<entry>14CD</entry>
</row>
<row><entry namest="1" nameend="9" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="9">
<colspec colname="1" colwidth="28PT" align="center"/>
<colspec colname="2" colwidth="35PT" align="char" char="."/>
<colspec colname="3" colwidth="28PT" align="char" char="."/>
<colspec colname="4" colwidth="35PT" align="char" char="."/>
<colspec colname="5" colwidth="28PT" align="char" char="."/>
<colspec colname="6" colwidth="35PT" align="char" char="."/>
<colspec colname="7" colwidth="28PT" align="char" char="."/>
<colspec colname="8" colwidth="35PT" align="char" char="."/>
<colspec colname="9" colwidth="28PT" align="char" char="."/>
<tbody valign="top">
<row>
<entry>&emsp;1</entry>
<entry>100</entry>
<entry>100</entry>
<entry>18</entry>
<entry>100</entry>
<entry>100</entry>
<entry>100</entry>
<entry>0.61</entry>
<entry>100</entry>
</row>
<row>
<entry>303</entry>
<entry>100</entry>
<entry>100</entry>
<entry>6</entry>
<entry>32</entry>
<entry>30</entry>
<entry>100</entry>
<entry>0.0036</entry>
<entry>100</entry>
</row>
<row>
<entry>&ensp;20</entry>
<entry>100</entry>
<entry>100</entry>
<entry>100</entry>
<entry>100</entry>
<entry>100</entry>
<entry>100</entry>
<entry>0.0065</entry>
<entry>100</entry>
</row>
<row>
<entry>&ensp;49</entry>
<entry>100</entry>
<entry>100</entry>
<entry>23</entry>
<entry>100</entry>
<entry>100</entry>
<entry>100</entry>
<entry>0.26</entry>
<entry>100</entry>
</row>
<row>
<entry>217</entry>
<entry>100</entry>
<entry>100</entry>
<entry>27</entry>
<entry>100</entry>
<entry>30</entry>
<entry>30</entry>
<entry>0.0785</entry>
<entry>100</entry>
</row>
<row>
<entry>&ensp;63</entry>
<entry>30</entry>
<entry>30</entry>
<entry>18</entry>
<entry>30</entry>
<entry>30</entry>
<entry>30</entry>
<entry>0.11</entry>
<entry>30</entry>
</row>
<row>
<entry>228</entry>
<entry>30</entry>
<entry>30</entry>
<entry>15</entry>
<entry>10</entry>
<entry>30</entry>
<entry>30</entry>
<entry>0.435</entry>
<entry>30</entry>
</row>
<row>
<entry>&ensp;39</entry>
<entry>100</entry>
<entry>100</entry>
<entry>16</entry>
<entry>100</entry>
<entry>100</entry>
<entry>10</entry>
<entry>0.0038</entry>
<entry>100</entry>
</row>
<row>
<entry>246</entry>
<entry>100</entry>
<entry>30</entry>
<entry>23</entry>
<entry>48</entry>
<entry>30</entry>
<entry>30</entry>
<entry>5.65</entry>
<entry>36</entry>
</row>
<row>
<entry>&ensp;231a</entry>
<entry>100</entry>
<entry>50</entry>
<entry>13</entry>
<entry>46</entry>
<entry>91</entry>
<entry>30</entry>
<entry>0.0090</entry>
<entry>30</entry>
</row>
<row>
<entry>232</entry>
<entry>30</entry>
<entry>30</entry>
<entry>17</entry>
<entry>30</entry>
<entry>30</entry>
<entry>30</entry>
<entry>0.18</entry>
<entry>30</entry>
</row>
<row>
<entry>&ensp;47</entry>
<entry>30</entry>
<entry>30</entry>
<entry>30</entry>
<entry>14</entry>
<entry>30</entry>
<entry>30</entry>
<entry>0.038</entry>
<entry>10</entry>
</row>
<row>
<entry>&ensp;249a</entry>
<entry>100</entry>
<entry>30</entry>
<entry>100</entry>
<entry>30</entry>
<entry>30</entry>
<entry>100</entry>
<entry>0.64</entry>
<entry>30</entry>
</row>
<row>
<entry>369</entry>
<entry>10</entry>
<entry>30</entry>
<entry>10</entry>
<entry>30</entry>
<entry>30</entry>
<entry>30</entry>
<entry>1.04</entry>
<entry>30</entry>
</row>
<row><entry namest="1" nameend="9" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-1500" lvl="0"><number>&lsqb;1500&rsqb;</number> The foregoing data in Tables I and II establish that the invention compounds of Formula I are potent inhibitors of MMP enzymes, and are especially useful due to their selective inhibition of MMP-13. Because of this potent and selective inhibitory activity, the invention compounds are especially useful to treat diseases mediated by the MMP enzymes, and particularly those mediated by MMP-13. </paragraph>
<paragraph id="P-1501" lvl="0"><number>&lsqb;1501&rsqb;</number> Administration of a compound of Formula 1, or a pharmaceutically acceptable salt thereof, to a mammal to treat the diseases mediated by MMP enzymes is preferably, although not necessarily, accomplished by administering the compound, or the salt thereof, in a pharmaceutical dosage form. </paragraph>
<paragraph id="P-1502" lvl="0"><number>&lsqb;1502&rsqb;</number> The compounds of the present invention can be prepared and administered in a wide variety of oral and parenteral dosage forms. Thus, the compounds of the present invention can be administered by injection, that is, intravenously, intramuscularly, intracutaneously, subcutaneously, intraduodenally, or intraperitoneally. Also, the compounds of the present invention can be administered by inhalation, for example, intranasally. Additionally, the compounds of the present invention can be administered transdermally. It will be obvious to those skilled in the art that the following dosage forms may comprise as the active component, either a compound of Formula I or a corresponding pharmaceutically acceptable salt of a compound of Formula I. The active compound generally is present in a concentration of about 5% to about 95% by weight of the formulation. </paragraph>
<paragraph id="P-1503" lvl="0"><number>&lsqb;1503&rsqb;</number> For preparing pharmaceutical compositions from the compounds of the present invention, pharmaceutically acceptable carriers can be either solid or liquid. Solid form preparations include powders, tablets, pills, capsules, cachets, suppositories, and dispersible granules. A solid carrier can be one or more substances which may also act as diluents, flavoring agents, solubilizers, lubricants, suspending agents, binders, preservatives, tablet disintegrating agents, or an encapsulating material. </paragraph>
<paragraph id="P-1504" lvl="0"><number>&lsqb;1504&rsqb;</number> In powders, the carrier is a finely divided solid which is in a mixture with the finely divided active component. </paragraph>
<paragraph id="P-1505" lvl="0"><number>&lsqb;1505&rsqb;</number> In tablets, the active component is mixed with the carrier having the necessary binding properties in suitable proportions and compacted in the shape and size desired. </paragraph>
<paragraph id="P-1506" lvl="0"><number>&lsqb;1506&rsqb;</number> The powders and tablets preferably contain from five or ten to about seventy percent of the active compound. Suitable carriers are magnesium carbonate, magnesium stearate, talc, sugar, lactose, pectin, dextrin, starch, gelatin, tragacanth, methylcellulose, sodium carboxymethylcellulose, a low melting wax, cocoa butter, and the like. The term &ldquo;preparation&rdquo; is intended to include the formulation of the active compound with encapsulating material as a carrier providing a capsule in which the active component, with or without other carriers, is surrounded by a carrier, which is thus in association with it. Similarly, cachets and lozenges are included. Tablets, powders, capsules, pills, cachets, and lozenges can be used as solid dosage forms suitable for oral administration. </paragraph>
<paragraph id="P-1507" lvl="0"><number>&lsqb;1507&rsqb;</number> For preparing suppositories, a low melting wax, such as a mixture of fatty acid glycerides or cocoa butter, is first melted and the active component is dispersed homogeneously therein, as by stirring. The molten homogenous mixture is then poured into convenient sized molds, allowed to cool, and thereby to solidify. </paragraph>
<paragraph id="P-1508" lvl="0"><number>&lsqb;1508&rsqb;</number> Liquid form preparations include solutions, suspensions, and emulsions, for example, water or water propylene glycol solutions. For parenteral injection, liquid preparations can be formulated in solution in aqueous polyethylene glycol solution. </paragraph>
<paragraph id="P-1509" lvl="0"><number>&lsqb;1509&rsqb;</number> Aqueous solutions suitable for oral use can be prepared by dissolving the active component in water and adding suitable colorants, flavors, stabilizing, and thickening agents as desired. </paragraph>
<paragraph id="P-1510" lvl="0"><number>&lsqb;1510&rsqb;</number> Aqueous suspensions suitable for oral use can be made by dispersing the finely divided active component in water with viscous material, such as natural or synthetic gums, resins, methylcellulose, sodium carboxymethylcellulose, and other well-known suspending agents. </paragraph>
<paragraph id="P-1511" lvl="0"><number>&lsqb;1511&rsqb;</number> Also included are solid form preparations which are intended to be converted, shortly before use, to liquid form preparations for oral administration. Such liquid forms include solutions, suspensions, and emulsions. These preparations may contain, in addition to the active component, colorants, flavors, stabilizers, buffers, artificial and natural sweeteners, dispersants, thickeners, solubilizing agents, and the like. </paragraph>
<paragraph id="P-1512" lvl="0"><number>&lsqb;1512&rsqb;</number> The pharmaceutical preparation is preferably in unit dosage form. In such form, the preparation is subdivided into unit doses containing appropriate quantities of the active component. The unit dosage form can be a packaged preparation, the package containing discrete quantities of preparation, such as packeted tablets, capsules, and powders in vials or ampoules. Also, the unit dosage form can be a capsule, tablet, cachet, or lozenge itself, or it can be the appropriate number of any of these in packaged form. </paragraph>
<paragraph id="P-1513" lvl="0"><number>&lsqb;1513&rsqb;</number> The quantity of active component in a unit dose preparation may be varied or adjusted from 1 mg to 1000 mg, preferably 10 mg to 100 mg according to the particular application and the potency of the active component. The composition can, if desired, also contain other compatible therapeutic agents. </paragraph>
<paragraph id="P-1514" lvl="0"><number>&lsqb;1514&rsqb;</number> In therapeutic use as agents to inhibit a matrix metalloproteinase enzyme for the treatment of atherosclerotic plaque rupture, aortic aneurysm, heart failure, restenosis, periodontal disease, corneal ulceration, cancer metastasis, tumor angiogenesis, arthritis, or other autoimmune or inflammatory disorders dependent upon breakdown of connective tissue, the compounds utilized in the pharmaceutical method of this invention are administered at a dose that is effective to inhibit the hydrolytic activity of one or more matrix metalloproteinase enzymes. The initial dosage of about 1 mg to about 100 mg per kilogram daily will be effective. A daily dose range of about 25 mg to about 75 mg per kilogram is preferred. The dosages, however, may be varied depending upon the requirements of the patient, the severity of the condition being treated, and the compound being employed. Determination of the proper dosage for a particular situation is within the skill of the art. Generally, treatment is initiated with smaller dosages which are less than the optimum dose of the compound. Thereafter, the dosage is increased by small increments until the optimum effect under the circumstance is reached. For convenience, the total daily dosage may be divided and administered in portions during the day if desired. Typical dosages will be from about 0.1 to about 500 mg/kg, and ideally about 25 to about 250 mg/kg, such that it will be an amount which is effective to treat the particular disease being prevented or controlled. </paragraph>
<paragraph id="P-1515" lvl="0"><number>&lsqb;1515&rsqb;</number> The following examples illustrate typical formulations provided by the invention. </paragraph>
</section>
<section>
<heading lvl="1">Formulation Example 1 </heading>
<paragraph id="P-1516" lvl="0"><number>&lsqb;1516&rsqb;</number>  
<table-cwu id="TABLE-US-00004">
<number>4</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Tablet Formulation</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="35PT" align="left"/>
<colspec colname="1" colwidth="77PT" align="left"/>
<colspec colname="2" colwidth="105PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Ingredient</entry>
<entry>Amount (mg)</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="35PT" align="left"/>
<colspec colname="1" colwidth="77PT" align="left"/>
<colspec colname="2" colwidth="105PT" align="char" char="."/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Compound of Example 1</entry>
<entry>25</entry>
</row>
<row>
<entry></entry>
<entry>Lactose</entry>
<entry>50</entry>
</row>
<row>
<entry></entry>
<entry>Corn starch (for mix)</entry>
<entry>10</entry>
</row>
<row>
<entry></entry>
<entry>Corn starch (paste)</entry>
<entry>10</entry>
</row>
<row>
<entry></entry>
<entry>Magnesium stearate (1%)</entry>
<entry>5</entry>
</row>
<row>
<entry></entry>
<entry>Total</entry>
<entry>100</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-1517" lvl="0"><number>&lsqb;1517&rsqb;</number> The fused pyrimidinone of Example 1, lactose, and corn starch (for mix) are blended to uniformity. The corn starch (for paste) is suspended in 200 mL of water and heated with stirring to form a paste. The paste is used to granulate the mixed powders. The wet granules are passed through a No. 8 hand screen and dried at 80&deg; C. The dry granules are lubricated with the 1% magnesium stearate and pressed into a tablet. Such tablets can be administered to a human from one to four times a day for treatment of atherosclerosis and arthritis. </paragraph>
</section>
<section>
<heading lvl="1">Formulation Example 2 </heading>
<paragraph id="P-1518" lvl="0"><number>&lsqb;1518&rsqb;</number>  
<table-cwu id="TABLE-US-00005">
<number>5</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Preparation for Oral Solution</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="35PT" align="left"/>
<colspec colname="1" colwidth="91PT" align="left"/>
<colspec colname="2" colwidth="91PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Ingredient</entry>
<entry>Amount</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="OFFSET" colwidth="35PT" align="left"/>
<colspec colname="1" colwidth="91PT" align="left"/>
<colspec colname="2" colwidth="49PT" align="right"/>
<colspec colname="3" colwidth="42PT" align="left"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Compound of Example 210</entry>
<entry>400</entry>
<entry>mg</entry>
</row>
<row>
<entry></entry>
<entry>Sorbitol solution (70% N.F.)</entry>
<entry>40</entry>
<entry>mL</entry>
</row>
<row>
<entry></entry>
<entry>Sodium benzoate</entry>
<entry>20</entry>
<entry>mg</entry>
</row>
<row>
<entry></entry>
<entry>Saccharin</entry>
<entry>5</entry>
<entry>mg</entry>
</row>
<row>
<entry></entry>
<entry>Red dye</entry>
<entry>10</entry>
<entry>mg</entry>
</row>
<row>
<entry></entry>
<entry>Cherry flavor</entry>
<entry>20</entry>
<entry>mg</entry>
</row>
<row>
<entry></entry>
<entry>Distilled water q.s.</entry>
<entry>100</entry>
<entry>mL</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-1519" lvl="0"><number>&lsqb;1519&rsqb;</number> The sorbitol solution is added to 40 mL of distilled water, and the fused pyrimidinone of Example 210 is dissolved therein. The saccharin, sodium benzoate, flavor, and dye are added and dissolved. The volume is adjusted to 100 mL with distilled water. Each milliliter of syrup contains 4 mg of invention compound. </paragraph>
</section>
<section>
<heading lvl="1">Formulation Example 3 </heading>
<paragraph id="P-1520" lvl="7"><number>&lsqb;1520&rsqb;</number> Parenteral Solution </paragraph>
<paragraph id="P-1521" lvl="0"><number>&lsqb;1521&rsqb;</number> In a solution of 700 mL of propylene glycol and 200 mL of water for injection is suspended 20 g of the compound of Example 14. After suspension is complete, the pH is adjusted to 6.5 with 1N sodium hydroxide, and the volume is made up to 1000 mL with water for injection. The formulation is sterilized, filled into 5.0 mL ampoules each containing 2.0 mL, and sealed under nitrogen. </paragraph>
<paragraph id="P-1522" lvl="0"><number>&lsqb;1522&rsqb;</number> As matrix metalloproteinase inhibitors, the compounds of Formula I are useful as agents for the treatment of multiple sclerosis. They are also useful as agents for the treatment of atherosclerotic plaque rupture, restenosis, periodontal disease, corneal ulceration, treatment of bums, decubital ulcers, wound repair, heart failure, cancer metastasis, tumor angiogenesis, arthritis, and other inflammatory disorders dependent upon tissue invasion by leukocytes. </paragraph>
<paragraph id="P-1523" lvl="0"><number>&lsqb;1523&rsqb;</number> It should be appreciated that in all invention embodiments described above or in the claims below, whenever an R group such as, for example, R<highlight><superscript>1</superscript></highlight>, R<highlight><superscript>2</superscript></highlight>, R<highlight><superscript>3</superscript></highlight>, R<highlight><superscript>4</superscript></highlight>, R<highlight><superscript>5</superscript></highlight>, or R<highlight><superscript>6</superscript></highlight>, is used more than once to define an invention compound, each use of the R group is independent of any other use of that same R group or, for that matter, any other R group, unless otherwise specified. </paragraph>
</section>
</detailed-description>
</subdoc-description>
<subdoc-claims>
<heading lvl="1">What is claimed is: </heading>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. A compound of Formula I </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00206">
<number>206</number>
<image id="EMI-C00206" he="85.2201" wi="198.02475" file="US20030004172A1-20030102-C00206.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00206" file="US20030004172A1-20030102-C00206.CDX"/>
<chemistry-mol-file id="CHEMMOL-00206" file="US20030004172A1-20030102-C00206.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>or a pharmaceutically acceptable salt thereof; wherein: 
<claim-text>W, together with the carbon atoms to which it is attached, form a 5-membered ring diradical </claim-text>
<claim-text>A is </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00207">
<number>207</number>
<image id="EMI-C00207" he="346.6071" wi="192.2697" file="US20030004172A1-20030102-C00207.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00207" file="US20030004172A1-20030102-C00207.CDX"/>
<chemistry-mol-file id="CHEMMOL-00207" file="US20030004172A1-20030102-C00207.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>B is O or NR<highlight><superscript>5</superscript></highlight>; or </claim-text>
<claim-text>A and B are taken together to form &mdash;C&equiv;C&mdash;; </claim-text>
<claim-text>X is O, S, SO, SO<highlight><subscript>2</subscript></highlight>, NR<highlight><superscript>5</superscript></highlight>, or CH<highlight><subscript>2</subscript></highlight>; </claim-text>
<claim-text>each Y independently is O or S; </claim-text>
<claim-text>R<highlight><superscript>1</superscript></highlight>, R<highlight><superscript>4</superscript></highlight>, and R<highlight><superscript>5 </superscript></highlight>independently are hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heterocyclic, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkanoyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </claim-text>
<claim-text>R<highlight><superscript>2 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>independently are hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, CN, NO<highlight><subscript>2</subscript></highlight>, NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </claim-text>
<claim-text>R<highlight><superscript>2 </superscript></highlight>may further be halo; </claim-text>
<claim-text>n is an integer of from 0 to 5; and </claim-text>
<claim-text>R<highlight><superscript>4 </superscript></highlight>and R<highlight><superscript>5 </superscript></highlight>when taken together with a nitrogen to which they are both attached complete a 3- to 8-membered ring containing carbon atoms and optionally containing O, S, or N, and substituted or unsubstituted; </claim-text>
<claim-text>with the proviso that R<highlight><superscript>1 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>are not both selected from: hydrogen and C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. A compound of Formula XI </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00208">
<number>208</number>
<image id="EMI-C00208" he="85.2201" wi="198.02475" file="US20030004172A1-20030102-C00208.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00208" file="US20030004172A1-20030102-C00208.CDX"/>
<chemistry-mol-file id="CHEMMOL-00208" file="US20030004172A1-20030102-C00208.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>or a pharmaceutically salt thereof, wherein: 
<claim-text>W, together with the carbon atoms to which it is attached, form a 5-membered ring diradical </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00209">
<number>209</number>
<image id="EMI-C00209" he="57.12525" wi="59.7618" file="US20030004172A1-20030102-C00209.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00209" file="US20030004172A1-20030102-C00209.CDX"/>
<chemistry-mol-file id="CHEMMOL-00209" file="US20030004172A1-20030102-C00209.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>each Y independently is O or S; </claim-text>
<claim-text>X is S, O, or NR<highlight><superscript>5</superscript></highlight>; </claim-text>
<claim-text>R<highlight><superscript>1</superscript></highlight>, R<highlight><superscript>4</superscript></highlight>, and R<highlight><superscript>5 </superscript></highlight>independently are hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heterocyclic, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkanoyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </claim-text>
<claim-text>R<highlight><superscript>2 </superscript></highlight>is hydrogen, halo, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, CN, NO<highlight><subscript>2</subscript></highlight>, NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </claim-text>
<claim-text>R<highlight><superscript>3 </superscript></highlight>is hydrogen, halo, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, CN, NO<highlight><subscript>2</subscript></highlight>, NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>q </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>q </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>q </subscript></highlight>heteroaryl; </claim-text>
<claim-text>n is 0, 1, or 2; </claim-text>
<claim-text>q is 2, 3, or 4; and </claim-text>
<claim-text>R<highlight><superscript>4 </superscript></highlight>and R<highlight><superscript>5 </superscript></highlight>when taken together with a nitrogen to which they are both attached complete a 3- to 8-membered ring containing carbon atoms and optionally containing O, S, or N, and substituted or unsubstituted; </claim-text>
<claim-text>with the proviso that R<highlight><superscript>1 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>are not both selected from hydrogen and C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. The compound according to <dependent-claim-reference depends_on="CLM-00002">claim 2</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof, wherein Y is O, and X is S. </claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. The compound according to <dependent-claim-reference depends_on="CLM-00002">claim 2</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof, wherein Y is O, and X is O. </claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. The compound according to <dependent-claim-reference depends_on="CLM-00002">claim 2</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof, wherein Y is O, and X is NR<highlight><superscript>5</superscript></highlight>, wherein R<highlight><superscript>5 </superscript></highlight>is hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heterocyclic, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkanoyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl. </claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. A compound of Formula II </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00210">
<number>210</number>
<image id="EMI-C00210" he="91.6839" wi="198.02475" file="US20030004172A1-20030102-C00210.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00210" file="US20030004172A1-20030102-C00210.CDX"/>
<chemistry-mol-file id="CHEMMOL-00210" file="US20030004172A1-20030102-C00210.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>or a pharmaceutically acceptable salt thereof, wherein: 
<claim-text>A is </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00211">
<number>211</number>
<image id="EMI-C00211" he="22.5666" wi="100.5858" file="US20030004172A1-20030102-C00211.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00211" file="US20030004172A1-20030102-C00211.CDX"/>
<chemistry-mol-file id="CHEMMOL-00211" file="US20030004172A1-20030102-C00211.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>B is O or NR<highlight><superscript>5</superscript></highlight>; or </claim-text>
<claim-text>A and B are taken together to form &mdash;C&equiv;C&mdash;; </claim-text>
<claim-text>each Y independently is O or S; </claim-text>
<claim-text>R<highlight><superscript>1</superscript></highlight>, R<highlight><superscript>4</superscript></highlight>, and R<highlight><superscript>5 </superscript></highlight>independently are hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heterocyclic, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkanoyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </claim-text>
<claim-text>R<highlight><superscript>2 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>independently are hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, CN, NO<highlight><subscript>2</subscript></highlight>, NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </claim-text>
<claim-text>R<highlight><superscript>2 </superscript></highlight>may further be halo; </claim-text>
<claim-text>n is an integer of from 0 to 5; and </claim-text>
<claim-text>R<highlight><superscript>4 </superscript></highlight>and R<highlight><superscript>5 </superscript></highlight>when taken together with a nitrogen to which they are both attached complete a 3- to 8-membered ring containing carbon atoms and optionally containing O, S, or N, and substituted or unsubstituted; </claim-text>
<claim-text>with the proviso that R<highlight><superscript>1 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>are not both selected from: hydrogen and C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. The compound according to <dependent-claim-reference depends_on="CLM-00006">claim 6</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof, wherein &mdash;A&mdash;B&mdash; is &mdash;C&equiv;C&mdash;. </claim-text>
</claim>
<claim id="CLM-00008">
<claim-text><highlight><bold>8</bold></highlight>. The compound according to <dependent-claim-reference depends_on="CLM-00006">claim 6</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof, wherein A is </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00212">
<number>212</number>
<image id="EMI-C00212" he="21.3759" wi="33.1128" file="US20030004172A1-20030102-C00212.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00212" file="US20030004172A1-20030102-C00212.CDX"/>
<chemistry-mol-file id="CHEMMOL-00212" file="US20030004172A1-20030102-C00212.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>and B is NR<highlight><superscript>5</superscript></highlight>, wherein R<highlight><superscript>5 </superscript></highlight>is hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heterocyclic, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkanoyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl. </claim-text>
</claim>
<claim id="CLM-00009">
<claim-text><highlight><bold>9</bold></highlight>. The compound according to <dependent-claim-reference depends_on="CLM-00006">claim 6</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof, wherein A is </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00213">
<number>213</number>
<image id="EMI-C00213" he="21.3759" wi="33.1128" file="US20030004172A1-20030102-C00213.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00213" file="US20030004172A1-20030102-C00213.CDX"/>
<chemistry-mol-file id="CHEMMOL-00213" file="US20030004172A1-20030102-C00213.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>and B is O. </claim-text>
</claim>
<claim id="CLM-00010">
<claim-text><highlight><bold>10</bold></highlight>. A compound of Formula III </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00214">
<number>214</number>
<image id="EMI-C00214" he="91.4571" wi="198.02475" file="US20030004172A1-20030102-C00214.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00214" file="US20030004172A1-20030102-C00214.CDX"/>
<chemistry-mol-file id="CHEMMOL-00214" file="US20030004172A1-20030102-C00214.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>or a pharmaceutically acceptable salt thereof, wherein: 
<claim-text>A is </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00215">
<number>215</number>
<image id="EMI-C00215" he="22.31145" wi="86.184" file="US20030004172A1-20030102-C00215.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00215" file="US20030004172A1-20030102-C00215.CDX"/>
<chemistry-mol-file id="CHEMMOL-00215" file="US20030004172A1-20030102-C00215.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>B is O or NR<highlight><superscript>5</superscript></highlight>; or </claim-text>
<claim-text>A and B are taken together to form &mdash;C&equiv;C&mdash;; </claim-text>
<claim-text>R<highlight><superscript>1</superscript></highlight>, R<highlight><superscript>4</superscript></highlight>, and R<highlight><superscript>5 </superscript></highlight>independently are hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heterocyclic, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkanoyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </claim-text>
<claim-text>R<highlight><superscript>2 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>independently are hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, CN, NO<highlight><subscript>2</subscript></highlight>, NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </claim-text>
<claim-text>R<highlight><superscript>2 </superscript></highlight>may further be halo; </claim-text>
<claim-text>n is an integer of from 0 to 5; and </claim-text>
<claim-text>R<highlight><superscript>4 </superscript></highlight>and R<highlight><superscript>5 </superscript></highlight>when taken together with a nitrogen to which they are both attached complete a 3- to 8-membered ring containing carbon atoms and optionally containing O, S, or N, and substituted or unsubstituted; </claim-text>
<claim-text>with the proviso that R<highlight><superscript>1 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>are not both selected from hydrogen and C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00011">
<claim-text><highlight><bold>11</bold></highlight>. A compound of Formula IV </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00216">
<number>216</number>
<image id="EMI-C00216" he="91.4571" wi="198.02475" file="US20030004172A1-20030102-C00216.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00216" file="US20030004172A1-20030102-C00216.CDX"/>
<chemistry-mol-file id="CHEMMOL-00216" file="US20030004172A1-20030102-C00216.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>or a pharmaceutically acceptable salt thereof, wherein: 
<claim-text>A is </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00217">
<number>217</number>
<image id="EMI-C00217" he="22.31145" wi="85.4469" file="US20030004172A1-20030102-C00217.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00217" file="US20030004172A1-20030102-C00217.CDX"/>
<chemistry-mol-file id="CHEMMOL-00217" file="US20030004172A1-20030102-C00217.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>B is O or NR<highlight><superscript>5</superscript></highlight>; or </claim-text>
<claim-text>A and B are taken together to form &mdash;C&equiv;C&mdash;; </claim-text>
<claim-text>R<highlight><superscript>1</superscript></highlight>, R<highlight><superscript>4</superscript></highlight>, and R<highlight><superscript>5 </superscript></highlight>independently are hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heterocyclic, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkanoyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </claim-text>
<claim-text>R<highlight><superscript>2 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>independently are hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, CH, NO<highlight><subscript>2</subscript></highlight>, NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </claim-text>
<claim-text>R<highlight><superscript>2 </superscript></highlight>may further be halo; </claim-text>
<claim-text>n is an integer of from 0 to 5; and </claim-text>
<claim-text>R<highlight><superscript>4 </superscript></highlight>and R<highlight><superscript>5 </superscript></highlight>when taken together with a nitrogen to which they are both attached complete a 3- to 8-membered ring containing carbon atoms and optionally containing O, S, or N, and substituted or unsubstituted; </claim-text>
<claim-text>with the proviso that R<highlight><superscript>1 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>are not both selected from hydrogen and C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00012">
<claim-text><highlight><bold>12</bold></highlight>. A compound of Formula V </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00218">
<number>218</number>
<image id="EMI-C00218" he="91.4571" wi="198.02475" file="US20030004172A1-20030102-C00218.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00218" file="US20030004172A1-20030102-C00218.CDX"/>
<chemistry-mol-file id="CHEMMOL-00218" file="US20030004172A1-20030102-C00218.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>or a pharmaceutically acceptable salt thereof, wherein: 
<claim-text>A is </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00219">
<number>219</number>
<image id="EMI-C00219" he="22.31145" wi="85.4469" file="US20030004172A1-20030102-C00219.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00219" file="US20030004172A1-20030102-C00219.CDX"/>
<chemistry-mol-file id="CHEMMOL-00219" file="US20030004172A1-20030102-C00219.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>B is O or NR<highlight><superscript>5</superscript></highlight>; or </claim-text>
<claim-text>A and B are taken together to form &mdash;C&equiv;C&mdash;; </claim-text>
<claim-text>R<highlight><superscript>1</superscript></highlight>, R<highlight><superscript>4</superscript></highlight>, and R<highlight><superscript>5 </superscript></highlight>independently are hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heterocyclic, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkanoyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </claim-text>
<claim-text>R<highlight><superscript>2 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>independently are hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, CH, NO<highlight><subscript>2</subscript></highlight>, NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </claim-text>
<claim-text>R<highlight><superscript>2 </superscript></highlight>may further be halo; </claim-text>
<claim-text>n is an integer of from 0 to 5; and </claim-text>
<claim-text>R<highlight><superscript>4 </superscript></highlight>and R<highlight><superscript>5 </superscript></highlight>when taken together with a nitrogen to which they are both attached complete a 3- to 8-membered ring containing carbon atoms and optionally containing O, S, or N, and substituted or unsubstituted; </claim-text>
<claim-text>with the proviso that R<highlight><superscript>1 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>are not both selected from hydrogen and C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00013">
<claim-text><highlight><bold>13</bold></highlight>. The compound according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, selected from: 
<claim-text>4-&lcub;6-&lsqb;3-(4-Methoxy-phenyl)-prop-1-ynyl&rsqb;-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid; </claim-text>
<claim-text>3-(4-Methanesulfonyl-benzyl)-6-&lsqb;3-(4-methoxy-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>4-&lcub;6-&lsqb;3-(3-Methoxy-phenyl)-prop-1-ynyl&rsqb;-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid; </claim-text>
<claim-text>3-(4-Methanesulfonyl-benzyl)-6-&lsqb;3-(3-methoxy-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>4-&lsqb;1-Methyl-2,4-dioxo-6-(3-pyridine-4-yl-prop-1-ynyl)-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rsqb;-benzoic acid; </claim-text>
<claim-text>3-(4-Methanesulfonyl-benzyl)-1-6-(3-pyridin-4-yl-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>4-&lsqb;1-Methyl-2,4-dioxo-6-(3-pyridine-3-yl-prop-1-ynyl)-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rsqb;-benzoic acid; </claim-text>
<claim-text>3-(4-Methanesulfonyl-benzyl)-1-6-(3-pyridin-3-yl-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>4-&lcub;6-&lsqb;3-(4-Fluoro-phenyl)-prop-1-ynyl&rsqb;-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid; </claim-text>
<claim-text>6-&lsqb;3-(4-Fluoro-phenyl)-prop-1-ynyl&rsqb;-3-(4-methanesulfonyl-benzyl)-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>4-&lcub;6-&lsqb;3-(3-Fluoro-phenyl)-prop-1-ynyl&rsqb;-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid; </claim-text>
<claim-text>6-&lsqb;3-(3-Fluoro-phenyl)-prop-1-ynyl&rsqb;-3-(4-methanesulfonyl-benzyl)-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>4-&lcub;6-&lsqb;3-(4-Chloro-phenyl)-prop-1-ynyl&rsqb;-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid; </claim-text>
<claim-text>6-&lsqb;3-(4-Chloro-phenyl)-prop-1-ynyl&rsqb;-3-(4-methanesulfonyl-benzyl)-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>4-&lcub;6-&lsqb;3-(3-Chloro-phenyl)-prop-1-ynyl&rsqb;-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid; </claim-text>
<claim-text>6-&lsqb;3-(3-Chloro-phenyl)-prop-1-ynyl&rsqb;-3-(4-methanesulfonyl-benzyl)-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>4-&lcub;6-&lsqb;3-(4-Bromo-phenyl)-prop-1-ynyl&rsqb;-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid; </claim-text>
<claim-text>6-&lsqb;3-(4-Bromo-phenyl)-prop-1-ynyl&rsqb;-3-(4-methanesulfonyl-benzyl)-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>4-&lcub;6-&lsqb;3-(3-Bromo-phenyl)-prop-1-ynyl&rsqb;-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid; </claim-text>
<claim-text>6-&lsqb;3-(3-Bromo-phenyl)-prop-1-ynyl&rsqb;-3-(4-methanesulfonyl-benzyl)-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>4-&lcub;1-Methyl-6-&lsqb;3-(4-nitro-phenyl)-prop-1-ynyl&rsqb;-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid; </claim-text>
<claim-text>3-(4-Methanesulfonyl-benzyl)-1-methyl-6-&lsqb;3-(4-nitro-phenyl)-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>4-&lcub;6-&lsqb;3-(2-Methoxy-pyridin-4-yl)-prop-1-ynyl&rsqb;-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid; </claim-text>
<claim-text>3-(4-Methanesulfonyl-benzyl)-6-&lsqb;3-(2-methoxy-pyridin-4-yl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>4-&lcub;1-Methyl-6-&lsqb;3-(4-methylsulfanyl-phenyl)-prop-1-ynyl&rsqb;-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid; </claim-text>
<claim-text>3-(4-Methanesulfonyl-benzyl)-1-methyl-6-&lsqb;3-(4-methylsulfanyl-phenyl)-prop-1-ynyl&rsqb;-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>4-&lcub;1-Methyl-6-&lsqb;3-(3-methylsulfanyl-phenyl)-prop-1-ynyl&rsqb;-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rcub;-benzoic acid; </claim-text>
<claim-text>3-(4-Methanesulfonyl-benzyl)-1-methyl-6-&lsqb;3-(3-methylsulfanyl-phenyl)-prop-1-ynyl&rsqb;-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>4-&lsqb;1-Methyl-2,4-dioxo-6-(3-p-tolyl-prop-1-ynyl)-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;benzoic acid; </claim-text>
<claim-text>3-(4-Methanesulfonyl-benzyl)-1-methyl-6-(3-p-tolyl-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>4-&lsqb;1-Methyl-2,4-dioxo-6-(3-m-tolyl-prop-1-ynyl)-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;benzoic acid; </claim-text>
<claim-text>3-(4-Methanesulfonyl-benzyl)-1-methyl-6-(3-m-tolyl-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-Benzyl-6-&lsqb;3-(4-methoxy-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-Benzyl-6-&lsqb;3-(3-methoxy-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-Benzyl-1-methyl-6-(3-pyridin-4-yl-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-Benzyl-1-methyl-6-(3-pyridin-3-yl-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-Benzyl-6-&lsqb;3-(4-fluoro-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-Benzyl-6-&lsqb;3-(3-fluoro-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-Benzyl-6-&lsqb;3-(4-chloro-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-Benzyl-6-&lsqb;3-(3-chloro-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-Benzyl-6-&lsqb;3-(4-bromo-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-Benzyl-6-&lsqb;3-(3-bromo-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-Benzyl-6-&lsqb;3-(2-methoxy-pyridin-4-yl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-Benzyl-1-methyl-6-&lsqb;3-(4-methylsulfanyl-phenyl)-prop-1-ynyl&rsqb;-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-Benzyl-1-methyl-6-&lsqb;3-(3-methylsulfanyl-phenyl)-prop-1-ynyl&rsqb;-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-Benzyl-1-methyl-6-(3-p-tolyl-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-Benzyl-1-methyl-6-(3-m-tolyl-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-(3-Fluoro-benzyl)-6-&lsqb;3-(4-methoxy-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-(3-Fluoro-benzyl)-6-&lsqb;3-(3-methoxy-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-(3-Fluoro-benzyl)-1-methyl-6-(3-pyridine-4-yl-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-(3-Fluoro-benzyl)-1-methyl-6-(3-pyridine-3-yl-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-(3-Fluoro-benzyl)-6-&lsqb;3-(4-fluoro-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-(3-Fluoro-benzyl)-6-&lsqb;3-(3-fluoro-phenyl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>6-&lsqb;3-(4-Chloro-phenyl)-prop-1-ynyl&rsqb;-3-(3-fluoro-benzyl)-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>6-&lsqb;3-(3-Chloro-phenyl)-prop-1-ynyl&rsqb;-3-(3-fluoro-benzyl)-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>6-&lsqb;3-(4-Bromo-phenyl)-prop-1-ynyl&rsqb;-3-(3-fluoro-benzyl)-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>6-&lsqb;3-(3-Bromo-phenyl)-prop-1-ynyl&rsqb;-3-(3-fluoro-benzyl)-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-(3-Fluoro-benzyl)-6-&lsqb;3-(2-methoxy-pyridin-4-yl)-prop-1-ynyl&rsqb;-1-methyl-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-(3-Fluoro-benzyl)-1-methyl-6-&lsqb;3-(4-methylsulfanyl-phenyl)-prop-1-ynyl&rsqb;-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-(3-Fluoro-benzyl)-1-methyl-6-&lsqb;3-(3-methylsulfanyl-phenyl)-prop-1-ynyl&rsqb;-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; </claim-text>
<claim-text>3-(3-Fluoro-benzyl)-1-methyl-6-(3-p-tolyl-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione; and </claim-text>
<claim-text>3-(3-Fluoro-benzyl)-1-methyl-6-(3-m-tolyl-prop-1-ynyl)-1H-thieno&lsqb;2,3-d&rsqb;pyrimidine-2,4-dione. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00014">
<claim-text><highlight><bold>14</bold></highlight>. The compound according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, selected from: 
<claim-text>3-(3-Methoxycarbonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(3-Methoxycarbonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Benzofuran-5-ylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-3-(4-methyl-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Acetylamino-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(4-vinyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(4-sulfamoyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Bromo-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-4-ylmethyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-phenethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-&lsqb;4-(2H-tetrazol-5-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Fluoro-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-4-ylmethyl ester; </claim-text>
<claim-text>3-(4-tert-Butyoxycarbonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-tert-Butyoxycarbonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid; </claim-text>
<claim-text>4-&lsqb;6-(4-Fluoro-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; </claim-text>
<claim-text>4-&lsqb;6-(4-Dimethylamino-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid, compound with trifluoro-acetic acid; </claim-text>
<claim-text>4-&lsqb;6-(2-Ethoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-3-ylmethyl&rsqb;-benzoic acid; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-&lsqb;4-(1H-tetrazol-5-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-3-&lsqb;4-(morpholine-4-sulfonyl)-benzyl&rsqb;-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-3-&lsqb;4-(morpholine-4-carbonyl)-benzyl&rsqb;-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>3-But-2-ynyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-&lsqb;3-(1H-tetrazol-5-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>3-(4-Cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; 
<claim-text>&lcub;4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-phenyl&rcub;-acetic acid; </claim-text>
</claim-text>
<claim-text>3-&lsqb;2-(2,4-Dichloro-benzenesulfonyl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>3-(4-Methanesulfonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(4-sulfamoyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-methoxy-pyridin-4-ylmethyl)-amide; </claim-text>
<claim-text>1-Methyl-3-(4-methylsulfamoyl-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>3-(4-Isopropylsulfamoyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-&lsqb;4-(pyrrolidine-1-sulfonyl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; and </claim-text>
<claim-text>1-Methyl-3-&lsqb;4-(4-methyl-piperidine-1-sulfonyl)-benzyl&rsqb;-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00015">
<claim-text><highlight><bold>15</bold></highlight>. The compound according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, selected from: 
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzofuran-2-ylmethyl ester; </claim-text>
<claim-text>3-(4-Bromo-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-4-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzyl ester; </claim-text>
<claim-text>4-&lcub;1-Methyl-2,4-dioxo-6-&lsqb;(pyridin-4-ylmethyl)-carbamoyl&rsqb;-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rcub;-benzoic acid, compound with trifluoro-acetic acid; </claim-text>
<claim-text>4-&lsqb;6-(4-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; </claim-text>
<claim-text>4-&lsqb;6-(3,4-Dimethoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid tert-butyl ester; </claim-text>
<claim-text>4-&lsqb;6-(3,4-Dimethoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; </claim-text>
<claim-text>4-&lsqb;6-(4-Bromo-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; </claim-text>
<claim-text>4-&lsqb;6-(4-Bromo-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid tert-butyl ester; </claim-text>
<claim-text>4-&lsqb;6-(3,5-Bis-trifluoromethyl-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; </claim-text>
<claim-text>4-&lsqb;6-(4-Chloro-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; </claim-text>
<claim-text>4-&lsqb;1-Methyl-2,4-dioxo-6-(4-sulfamoyl-benzylcarbamoyl)-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; </claim-text>
<claim-text>3-(4-Fluoro-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-(4-Iodo-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>3-(4-Dimethylsulfamoyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-(3-Methoxy-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-(4-Cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-(4-Acetylamino-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>5-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-furan-2-carboxylic acid ethyl ester; </claim-text>
<claim-text>3-(4-Cyano-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-&lsqb;4-(5-thioxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid 2-dimethylamino-ethyl ester; </claim-text>
<claim-text>3-Cyclohexylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-Cyclohexylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid furan-3-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pentafluorophenylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-ethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-cyclopropylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (pyridin-4-ylmethyl)-amide </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-bromo-benzyl ester; </claim-text>
<claim-text>4-&lsqb;6-(3-Difluoromethoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; </claim-text>
<claim-text>4-&lsqb;6-(3-Difluoromethoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid tert-butyl ester; </claim-text>
<claim-text>4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; </claim-text>
<claim-text>4-&lsqb;6-(4-Methanesulfonyl-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid tert-butyl ester; </claim-text>
<claim-text>4-&lsqb;6-(4-Methanesulfonyl-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; </claim-text>
<claim-text>4-&lsqb;1-Methyl-2,4-dioxo-6-(2-pyridin-4-yl-ethylcarbamoyl)-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(4-trifluoromethoxy-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </claim-text>
<claim-text>4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid methyl ester; </claim-text>
<claim-text>3-(2,3-Dihydro-benzofuran-6-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </claim-text>
<claim-text>1-Methyl-3-(2-methyl-thiazol-5-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-&lsqb;4-(1H-tetrazol-5-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-fluoro-benzylamide; </claim-text>
<claim-text>3-Benzyl-2-methoxy-4-oxo-3,4-dihydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid 2,2-dimethyl-propionyloxymethyl ester; </claim-text>
<claim-text>4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-cyclohexanecarboxylic acid; </claim-text>
<claim-text>4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-cyclohexanecarboxylic acid methyl ester; </claim-text>
<claim-text>1-&lcub;4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-phenyl&rcub;-cyclopropanecarboxylic acid methyl ester; </claim-text>
<claim-text>1-&lcub;4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-phenyl&rcub;-cyclopropanecarboxylic acid tert-butyl ester; </claim-text>
<claim-text>1-&lcub;4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-phenyl&rcub;-cyclopropanecarboxylic acid; </claim-text>
<claim-text>2-&lcub;4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-phenoxy&rcub;-2-methyl-propionic acid tert-butyl ester; </claim-text>
<claim-text>2-&lcub;4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-phenoxy&rcub;-2-methyl-propionic acid; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-furo&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(3-Methoxy-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Biphenyl-4-ylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Methanesulfonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Methanesulfonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-3-(4-methyl-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-phenethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Amino-6-phenylamino-1,3,5-triazin-2-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(4-trifluoromethyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(6-Cyano-hexyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-&lsqb;2-(2,5-Dimethoxy-phenyl)-2-oxo-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(3-Iodo-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(3-trifluoromethyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(2,4-Bis-trifluoromethyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-&lsqb;2-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-&lsqb;2-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(2-Carboxy-allyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(2-Carboxy-allyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(3-Amino-propyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(1,3-Dioxo-1,3-dihydro-isoindol-2-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Fluoro-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-3-oxiranylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-3-((S)-2-methyl-butyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(4-phenoxy-butyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(2-Cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(3-phenoxy-propyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Hex-5-enyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-pyridin-3-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-&lsqb;2-Hydroxy-3-(naphthalen-1-yloxy)-propyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1,3-Dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Cyclobutylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Allyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-prop-2-ynyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-But-2-ynyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(2-phenoxy-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(2-phenoxy-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-((R)-3-Hydroxy-2-methyl-propyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Isobutyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(6-Chloro-pyridin-3-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(2-Benzenesulfonylmethyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-3-naphthalen-1-ylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(2-trifluoromethyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(3-Chloro-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Methoxycarbonyl-butyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; 
<claim-text>3-Ethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
</claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-fluoro-benzyl ester; </claim-text>
<claim-text>3-&lsqb;2-(4-Chloro-benzenesulfonyl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(2-Acetoxy-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-phenoxy-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,6-dichloro-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid butyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,3-dihydro-1,4-benzodioxin-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-diethylamino-1-methyl-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-fluoro-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-isopropyl-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-p-tolyl-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-trifluoromethyl-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cyclobutylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,6-difluoro-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-(2-hydroxy-phenyl)-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-(2-hydroxy-phenyl)-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-methyl-piperidin-4-yl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-methyl-piperidin-4-yl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-3-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-pyridin-3-yl-propyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-dimethylamino-1-methyl-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid tetrahydro-pyran-4-yl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,2,2-trifluoro-1-trifluoromethyl-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-trifluoromethyl-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-benzyloxy-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,2,2-trichloro-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid phenethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-ethyl-oxetan-3-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-morpholin-4-yl-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-pyrrolidin-1-yl-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-pyrrolidin-1-yl-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-(2-ethoxy-ethoxy)-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid tetrahydro-pyran-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-nitro-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pentyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-phenyl-propyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-phenoxy-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3,5-dimethoxy-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methyl-butyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-chloro-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-ethyl-piperidin-3-yl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-benzyloxy-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid isobutyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-(4-methoxy-phenyl)-propyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-chloro-6-fluoro-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (S)-(tetrahydro-furan-3-yl)ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-pyridin-2-yl-propyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-piperidin-2-yl-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 5-bromo-2-methoxy-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cycloheptylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1,2,3,4-tetrahydro-naphthalen-1-yl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (S)-1-pyrrolidin-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-chloro-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1,3-benzodioxol-5-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methylsulfanyl-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methylsulfanyl-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3,4-dichloro-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3,3-diphenyl-propyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-pyridin-2-yl-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid furan-3-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid but-3-enyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-cyano-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-ethoxy-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cyano-phenyl-methyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-trifluoromethyl-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methyl-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid phenethyl-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cyclopropylamide; </claim-text>
<claim-text>1-Methyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(4-sulfamoyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(3-oxo-3-phenyl-propyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>3-&lsqb;4-(N-Hydroxycarbamimidoyl)-benzyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-&lsqb;4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-&lsqb;4-(5-thioxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-benzyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>4-(5-Isopropyl-2H-pyrazol-3-yl)-pyridine; </claim-text>
<claim-text>3-Cyanomethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; 
<claim-text>(E)-4-&lsqb;6-(4-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-yl&rsqb;-but-2-enoic acid methyl ester; </claim-text>
<claim-text>(E)-4-&lsqb;6-(4-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-yl&rsqb;-but-2-enoic acid; </claim-text>
</claim-text>
<claim-text>3-(2-Benzenesulfonyl-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>2-Methoxy-4-&lsqb;6-(4-methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid methyl ester; </claim-text>
<claim-text>3-(2-Methoxymethyl-1,1,3-trioxo-2,3-dihydro-1H-1l<highlight><superscript>6</superscript></highlight>-1,2-benzisothiazol-6-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-3-oct-2-ynyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-&lsqb;2-(4-Chloro-benzenesulfonylamino)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-&lsqb;2-(4-Bromo-phenoxy)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-&lsqb;2-(4-Bromo-phenoxy)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>3-&lsqb;2-(4-Fluoro-phenoxy)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-&lsqb;2-(4-Chloro-benzenesulfonyl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-&lsqb;2-(4-Fluoro-phenoxy)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-methoxy-pyridin-4-ylmethyl)-amide; </claim-text>
<claim-text>3-Cyclohexylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>4-&lsqb;6-(4-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-2-methyl-benzoic acid methyl ester; </claim-text>
<claim-text>4-&lsqb;6-(4-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid methyl ester; </claim-text>
<claim-text>2-Methoxy-4-&lsqb;6-(3-methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-benzoic acid methyl ester; </claim-text>
<claim-text>4-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-2-methyl-benzoic acid methyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(3-oxo-3-phenyl-propyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-&lsqb;2-(4-Chloro-phenoxy)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-&lsqb;2-(3-trifluoromethyl-benzenesulfonyl)-ethyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-&lsqb;2-(3-trifluoromethyl-benzenesulfonyl)-ethyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-&lsqb;2-(4-Chloro-benzenesulfonyl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; and </claim-text>
<claim-text>3-(2-Amino-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00016">
<claim-text><highlight><bold>16</bold></highlight>. The compound according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, selected from: 
<claim-text>1-Methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid; </claim-text>
<claim-text>4-(6-Carbamoyl-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl)-2-methyl-benzoic acid; </claim-text>
<claim-text>4-(6-Carbamoyl-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl)-2-methyl-benzoic acid methyl ester; </claim-text>
<claim-text>4-&lsqb;6-(3-Hydroxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-2-methyl-benzoic acid; </claim-text>
<claim-text>4-(6-Carbamoyl-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl)-2-hydroxy-benzoic acid; </claim-text>
<claim-text>3-(2-Amino-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; and </claim-text>
<claim-text>4-(2,5-Di-pyridin-4-yl-thiophen-3-yl)-benzaldehyde. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00017">
<claim-text><highlight><bold>17</bold></highlight>. The compound according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, selected from: 
<claim-text>1-Methyl-2,4-dioxo-3-(1-phenyl-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(3-oxo-3-phenyl-propyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-((S)-3,7-Dimethyl-oct-6-enyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-(2-Ethyl-hexyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-(5-Cyano-pentyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-(E)-But-2-enyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-3-(2-naphthalen-1-yl-ethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(E)-pent-2-enyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(2-phenylsulfanyl-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-sec-Butyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-3-(2-methyl-allyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-(1-Ethyl-propyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-pent-2-ynyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-(2-Benzenesulfonyl-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-3-(3-methyl-but-2-enyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-&lsqb;2-(4-Fluoro-benzenesulfonyl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-&lsqb;2-(toluene-4-sulfonyl)-ethyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-&lsqb;3-(4-Fluoro-phenyl)-3-oxo-propyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-&lsqb;3-(4-Chloro-phenyl)-3-oxo-propyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-(2-Benzoylamino-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-&lsqb;2-(4-Bromo-phenoxy)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-Benzofurazan-5-ylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(2-phenoxy-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>&lcub;5-&lsqb;6-(4-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-isoxazol-3-yl&rcub;-carbamic acid methyl ester; </claim-text>
<claim-text>3-Benzyloxycarbonylamino-5-&lsqb;6-(4-methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-yl&rsqb;-4-oxo-pentanoic acid tert-butyl ester; </claim-text>
<claim-text>3-&lsqb;2-(4-Chloro-phenylsulfanyl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(1-phenyl-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(E)-pent-2-enyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimdine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>3-(2-Ethyl-hexyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(2-phenylmethanesulfonyl-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>3-(5-Cyano-pentyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>3-(E)-But-2-enyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-3-(2-naphthalen-1-yl-ethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(E)-pent-2-enyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(2-phenylsulfanyl-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>3-sec-Butyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-3-(2-methyl-allyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>3-(1-Ethyl-propyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-pent-2-ynyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-3-(3-methyl-but-2-enyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; 
<claim-text>1-Methyl-2,4-dioxo-3-&lsqb;2-(toluene-4-sulfonyl)-ethyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
</claim-text>
<claim-text>3-(2-Benzoylamino-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>3-&lsqb;2-(4-Bromo-phenoxy)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>3-Benzofurazan-5-ylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(2-phenoxy-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>&lcub;5-&lsqb;6-(3-Methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-ylmethyl&rsqb;-isoxazol-3-yl&rcub;-carbamic acid methyl ester; and </claim-text>
<claim-text>3-Benzyloxycarbonylamino-5-&lsqb;6-(3-methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-thieno&lsqb;2,3-d&rsqb;pyrimidin-3-yl&rsqb;-4-oxo-pentanoic acid tert-butyl ester. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00018">
<claim-text><highlight><bold>18</bold></highlight>. The compound according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, selected from: 
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Pyridyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Pyridyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;-pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (4-pyridyl)ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (4-pyridyl)ester; </claim-text>
<claim-text>3-(4-Pyridyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (4-pyridyl)ester; </claim-text>
<claim-text>3-(4-Pyridyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;-pyrimidine-6-carboxylic acid (4-pyridyl)ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid piperoyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid piperoyl ester; </claim-text>
<claim-text>3-Piperoyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid piperoyl ester; </claim-text>
<claim-text>3-Piperoyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;-pyrimidine-6-carboxylic acid piperoyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-furo&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-1H-pyrrolo&lsqb;2,3-d&rsqb;-pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Benzyl-1,7-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-1H-pyrrolo&lsqb;2,3-d&rsqb;-pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Benzyl-1,7-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-1H-pyrrolo&lsqb;2,3-d&rsqb;-pyrimidine-6-carboxylic acid benzofuran-6-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-1H-pyrrolo&lsqb;2,3-d&rsqb;-pyrimidine-6-carboxylic acid benzofuran-6-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-furo&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzofuran-6-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzofuran-6-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1,7-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-1H-pyrrolo&lsqb;2,3-d&rsqb;-pyrimidine-6-carboxylic acid benzothiophene-6-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-1H-pyrrolo&lsqb;2,3-d&rsqb;-pyrimidine-6-carboxylic acid benzothiophene-6-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-furo&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzothiophene-6-ylmethyl ester; and </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzothiophene-6-ylmethyl ester. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00019">
<claim-text><highlight><bold>19</bold></highlight>. A compound according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof, selected from: 
<claim-text>3-(3-Methoxy-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Chloro-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Fluoro-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(3-Chloro-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-3-(2-methyl-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-3-(4-methyl-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Carboxy-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(3-trifluoromethyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Biphenyl-4-ylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(2-trifluoromethyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(3-Cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(2-Cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(4-trifluoromethyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-&lsqb;2-Hydroxy-3-(naphthalen-1-yloxy)-propyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(3-Chloro-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-3-naphthalen-1-ylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(6-Chloro-benzo&lsqb;1,3&rsqb;dioxol-5-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(4-oxo-4-thiophen-2-yl-butyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-pyridin-4-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(4-m-tolyloxy-butyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(3,5-Dimethyl-isoxazol-4-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Dioxo-1,3-dihydro-isoindol-2-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Dihydro-benzo&lsqb;1,4&rsqb;dioxin-2-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-pyridin-2-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-&lsqb;2-(2,5-Dimethoxy-phenyl)-2-oxo-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Benzyloxymethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(4-m-tolyloxy-butyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(2-phenylmethanesulfonyl-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Amino-6-phenylamino-&lsqb;1,3,5&rsqb;triazin-2-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-&lsqb;4-(4-Fluoro-phenyl)-4-oxo-butyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-&lsqb;4-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-butyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(4-phenoxy-butyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(4-oxo-4-phenyl-butyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(2-phenoxy-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-&lcub;3-&lsqb;4-(3-Chloro-phenyl)-piperazin-1-yl&rsqb;-propyl&rcub;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-&lsqb;1-Bromo-2-(1H-indol-3-yl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(2-Benzenesulfinyl-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-&lsqb;3-(3-Fluoro-phenylcarbamoyl)-propyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-&lsqb;2-(2-trifluoromethyl-phenylcarbamoyl)-ethyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-&lsqb;2-(4-Methoxy-phenyl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-&lsqb;2-(4-Chloro-2-nitro-phenoxy)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-3-(5-nitro-furan-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(1-Benzyl-1H-imidazol-2-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-&lsqb;3-(Benzyl-methyl-amino)-propyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(Bis-trifluoromethyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-&lsqb;3-(2-Bromo-4-methyl-phenoxy)-propyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Benzenesulfonylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-&lsqb;2-(4-Chloro-benzenesulfonyl)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Benzo&lsqb;1,3&rsqb;dioxol-5-ylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(3-Iodo-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(4-trifluoromethoxy-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Acetoxy-butyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Methanesulfonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(4-&lsqb;1,2,3&rsqb;thiadiazol-4-yl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(5-Methoxycarbonyl-furan-2-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(2-Carboxy-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(3-pyrrol-1-yl-propyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(3-Carboxy-propyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(2-Cyano-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(3-Ethoxycarbonyl-furan-2-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(3-Amino-propyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(3-Cyano-propyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(2-Hydroxy-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(2-Carboxy-hexyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(2,2,2-trifluoro-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(2,2,2-trifluoro-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxyl carboxylic acid benzyl ester; </claim-text>
<claim-text>Iodomethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(2-Fluoro-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>Methyl-2,4-dioxo-3-(tetrahydro-furan-2-ylmethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-&lsqb;1-(4-Carboxy-phenyl-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(Hex-5-enyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(2-Ethyl-butyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(2,2,2-trifluoro-ethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxyl pyrimidine acid benzyl ester; </claim-text>
<claim-text>3-(Diethoxy-phosphorylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-But-2-ynyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; 
<claim-text>Bromo-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid; </claim-text>
</claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-&lsqb;2-(tetrahydro-pyran-2-yloxy)-ethyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-propyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(2-Acetoxy-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid; </claim-text>
<claim-text>3-Butyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Isobutyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Ethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(3-Bromo-propyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Cyclohexylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(2-Ethylamino-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Cyclobutylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-((R)-3-Hydroxy-2-methyl-propyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Hydroxy-butyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(2-Ethoxy-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Isobutyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(2-Chloro-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-3-(3-methyl-but-2-enyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Allyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(2,2-Dimethoxy-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-3-oxiranylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-propyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Benzo&lsqb;1,2,5&rsqb;oxadiazol-5-ylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(3-Hydroxy-2,2-dimethyl-propyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(2-Carboxy-ethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Propyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(4-sulfamoyl-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-3-(4-methylsulfamoyl-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Dimethylsulfamoyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Methanesulfonylamino-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-&lsqb;4-(Methanesulfonyl-methyl-amino)-benzyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Acetylamino-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-&lsqb;4-(Acetyl-methyl-amino)-benzyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Dimethylamino-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-3-(4-methylamino-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Carbamoyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Dimethylcarbamoyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Carboxy-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Methoxycarbonyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-&lcub;4-&lsqb;Bis-(2-hydroxy-ethyl)-amino&rsqb;-benzyl&rcub;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(3,5-Dimethoxy-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-tert-Butyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(4-trifluoromethoxy-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Methanesulfonyl-benzyl)-1-methyl -2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>2,4-Dioxo-3-&lsqb;1,3,4&rsqb;thiadiazol-2-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Isoxazol-3-ylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Oxazol-2-ylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>2,4-Dioxo-3-thiazol-2-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(1H-Imidazol-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(1-Methyl-1H-imidazol-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(1-Methyl-1H-pyrrol-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>2,4-Dioxo-3-(1H-pyrrol-2-ylmethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>2,4-Dioxo-3-(1H-pyrrol-2-ylmethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>2,4-Dioxo-3-thiophen-2-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>2,4-Dioxo-3-&lsqb;1,2,3,4&rsqb;tetrazin-5-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>2,4-Dioxo-3-&lsqb;1,2,4,5&rsqb;tetrazin-3-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(1-Methyl-piperidin-4-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>2,4-Dioxo-3-pyrimidin-2-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>2,4-Dioxo-3-(2H-pyran-2-ylmethyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(1H-Imidazo&lsqb;4,5-b&rsqb;pyridin-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(1H-Benzoimidazol-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Benzo&lsqb;b&rsqb;thiophen-2-ylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>2,4-Dioxo-3-quinolin-2-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(2H-Chromen-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(1H-Benzoimidazol-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(1-Methyl-1H-benzoimidazol-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(1H-Indol-2-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid furan-3-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-ethyl-propyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1,1-dioxo-tetrahydro-1l<highlight><superscript>6</superscript></highlight>-thiophen-3-yl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-hydroxy-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-oxy-pyridin-4-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid but-3-enyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-diethylamino-propyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-cyano-1-phenyl-methyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-amino-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-oxy-pyridin-3-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-ethoxy-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid thiophen-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,6-dichloro-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid dimethylamino-methyl-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,2-diphenyl-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-pyridin-2-yl-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-ethanesulfonyl-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid diethylamino-methyl-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid dimethylamino-methyl-propyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-(2-chloro-phenoxy)-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-(2-ethoxy-ethoxy)-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-hydroxy-benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-morpholin-4-yl-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,3-dihydro-benzo&lsqb;1,4&rsqb;dioxin-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-methyl-piperidin-4-yl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-(4-hydroxy-phenyl)-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-cyano-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid hexyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-fluoro-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-hydroxy-6-methyl-pyridin-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-benzyloxy-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-methoxy-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,2,2-trifluoro-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,2,2-trichloro-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-3-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-4-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-pyridin-3-yl-propyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-phenoxy-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1,3-dimethyl-butyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-methyl-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-phenyl-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-benzyl-piperidin-4-yl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid propyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid methyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-trifluoromethyl-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-p-tolyl-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-trifluoromethyl-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid tetrahydro-furan-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid octahydro-inden-5-yl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-amino-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-aziridin-1-yl-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methyl-but-2-enyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid trifluoro-trifluoromethyl-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid phenethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-methoxy-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid biphenyl-4-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-chloro-6-fluoro-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid tetrahydro-pyran-4-yl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-ethyl-oxetan-3-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid butyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-(2-hydroxy-phenyl)-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-(4-fluoro-phenyl)-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cyclopropylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-ethyl-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (S)-1-phenyl-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,6-difluoro-benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cyclobutyl methyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-pyridin-4-yl-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-hydroxy-cyclopentyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-pentafluorophenyl-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-benzyloxycarbonylamino-ethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid ethyl ester; </claim-text>
<claim-text>2-&lcub;&lsqb;1-(3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidin-6-yl)-methanoyl&rsqb;-amino&rcub;-3-phenyl-propionic acid methyl ester; </claim-text>
<claim-text>(3-&lcub;&lsqb;1-(3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidin-6-yl)-methanoyl&rsqb;-amino&rcub;-propyl)-carbamic acid tert-butyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzofuran-5-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzofuran-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid thiophen-3-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3H-&lsqb;1,2,3&rsqb;oxathiazol-5-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3H-&lsqb;1,2,3&rsqb;oxathiazol-5-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;1,4,2&rsqb;dioxazol-3-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;1,4,2&rsqb;dioxazol-3-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid furazan-3-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid furazan-3-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;1,2,4&rsqb;oxadiazol-5-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;1,2,4&rsqb;oxadiazol-5-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3H-&lsqb;1,2,3&rsqb;triazol-4-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3H-&lsqb;1,2,3&rsqb;triazol-4-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2H-&lsqb;1,2,4&rsqb;triazol-3-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2H-&lsqb;1,2,4&rsqb;triazol-3-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid isoxazol-5-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid isoxazol-5-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid oxazol-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid oxazol-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid isothiazol-5-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid isothiazol-5-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid thiazol-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid thiazol-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1H-imidazol-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2H-imidazol-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1H-pyrazol-3-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2H-pyrazol-3-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1H-pyrrol-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2H-pyrrol-2-ylmethyl ester; </claim-text>
<claim-text>3-Furazan-3-ylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2H-chromen-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2H-thiochromen-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2H-thiochromen-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;1,3,4&rsqb;thiadiazol-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;1,3,4&rsqb;thiadiazol-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1H-benzoimidazol-5-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1H-benzoimidazol-5-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1H-benzoimidazol-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1H-benzoimidazol-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1H-indol-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1H-indol-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1H-indol-5-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1H-indol-5-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,3-dihydro-benzofuran-5-ylmethyl ester; and </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,3-dihydro-benzofuran-5-ylmethyl ester. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00020">
<claim-text><highlight><bold>20</bold></highlight>. The compound according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, selected from: 
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-pyridin-4-yl-ethyl)-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-morpholin-4-yl-ethyl)-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methyl-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid sec-butylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cyclopentylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cyclopropylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cyanomethyl-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cyclohexylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methyl-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (3-ethoxy-propyl)-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-chloro-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-methyl-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2,2-diphenyl-ethyl)-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (pyridin-3-ylmethyl)-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid cyclopropylmethyl-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (1-ethyl-pyrrolidin-2-ylmethyl)-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (pyridin-2-ylmethyl)-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(3,4-dimethoxy-phenyl)-ethyl&rsqb;-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (furan-2-ylmethyl)-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-fluoro-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-bromo-ethyl)-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-sulfamoyl-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid phenethyl-amide; </claim-text>
<claim-text>(S)-2-&lcub;&lsqb;1-(3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidin-6-yl)-methanoyl&rsqb;-amino&rcub;-propionic acid; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (1-phenyl-ethyl)-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-methoxy-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-bromo-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(4-sulfamoyl-phenyl)-ethyl&rsqb;-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (3-imidazol-1-yl-propyl)-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(2-methoxy-phenyl)-ethyl&rsqb;-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-trifluoromethyl-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-amino-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(4-fluoro-phenyl)-ethyl&rsqb;-amide; and </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid ((R)-2-hydroxy-1-methyl-ethyl)-amide. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00021">
<claim-text><highlight><bold>21</bold></highlight>. The compound according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof, selected from: 
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid methyl ester; </claim-text>
<claim-text>3-(4-Bromo-benzyl)-5-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Fluoro-benzyl)-5-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid pyridin-4-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzo&lsqb;b&rsqb;thiophen-2-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 1-methyl-1H-indol-5-ylmethyl ester; </claim-text>
<claim-text>3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid thiophen-3-ylmethyl ester; </claim-text>
<claim-text>3-1,3-Benzodioxol-5-ylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-pyridin-4-ylmethyl-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-tert-Butyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(3,4-Dichloro-benzyl)-5-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(4-trifluoromethoxy-benzyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>1-Methyl-3-naphthalen-2-ylmethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(4-Cyano-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzofuran-5-ylmethyl ester; </claim-text>
<claim-text>3-(3,5-Dimethoxy-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-(3,5-Dinitro-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid benzyl ester; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid; and </claim-text>
<claim-text>3-(4-Carboxy-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-ethoxy-benzyl ester. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00022">
<claim-text><highlight><bold>22</bold></highlight>. The compound according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof, selected from: 
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(3,4-dimethoxy-phenyl)-ethyl&rsqb;-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-amino-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(4-chloro-phenyl)-ethyl&rsqb;-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (biphenyl-2-ylmethyl)-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3,4-dimethoxy-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-pyridin-4-yl-ethyl)-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-difluoromethoxy-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(3-ethoxy-phenyl)-ethyl&rsqb;-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-chloro-4-fluoro-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,4-dichloro-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-phenyl-propyl)-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3,4,5-trimethoxy-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-chloro-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3,5-dimethoxy-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,3-dimethoxy-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-trifluoromethyl-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-methoxy-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-methyl-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (4-phenyl-butyl)-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (pyridin-3-ylmethyl)-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid ((S)-2,2-dimethyl-4-phenyl-1,3-dioxinan-5-yl)-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(3-methoxy-phenyl)-ethyl&rsqb;-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (thiophen-2-ylmethyl)-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2-chloro-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (5-methyl-furan-2-ylmethyl)-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2,2-diphenyl-ethyl)-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(2-methoxy-phenyl)-ethyl&rsqb;-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(3-trifluoromethyl-phenyl)-ethyl&rsqb;-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-bromo-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(1H-indol-3-yl)-ethyl&rsqb;-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3,5-dichloro-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid indan-1-ylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (furan-2-ylmethyl)-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(4-methoxy-phenyl)-ethyl&rsqb;-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 2,4-dimethoxy-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-chloro-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (1-phenyl-ethyl)-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3,4-dichloro-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-fluoro-3-trifluoromethyl-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-pyridin-2-yl-ethyl)-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(2,4-dimethyl-phenyl)-ethyl&rsqb;-amide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid&lsqb;2-(2,4-dichloro-phenyl)-ethyl&rsqb;-amide; </claim-text>
<claim-text>1,3-Dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>3-Cyanomethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-Benzyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>3-(4-Cyclopropylsulfamoyl-benzyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-3-(6-nitro-pyridin-3-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-3-(6-nitro-pyridin-3-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-3-(6-nitro-pyridin-3-ylmethyl)-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-methoxy-pyridin-4-ylmethyl)-amide; </claim-text>
<claim-text>3-Cyclohexylmethyl-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (2-methoxy-pyridin-4-ylmethyl)-amide; </claim-text>
<claim-text>3-&lcub;2-&lsqb;(1H-Benzimidazole-5-carbonyl)-amino&rsqb;-ethyl&rcub;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-&lsqb;2-(3-piperidin-1-yl-propionylamino)-ethyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-&lcub;2-&lsqb;(6-pyrazol-1-yl-pyridine-3-carbonyl)-amino&rsqb;-ethyl&rcub;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>3-&lsqb;2-(4-Diethylamino-benzoylamino)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>3-&lcub;2-&lsqb;(6-Chloro-pyridine-3-carbonyl)-amino&rsqb;-ethyl&rcub;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-&lcub;2-&lsqb;(1H-pyrrole-2-carbonyl)-amino&rsqb;-ethyl&rcub;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>3-&lsqb;2-(2-Dimethylamino-acetylamino)-ethyl&rsqb;-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-&lcub;2-&lsqb;(pyrazine-2-carbonyl)-amino&rsqb;-ethyl&rcub;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-3-&lsqb;2-(2-methyl-2-methylamino-propionylamino)-ethyl&rsqb;-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-&lcub;2-&lsqb;(pyrrolidine-2-carbonyl)-amino&rsqb;-ethyl&rcub;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-&lcub;2-&lsqb;3-(5-phenyl-1H-pyrrol-2-yl)-propionylamino&rsqb;-ethyl&rcub;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-&lcub;2-&lsqb;2-(pyridin-4-ylsulfanyl)-acetylamino&rsqb;-ethyl&rcub;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>3-(6-Amino-pyridin-3-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-(3-phenyl-prop-2-ynyl)-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-(6-Amino-pyridin-3-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>3-(6-Amino-pyridin-3-ylmethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid (pyridin-4-ylmethyl)-amide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-&lsqb;2-(pyridin-2-ylamino)-ethyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-&lsqb;2-(pyrimidin-2-ylamino)-ethyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 4-methoxy-benzylamide; and </claim-text>
<claim-text>1-Methyl-2,4-dioxo-3-&lsqb;2-(pyrimidin-2-ylamino)-ethyl&rsqb;-1,2,3,4-tetrahydro-thieno&lsqb;2,3-d&rsqb;pyrimidine-6-carboxylic acid 3-methoxy-benzylamide. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00023">
<claim-text><highlight><bold>23</bold></highlight>. A pharmaceutical composition, comprising a compound of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable carrier, diluent, or excipient. </claim-text>
</claim>
<claim id="CLM-00024">
<claim-text><highlight><bold>24</bold></highlight>. A pharmaceutical composition, comprising a compound of <dependent-claim-reference depends_on="CLM-00002">claim 2</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable carrier, diluent, or excipient. </claim-text>
</claim>
<claim id="CLM-00025">
<claim-text><highlight><bold>25</bold></highlight>. A method for inhibiting MMP-13 in an animal, comprising administering to the animal an MMP-13 inhibiting amount of a compound of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof. </claim-text>
</claim>
<claim id="CLM-00026">
<claim-text><highlight><bold>26</bold></highlight>. A method for inhibiting MMP-13 in an animal, comprising administering to the animal an MMP-13 inhibiting amount of a compound of <dependent-claim-reference depends_on="CLM-00002">claim 2</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof. </claim-text>
</claim>
<claim id="CLM-00027">
<claim-text><highlight><bold>27</bold></highlight>. A method for treating a disease mediated by an MMP-13 enzyme, comprising administering to a patient suffering from such a disease an effective amount of a compound of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof. </claim-text>
</claim>
<claim id="CLM-00028">
<claim-text><highlight><bold>28</bold></highlight>. A method for treating a disease mediated by an MMP-13 enzyme, comprising administering to a patient suffering from such a disease an effective amount of a compound of <dependent-claim-reference depends_on="CLM-00002">claim 2</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof. </claim-text>
</claim>
<claim id="CLM-00029">
<claim-text><highlight><bold>29</bold></highlight>. A method for treating a cancer, comprising administering to a patient suffering from such a disease an anticancer effective amount of a compound of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof. </claim-text>
</claim>
<claim id="CLM-00030">
<claim-text><highlight><bold>30</bold></highlight>. A method for treating breast carcinoma, comprising administering to a patient suffering from such a disease an anticancer effective amount of a compound of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof. </claim-text>
</claim>
<claim id="CLM-00031">
<claim-text><highlight><bold>31</bold></highlight>. A method for treating a rheumatoid arthritis, comprising administering to a patient suffering from such a disease an effective amount of a compound of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof. </claim-text>
</claim>
<claim id="CLM-00032">
<claim-text><highlight><bold>32</bold></highlight>. A method for treating a osteoarthritis, comprising administering to a patient suffering from such a disease an effective amount of a compound of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof. </claim-text>
</claim>
<claim id="CLM-00033">
<claim-text><highlight><bold>33</bold></highlight>. A method for treating a heart failure, comprising administering to a patient suffering from such a disease an effective amount of a compound of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof. </claim-text>
</claim>
<claim id="CLM-00034">
<claim-text><highlight><bold>34</bold></highlight>. A method for treating a inflammation, comprising administering to a patient suffering from such a disease an effective amount of a compound of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof. </claim-text>
</claim>
<claim id="CLM-00035">
<claim-text><highlight><bold>35</bold></highlight>. A method for treating a cancer, comprising administering to a patient suffering from such a disease an anticancer effective amount of a compound of <dependent-claim-reference depends_on="CLM-00002">claim 2</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof. </claim-text>
</claim>
<claim id="CLM-00036">
<claim-text><highlight><bold>36</bold></highlight>. A method for treating breast carcinoma, comprising administering to a patient suffering from such a disease an anticancer effective amount of a compound of <dependent-claim-reference depends_on="CLM-00002">claim 2</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof. </claim-text>
</claim>
<claim id="CLM-00037">
<claim-text><highlight><bold>37</bold></highlight>. A method for treating a rheumatoid arthritis, comprising administering to a patient suffering from such a disease an effective amount of a compound of <dependent-claim-reference depends_on="CLM-00002">claim 2</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof. </claim-text>
</claim>
<claim id="CLM-00038">
<claim-text><highlight><bold>38</bold></highlight>. A method for treating a osteoarthritis, comprising administering to a patient suffering from such a disease an effective amount of a compound of <dependent-claim-reference depends_on="CLM-00002">claim 2</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof. </claim-text>
</claim>
<claim id="CLM-00039">
<claim-text><highlight><bold>39</bold></highlight>. A method for treating a heart failure, comprising administering to a patient suffering from such a disease an effective amount of a compound of <dependent-claim-reference depends_on="CLM-00002">claim 2</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof. </claim-text>
</claim>
<claim id="CLM-00040">
<claim-text><highlight><bold>40</bold></highlight>. A method for treating a inflammation, comprising administering to a patient suffering from such a disease an effective amount of a compound of <dependent-claim-reference depends_on="CLM-00002">claim 2</dependent-claim-reference>, or a pharmaceutically acceptable salt thereof. </claim-text>
</claim>
<claim id="CLM-00041">
<claim-text><highlight><bold>41</bold></highlight>. A compound of Formula I </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00220">
<number>220</number>
<image id="EMI-C00220" he="74.64555" wi="198.02475" file="US20030004172A1-20030102-C00220.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00220" file="US20030004172A1-20030102-C00220.CDX"/>
<chemistry-mol-file id="CHEMMOL-00220" file="US20030004172A1-20030102-C00220.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>and the pharmaceutically acceptable salts thereof; wherein: 
<claim-text>W is </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00221">
<number>221</number>
<image id="EMI-C00221" he="346.6071" wi="192.2697" file="US20030004172A1-20030102-C00221.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00221" file="US20030004172A1-20030102-C00221.CDX"/>
<chemistry-mol-file id="CHEMMOL-00221" file="US20030004172A1-20030102-C00221.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>A is </claim-text>
<claim-text>B is O or NR<highlight><superscript>5</superscript></highlight>; </claim-text>
<claim-text>X is O, S, SO, SO<highlight><subscript>2</subscript></highlight>, NR<highlight><superscript>5</superscript></highlight>, or CH<highlight><subscript>2</subscript></highlight>; </claim-text>
<claim-text>each Y independently is O or S; </claim-text>
<claim-text>R<highlight><superscript>1</superscript></highlight>, R<highlight><superscript>4</superscript></highlight>, and R<highlight><superscript>5 </superscript></highlight>independently are hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heterocyclic, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkanoyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </claim-text>
<claim-text>R<highlight><superscript>2 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>independently are hydrogen, halo, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, CH, NO<highlight><subscript>2</subscript></highlight>, NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </claim-text>
<claim-text>n is 0, 1, or 2; </claim-text>
<claim-text>R<highlight><superscript>4 </superscript></highlight>and R<highlight><superscript>5 </superscript></highlight>when taken together with the nitrogen to which they are attached complete a 3- to 8-membered ring optionally containing O, S, or N, and substituted or unsubstituted. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00042">
<claim-text><highlight><bold>42</bold></highlight>. A compound of Formula II </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00222">
<number>222</number>
<image id="EMI-C00222" he="91.4571" wi="198.02475" file="US20030004172A1-20030102-C00222.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00222" file="US20030004172A1-20030102-C00222.CDX"/>
<chemistry-mol-file id="CHEMMOL-00222" file="US20030004172A1-20030102-C00222.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>wherein: 
<claim-text>each Y independently is O or S; </claim-text>
<claim-text>R<highlight><superscript>1</superscript></highlight>, R<highlight><superscript>4</superscript></highlight>, and R<highlight><superscript>5 </superscript></highlight>independently are hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heterocyclic, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkanoyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </claim-text>
<claim-text>R<highlight><superscript>2 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>independently are hydrogen, halo, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, CH, NO<highlight><subscript>2</subscript></highlight>, NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </claim-text>
<claim-text>n is 0, 1, or 2; </claim-text>
<claim-text>R<highlight><superscript>4 </superscript></highlight>and R<highlight><superscript>5 </superscript></highlight>when taken together with the nitrogen to which they are attached complete a 3- to 8-membered ring optionally containing O, S, or N, and substituted or unsubstituted. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00043">
<claim-text><highlight><bold>43</bold></highlight>. A compound of Formula III </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00223">
<number>223</number>
<image id="EMI-C00223" he="91.4571" wi="198.02475" file="US20030004172A1-20030102-C00223.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00223" file="US20030004172A1-20030102-C00223.CDX"/>
<chemistry-mol-file id="CHEMMOL-00223" file="US20030004172A1-20030102-C00223.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>wherein: 
<claim-text>each Y independently is O or S; </claim-text>
<claim-text>R<highlight><superscript>1</superscript></highlight>, R<highlight><superscript>4</superscript></highlight>, and R<highlight><superscript>5 </superscript></highlight>independently are hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heterocyclic, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkanoyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </claim-text>
<claim-text>R<highlight><superscript>2 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>independently are hydrogen, halo, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, CN, NO<highlight><subscript>2</subscript></highlight>, NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </claim-text>
<claim-text>n is 0, 1, or 2; </claim-text>
<claim-text>R<highlight><superscript>4 </superscript></highlight>and R<highlight><superscript>5 </superscript></highlight>when taken together with the nitrogen to which they are attached complete a 3- to 8-membered ring optionally containing O, S, or N, and substituted or unsubstituted. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00044">
<claim-text><highlight><bold>44</bold></highlight>. A compound of Formula IV </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00224">
<number>224</number>
<image id="EMI-C00224" he="91.4571" wi="198.02475" file="US20030004172A1-20030102-C00224.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00224" file="US20030004172A1-20030102-C00224.CDX"/>
<chemistry-mol-file id="CHEMMOL-00224" file="US20030004172A1-20030102-C00224.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>wherein: 
<claim-text>each Y independently is O or S; </claim-text>
<claim-text>R<highlight><superscript>1</superscript></highlight>, R<highlight><superscript>4</superscript></highlight>, and R<highlight><superscript>5 </superscript></highlight>independently are hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heterocyclic, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkanoyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </claim-text>
<claim-text>R<highlight><superscript>2 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>independently are hydrogen, halo, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, CN, NO<highlight><subscript>2</subscript></highlight>, NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </claim-text>
<claim-text>n is 0, 1, or 2; </claim-text>
<claim-text>R<highlight><superscript>4 </superscript></highlight>and R<highlight><superscript>5 </superscript></highlight>when taken together with the nitrogen to which they are attached complete a 3- to 8-membered ring optionally containing O, S, or N, and substituted or unsubstituted. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00045">
<claim-text><highlight><bold>45</bold></highlight>. A compound of Formula V </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00225">
<number>225</number>
<image id="EMI-C00225" he="91.4571" wi="198.02475" file="US20030004172A1-20030102-C00225.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00225" file="US20030004172A1-20030102-C00225.CDX"/>
<chemistry-mol-file id="CHEMMOL-00225" file="US20030004172A1-20030102-C00225.MOL"/>
</chemistry-cwu>
<claim-text>wherein R<highlight><superscript>1</superscript></highlight>, R<highlight><superscript>2</superscript></highlight>, R<highlight><superscript>3</superscript></highlight>, R<highlight><superscript>4</superscript></highlight>, and R<highlight><superscript>5</superscript></highlight>; </claim-text>
<claim-text>each Y independently is O or S; </claim-text>
<claim-text>R<highlight><superscript>1</superscript></highlight>, R<highlight><superscript>4</superscript></highlight>, and R<highlight><superscript>5 </superscript></highlight>independently are hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heterocyclic, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkanoyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </claim-text>
<claim-text>R<highlight><superscript>2 </superscript></highlight>and R<highlight><superscript>3 </superscript></highlight>independently are hydrogen, halo, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl, CN, NO<highlight><subscript>2</subscript></highlight>, NR<highlight><superscript>4</superscript></highlight>R<highlight><superscript>5</superscript></highlight>, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>cycloalkyl, (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>aryl, or (CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>n </subscript></highlight>heteroaryl; </claim-text>
<claim-text>n is 0, 1, or 2; </claim-text>
<claim-text>R<highlight><superscript>4 </superscript></highlight>and R<highlight><superscript>5 </superscript></highlight>when taken together with the nitrogen to which they are attached complete a 3- to 8-membered ring optionally containing O, S, or N, and substituted or unsubstituted. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00046">
<claim-text><highlight><bold>46</bold></highlight>. A pharmaceutical composition comprising a compound of <dependent-claim-reference depends_on="CLM-00044">claim 41</dependent-claim-reference> together with a pharmaceutically acceptable carrier, diluent, or excipient. </claim-text>
</claim>
<claim id="CLM-00047">
<claim-text><highlight><bold>47</bold></highlight>. A pharmaceutical composition comprising a compound of <dependent-claim-reference depends_on="CLM-00044">claim 42</dependent-claim-reference> together with a pharmaceutically acceptable carrier, diluent, or excipient. </claim-text>
</claim>
<claim id="CLM-00048">
<claim-text><highlight><bold>48</bold></highlight>. A method for inhibiting MMP-13 enzymes in animals comprising administering to the animal an MMP-13 inhibiting amount of a compound of <dependent-claim-reference depends_on="CLM-00044">claim 41</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00049">
<claim-text><highlight><bold>49</bold></highlight>. A method for treating cancer comprising administering to a patient having cancer and in need of treatment an anticancer effective amount of a compound of <dependent-claim-reference depends_on="CLM-00044">claim 41</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00050">
<claim-text><highlight><bold>50</bold></highlight>. A method for treating arthritis comprising administering to a patient in need of treatment an anti-arthritic amount of a compound of <dependent-claim-reference depends_on="CLM-00044">claim 41</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00051">
<claim-text><highlight><bold>51</bold></highlight>. The method of claim <highlight><bold>50</bold></highlight> wherein the arthritis is osteoarthritis. </claim-text>
</claim>
<claim id="CLM-00052">
<claim-text><highlight><bold>52</bold></highlight>. The method of claim <highlight><bold>50</bold></highlight> wherein the arthritis is rheumatoid arthritis.</claim-text>
</claim>
</subdoc-claims>
</patent-application-publication>
